data_2fui_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fui _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.643 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 110.236 -0.283 . . . . 50.0 110.236 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.3 m-85 -97.8 -72.77 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.168 -0.613 . . . . 25.0 111.528 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 6.2 t -39.01 112.04 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 16.66 111.597 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 pt -48.02 -8.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.541 -0.754 . . . . 50.0 109.682 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.969 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -86.02 30.52 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.742 -1.117 . . . . 16.66 110.343 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 14.0 pttp 43.4 58.87 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.77 -0.65 . . . . 25.0 112.144 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.32 124.34 2.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 110.022 -0.362 . . . . 50.0 110.022 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 25.0 Cg_exo -57.22 164.17 7.07 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.614 2.209 . . . . 50.0 113.352 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.737 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 16.1 t80 -60.23 145.78 46.04 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.517 -0.765 . . . . 50.0 110.74 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' LYS . 92.6 m-20 -141.46 111.84 6.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.03 -0.986 . . . . 50.0 110.848 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.51 -22.45 8.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 50.0 110.448 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -71.11 -30.38 66.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.633 -1.247 . . . . 50.0 107.633 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -100.26 149.36 23.66 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.165 -1.834 . . . . 50.0 108.034 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 39.5 p90 -108.62 151.72 25.75 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.865 -0.734 . . . . 16.66 110.296 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.3 m-85 -126.86 165.44 19.34 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 123.152 1.454 . . . . 50.0 113.943 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.776 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.52 118.71 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 111.242 -2.708 . . . . 16.66 105.25 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -83.32 127.0 7.78 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.039 -1.077 . . . . 16.66 115.563 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.43 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -48.21 107.27 0.12 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.875 -1.162 . . . . 16.66 107.928 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 51' ' ' TYR . 76.6 m-20 -51.08 -37.27 44.69 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.993 -0.683 . . . . 25.0 110.53 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.654 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -114.29 -14.56 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.042 0.386 . . . . 50.0 112.042 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.256 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.9 14.2 32.52 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.472 -0.891 . . . . 16.66 111.865 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 14.3 pt20 30.35 48.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.893 0.701 . . . . 16.66 112.893 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.623 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.13 166.11 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.971 -0.381 . . . . 50.0 109.971 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.488 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.61 130.98 37.27 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.868 -0.333 . . . . 16.66 111.279 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.2 144.99 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.05 -0.26 . . . . 50.0 111.024 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.781 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -52.03 143.02 14.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.714 -1.588 . . . . 16.66 106.714 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.18 -60.31 2.72 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.432 -1.366 . . . . 16.66 111.478 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -69.19 -18.24 63.89 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.565 -0.454 . . . . 50.0 110.44 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.09 -30.67 11.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.656 -0.818 . . . . 16.66 108.814 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.8 4.16 7.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.411 -0.813 . . . . 16.66 111.637 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.72 46.08 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.366 -0.694 . . . . 16.66 111.366 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.457 HG12 ' H ' ' A' ' 41' ' ' LEU . 3.5 tt -119.17 167.73 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 16.66 111.885 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' H ' HG12 ' A' ' 40' ' ' ILE . 42.0 mt -68.69 164.48 21.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.168 -0.923 . . . . 50.0 110.646 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 36.8 mt-30 -80.56 -43.97 19.78 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.965 -1.494 . . . . 25.0 106.965 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.739 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -62.76 -41.13 99.08 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 112.378 -2.192 . . . . 50.0 107.714 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.815 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.3 mm-40 -43.63 -16.35 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -78.93 -44.47 22.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.427 -0.806 . . . . 25.0 110.468 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 43' ' ' SER . 96.4 mt-10 -87.94 -51.91 5.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.583 1.327 . . . . 50.0 114.583 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.879 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.68 20.38 0.24 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.795 0.807 . . . . 16.66 111.03 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.815 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.5 tp -110.44 143.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.272 -1.331 . . . . 25.0 112.9 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -165.98 29.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.381 -1.281 . . . . 50.0 109.448 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -166.33 11.43 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.593 -0.892 . . . . 50.0 108.593 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -67.09 146.9 53.81 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 16.66 109.761 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.645 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 21.7 t -125.16 156.95 34.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.912 -1.04 . . . . 50.0 110.016 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.43 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.5 p -78.57 157.23 77.51 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-N 115.592 -0.731 . . . . 16.66 110.078 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 41.5 Cg_endo -77.84 -30.13 3.94 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 121.963 1.776 . . . . 16.66 111.585 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -72.26 -29.59 64.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.99 -1.115 . . . . 50.0 107.99 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.2 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 114.324 -1.307 . . . . 16.66 110.735 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.522 -0.123 0 N-CA-C 109.483 -0.562 . . . . 50.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.14 -69.1 0.77 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.385 -0.526 . . . . 25.0 110.463 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -41.59 129.37 3.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 16.66 111.133 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 pt -58.16 -7.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -82.39 -1.87 51.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.844 -1.525 . . . . 16.66 110.985 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 46.2 mttm 70.95 56.76 0.22 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.463 -0.335 . . . . 25.0 111.299 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.688 ' HG1' ' HE2' ' A' ' 34' ' ' HIS . 23.0 p -141.1 147.74 48.82 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.409 -0.36 . . . . 50.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.32 150.93 47.82 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.411 2.074 . . . . 50.0 111.846 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.723 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 22.2 t80 -62.65 139.98 58.67 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.11 0.481 . . . . 50.0 110.075 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 21' ' ' LYS . 87.4 m-20 -141.32 120.47 12.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.5 -0.773 . . . . 50.0 110.286 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.1 -17.08 6.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -70.21 -32.07 69.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 11.3 tptt -95.8 150.21 20.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.782 -2.008 . . . . 50.0 108.165 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 31.6 p90 -111.0 149.15 31.1 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.589 -0.523 . . . . 16.66 109.589 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 11.8 m-85 -128.73 169.78 14.09 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 123.703 1.716 . . . . 50.0 115.374 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.748 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.84 118.39 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 110.167 -3.197 . . . . 16.66 104.464 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -87.12 123.15 6.43 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 119.636 -1.269 . . . . 16.66 115.147 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.421 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -53.41 106.98 0.2 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.488 -1.356 . . . . 16.66 108.154 176.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 92.8 m-20 -61.04 -34.96 75.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.474 0.654 . . . . 25.0 109.394 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.53 ' C ' ' NE2' ' A' ' 30' ' ' GLN . 11.6 tpt180 -101.28 -34.51 9.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.891 -1.05 . . . . 50.0 111.632 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.238 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -92.54 5.82 49.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.826 -0.75 . . . . 16.66 112.148 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.845 ' H ' HE21 ' A' ' 30' ' ' GLN . 0.0 OUTLIER 38.95 36.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.751 1.019 . . . . 16.66 113.751 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.534 ' OD1' ' HB2' ' A' ' 26' ' ' CYS . 1.9 p30 -132.83 166.87 21.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.988 0.813 . . . . 50.0 110.449 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.582 ' HE3' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -128.66 138.18 52.03 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.218 0.822 . . . . 16.66 113.218 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.68 ' OH ' ' CB ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -133.63 151.71 51.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.324 -0.398 . . . . 50.0 110.94 177.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.688 ' HE2' ' HG1' ' A' ' 15' ' ' THR . 0.0 OUTLIER -58.17 140.19 53.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.589 -1.634 . . . . 16.66 106.589 176.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.81 -54.3 5.09 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.159 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.59 ' HD2' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.76 -20.3 64.36 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.53 -0.468 . . . . 50.0 110.309 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.2 t -51.32 -31.77 22.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 119.682 -0.807 . . . . 16.66 108.944 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.52 14.92 7.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.183 -0.917 . . . . 16.66 111.358 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.21 46.26 43.83 Favored Glycine 0 N--CA 1.463 0.47 0 C-N-CA 121.254 -0.498 . . . . 16.66 112.039 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.48 167.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 16.66 111.381 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.23 164.69 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.755 -0.657 . . . . 50.0 110.566 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.35 -55.37 5.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.45 -0.796 . . . . 25.0 110.364 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.573 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.3 m -69.5 -15.47 63.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 50.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -42.6 -19.8 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.322 -0.854 . . . . 50.0 111.115 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -74.44 -45.13 48.38 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.463 -0.495 . . . . 25.0 111.514 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.05 -45.31 10.29 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.247 1.203 . . . . 50.0 114.247 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 43' ' ' SER . 2.1 pp -55.78 -30.79 61.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.051 0.76 . . . . 16.66 113.051 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.628 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 2.4 pp -86.52 172.38 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.931 -0.708 . . . . 25.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.3 28.18 0.17 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.642 -1.163 . . . . 50.0 109.901 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.57 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.166 -1.42 . . . . 50.0 107.166 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.9 t80 -66.7 145.58 55.39 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.799 -1.091 . . . . 16.66 111.121 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.632 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 22.3 t -133.37 154.11 38.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 113.848 -1.524 . . . . 50.0 108.575 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.421 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 5.8 p -79.92 161.99 63.98 Favored Pre-proline 0 N--CA 1.411 -2.405 0 CA-C-O 121.318 0.58 . . . . 16.66 110.005 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 19.3 Cg_endo -82.67 -27.46 2.11 Favored 'Trans proline' 0 C--N 1.28 -3.043 0 C-N-CA 121.997 1.798 . . . . 16.66 111.625 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -74.28 -30.39 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.087 -1.079 . . . . 50.0 108.087 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.6 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 114.43 -1.259 . . . . 16.66 110.675 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.591 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.909 0.385 . . . . 50.0 110.644 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.801 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.39 -79.04 0.47 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 34.9 t -41.04 128.43 2.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.27 . . . . 16.66 112.464 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.445 HG22 ' CD2' ' A' ' 33' ' ' TYR . 13.0 pt -62.9 -10.3 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 1.047 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -76.69 -0.76 24.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.59 -1.641 . . . . 16.66 110.375 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 62.84 53.22 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.376 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.82 125.33 11.68 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.4 -0.364 . . . . 50.0 110.097 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.03 146.64 8.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.165 1.91 . . . . 50.0 112.08 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 9.9 t80 -64.76 137.49 57.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.166 0.508 . . . . 50.0 110.689 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 52.6 t0 -140.56 135.42 31.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.838 -0.801 . . . . 50.0 108.838 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.86 -18.12 30.02 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.912 -0.715 . . . . 50.0 109.239 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -60.82 -45.36 94.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.499 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.719 ' HZ2' ' HE2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -86.28 161.7 18.63 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.336 -1.357 . . . . 50.0 107.336 176.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -117.82 136.9 53.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.058 -0.719 . . . . 16.66 109.058 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.759 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 5.6 m-85 -112.64 165.84 11.89 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 124.187 1.946 . . . . 50.0 115.591 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.746 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 109.324 -3.58 . . . . 16.66 103.944 176.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -132.7 123.22 3.45 Favored Glycine 0 C--N 1.319 -0.394 0 C-N-CA 117.928 -2.082 . . . . 16.66 114.709 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.391 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.14 108.8 0.16 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.895 -1.15 . . . . 16.66 107.895 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 22.6 t70 -64.92 -31.04 72.09 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -109.08 -20.09 13.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.105 -1.407 . . . . 50.0 111.597 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -109.4 11.81 24.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.334 -0.947 . . . . 16.66 112.2 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 20.6 pt20 33.84 52.91 0.47 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.789 -0.187 . . . . 16.66 111.481 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.653 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -132.85 166.31 22.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.05 -0.26 . . . . 50.0 110.663 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.653 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -139.44 132.12 28.95 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 121.288 0.566 . . . . 16.66 112.238 -177.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.599 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -137.45 153.19 50.14 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.96 -0.564 . . . . 50.0 112.305 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.719 ' HE2' ' HZ2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -58.89 146.62 36.9 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 105.149 -2.167 . . . . 16.66 105.149 175.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.3 -48.55 33.2 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 119.247 -1.454 . . . . 16.66 111.008 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.411 ' C ' ' CD ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -76.91 -18.09 58.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 4.0 t -50.3 -31.65 14.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.645 -0.872 . . . . 16.66 108.645 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.59 14.77 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.972 -1.013 . . . . 16.66 110.798 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.74 46.15 70.18 Favored Glycine 0 N--CA 1.462 0.385 0 N-CA-C 111.569 -0.612 . . . . 16.66 111.569 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.2 167.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.211 0.529 . . . . 16.66 111.732 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.07 164.5 8.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.392 -0.822 . . . . 50.0 110.653 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.678 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.3 pt20 -79.86 -53.46 6.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.269 0.557 . . . . 25.0 110.059 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.681 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 74.5 m -63.98 -22.8 67.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.634 -0.876 . . . . 50.0 108.634 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.547 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.66 -19.46 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.26 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -69.62 -53.64 17.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.924 -1.034 . . . . 25.0 110.665 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' SER . 11.9 tm-20 -89.52 -43.46 10.8 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.105 1.52 . . . . 50.0 115.105 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 43' ' ' SER . 2.5 pp -54.72 -30.49 56.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.189 0.811 . . . . 16.66 113.189 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 2.6 pp -85.77 174.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.653 0.74 . . . . 25.0 109.467 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.15 -51.63 0.77 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.475 -1.239 . . . . 50.0 110.206 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -108.65 59.89 0.6 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 50.0 108.067 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.735 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.2 t80 -65.92 144.02 57.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.635 0.731 . . . . 16.66 110.357 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 5.6 t -123.98 156.3 31.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.443 -1.253 . . . . 50.0 109.058 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.391 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.7 p -85.8 160.52 52.72 Favored Pre-proline 0 N--CA 1.414 -2.239 0 CA-C-O 121.675 0.75 . . . . 16.66 110.685 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.1 Cg_endo -78.34 -22.75 9.32 Favored 'Trans proline' 0 C--N 1.278 -3.14 0 C-N-CA 122.061 1.841 . . . . 16.66 111.223 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -77.61 -31.09 52.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.382 -0.826 . . . . 50.0 108.963 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.188 0 CA-C-N 115.344 -0.844 . . . . 16.66 110.952 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.551 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 110.146 -0.316 . . . . 50.0 110.146 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.587 ' CD2' ' CD1' ' A' ' 32' ' ' TRP . 19.5 m-85 -105.32 -73.4 0.68 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 48.7 t -39.84 128.86 2.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.362 0.601 . . . . 16.66 111.916 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.5 pt -59.59 -7.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.128 -1.064 . . . . 50.0 108.128 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -77.42 2.14 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.716 -1.584 . . . . 16.66 110.928 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 42.0 mttm 69.34 54.81 0.4 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.189 -0.46 . . . . 25.0 111.773 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.67 125.18 2.49 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.537 -0.301 . . . . 50.0 110.258 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' N ' ' HB2' ' A' ' 9' ' ' LEU . 24.6 Cg_exo -56.02 176.47 0.18 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.677 2.252 . . . . 50.0 113.586 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -58.18 143.82 42.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.825 0.821 . . . . 50.0 111.402 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.5 m-20 -136.07 98.03 3.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.162 -1.381 . . . . 50.0 108.755 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -50.7 -14.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.266 0.555 . . . . 50.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 18' ' ' ASP . 24.3 m -80.77 -29.53 36.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.802 -1.184 . . . . 50.0 107.802 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 18' ' ' ASP . 25.3 tptt -100.12 130.09 46.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.62 -1.627 . . . . 50.0 107.636 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.521 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 43.9 p90 -97.0 142.14 29.31 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.078 -0.51 . . . . 16.66 111.091 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CD2' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -119.96 173.78 6.86 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 124.441 2.067 . . . . 50.0 115.151 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.827 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.13 123.5 60.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 108.994 -3.73 . . . . 16.66 104.623 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -89.21 126.34 8.18 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 119.478 -1.344 . . . . 16.66 115.656 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.438 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.16 121.17 3.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.359 -1.348 . . . . 16.66 107.359 176.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.4 t70 -68.3 -31.64 71.22 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.578 0.704 . . . . 25.0 109.216 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -113.56 -26.46 8.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.588 -1.187 . . . . 50.0 111.81 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.283 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -95.26 12.58 28.49 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.8 -0.76 . . . . 16.66 112.607 -177.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 11.4 pt20 29.92 47.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.823 0.675 . . . . 16.66 112.823 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.56 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -131.36 164.1 26.41 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.069 -0.252 . . . . 50.0 110.544 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.587 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -134.39 125.6 27.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.907 -0.317 . . . . 16.66 111.832 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.649 ' OH ' ' CB ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -131.89 157.45 43.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 121.033 -0.267 . . . . 50.0 111.605 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.753 ' CD2' ' H ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.19 140.48 38.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.392 -1.336 . . . . 16.66 107.392 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.56 -42.57 20.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.379 -1.391 . . . . 16.66 110.615 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.27 -20.47 55.06 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.758 -0.46 . . . . 50.0 109.758 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.3 t -51.33 -32.49 25.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.799 -0.815 . . . . 16.66 108.799 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.5 11.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.028 -0.987 . . . . 16.66 110.988 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.96 45.57 50.37 Favored Glycine 0 N--CA 1.461 0.318 0 CA-C-N 115.934 -0.576 . . . . 16.66 111.837 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.512 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -106.55 163.81 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.89 0.376 . . . . 16.66 110.462 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.748 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.2 mm? -64.73 163.2 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 50.0 110.262 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -56.6 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.413 -0.812 . . . . 25.0 110.63 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.9 m -66.81 -14.64 62.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.151 -0.931 . . . . 50.0 109.164 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.987 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 3.0 tt0 -44.93 -44.47 9.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.523 -0.762 . . . . 50.0 111.056 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.12 -35.04 6.64 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.538 -0.465 . . . . 25.0 111.624 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -87.03 -52.64 5.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.796 0.665 . . . . 50.0 112.796 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 4.2 pp -71.95 4.98 2.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.372 -0.831 . . . . 16.66 111.452 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.987 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -107.34 130.62 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 119.695 -0.802 . . . . 25.0 111.21 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.88 -72.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.815 -1.084 . . . . 50.0 112.345 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.21 68.68 0.81 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.302 -0.629 . . . . 50.0 109.302 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.3 147.43 53.32 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.612 -0.722 . . . . 16.66 109.53 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.677 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.6 t -119.99 155.11 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.469 -0.787 . . . . 50.0 109.023 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.438 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -84.83 160.79 54.95 Favored Pre-proline 0 N--CA 1.412 -2.334 0 CA-C-N 115.596 -0.729 . . . . 16.66 110.944 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 39.0 Cg_endo -77.81 -26.34 6.91 Favored 'Trans proline' 0 C--N 1.279 -3.127 0 C-N-CA 122.251 1.967 . . . . 16.66 111.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.79 -34.05 71.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.193 -1.04 . . . . 50.0 108.193 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 114.784 -1.098 . . . . 16.66 110.309 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.707 0.289 . . . . 50.0 111.419 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.654 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.0 m-85 -101.85 -67.34 0.87 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.498 -0.927 . . . . 25.0 108.498 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 4.6 t -41.43 114.71 0.54 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.957 -1.019 . . . . 16.66 110.638 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.3 pt -50.92 -8.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.575 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.946 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.68 6.72 10.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.832 -1.076 . . . . 16.66 110.7 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm 64.09 52.63 1.97 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.145 -0.48 . . . . 25.0 111.405 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.43 144.31 22.62 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 50.0 109.669 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.71 155.85 68.35 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.585 2.19 . . . . 50.0 112.408 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.705 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 30.6 t80 -58.24 148.48 27.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 50.0 109.833 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.649 ' H ' ' HH ' ' A' ' 23' ' ' TYR . 91.3 m-20 -140.57 111.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.763 -0.653 . . . . 50.0 111.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.84 -17.37 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 50.0 110.043 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.5 m -76.35 -29.27 57.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.585 -1.265 . . . . 50.0 107.585 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 18' ' ' ASP . 6.7 tptm -99.49 156.47 17.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.456 -1.702 . . . . 50.0 108.492 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 35.4 p90 -111.06 152.25 27.12 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.45 -0.5 . . . . 16.66 110.364 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.705 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 9.5 m-85 -130.46 168.83 16.38 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 123.42 1.581 . . . . 50.0 114.256 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.767 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.36 123.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 110.932 -2.849 . . . . 16.66 105.53 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.52 120.08 6.16 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.876 -1.154 . . . . 16.66 115.773 -174.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.439 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.21 107.6 0.13 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.273 -1.38 . . . . 16.66 107.273 175.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 89.7 m-20 -65.52 -34.08 77.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -92.71 -39.55 11.2 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.519 -1.673 . . . . 50.0 110.935 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.276 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.09 -28.4 27.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.918 -0.713 . . . . 16.66 111.49 -178.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.755 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER 76.13 28.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.486 0.921 . . . . 16.66 113.486 178.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.518 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.96 166.18 22.97 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 119.776 -0.77 . . . . 50.0 111.079 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 140.66 50.72 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.922 0.712 . . . . 16.66 112.922 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.69 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -133.62 144.38 49.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.454 -0.339 . . . . 50.0 111.061 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.721 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -56.34 139.31 48.88 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.395 -1.706 . . . . 16.66 106.395 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -42.8 -54.34 5.07 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.843 -1.17 . . . . 16.66 111.53 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.466 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.61 -20.28 62.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.486 -0.486 . . . . 50.0 109.784 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.5 -31.88 25.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.281 -0.637 . . . . 16.66 109.281 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.57 13.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.344 -0.844 . . . . 16.66 111.185 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.51 45.98 57.42 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.793 -0.523 . . . . 16.66 111.793 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.86 167.51 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.137 0.494 . . . . 16.66 111.363 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 42.4 mt -61.47 164.85 5.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.555 -0.748 . . . . 50.0 110.582 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.495 HE21 ' HB3' ' A' ' 42' ' ' GLN . 1.1 tt0 -77.92 -55.1 5.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 25.0 110.314 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.601 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 72.7 m -70.78 -15.24 62.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.507 -0.769 . . . . 50.0 109.441 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.552 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -41.97 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.564 -0.744 . . . . 50.0 110.755 -178.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.64 -45.5 58.65 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.939 -0.573 . . . . 25.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 43' ' ' SER . 97.1 mt-10 -88.93 -45.69 9.48 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.593 1.331 . . . . 50.0 114.593 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 43' ' ' SER . 1.8 pp -55.29 -29.28 57.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.948 0.721 . . . . 16.66 112.948 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.6 pp -86.06 174.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.803 0.811 . . . . 25.0 109.641 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -124.51 -69.74 0.79 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.261 -1.336 . . . . 50.0 110.91 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -101.31 70.57 1.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.916 -1.142 . . . . 50.0 107.916 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.3 t80 -65.74 140.12 58.42 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.433 -0.803 . . . . 16.66 110.728 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.72 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.5 t -120.29 155.16 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 114.458 -1.246 . . . . 50.0 108.556 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.439 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -87.28 160.21 49.03 Favored Pre-proline 0 N--CA 1.414 -2.275 0 CA-C-O 121.39 0.614 . . . . 16.66 110.491 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 24.8 Cg_endo -81.52 -25.24 3.86 Favored 'Trans proline' 0 C--N 1.279 -3.095 0 C-N-CA 122.085 1.857 . . . . 16.66 110.764 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -71.34 -35.67 71.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.095 -0.957 . . . . 50.0 108.565 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-N 115.225 -0.898 . . . . 16.66 110.413 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.725 0.297 . . . . 50.0 110.303 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -69.46 -99.13 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.173 -0.676 . . . . 25.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 15.6 t -40.34 121.86 1.46 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.497 -0.774 . . . . 16.66 112.456 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 pt -59.09 -7.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.521 -1.218 . . . . 50.0 108.807 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.981 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.11 10.45 2.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.414 -1.266 . . . . 16.66 110.848 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.0 mttm 65.63 51.5 1.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.045 -0.525 . . . . 25.0 111.989 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 148.1 31.37 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.736 -0.385 . . . . 50.0 110.552 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.3 158.56 48.38 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.728 2.285 . . . . 50.0 111.8 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.2 t80 -58.31 144.84 39.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.662 -0.415 . . . . 50.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 92.5 m-20 -140.79 116.64 10.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.85 -0.614 . . . . 50.0 110.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.87 -12.86 4.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.389 -0.597 . . . . 50.0 109.389 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 m -79.33 -21.12 46.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.1 tptm -112.98 153.08 28.61 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.524 -1.671 . . . . 50.0 107.824 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 52.2 p90 -111.13 154.11 24.77 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.228 -0.589 . . . . 16.66 110.607 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.765 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.5 m-85 -127.8 169.8 13.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 123.779 1.752 . . . . 50.0 114.475 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.738 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.79 178.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.128 -3.214 . . . . 16.66 103.796 176.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.89 125.45 2.71 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 117.521 -2.275 . . . . 16.66 114.158 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.38 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 105.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.366 -1.346 . . . . 16.66 107.366 176.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' TYR . 84.5 m-20 -71.19 -19.95 62.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -111.61 -18.22 12.85 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.002 -1.454 . . . . 50.0 110.908 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.207 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -122.8 18.06 10.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.323 -0.951 . . . . 16.66 112.708 -178.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.569 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 19.3 pt20 32.93 54.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.202 0.445 . . . . 16.66 112.202 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.622 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -133.94 167.51 20.46 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 121.096 -0.242 . . . . 50.0 110.485 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.629 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -138.76 133.26 31.95 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.432 0.53 . . . . 16.66 112.432 -177.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.703 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -139.49 155.02 47.82 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.006 -0.543 . . . . 50.0 112.06 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.796 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -61.51 141.79 57.48 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 106.243 -1.762 . . . . 16.66 106.243 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.52 -58.53 4.0 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.633 -1.27 . . . . 16.66 111.518 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -20.95 66.05 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.5 t -51.72 -31.77 27.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.126 -0.63 . . . . 16.66 109.482 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.34 12.52 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.442 -0.799 . . . . 16.66 111.128 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.85 25.09 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 111.608 -0.597 . . . . 16.66 111.608 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.01 167.46 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.178 0.513 . . . . 16.66 112.038 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.49 164.15 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 50.0 110.432 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.638 ' HG2' ' H ' ' A' ' 43' ' ' SER . 7.9 pt20 -82.12 -49.38 10.24 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.963 ' O ' HD12 ' A' ' 47' ' ' LEU . 5.7 m -59.53 -39.0 82.5 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.422 -1.717 . . . . 50.0 107.459 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.718 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -40.15 -16.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.288 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -63.1 -61.65 2.23 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.249 -0.581 . . . . 25.0 111.649 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' A' ' 48' ' ' ILE . 47.4 mp0 -91.87 -47.35 7.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.857 1.799 . . . . 50.0 115.857 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 1.146 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -65.71 14.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.495 1.295 . . . . 16.66 114.495 -174.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 44' ' ' GLU . 2.5 pp -117.15 169.45 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 120.133 -0.627 . . . . 25.0 109.962 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 53.3 t0 -165.42 27.59 0.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.748 0.785 . . . . 50.0 109.935 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.46 16.09 0.52 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.248 -1.39 . . . . 50.0 107.248 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.634 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.3 t80 -67.37 147.61 52.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.802 -1.09 . . . . 16.66 110.511 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 25.2 t -137.26 157.57 34.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.888 -1.505 . . . . 50.0 108.917 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.38 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.0 p -80.03 158.21 72.71 Favored Pre-proline 0 N--CA 1.414 -2.254 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 11.0 Cg_endo -81.35 -27.94 2.57 Favored 'Trans proline' 0 C--N 1.273 -3.406 0 C-N-CA 121.842 1.694 . . . . 16.66 110.932 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -71.97 -33.83 68.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.461 -0.79 . . . . 50.0 108.877 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.151 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-N 115.59 -0.732 . . . . 16.66 110.559 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.602 0.239 . . . . 50.0 110.714 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 2.7 m-85 -106.12 -6.26 18.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.364 0.602 . . . . 25.0 111.014 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -104.15 123.08 46.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.923 -1.035 . . . . 16.66 110.844 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' A' ' 33' ' ' TYR . 14.0 pt -59.96 -8.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.203 -1.406 . . . . 50.0 107.203 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.961 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -84.79 2.19 43.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.47 -1.696 . . . . 16.66 109.472 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mttp 67.78 64.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.553 -0.749 . . . . 25.0 112.246 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.43 HG23 ' HE2' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -155.3 141.64 13.13 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.709 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.98 158.73 52.66 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.657 2.238 . . . . 50.0 112.104 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.753 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 20.0 t80 -69.37 139.07 54.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.078 0.466 . . . . 50.0 110.936 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 11.5 t70 -140.58 128.62 22.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.593 -0.731 . . . . 50.0 109.47 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.6 -21.9 41.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.074 -0.512 . . . . 50.0 110.907 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -67.17 -33.79 76.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.744 -1.206 . . . . 50.0 107.744 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.644 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -85.41 152.49 23.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.259 -1.791 . . . . 50.0 109.114 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 22.0 p90 -114.17 140.6 48.4 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.32 -0.993 . . . . 16.66 108.32 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.753 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 28.5 m-85 -122.61 171.35 9.19 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 124.089 1.9 . . . . 50.0 115.621 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.79 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.28 118.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 109.513 -3.494 . . . . 16.66 103.977 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -90.42 125.64 8.01 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.58 -1.295 . . . . 16.66 116.279 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.415 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -46.64 108.45 0.14 Allowed 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.31 -1.367 . . . . 16.66 107.31 175.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 57.3 t0 -61.52 -29.3 69.9 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.018 -0.734 . . . . 25.0 109.018 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.42 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 13.6 ttt85 -113.72 -20.36 11.19 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.705 -1.134 . . . . 50.0 112.344 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.245 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -107.96 20.29 18.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.317 -0.953 . . . . 16.66 112.981 -177.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 29' ' ' CYS . 16.4 pt20 31.06 47.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.521 0.563 . . . . 16.66 112.521 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.529 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -131.54 159.79 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.748 -0.381 . . . . 50.0 110.703 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -135.74 122.87 21.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.727 0.299 . . . . 16.66 111.049 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.679 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -124.09 153.66 41.1 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.456 -0.307 . . . . 50.0 111.406 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.748 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -54.8 146.42 17.24 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.728 -1.953 . . . . 16.66 105.728 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -46.2 -53.18 9.52 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 119.461 -1.352 . . . . 16.66 111.505 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -73.7 -19.4 60.83 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.715 -0.476 . . . . 50.0 109.715 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.6 t -49.96 -31.29 12.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.77 9.45 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.203 -0.908 . . . . 16.66 110.3 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.79 45.83 20.16 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.395 -0.682 . . . . 16.66 111.395 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 ' CD1' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -117.3 167.53 10.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.91 0.386 . . . . 16.66 110.876 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 90.1 mt -65.64 163.24 16.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.338 0.589 . . . . 50.0 109.666 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.07 -54.88 5.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.937 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.0 t -70.32 -14.77 62.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.431 -0.804 . . . . 50.0 110.677 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.639 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.7 mt-10 -44.4 -30.1 0.79 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.648 -0.421 . . . . 50.0 111.159 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -37.66 88.11 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.07 -0.652 . . . . 25.0 110.53 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.3 mm-40 -87.89 -33.17 18.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.227 1.195 . . . . 50.0 114.227 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 3.7 pp -94.31 16.24 15.51 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 112.716 0.636 . . . . 16.66 112.716 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -120.17 146.87 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 C-N-CA 118.704 -1.198 . . . . 25.0 112.888 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -94.38 -81.22 0.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.074 -0.966 . . . . 50.0 111.792 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.27 69.89 1.03 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.585 -0.279 . . . . 50.0 110.449 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.617 ' CG ' ' HB ' ' A' ' 24' ' ' ILE . 5.1 t80 -67.28 138.85 57.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.476 -0.89 . . . . 16.66 108.802 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.6 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 23.9 t -119.38 150.81 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.722 -0.672 . . . . 50.0 109.315 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.415 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.8 p -80.99 160.91 64.94 Favored Pre-proline 0 N--CA 1.411 -2.395 0 CA-C-N 115.316 -0.857 . . . . 16.66 110.052 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 27.9 Cg_endo -80.43 -29.16 2.52 Favored 'Trans proline' 0 C--N 1.278 -3.177 0 C-N-CA 122.001 1.8 . . . . 16.66 111.405 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -70.83 -32.88 70.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.789 -1.096 . . . . 16.66 110.34 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.751 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 110.453 -0.203 . . . . 50.0 110.453 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -59.55 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.389 0.614 . . . . 25.0 110.491 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 43.4 t -37.67 122.51 0.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.034 -0.985 . . . . 16.66 113.298 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' LYS . 8.8 pt -59.95 -13.98 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 114.862 -1.063 . . . . 50.0 108.138 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.965 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -72.25 4.5 3.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.811 -1.54 . . . . 16.66 110.137 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' ILE . 28.6 mtpt 65.85 50.29 1.54 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.488 -0.778 . . . . 25.0 112.065 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.462 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -141.23 123.51 9.41 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.01 156.66 12.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.346 2.031 . . . . 50.0 111.948 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 4.5 t80 -61.28 134.25 56.77 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.293 0.568 . . . . 50.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 20' ' ' SER . 88.1 m-20 -141.46 116.02 9.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.085 -0.961 . . . . 50.0 108.83 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -43.92 -13.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.627 -0.429 . . . . 50.0 110.481 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -62.84 -38.41 90.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.748 -0.834 . . . . 50.0 108.748 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.726 ' HZ2' ' NE2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -99.85 167.52 10.47 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.449 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 52.1 p90 -120.77 142.32 49.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.694 -0.684 . . . . 16.66 109.168 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 2.9 m-85 -114.03 155.49 25.82 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 123.791 1.758 . . . . 50.0 115.414 -175.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.725 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -121.92 126.43 74.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 110.2 -3.182 . . . . 16.66 105.123 176.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.66 123.68 7.41 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.556 -1.307 . . . . 16.66 115.054 -175.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -49.86 107.0 0.13 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.65 -1.275 . . . . 16.66 108.89 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 80.8 m-20 -56.88 -35.13 68.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.265 -0.574 . . . . 25.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.71 -12.71 13.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 50.0 111.873 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -110.21 12.58 23.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.323 -0.951 . . . . 16.66 111.57 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.5 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 10.0 pt20 29.92 53.43 0.12 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.941 0.4 . . . . 16.66 111.101 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.645 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 2.8 m-20 -132.45 166.64 21.54 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.31 -0.404 . . . . 50.0 110.189 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -141.36 132.8 26.81 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.333 -0.547 . . . . 16.66 111.676 -177.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.646 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -138.56 155.47 48.34 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 50.0 112.494 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.726 ' NE2' ' HZ2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -60.62 146.58 44.87 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 105.064 -2.198 . . . . 16.66 105.064 175.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.0 -51.27 25.37 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 119.136 -1.507 . . . . 16.66 110.831 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -18.48 60.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.712 -0.395 . . . . 50.0 109.953 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.0 t -50.39 -32.48 17.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.066 -0.716 . . . . 16.66 109.066 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.18 18.68 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.016 -0.993 . . . . 16.66 111.219 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.98 46.19 82.92 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 111.513 -0.635 . . . . 16.66 111.513 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.535 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.88 164.01 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.864 0.364 . . . . 16.66 110.934 -178.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.755 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 10.4 mp -58.0 164.76 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.245 0.545 . . . . 50.0 110.162 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -56.26 4.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.34 -0.845 . . . . 25.0 110.985 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' ALA . 67.4 m -71.23 -15.55 62.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.59 -0.732 . . . . 50.0 109.236 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.755 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 2.1 tt0 -43.36 -19.13 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.481 -0.781 . . . . 50.0 111.172 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -68.56 -47.01 67.92 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.432 -0.507 . . . . 25.0 111.19 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.25 -45.69 9.86 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.261 1.208 . . . . 50.0 114.261 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 48' ' ' ILE . 2.3 pp -55.15 -28.16 50.76 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.842 0.682 . . . . 16.66 112.842 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.6 pp -85.76 174.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.607 0.718 . . . . 25.0 109.349 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -137.46 -53.88 0.68 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.642 -1.163 . . . . 50.0 110.455 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -103.69 56.35 0.74 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.823 -1.177 . . . . 50.0 107.823 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.66 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.3 t80 -65.27 141.46 58.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.537 0.684 . . . . 16.66 109.876 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.1 t -126.06 154.83 35.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.375 -1.284 . . . . 50.0 109.288 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -82.21 159.51 64.84 Favored Pre-proline 0 N--CA 1.413 -2.289 0 CA-C-N 115.69 -0.686 . . . . 16.66 109.824 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 22.6 Cg_endo -81.28 -25.65 3.79 Favored 'Trans proline' 0 C--N 1.275 -3.297 0 C-N-CA 121.962 1.775 . . . . 16.66 111.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -74.79 -32.59 62.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.719 . . . . 50.0 109.101 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.145 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 16.66 110.907 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.592 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.9 m-85 -94.04 -71.92 0.64 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.562 -0.533 . . . . 25.0 109.562 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 37.4 t -40.52 111.0 0.17 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.5 -0.773 . . . . 16.66 110.334 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 14' ' ' LYS . 18.8 pt -51.84 -7.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.918 -0.771 . . . . 50.0 108.918 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -83.49 30.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.484 -1.234 . . . . 16.66 109.392 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 12' ' ' ILE . 48.8 pttt 42.66 55.81 4.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.489 -0.778 . . . . 25.0 111.619 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 p -145.54 141.55 17.06 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.51 -0.314 . . . . 50.0 110.28 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.2 154.01 56.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.451 2.101 . . . . 50.0 111.482 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 17.5 t80 -57.81 138.71 55.37 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.05 -0.66 . . . . 50.0 109.84 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.5 m-20 -141.56 118.58 11.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.1 -0.955 . . . . 50.0 110.435 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -51.23 -22.9 2.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.055 -0.72 . . . . 50.0 109.055 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -63.45 -35.4 80.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.972 -1.121 . . . . 50.0 107.972 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -90.9 155.14 18.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 113.868 -1.514 . . . . 50.0 108.926 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' PHE . 46.0 p90 -118.39 123.34 45.02 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.03 0.919 . . . . 16.66 110.168 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 m-85 -103.03 162.55 12.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 123.769 1.747 . . . . 50.0 114.879 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.826 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -130.8 117.46 38.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 110.183 -3.189 . . . . 16.66 103.63 176.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.28 135.46 13.34 Favored Glycine 0 C--N 1.316 -0.543 0 N-CA-C 116.866 1.507 . . . . 16.66 116.866 -173.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.45 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.7 OUTLIER -46.86 117.78 1.8 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.946 -1.627 . . . . 16.66 108.503 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.625 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.9 t70 -51.71 -46.49 63.93 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.662 -0.815 . . . . 25.0 109.818 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -117.34 -5.94 11.27 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.212 0.819 . . . . 50.0 113.212 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.265 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -98.08 14.66 26.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 118.669 -1.212 . . . . 16.66 111.37 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.569 ' CD ' ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER 30.53 50.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.716 . . . . 16.66 111.963 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.552 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 10.2 m-20 -131.87 163.92 27.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.414 -0.357 . . . . 50.0 110.193 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.549 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -136.57 126.22 25.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.74 0.305 . . . . 16.66 110.832 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.647 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.8 141.82 51.85 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.796 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 6.6 p-80 -56.02 146.99 20.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.649 -1.612 . . . . 16.66 106.649 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -40.36 -60.7 1.95 Allowed Glycine 0 C--N 1.306 -1.111 0 C-N-CA 119.913 -1.137 . . . . 16.66 113.382 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.437 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.82 -20.36 64.31 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.221 0.534 . . . . 50.0 109.783 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -49.3 -25.9 2.69 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.343 -0.984 . . . . 16.66 108.343 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' A' ' 36' ' ' ARG . 17.7 m -124.32 7.8 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.184 -0.916 . . . . 16.66 111.345 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 79.35 46.38 8.14 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.824 -0.91 . . . . 16.66 110.824 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' LEU . 1.1 tp -106.0 155.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.019 0.437 . . . . 16.66 110.692 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' O ' HG21 ' A' ' 40' ' ' ILE . 2.7 mt -61.92 166.19 4.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.942 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -70.61 -53.55 15.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.76 -0.654 . . . . 25.0 109.362 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' ALA . 75.6 m -75.58 -14.65 60.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.218 -0.901 . . . . 50.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.984 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -43.11 -18.17 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.932 -0.576 . . . . 50.0 110.203 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.06 -43.55 64.72 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.519 -0.472 . . . . 25.0 110.969 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.683 ' C ' ' H ' ' A' ' 48' ' ' ILE . 97.4 mt-10 -87.6 -52.98 5.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.138 0.792 . . . . 50.0 113.138 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.521 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.67 9.08 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.049 -0.523 . . . . 16.66 110.63 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.984 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -112.62 135.66 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.282 -0.872 . . . . 25.0 112.146 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 59.5 t0 -91.59 -71.89 0.61 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.996 -1.002 . . . . 50.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' OE1' ' OD1' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -130.29 78.42 1.84 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.889 -0.782 . . . . 50.0 108.889 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.762 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.31 147.32 53.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.026 -0.731 . . . . 16.66 109.026 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.762 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 21.5 t -110.71 158.87 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.243 -0.583 . . . . 50.0 109.9 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.45 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -89.38 159.61 44.06 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 115.704 -0.68 . . . . 16.66 110.12 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 43.4 Cg_endo -79.28 -30.45 2.6 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 C-N-CA 121.746 1.631 . . . . 16.66 110.834 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.91 -32.99 73.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.588 -1.264 . . . . 50.0 107.588 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.115 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.1 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 114.177 -1.374 . . . . 16.66 109.914 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.498 0.19 . . . . 50.0 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.8 m-85 -106.17 -67.35 0.94 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.7 t -41.63 116.53 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.27 -0.877 . . . . 16.66 110.742 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.3 pt -52.3 -7.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.18 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.947 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -79.85 3.08 20.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.662 -1.153 . . . . 16.66 110.671 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.1 mttp 67.94 55.17 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.187 -0.46 . . . . 25.0 111.786 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.492 ' CG2' ' HE2' ' A' ' 34' ' ' HIS . 0.6 OUTLIER -147.62 145.2 20.7 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 110.063 -0.347 . . . . 50.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.58 150.37 79.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.447 2.098 . . . . 50.0 111.874 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.741 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.0 t80 -54.26 146.24 15.82 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.49 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 91.2 m-20 -140.56 112.75 7.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.999 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.21 -17.6 7.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 50.0 109.934 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 t -72.11 -31.93 66.49 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.313 -1.366 . . . . 50.0 107.313 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -97.93 157.28 16.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.07 -1.877 . . . . 50.0 109.006 179.079 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 45.5 p90 -114.17 146.58 40.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.303 -0.559 . . . . 16.66 109.978 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.741 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 5.7 m-85 -122.83 165.22 16.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 123.355 1.55 . . . . 50.0 114.269 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.772 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -123.96 119.66 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 111.099 -2.773 . . . . 16.66 105.18 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -84.96 124.33 6.69 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.545 -1.312 . . . . 16.66 114.534 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.435 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -46.8 107.78 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.656 -1.609 . . . . 16.66 106.656 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 54.9 t0 -59.89 -29.82 68.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -113.89 -13.34 12.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.548 -1.205 . . . . 50.0 111.695 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.326 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -112.3 10.54 20.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 119.861 -0.735 . . . . 16.66 111.798 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.593 ' NE2' ' O ' ' A' ' 29' ' ' CYS . 3.8 pp0? 34.02 49.65 0.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.188 0.44 . . . . 16.66 112.188 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.697 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.1 m120 -132.25 166.19 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.946 -0.39 . . . . 50.0 109.946 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -134.53 133.04 39.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 120.801 -0.36 . . . . 16.66 111.936 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.77 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -132.94 143.58 49.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.012 178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.793 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -51.27 143.33 11.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.923 -1.51 . . . . 16.66 106.923 176.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.11 -59.59 2.91 Favored Glycine 0 C--N 1.318 -0.437 0 C-N-CA 119.885 -1.15 . . . . 16.66 111.396 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -19.06 63.99 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.762 -0.375 . . . . 50.0 110.394 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.08 -30.2 10.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.539 -0.911 . . . . 16.66 108.539 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.52 8.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.251 -0.886 . . . . 16.66 111.146 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.66 45.52 10.76 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.167 -0.54 . . . . 16.66 112.268 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.488 ' CG2' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -112.98 167.07 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.131 0.491 . . . . 16.66 110.923 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 6.5 mp -64.24 161.87 15.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 50.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -54.33 6.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.859 -0.793 . . . . 25.0 108.859 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.9 t -60.01 -12.52 8.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.707 -1.133 . . . . 50.0 109.07 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.821 ' CD ' ' N ' ' A' ' 45' ' ' ALA . 1.9 pp20? -40.49 -55.75 2.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.211 -0.904 . . . . 50.0 111.068 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.821 ' N ' ' CD ' ' A' ' 44' ' ' GLU . . . -56.55 -26.22 54.36 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.342 -0.844 . . . . 25.0 110.473 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' SER . 84.6 tt0 -86.77 -25.45 24.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.181 0.515 . . . . 50.0 111.965 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.451 ' H ' ' HG ' ' A' ' 47' ' ' LEU . 4.2 pp -117.92 11.51 13.48 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 115.599 -0.728 . . . . 16.66 112.35 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.789 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -119.15 145.39 25.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.097 -1.041 . . . . 25.0 111.864 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.505 ' N ' HD11 ' A' ' 48' ' ' ILE . 22.5 t70 -146.65 -42.62 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.163 -0.926 . . . . 50.0 111.628 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -94.21 24.88 4.09 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 2.7 t80 -65.28 141.74 58.51 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.47 -0.786 . . . . 16.66 109.061 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 4.9 t -129.32 157.77 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.822 -1.081 . . . . 50.0 108.423 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.435 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.3 p -79.62 158.92 72.84 Favored Pre-proline 0 N--CA 1.414 -2.265 0 CA-C-O 121.66 0.743 . . . . 16.66 110.693 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 23.8 Cg_endo -81.05 -15.75 10.24 Favored 'Trans proline' 0 C--N 1.278 -3.146 0 C-N-CA 122.15 1.9 . . . . 16.66 111.573 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.533 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 11.4 pt20 -87.53 -30.38 20.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 50.0 109.52 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.156 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-N 115.924 -0.58 . . . . 16.66 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.679 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 110.461 -0.2 . . . . 50.0 110.461 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.616 ' CD2' ' CD1' ' A' ' 32' ' ' TRP . 2.6 m-85 -95.38 -75.49 0.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 120.107 -0.637 . . . . 25.0 112.04 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 11.4 t -38.39 118.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.428 0.632 . . . . 16.66 112.146 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 pt -53.31 -7.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.148 -0.933 . . . . 50.0 108.97 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.27 5.51 19.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.396 -1.274 . . . . 16.66 110.911 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 68.14 51.68 0.71 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.168 -0.469 . . . . 25.0 111.891 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 ' H ' HD22 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -150.27 124.96 4.67 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.932 -0.307 . . . . 50.0 110.792 179.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 38.1 Cg_exo -55.19 162.68 5.34 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.644 2.229 . . . . 50.0 112.654 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.87 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 11.4 t80 -63.3 138.39 58.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.538 0.685 . . . . 50.0 111.128 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.859 ' H ' ' HH ' ' A' ' 23' ' ' TYR . 70.8 m-20 -142.91 131.6 22.59 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.652 -1.158 . . . . 50.0 109.951 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.07 -20.74 62.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 50.0 110.395 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -63.11 -30.03 71.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.699 0.761 . . . . 50.0 109.1 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.716 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -106.09 158.35 16.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 114.378 -1.283 . . . . 50.0 107.685 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.417 ' CE2' ' HA3' ' A' ' 35' ' ' GLY . 45.8 p90 -119.38 137.91 53.43 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.082 -0.647 . . . . 16.66 109.288 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.87 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 2.2 m-85 -111.02 170.3 8.19 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 124.066 1.889 . . . . 50.0 115.331 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.825 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.32 118.72 24.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 109.747 -3.388 . . . . 16.66 105.07 177.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.63 124.8 6.99 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.037 1.175 . . . . 16.66 116.037 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.472 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -49.17 107.41 0.14 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.6 -1.259 . . . . 16.66 107.6 175.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.493 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 83.7 m-20 -61.4 -35.61 77.99 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.352 0.596 . . . . 25.0 109.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -19.56 14.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.103 -0.953 . . . . 50.0 111.327 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.315 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -94.39 -29.07 15.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.611 -0.835 . . . . 16.66 110.53 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.589 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 75.89 26.16 1.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.336 0.865 . . . . 16.66 113.336 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.708 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 14.7 p30 -132.63 167.41 20.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.859 -0.525 . . . . 50.0 110.091 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -121.31 145.04 48.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.429 0.899 . . . . 16.66 113.429 -176.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.708 ' OH ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -132.39 146.65 52.11 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.108 -0.496 . . . . 50.0 110.457 176.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.844 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -55.03 143.23 27.33 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.578 -1.638 . . . . 16.66 106.578 176.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -42.6 -58.3 3.57 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.0 -1.095 . . . . 16.66 111.697 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.434 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -71.61 -18.36 62.22 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.822 -0.351 . . . . 50.0 110.178 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.9 t -49.54 -31.47 10.4 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.799 -0.76 . . . . 16.66 109.003 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.96 12.27 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.229 -0.896 . . . . 16.66 111.066 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.79 45.44 58.11 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.811 -0.631 . . . . 16.66 111.709 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.04 167.66 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.161 0.505 . . . . 16.66 111.219 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.8 mt -62.76 164.5 7.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.584 -0.734 . . . . 50.0 110.911 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.1 -55.13 5.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.166 -0.925 . . . . 25.0 110.426 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.594 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.8 m -66.11 -15.78 63.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.863 -1.062 . . . . 50.0 109.625 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.501 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 0.7 OUTLIER -42.65 -32.88 0.63 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.267 0.556 . . . . 50.0 109.753 -179.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.05 -38.8 72.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.56 -0.745 . . . . 25.0 110.399 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' SER . 36.5 tp10 -88.31 -10.67 48.75 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.808 1.04 . . . . 50.0 113.808 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 43' ' ' SER . 4.1 pp -115.76 16.51 16.33 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.34 0.496 . . . . 16.66 112.34 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.55 HG13 ' H ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -124.7 160.08 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 118.45 -1.3 . . . . 25.0 113.763 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' H ' HG13 ' A' ' 48' ' ' ILE . 54.3 t0 -130.43 -44.8 1.11 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.163 -1.38 . . . . 50.0 111.027 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' C ' ' OD2' ' A' ' 27' ' ' ASP . 95.5 mt-10 -120.97 52.22 1.21 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.593 -0.276 . . . . 50.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.612 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 1.5 t80 -66.78 137.56 56.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.267 -0.973 . . . . 16.66 108.375 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.564 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 12.3 t -116.92 153.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.472 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -82.13 161.83 58.88 Favored Pre-proline 0 N--CA 1.409 -2.513 0 CA-C-N 115.217 -0.901 . . . . 16.66 110.859 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.4 Cg_endo -79.48 -26.47 4.86 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.113 1.876 . . . . 16.66 111.388 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -74.37 -30.96 62.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.194 -1.039 . . . . 50.0 108.194 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 2.5 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 114.608 -1.178 . . . . 16.66 110.988 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.235 -0.283 . . . . 50.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.598 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.8 m-85 -99.71 -64.44 1.04 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.9 t -46.47 118.55 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.084 -0.962 . . . . 16.66 110.28 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.0 pt -53.62 -7.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.927 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -87.78 28.76 0.97 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.319 -1.309 . . . . 16.66 110.665 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.9 pttm 41.56 65.88 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 25.0 111.685 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 139.15 11.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.094 -0.503 . . . . 50.0 109.731 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.64 154.93 72.04 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.348 2.032 . . . . 50.0 112.049 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.747 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 25.6 t80 -55.43 147.3 17.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.034 0.445 . . . . 50.0 109.918 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 21' ' ' LYS . 91.1 m-20 -140.58 109.08 5.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.013 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.3 -14.7 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.1 m -76.65 -29.81 56.56 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -100.9 155.02 18.18 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.234 -1.803 . . . . 50.0 107.997 178.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 32.1 p90 -109.61 152.84 25.02 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.193 -0.603 . . . . 16.66 110.584 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.747 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.9 m-85 -128.24 162.05 27.9 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.46 1.6 . . . . 50.0 114.294 -177.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.835 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.11 117.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 110.883 -2.871 . . . . 16.66 104.188 176.049 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.81 131.17 10.4 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.953 -1.118 . . . . 16.66 115.685 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.411 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -47.36 108.03 0.14 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.481 -1.303 . . . . 16.66 107.481 176.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.62 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 51.2 t0 -61.13 -31.8 71.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.313 0.577 . . . . 25.0 109.704 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' O ' ' CD ' ' A' ' 28' ' ' ARG . 7.5 tpt180 -113.1 -16.15 12.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.09 -0.959 . . . . 50.0 112.023 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.192 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -112.15 14.01 20.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.174 -1.01 . . . . 16.66 112.569 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.528 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 21.1 pt20 39.29 44.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.282 1.586 . . . . 16.66 115.282 176.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.575 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -134.15 165.98 23.81 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.407 -0.917 . . . . 50.0 110.631 177.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -127.52 135.71 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 16.66 111.823 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.672 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -134.97 144.88 47.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.276 -0.42 . . . . 50.0 110.691 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.766 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -53.51 142.11 23.32 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.645 -1.613 . . . . 16.66 106.645 176.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.19 -56.34 4.0 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 119.784 -1.198 . . . . 16.66 111.547 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -18.51 61.96 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.45 -0.5 . . . . 50.0 110.203 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.23 -29.85 10.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.83 14.61 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.246 -0.888 . . . . 16.66 111.108 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.85 46.18 47.11 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.102 -0.571 . . . . 16.66 111.758 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.406 ' CD1' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -115.58 162.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 16.66 110.85 -179.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' A' ' 42' ' ' GLN . 2.0 tp -64.54 163.79 12.9 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 121.047 0.451 . . . . 50.0 109.992 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.813 ' HG2' ' H ' ' A' ' 43' ' ' SER . 4.2 pt20 -80.05 -53.44 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.009 -0.541 . . . . 25.0 110.075 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.813 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 29.6 t -64.98 -22.38 66.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 1.029 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.8 mt-10 -44.83 -17.45 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.555 ' N ' ' C ' ' A' ' 43' ' ' SER . . . -70.44 -45.11 66.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.479 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.712 ' C ' ' H ' ' A' ' 48' ' ' ILE . 96.4 mt-10 -88.5 -53.29 4.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.256 0.836 . . . . 50.0 113.256 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.593 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.73 11.56 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.144 0.497 . . . . 16.66 110.572 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 1.029 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -114.42 136.34 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.159 -0.928 . . . . 25.0 112.042 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.07 -73.64 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 50.0 111.818 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.53 71.95 1.24 Allowed 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.191 -0.67 . . . . 50.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.713 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.22 145.3 55.94 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.593 -0.73 . . . . 16.66 109.715 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.713 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 11.2 t -112.57 157.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.659 -0.701 . . . . 50.0 109.234 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.411 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.2 p -86.66 155.82 56.15 Favored Pre-proline 0 N--CA 1.409 -2.485 0 CA-C-N 115.572 -0.74 . . . . 16.66 110.546 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -67.97 -32.38 28.65 Favored 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 122.099 1.866 . . . . 16.66 111.093 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.38 -32.72 71.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 50.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.238 0 CA-C-N 115.422 -0.808 . . . . 16.66 111.4 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.232 0.154 0 N-CA-C 110.247 -0.279 . . . . 50.0 110.247 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 1.6 m-85 -100.7 -70.89 0.72 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.0 t -41.22 116.18 0.71 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.195 -0.911 . . . . 16.66 111.034 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.1 pt -54.51 -8.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.533 -0.758 . . . . 50.0 109.265 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.971 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -80.67 8.03 8.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.698 -1.137 . . . . 16.66 110.694 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? 65.36 53.5 1.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 25.0 111.773 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 142.77 16.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.53 155.01 67.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.607 2.205 . . . . 50.0 112.643 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.708 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 14.6 t80 -63.09 140.85 58.91 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.243 -0.435 . . . . 50.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 45.2 t0 -140.57 126.32 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 50.0 110.299 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.77 -14.45 32.67 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.669 -0.696 . . . . 50.0 110.328 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -75.35 -30.15 60.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.35 -1.352 . . . . 50.0 107.35 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 8.2 tptp -99.92 153.95 18.76 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.316 -1.765 . . . . 50.0 108.159 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 45.8 p90 -110.55 152.01 26.92 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.315 -0.554 . . . . 16.66 110.582 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -129.21 165.46 21.31 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.422 1.582 . . . . 50.0 114.645 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.741 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -125.19 123.02 64.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 110.777 -2.92 . . . . 16.66 104.45 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -91.92 123.33 7.18 Favored Glycine 0 C--N 1.317 -0.472 0 C-N-CA 119.52 -1.324 . . . . 16.66 115.913 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.468 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.92 108.59 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.929 -1.508 . . . . 16.66 106.929 175.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 90.3 m-20 -66.67 -23.93 66.2 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -112.58 -22.59 10.7 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.085 -1.416 . . . . 50.0 111.634 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.261 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -106.66 12.85 28.82 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.677 -0.809 . . . . 16.66 111.762 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.509 ' HG2' ' C ' ' A' ' 29' ' ' CYS . 22.8 pt20 34.97 45.54 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.726 0.639 . . . . 16.66 112.726 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.54 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.5 t-20 -132.92 166.59 21.99 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.41 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -135.5 130.47 34.7 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 121.034 -0.267 . . . . 16.66 111.09 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.96 145.45 51.63 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.922 -0.311 . . . . 50.0 111.175 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.778 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -54.78 141.24 33.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.722 -1.585 . . . . 16.66 106.722 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.24 -59.79 2.9 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.433 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -20.27 66.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 50.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.0 t -50.94 -31.11 16.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.888 -0.782 . . . . 16.66 108.888 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.23 14.04 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.254 -0.885 . . . . 16.66 110.894 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.19 45.7 60.63 Favored Glycine 0 N--CA 1.46 0.287 0 CA-C-N 115.885 -0.598 . . . . 16.66 111.741 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.478 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -107.8 164.63 4.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.949 0.404 . . . . 16.66 110.538 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.792 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 74.2 mt -58.7 163.96 3.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.875 -0.602 . . . . 50.0 109.982 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.428 HE21 ' HB3' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -78.4 -55.44 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.295 -0.866 . . . . 25.0 110.996 -178.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -70.48 -15.82 62.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.506 -0.77 . . . . 50.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.792 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 1.3 mt-10 -45.77 -19.83 0.07 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.851 -0.613 . . . . 50.0 111.866 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.22 -48.06 77.32 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.931 -0.708 . . . . 25.0 111.334 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.57 -45.88 9.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.182 1.549 . . . . 50.0 115.182 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 1.9 pp -55.26 -32.61 62.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 114.208 1.188 . . . . 16.66 114.208 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.715 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.2 pp -86.0 171.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.532 -0.867 . . . . 25.0 109.913 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -162.99 9.62 0.06 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.89 -1.05 . . . . 50.0 109.631 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -145.44 30.63 1.11 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.661 -1.607 . . . . 50.0 106.661 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.697 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 9.6 t80 -66.12 147.56 53.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.225 -1.352 . . . . 16.66 110.873 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.697 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.4 t -132.55 156.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.053 -1.431 . . . . 50.0 108.652 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.468 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -79.53 156.65 75.56 Favored Pre-proline 0 N--CA 1.409 -2.521 0 CA-C-O 121.586 0.708 . . . . 16.66 110.003 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 86.1 Cg_endo -71.27 -28.12 18.84 Favored 'Trans proline' 0 C--N 1.273 -3.412 0 C-N-CA 121.835 1.69 . . . . 16.66 110.601 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -71.85 -35.97 70.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.27 -1.011 . . . . 50.0 108.27 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.243 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.176 0 CA-C-N 115.091 -0.958 . . . . 16.66 110.621 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.463 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 110.329 -0.249 . . . . 50.0 110.329 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.35 -68.72 0.79 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.119 0.485 . . . . 25.0 109.952 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.3 t -40.79 115.47 0.58 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 16.66 110.932 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.416 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 5.8 pt -52.75 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 50.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.999 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.67 4.22 16.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 16.66 110.333 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm 66.49 55.58 0.81 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.821 -0.627 . . . . 25.0 112.045 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.3 142.05 16.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.792 -0.447 . . . . 50.0 109.792 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.01 153.43 78.36 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.272 1.982 . . . . 50.0 112.292 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.5 t80 -58.05 146.2 33.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.538 -0.542 . . . . 50.0 109.538 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.515 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 96.0 m-20 -140.93 116.97 10.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.656 -0.702 . . . . 50.0 111.325 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.54 -16.7 26.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.059 -0.519 . . . . 50.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -76.36 -27.99 56.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 5.9 tptm -101.89 154.63 18.76 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.346 -1.752 . . . . 50.0 108.185 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 53.5 p90 -111.17 151.23 28.43 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.376 -0.529 . . . . 16.66 110.548 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.7 m-85 -128.9 168.26 16.22 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 123.314 1.531 . . . . 50.0 114.286 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.767 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.43 126.17 68.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 111.118 -2.764 . . . . 16.66 105.29 176.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.89 122.29 6.87 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.757 -1.211 . . . . 16.66 115.601 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.313 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -48.38 115.29 1.16 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.028 -1.086 . . . . 16.66 108.555 176.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.6 t70 -58.68 -34.02 70.8 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.355 -0.538 . . . . 25.0 109.871 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -113.32 -23.88 9.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.707 -0.678 . . . . 50.0 111.32 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.313 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -91.54 4.88 51.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.983 -0.687 . . . . 16.66 111.324 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.498 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 6.5 pt20 30.75 48.59 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.11 -0.496 . . . . 16.66 111.615 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.62 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -131.55 166.4 21.47 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.847 -0.427 . . . . 50.0 109.847 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.48 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.18 132.57 39.95 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.837 -0.345 . . . . 16.66 111.052 -178.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.02 144.97 51.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.779 -0.369 . . . . 50.0 111.327 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.753 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -56.47 140.06 47.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.392 -1.707 . . . . 16.66 106.392 176.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.12 -58.57 3.23 Favored Glycine 0 C--N 1.31 -0.899 0 C-N-CA 119.622 -1.275 . . . . 16.66 112.098 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -66.75 -21.3 66.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.58 -29.84 18.72 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.656 -0.702 . . . . 16.66 109.304 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.56 2.24 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.706 -0.679 . . . . 16.66 112.002 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.9 46.4 6.72 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.417 -0.673 . . . . 16.66 111.417 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.452 HG23 ' HG2' ' A' ' 44' ' ' GLU . 1.4 tt -118.69 159.92 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.05 0.453 . . . . 16.66 111.828 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.623 ' C ' ' HG3' ' A' ' 44' ' ' GLU . 4.1 mm? -46.91 169.61 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.58 -0.736 . . . . 50.0 110.991 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -56.33 4.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.702 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' ALA . 61.5 m -79.03 -16.07 57.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.637 -0.71 . . . . 50.0 111.446 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.765 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -43.34 -21.35 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.87 0.367 . . . . 50.0 110.166 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.505 ' N ' ' OE1' ' A' ' 44' ' ' GLU . . . -60.14 -51.52 69.24 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.037 -0.528 . . . . 25.0 111.418 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.77 -44.16 10.17 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.808 1.41 . . . . 50.0 114.808 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.632 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 3.1 pp -55.47 -28.09 52.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.661 0.985 . . . . 16.66 113.661 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.765 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.4 pp -85.71 172.48 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 119.862 -0.735 . . . . 25.0 110.028 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 48.6 t0 -156.35 0.48 0.14 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.571 -1.195 . . . . 50.0 109.982 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.33 33.67 2.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.413 -1.328 . . . . 50.0 107.413 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.1 t80 -65.94 145.88 55.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.197 -0.91 . . . . 16.66 110.032 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.691 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 20.3 t -133.73 155.73 40.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.058 -1.428 . . . . 50.0 108.991 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.998 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 7.2 p -81.72 154.42 70.78 Favored Pre-proline 0 N--CA 1.413 -2.287 0 CA-C-O 121.501 0.667 . . . . 16.66 109.98 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -74.4 -28.22 10.52 Favored 'Trans proline' 0 C--N 1.274 -3.379 0 C-N-CA 122.058 1.839 . . . . 16.66 110.947 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.416 ' NE2' ' CG2' ' A' ' 12' ' ' ILE . 96.2 mt-30 -70.32 -33.58 71.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.131 -1.063 . . . . 50.0 108.131 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.185 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 114.767 -1.106 . . . . 16.66 110.277 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.94 0.4 . . . . 50.0 111.082 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.3 m-85 -73.62 -103.21 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.951 -0.568 . . . . 25.0 110.993 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 18.7 t -37.87 120.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.819 0.818 . . . . 16.66 113.206 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.5 pt -59.29 -8.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.112 -1.404 . . . . 50.0 108.843 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.95 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.94 8.81 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.367 -1.288 . . . . 16.66 110.565 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.634 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 63.43 71.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.571 0.7 . . . . 25.0 110.086 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.03 124.67 1.12 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.939 -0.573 . . . . 50.0 110.757 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.45 154.9 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.287 1.991 . . . . 50.0 112.111 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -56.85 146.1 27.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.044 0.449 . . . . 50.0 110.074 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.2 m-20 -140.75 114.78 9.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.764 -0.653 . . . . 50.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.66 -10.81 2.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 18' ' ' ASP . 26.4 m -79.97 -24.8 40.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.358 -1.349 . . . . 50.0 107.358 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ASP . 4.7 tptm -107.56 153.56 22.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.59 -1.641 . . . . 50.0 107.94 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 39.2 p90 -110.13 153.47 24.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 120.11 -0.636 . . . . 16.66 111.011 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.742 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -126.59 164.0 22.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 123.504 1.621 . . . . 50.0 114.645 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.778 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.76 117.86 31.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 110.861 -2.881 . . . . 16.66 105.091 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -82.93 133.08 11.57 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 119.944 -1.122 . . . . 16.66 115.06 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -47.94 107.37 0.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.752 -1.224 . . . . 16.66 107.705 176.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.44 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 59.1 t0 -51.05 -41.43 59.87 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.85 -0.74 . . . . 25.0 110.23 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 56' ' ' CYS . 14.7 ptp180 -115.67 -4.51 12.19 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.83 0.678 . . . . 50.0 112.83 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.237 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -108.66 13.51 25.1 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 118.825 -1.15 . . . . 16.66 111.326 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER 33.69 52.33 0.42 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.268 -0.423 . . . . 16.66 110.72 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.608 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -132.57 166.44 22.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.189 -0.3 . . . . 50.0 110.189 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.658 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -139.89 132.14 28.24 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.004 0.742 . . . . 16.66 113.004 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.716 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -139.93 152.62 46.51 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.036 -0.529 . . . . 50.0 111.649 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.788 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -59.04 142.55 51.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.694 -1.595 . . . . 16.66 106.694 175.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.84 -60.31 2.98 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.058 -1.068 . . . . 16.66 111.713 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -20.12 65.91 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.324 -0.55 . . . . 50.0 110.183 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.7 t -51.19 -31.32 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.199 -0.667 . . . . 16.66 109.199 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.408 HG13 ' CD2' ' A' ' 33' ' ' TYR . 2.7 m -115.67 14.28 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.472 -0.786 . . . . 16.66 110.675 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.14 46.0 23.41 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 115.636 -0.711 . . . . 16.66 112.432 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.408 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.55 167.24 5.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.928 0.394 . . . . 16.66 110.581 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.61 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 85.6 mt -67.16 164.29 18.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.499 0.666 . . . . 50.0 110.662 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.415 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.6 OUTLIER -80.03 -54.96 5.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.034 -0.985 . . . . 25.0 111.086 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 m -65.81 -17.85 64.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 50.0 110.096 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.756 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.0 mt-10 -45.64 -38.28 6.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.353 -0.539 . . . . 50.0 110.658 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.37 -36.5 43.47 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.077 -0.649 . . . . 25.0 110.897 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -87.74 -44.46 11.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.601 0.963 . . . . 50.0 113.601 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.552 ' CG ' ' HA ' ' A' ' 44' ' ' GLU . 2.2 pp -86.46 17.13 3.98 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.285 -0.87 . . . . 16.66 112.013 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.756 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 4.1 tp -120.81 150.01 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 C-N-CA 119.056 -1.058 . . . . 25.0 112.984 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -170.17 29.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.614 -1.175 . . . . 50.0 110.411 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -161.03 9.02 0.08 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.671 -0.863 . . . . 50.0 108.671 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -67.22 147.63 52.8 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.54 -0.755 . . . . 16.66 109.35 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.589 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 14.8 t -126.03 157.76 35.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.143 -0.935 . . . . 50.0 109.43 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.9 p -79.84 156.87 74.71 Favored Pre-proline 0 N--CA 1.412 -2.353 0 CA-C-N 115.749 -0.66 . . . . 16.66 110.164 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 28.9 Cg_endo -80.25 -23.78 6.04 Favored 'Trans proline' 0 C--N 1.276 -3.239 0 C-N-CA 121.783 1.655 . . . . 16.66 110.786 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -72.64 -35.63 67.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.485 -0.932 . . . . 50.0 108.485 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.166 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.03 -0.986 . . . . 16.66 110.609 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.524 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 N-CA-C 109.93 -0.396 . . . . 50.0 109.93 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.6 m-85 -91.06 -71.34 0.64 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.411 -0.588 . . . . 25.0 109.411 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.1 t -41.38 113.41 0.4 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.653 -0.703 . . . . 16.66 110.772 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 pt -53.12 -7.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 50.0 109.414 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.972 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -81.25 6.72 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.729 -1.123 . . . . 16.66 110.892 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 66.97 56.12 0.68 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.13 -0.487 . . . . 25.0 111.916 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 135.94 10.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.91 -0.316 . . . . 50.0 110.352 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.48 156.72 39.98 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.321 2.014 . . . . 50.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.724 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.7 t80 -59.35 146.25 40.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.033 0.444 . . . . 50.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.503 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 95.4 m-20 -141.39 113.07 7.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.638 -0.71 . . . . 50.0 111.249 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.36 -20.87 13.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.968 0.413 . . . . 50.0 110.103 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.4 m -71.95 -30.99 65.87 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.582 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -99.05 150.37 22.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.265 -1.789 . . . . 50.0 107.954 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CE2' ' NH2' ' A' ' 36' ' ' ARG . 51.0 p90 -108.78 150.41 27.65 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.06 -0.656 . . . . 16.66 110.601 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.724 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.6 m-85 -127.76 166.0 19.02 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 123.362 1.553 . . . . 50.0 113.925 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.765 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.55 124.3 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 111.114 -2.766 . . . . 16.66 105.57 176.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -87.95 127.1 8.37 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.993 -1.099 . . . . 16.66 115.529 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.474 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -48.62 121.28 4.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.499 -1.297 . . . . 16.66 107.499 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -62.55 -34.21 76.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.507 0.67 . . . . 25.0 109.571 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -113.56 -27.85 7.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.841 -1.072 . . . . 50.0 111.477 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.293 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -89.91 8.23 33.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.945 -0.702 . . . . 16.66 111.81 -177.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.54 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 2.8 pt20 30.13 49.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 16.66 112.005 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.668 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -131.6 165.69 23.09 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.92 -0.4 . . . . 50.0 109.92 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -132.54 132.68 42.87 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.939 -0.304 . . . . 16.66 111.389 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.672 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.7 145.76 52.01 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.865 -0.334 . . . . 50.0 111.148 178.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.79 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -54.43 140.2 34.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.285 -1.746 . . . . 16.66 106.285 176.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.725 ' H ' HH21 ' A' ' 36' ' ' ARG . . . -42.29 -56.34 4.06 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 119.433 -1.365 . . . . 16.66 111.516 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.739 ' H ' ' NE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.55 -19.7 62.86 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.516 -0.474 . . . . 50.0 110.241 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.41 -30.94 13.62 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.866 -0.791 . . . . 16.66 108.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.71 13.58 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.117 -0.947 . . . . 16.66 110.631 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.34 46.25 50.35 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.345 -0.702 . . . . 16.66 111.345 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.38 167.93 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.124 0.488 . . . . 16.66 111.647 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 7.3 mp -62.38 163.64 8.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 50.0 110.446 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.587 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.1 pt20 -82.33 -46.56 13.44 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.18 -1.045 . . . . 25.0 108.18 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -63.8 -29.25 70.47 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.647 -1.615 . . . . 50.0 108.687 179.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.799 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.8 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.005 -0.739 . . . . 50.0 109.005 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -79.13 -41.93 27.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.298 -0.864 . . . . 25.0 110.538 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' SER . 48.5 mp0 -87.9 -52.13 5.45 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.696 1.369 . . . . 50.0 114.696 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.842 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.56 19.22 0.28 Allowed 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.481 0.658 . . . . 16.66 111.108 -177.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.799 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.3 tp -114.71 144.56 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 114.749 -1.114 . . . . 25.0 113.299 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -168.09 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.155 -1.384 . . . . 50.0 109.313 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -166.39 13.12 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.415 -0.957 . . . . 50.0 108.415 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -67.58 147.26 52.99 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.357 -0.838 . . . . 16.66 109.706 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.1 t -124.71 159.26 31.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.845 -1.071 . . . . 50.0 109.293 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.474 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -83.87 152.93 63.52 Favored Pre-proline 0 N--CA 1.411 -2.383 0 CA-C-O 121.611 0.72 . . . . 16.66 110.359 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.25 -27.61 16.32 Favored 'Trans proline' 0 C--N 1.274 -3.378 0 C-N-CA 121.892 1.728 . . . . 16.66 110.877 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -70.42 -33.67 71.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.31 -0.859 . . . . 50.0 108.827 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.253 -0.885 . . . . 16.66 110.567 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.37 0.128 . . . . 50.0 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.9 m-85 -95.53 -68.36 0.8 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.2 t -43.48 116.26 0.91 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.648 -0.705 . . . . 16.66 110.458 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.9 pt -51.95 -7.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.071 -0.714 . . . . 50.0 109.071 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -78.31 2.78 17.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.572 -1.195 . . . . 16.66 110.55 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.22 54.41 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.982 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.07 146.77 26.9 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.005 -0.369 . . . . 50.0 110.005 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 152.69 76.08 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.513 2.142 . . . . 50.0 111.941 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.6 t80 -55.97 146.06 23.41 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.759 -0.46 . . . . 50.0 109.759 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.0 m-20 -140.71 113.15 8.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.786 -0.643 . . . . 50.0 111.017 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.64 -17.76 9.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 50.0 109.842 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -71.58 -30.81 66.25 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.112 -1.44 . . . . 50.0 107.112 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 3.1 tptm -100.55 156.88 17.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 112.973 -1.922 . . . . 50.0 108.957 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 52.8 p90 -113.45 149.07 34.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 115.885 -0.598 . . . . 16.66 110.024 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 m-85 -127.15 166.75 17.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 123.379 1.561 . . . . 50.0 114.236 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.75 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.19 126.22 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 111.013 -2.812 . . . . 16.66 105.007 176.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.58 121.22 6.53 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.587 -1.292 . . . . 16.66 116.157 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.44 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.32 117.69 2.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.911 -1.145 . . . . 16.66 108.002 175.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 51' ' ' TYR . 87.3 m-20 -69.26 -30.18 68.24 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.652 0.739 . . . . 25.0 109.245 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -110.43 -23.15 11.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.597 -1.183 . . . . 50.0 111.452 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.292 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 9.93 40.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.888 -0.725 . . . . 16.66 111.683 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.547 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 8.9 pt20 30.37 48.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 16.66 112.405 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.582 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.14 166.16 22.42 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 120.929 -0.308 . . . . 50.0 110.373 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -133.94 130.75 38.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.184 -0.206 . . . . 16.66 110.906 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -128.45 144.44 51.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.792 -0.363 . . . . 50.0 111.393 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.748 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -54.19 140.59 32.04 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.28 -1.748 . . . . 16.66 106.28 176.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -41.9 -59.94 2.72 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.855 -1.164 . . . . 16.66 111.929 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -67.87 -19.79 65.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.458 -0.497 . . . . 50.0 109.971 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.1 t -50.4 -30.7 13.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.664 -0.865 . . . . 16.66 108.664 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.6 12.66 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.255 -0.884 . . . . 16.66 110.962 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.67 45.84 50.47 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.034 -0.603 . . . . 16.66 111.68 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.5 167.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.421 . . . . 16.66 111.495 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 8.0 mp -59.64 164.72 3.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 50.0 110.555 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.06 -55.39 5.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.515 -0.766 . . . . 25.0 110.523 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.516 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.4 m -70.86 -15.16 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 50.0 109.368 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.569 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -42.17 -20.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.467 -0.788 . . . . 50.0 110.938 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.34 -47.52 60.67 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.396 -0.522 . . . . 25.0 110.992 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -88.93 -43.46 11.15 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.745 1.387 . . . . 50.0 114.745 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 43' ' ' SER . 2.5 pp -55.39 -30.84 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.306 0.854 . . . . 16.66 113.306 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.3 pp -86.67 172.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.744 0.783 . . . . 25.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.35 13.2 0.14 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.403 -1.271 . . . . 50.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -155.54 36.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.753 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 18.5 t80 -65.96 145.88 55.37 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.674 -1.148 . . . . 16.66 111.014 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.753 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 11.7 t -129.71 157.55 42.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.942 -1.481 . . . . 50.0 108.608 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.44 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.2 p -86.35 158.36 54.99 Favored Pre-proline 0 N--CA 1.414 -2.236 0 CA-C-O 121.574 0.702 . . . . 16.66 110.578 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 29.8 Cg_endo -79.8 -22.7 7.44 Favored 'Trans proline' 0 C--N 1.278 -3.133 0 C-N-CA 121.97 1.78 . . . . 16.66 110.403 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -72.52 -35.76 68.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.062 -1.088 . . . . 50.0 108.062 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.17 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 CA-C-N 114.881 -1.054 . . . . 16.66 109.856 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.615 HD11 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.333 -0.247 . . . . 50.0 110.333 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 32' ' ' TRP . 1.5 m-85 -87.16 -94.99 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.007 0.373 . . . . 25.0 112.007 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -37.45 132.72 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.69 0.757 . . . . 16.66 112.773 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.416 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -61.15 -7.75 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.671 -1.149 . . . . 50.0 108.692 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.59 4.95 14.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.001 -1.454 . . . . 16.66 110.852 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 67.31 47.6 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.269 -0.423 . . . . 25.0 111.038 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.466 ' H ' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -140.27 124.61 10.84 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.618 -0.264 . . . . 50.0 110.617 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.68 160.47 11.78 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.626 2.217 . . . . 50.0 112.878 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.751 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 10.4 t80 -66.3 138.51 57.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.047 -0.524 . . . . 50.0 111.104 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 54.3 t0 -140.54 127.01 20.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.653 -0.703 . . . . 50.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.92 -12.83 4.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.991 -0.549 . . . . 50.0 109.608 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 18' ' ' ASP . 19.4 m -75.64 -26.81 58.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HG2' ' CG ' ' A' ' 34' ' ' HIS . 15.5 tptt -101.5 152.17 21.09 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.489 -1.687 . . . . 50.0 108.129 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 55.3 p90 -113.08 147.21 37.75 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.182 -0.607 . . . . 16.66 110.154 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.0 m-85 -123.23 164.23 19.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 123.914 1.816 . . . . 50.0 115.538 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.795 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.68 117.96 21.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 109.953 -3.294 . . . . 16.66 104.286 176.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -89.73 129.87 9.92 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.778 -1.201 . . . . 16.66 115.455 -174.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.386 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 106.99 0.11 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.898 -1.519 . . . . 16.66 106.898 175.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -69.54 -20.01 63.69 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -112.86 -25.46 9.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.839 -1.528 . . . . 50.0 111.566 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.21 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -111.31 15.88 21.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.932 -0.707 . . . . 16.66 112.197 -178.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.515 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 30.96 54.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 16.66 111.87 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 5.5 m-20 -132.54 167.06 20.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.411 -0.359 . . . . 50.0 110.223 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.673 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -141.03 129.48 22.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.311 0.856 . . . . 16.66 113.311 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.662 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -141.43 158.34 44.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.873 -0.603 . . . . 50.0 111.771 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.645 ' CG ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.98 134.85 55.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.9 -1.889 . . . . 16.66 105.9 174.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.6 -44.85 5.44 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 119.502 -1.332 . . . . 16.66 111.545 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -68.53 -29.88 68.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.57 0.7 . . . . 50.0 109.238 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.933 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 4.2 t -51.6 -26.66 9.25 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.791 -1.095 . . . . 16.66 109.621 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.53 16.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.296 -0.866 . . . . 16.66 110.622 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.21 47.58 57.9 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.733 -0.667 . . . . 16.66 111.828 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.564 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -115.63 167.02 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.777 -0.369 . . . . 16.66 110.984 -178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.705 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.8 mm? -62.33 164.59 6.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.287 0.565 . . . . 50.0 110.412 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -56.05 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.13 -0.941 . . . . 25.0 110.911 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -69.35 -16.15 63.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.683 -0.689 . . . . 50.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.732 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 1.6 tt0 -48.22 -20.24 0.36 Allowed 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.488 -0.778 . . . . 50.0 111.464 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.0 -51.82 67.71 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.944 -0.702 . . . . 25.0 111.671 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 48' ' ' ILE . 78.2 mm-40 -90.1 -46.65 8.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.9 1.445 . . . . 50.0 114.9 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.583 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 3.1 pp -56.02 16.19 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.347 1.24 . . . . 16.66 114.347 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.732 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -134.48 171.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.406 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 46.0 t0 -173.36 36.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.82 -1.082 . . . . 50.0 108.994 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.03 20.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 2.4 t80 -66.82 148.68 51.62 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.547 -1.206 . . . . 16.66 110.522 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.646 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.3 t -129.87 152.26 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.302 -1.317 . . . . 50.0 109.43 178.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.386 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.3 p -78.95 162.45 64.71 Favored Pre-proline 0 N--CA 1.411 -2.391 0 CA-C-N 115.232 -0.894 . . . . 16.66 110.102 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 15.5 Cg_endo -81.23 -27.84 2.68 Favored 'Trans proline' 0 C--N 1.276 -3.279 0 C-N-CA 121.875 1.717 . . . . 16.66 110.848 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -67.93 -35.63 78.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.895 -1.15 . . . . 50.0 107.895 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.189 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 114.892 -1.049 . . . . 16.66 109.552 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.661 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -82.28 -89.19 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 1.5 t -39.71 114.43 0.42 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.844 -0.617 . . . . 16.66 111.29 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -59.7 -8.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.16 -0.927 . . . . 50.0 109.588 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 1.137 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -71.21 7.34 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.425 -0.807 . . . . 16.66 109.923 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 12' ' ' ILE . 3.5 mtpm? 65.91 48.73 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.576 -0.738 . . . . 25.0 111.484 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.404 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -143.17 124.19 8.2 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.778 -0.369 . . . . 50.0 110.287 179.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.1 152.03 3.72 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.748 2.299 . . . . 50.0 112.801 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.7 t80 -67.57 145.02 55.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' LYS . 91.3 m-20 -140.82 116.68 10.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.831 -0.622 . . . . 50.0 110.355 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 -13.57 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.443 -0.577 . . . . 50.0 109.443 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -75.13 -25.69 58.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.513 -1.291 . . . . 50.0 107.513 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -101.39 155.3 18.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.433 -1.712 . . . . 50.0 108.113 178.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 51.8 p90 -110.25 153.21 25.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.889 -0.724 . . . . 16.66 110.588 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.3 m-85 -125.26 162.71 24.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.47 1.605 . . . . 50.0 114.534 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.805 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -131.58 117.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.803 -2.908 . . . . 16.66 104.601 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.77 131.96 11.03 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 119.782 -1.199 . . . . 16.66 116.025 -174.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.394 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -46.33 105.74 0.07 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.026 -1.472 . . . . 16.66 107.026 175.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 28' ' ' ARG . 43.4 p-10 -75.4 -11.4 60.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.568 -1.271 . . . . 25.0 107.568 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.483 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 23.4 ttm180 -113.7 -22.98 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.742 -1.572 . . . . 50.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.183 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -120.22 18.5 12.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 119.927 -0.709 . . . . 16.66 112.346 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.498 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 13.9 pt20 32.97 54.11 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.763 0.283 . . . . 16.66 111.763 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.614 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 4.8 m-20 -133.09 167.84 19.58 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 110.165 -0.309 . . . . 50.0 110.165 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.643 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -138.67 133.02 31.79 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.869 0.692 . . . . 16.66 112.869 -177.037 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.625 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -140.83 145.13 35.86 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.97 -0.559 . . . . 50.0 111.283 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.885 ' HD1' ' CB ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -55.89 150.03 13.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 106.368 -1.715 . . . . 16.66 106.368 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.08 -61.56 7.03 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 119.468 -1.348 . . . . 16.66 112.747 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -20.69 62.76 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.346 -0.541 . . . . 50.0 110.462 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 13.9 t -54.14 -29.24 44.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.488 -0.885 . . . . 16.66 108.941 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -112.61 11.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 16.66 110.34 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.06 46.96 20.15 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.862 -0.608 . . . . 16.66 111.774 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.64 167.58 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 16.66 111.546 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 7.4 mp -64.68 161.6 17.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.248 -0.887 . . . . 50.0 110.152 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.4 pt20 -82.12 -41.16 20.84 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.693 ' O ' HD12 ' A' ' 47' ' ' LEU . 69.6 m -60.88 -39.04 87.74 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 112.336 -2.211 . . . . 50.0 109.266 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.793 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -41.39 -17.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.935 -0.575 . . . . 50.0 110.037 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -76.4 -46.17 28.42 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.074 -0.512 . . . . 25.0 110.806 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.0 mm-40 -88.95 -51.23 5.73 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.069 1.507 . . . . 50.0 115.069 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.904 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.18 20.32 0.39 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.563 0.697 . . . . 16.66 111.761 -177.07 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.2 tp -111.43 139.04 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 25.0 111.915 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -116.19 -58.68 2.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.405 -1.27 . . . . 50.0 111.822 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 2.3 pm0 -118.83 59.48 0.82 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.166 -0.679 . . . . 50.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.0 t80 -66.37 142.07 57.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.175 -0.61 . . . . 16.66 109.368 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.684 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 6.7 t -117.33 152.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.543 -0.753 . . . . 50.0 109.716 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.394 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.4 p -83.99 157.85 62.54 Favored Pre-proline 0 N--CA 1.41 -2.45 0 CA-C-N 114.936 -1.029 . . . . 16.66 110.35 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.19 -25.69 5.69 Favored 'Trans proline' 0 C--N 1.278 -3.183 0 C-N-CA 121.92 1.746 . . . . 16.66 110.477 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -71.96 -33.49 68.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.945 -1.025 . . . . 50.0 108.936 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.168 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.148 0 CA-C-N 115.329 -0.85 . . . . 16.66 110.743 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.025 -0.361 . . . . 50.0 110.025 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -103.03 -69.96 0.78 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.849 -0.34 . . . . 25.0 110.106 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 35.7 t -41.6 130.61 3.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 16.66 110.719 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.9 pt -57.74 -7.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.269 -1.011 . . . . 50.0 108.269 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.74 -5.85 56.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.899 -1.501 . . . . 16.66 110.897 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 22.1 mtmm 72.18 52.8 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.186 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.68 139.33 23.97 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 109.906 -0.405 . . . . 50.0 109.906 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.66 153.96 74.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.453 2.102 . . . . 50.0 112.331 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -63.05 140.29 58.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.13 0.491 . . . . 50.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.623 ' H ' ' HH ' ' A' ' 23' ' ' TYR . 82.1 m-20 -141.8 119.86 12.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.487 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.81 -22.34 9.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.95 -0.389 . . . . 50.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 m -68.79 -34.11 74.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.528 -1.286 . . . . 50.0 107.528 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 4.6 ttmt -93.33 139.3 30.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.304 -1.771 . . . . 50.0 107.584 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 45.1 p90 -105.13 143.01 33.9 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.134 -0.627 . . . . 16.66 110.173 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -122.13 173.19 7.73 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 123.941 1.829 . . . . 50.0 114.78 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.78 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.69 179.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 109.685 -3.416 . . . . 16.66 104.018 176.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.06 124.14 2.48 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 117.658 -2.211 . . . . 16.66 114.36 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 1.447 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -48.04 110.65 0.35 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.052 -1.074 . . . . 16.66 108.739 177.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.502 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 57.2 t0 -46.57 -41.95 15.22 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.081 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD3' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.39 -13.81 11.0 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 112.407 0.521 . . . . 50.0 112.407 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 1.347 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -88.49 0.17 56.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.937 -1.105 . . . . 16.66 111.272 -178.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.443 HE21 ' C ' ' A' ' 28' ' ' ARG . 8.9 mm-40 40.85 45.98 2.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.551 -0.295 . . . . 16.66 110.347 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.575 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -132.31 166.28 22.27 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.755 -0.378 . . . . 50.0 110.604 -177.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -140.82 127.77 20.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.56 -0.456 . . . . 16.66 111.428 -178.445 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.74 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -127.67 156.43 42.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.94 -0.573 . . . . 50.0 110.866 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.532 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -61.46 141.0 57.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.154 -1.795 . . . . 16.66 106.154 176.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -43.4 -48.48 6.96 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 119.42 -1.371 . . . . 16.66 111.261 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -19.76 59.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.349 -0.54 . . . . 50.0 110.037 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.92 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -51.6 -30.71 22.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.562 -0.855 . . . . 16.66 109.241 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.43 8.59 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.487 -0.779 . . . . 16.66 111.427 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.57 45.86 7.68 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.124 -0.56 . . . . 16.66 112.204 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.15 167.34 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.222 0.534 . . . . 16.66 111.608 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' CB ' ' OE1' ' A' ' 44' ' ' GLU . 4.0 mm? -67.02 164.58 17.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.481 -0.781 . . . . 50.0 110.46 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.713 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.8 pt20 -80.55 -54.26 5.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 25.0 110.902 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.713 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 49.5 m -60.35 -28.26 68.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.063 -1.088 . . . . 50.0 108.063 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.944 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -43.67 -17.03 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.305 -1.316 . . . . 50.0 109.928 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.27 -48.16 58.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.98 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.731 ' C ' ' H ' ' A' ' 48' ' ' ILE . 84.8 tt0 -87.66 -52.91 5.06 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.096 0.776 . . . . 50.0 113.096 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.593 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -57.78 5.6 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.385 0.612 . . . . 16.66 110.516 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.944 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -105.15 133.02 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.714 -177.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -87.7 -74.38 0.45 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.995 -1.002 . . . . 50.0 111.522 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 27' ' ' ASP . 80.7 tt0 -122.08 74.0 1.13 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.73 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.09 146.6 54.47 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.774 -0.648 . . . . 16.66 109.324 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 43.7 t -117.09 159.24 17.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.805 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 1.447 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -87.5 161.11 46.38 Favored Pre-proline 0 N--CA 1.415 -2.177 0 CA-C-O 121.425 0.631 . . . . 16.66 110.22 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 34.6 Cg_endo -80.33 -32.55 1.27 Allowed 'Trans proline' 0 C--N 1.28 -3.059 0 C-N-CA 121.862 1.708 . . . . 16.66 111.741 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -72.96 -28.81 62.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 1.104 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 61.4 m . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 114.121 -1.4 . . . . 16.66 111.0 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -53.62 147.96 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.756 2.304 . . . . 0.0 112.053 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.1 mt -58.07 -35.0 70.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.402 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.72 174.69 47.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.937 -0.865 . . . . 50.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.4 t -147.87 146.76 29.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 50.0 110.709 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.3 157.39 31.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 50.0 110.227 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -81.09 174.93 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.254 0.55 . . . . 50.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -128.75 179.89 5.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.338 -0.847 . . . . 50.0 111.119 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.643 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.98 176.55 0.69 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 50.0 110.236 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.3 m-85 -97.8 -72.77 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.168 -0.613 . . . . 25.0 111.528 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 6.2 t -39.01 112.04 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 16.66 111.597 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 pt -48.02 -8.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.541 -0.754 . . . . 50.0 109.682 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.969 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -86.02 30.52 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.742 -1.117 . . . . 16.66 110.343 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 14.0 pttp 43.4 58.87 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.77 -0.65 . . . . 25.0 112.144 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.32 124.34 2.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 110.022 -0.362 . . . . 50.0 110.022 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 25.0 Cg_exo -57.22 164.17 7.07 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.614 2.209 . . . . 50.0 113.352 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.737 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 16.1 t80 -60.23 145.78 46.04 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.517 -0.765 . . . . 50.0 110.74 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' LYS . 92.6 m-20 -141.46 111.84 6.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.03 -0.986 . . . . 50.0 110.848 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.51 -22.45 8.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 50.0 110.448 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -71.11 -30.38 66.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.633 -1.247 . . . . 50.0 107.633 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -100.26 149.36 23.66 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.165 -1.834 . . . . 50.0 108.034 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 39.5 p90 -108.62 151.72 25.75 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.865 -0.734 . . . . 16.66 110.296 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.3 m-85 -126.86 165.44 19.34 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 123.152 1.454 . . . . 50.0 113.943 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.776 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.52 118.71 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 111.242 -2.708 . . . . 16.66 105.25 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -83.32 127.0 7.78 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.039 -1.077 . . . . 16.66 115.563 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.43 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -48.21 107.27 0.12 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.875 -1.162 . . . . 16.66 107.928 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 51' ' ' TYR . 76.6 m-20 -51.08 -37.27 44.69 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.993 -0.683 . . . . 25.0 110.53 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.654 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -114.29 -14.56 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.042 0.386 . . . . 50.0 112.042 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.256 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.9 14.2 32.52 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.472 -0.891 . . . . 16.66 111.865 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 14.3 pt20 30.35 48.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.893 0.701 . . . . 16.66 112.893 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.623 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.13 166.11 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.971 -0.381 . . . . 50.0 109.971 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.488 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.61 130.98 37.27 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.868 -0.333 . . . . 16.66 111.279 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.2 144.99 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.05 -0.26 . . . . 50.0 111.024 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.781 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -52.03 143.02 14.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.714 -1.588 . . . . 16.66 106.714 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.18 -60.31 2.72 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.432 -1.366 . . . . 16.66 111.478 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -69.19 -18.24 63.89 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.565 -0.454 . . . . 50.0 110.44 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.09 -30.67 11.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.656 -0.818 . . . . 16.66 108.814 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.8 4.16 7.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.411 -0.813 . . . . 16.66 111.637 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.72 46.08 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.366 -0.694 . . . . 16.66 111.366 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.457 HG12 ' H ' ' A' ' 41' ' ' LEU . 3.5 tt -119.17 167.73 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 16.66 111.885 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' H ' HG12 ' A' ' 40' ' ' ILE . 42.0 mt -68.69 164.48 21.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.168 -0.923 . . . . 50.0 110.646 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 36.8 mt-30 -80.56 -43.97 19.78 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.965 -1.494 . . . . 25.0 106.965 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.739 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -62.76 -41.13 99.08 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 112.378 -2.192 . . . . 50.0 107.714 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.815 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.3 mm-40 -43.63 -16.35 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -78.93 -44.47 22.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.427 -0.806 . . . . 25.0 110.468 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 43' ' ' SER . 96.4 mt-10 -87.94 -51.91 5.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.583 1.327 . . . . 50.0 114.583 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.879 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.68 20.38 0.24 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.795 0.807 . . . . 16.66 111.03 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.815 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.5 tp -110.44 143.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.272 -1.331 . . . . 25.0 112.9 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -165.98 29.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.381 -1.281 . . . . 50.0 109.448 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -166.33 11.43 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.593 -0.892 . . . . 50.0 108.593 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -67.09 146.9 53.81 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 16.66 109.761 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.645 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 21.7 t -125.16 156.95 34.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.912 -1.04 . . . . 50.0 110.016 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.43 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.5 p -78.57 157.23 77.51 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-N 115.592 -0.731 . . . . 16.66 110.078 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 41.5 Cg_endo -77.84 -30.13 3.94 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 121.963 1.776 . . . . 16.66 111.585 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -72.26 -29.59 64.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.99 -1.115 . . . . 50.0 107.99 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.2 m -62.76 -45.42 92.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.324 -1.307 . . . . 16.66 110.735 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -52.61 -36.71 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.677 -0.692 . . . . 50.0 110.566 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -37.04 79.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.514 -0.55 . . . . 50.0 109.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 56' ' ' CYS . 72.8 p -83.83 -34.94 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.753 -0.658 . . . . 50.0 111.319 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' N ' ' HG1' ' A' ' 59' ' ' THR . 66.6 mm-40 -38.27 -68.29 0.16 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.947 -0.301 . . . . 50.0 111.121 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 52.1 p30 -152.57 170.06 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 50.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.999 -1.001 . . . . 50.0 110.534 -179.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 4' ' ' GLY . 34.8 Cg_endo -65.66 -27.02 53.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.765 2.31 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 2' ' ' PRO . 10.6 mp 39.01 23.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -110.3 128.57 8.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.031 -0.828 . . . . 50.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.1 p -169.74 -149.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.226 -0.287 . . . . 50.0 110.226 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -74.09 105.76 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.882 -0.414 . . . . 50.0 109.882 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -127.36 165.56 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.228 0.537 . . . . 50.0 111.262 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -104.57 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.359 -0.837 . . . . 50.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.9 mt -61.26 151.19 32.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.483 -0.562 . . . . 50.0 109.483 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.14 -69.1 0.77 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.385 -0.526 . . . . 25.0 110.463 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -41.59 129.37 3.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 16.66 111.133 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 pt -58.16 -7.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -82.39 -1.87 51.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.844 -1.525 . . . . 16.66 110.985 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 46.2 mttm 70.95 56.76 0.22 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.463 -0.335 . . . . 25.0 111.299 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.688 ' HG1' ' HE2' ' A' ' 34' ' ' HIS . 23.0 p -141.1 147.74 48.82 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.409 -0.36 . . . . 50.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.32 150.93 47.82 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.411 2.074 . . . . 50.0 111.846 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.723 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 22.2 t80 -62.65 139.98 58.67 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.11 0.481 . . . . 50.0 110.075 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 21' ' ' LYS . 87.4 m-20 -141.32 120.47 12.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.5 -0.773 . . . . 50.0 110.286 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.1 -17.08 6.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -70.21 -32.07 69.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 11.3 tptt -95.8 150.21 20.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.782 -2.008 . . . . 50.0 108.165 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 31.6 p90 -111.0 149.15 31.1 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.589 -0.523 . . . . 16.66 109.589 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 11.8 m-85 -128.73 169.78 14.09 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 123.703 1.716 . . . . 50.0 115.374 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.748 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.84 118.39 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 110.167 -3.197 . . . . 16.66 104.464 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -87.12 123.15 6.43 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 119.636 -1.269 . . . . 16.66 115.147 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.421 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -53.41 106.98 0.2 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.488 -1.356 . . . . 16.66 108.154 176.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 92.8 m-20 -61.04 -34.96 75.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.474 0.654 . . . . 25.0 109.394 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.53 ' C ' ' NE2' ' A' ' 30' ' ' GLN . 11.6 tpt180 -101.28 -34.51 9.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.891 -1.05 . . . . 50.0 111.632 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.238 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -92.54 5.82 49.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.826 -0.75 . . . . 16.66 112.148 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.845 ' H ' HE21 ' A' ' 30' ' ' GLN . 0.0 OUTLIER 38.95 36.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.751 1.019 . . . . 16.66 113.751 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.534 ' OD1' ' HB2' ' A' ' 26' ' ' CYS . 1.9 p30 -132.83 166.87 21.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.988 0.813 . . . . 50.0 110.449 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.582 ' HE3' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -128.66 138.18 52.03 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.218 0.822 . . . . 16.66 113.218 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.68 ' OH ' ' CB ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -133.63 151.71 51.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.324 -0.398 . . . . 50.0 110.94 177.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.688 ' HE2' ' HG1' ' A' ' 15' ' ' THR . 0.0 OUTLIER -58.17 140.19 53.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.589 -1.634 . . . . 16.66 106.589 176.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.81 -54.3 5.09 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.159 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.59 ' HD2' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.76 -20.3 64.36 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.53 -0.468 . . . . 50.0 110.309 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.2 t -51.32 -31.77 22.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 119.682 -0.807 . . . . 16.66 108.944 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.52 14.92 7.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.183 -0.917 . . . . 16.66 111.358 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.21 46.26 43.83 Favored Glycine 0 N--CA 1.463 0.47 0 C-N-CA 121.254 -0.498 . . . . 16.66 112.039 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.48 167.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 16.66 111.381 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.23 164.69 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.755 -0.657 . . . . 50.0 110.566 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.35 -55.37 5.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.45 -0.796 . . . . 25.0 110.364 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.573 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.3 m -69.5 -15.47 63.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 50.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.628 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -42.6 -19.8 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.322 -0.854 . . . . 50.0 111.115 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -74.44 -45.13 48.38 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.463 -0.495 . . . . 25.0 111.514 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.05 -45.31 10.29 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.247 1.203 . . . . 50.0 114.247 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 43' ' ' SER . 2.1 pp -55.78 -30.79 61.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.051 0.76 . . . . 16.66 113.051 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.628 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 2.4 pp -86.52 172.38 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.931 -0.708 . . . . 25.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.3 28.18 0.17 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.642 -1.163 . . . . 50.0 109.901 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.57 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.166 -1.42 . . . . 50.0 107.166 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.9 t80 -66.7 145.58 55.39 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.799 -1.091 . . . . 16.66 111.121 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.632 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 22.3 t -133.37 154.11 38.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 113.848 -1.524 . . . . 50.0 108.575 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.421 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 5.8 p -79.92 161.99 63.98 Favored Pre-proline 0 N--CA 1.411 -2.405 0 CA-C-O 121.318 0.58 . . . . 16.66 110.005 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 19.3 Cg_endo -82.67 -27.46 2.11 Favored 'Trans proline' 0 C--N 1.28 -3.043 0 C-N-CA 121.997 1.798 . . . . 16.66 111.625 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -74.28 -30.39 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.087 -1.079 . . . . 50.0 108.087 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.6 m -61.67 -43.42 98.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.43 -1.259 . . . . 16.66 110.675 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.446 ' OE1' ' OE1' ' A' ' 60' ' ' GLU . 26.5 mm100 -53.07 -36.43 60.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 50.0 110.722 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.1 m -61.83 -38.58 88.71 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.742 -0.383 . . . . 50.0 110.456 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.6 p -98.84 -22.45 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.284 -0.416 . . . . 50.0 111.358 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' CYS . 74.7 tt0 -56.58 -33.98 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.851 -0.339 . . . . 50.0 110.451 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 53.3 p30 -74.25 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 50.0 110.685 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.053 -0.975 . . . . 50.0 110.481 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.74 -21.81 26.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.816 2.344 . . . . 0.0 111.978 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.594 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 2.3 mm? -88.16 142.37 27.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.301 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.0 -175.2 35.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.925 -0.87 . . . . 50.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 6' ' ' ASP . 56.5 m -154.31 -116.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.32 . . . . 50.0 110.579 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 5' ' ' SER . 4.6 p-10 43.43 24.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 50.0 110.781 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -130.43 167.12 19.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 50.0 110.592 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.56 -177.23 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.834 -0.621 . . . . 50.0 110.463 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.591 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -75.35 174.81 9.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 50.0 110.644 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.801 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.39 -79.04 0.47 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 34.9 t -41.04 128.43 2.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.27 . . . . 16.66 112.464 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.445 HG22 ' CD2' ' A' ' 33' ' ' TYR . 13.0 pt -62.9 -10.3 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 1.047 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -76.69 -0.76 24.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.59 -1.641 . . . . 16.66 110.375 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 62.84 53.22 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.376 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.82 125.33 11.68 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.4 -0.364 . . . . 50.0 110.097 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.03 146.64 8.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.165 1.91 . . . . 50.0 112.08 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 9.9 t80 -64.76 137.49 57.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.166 0.508 . . . . 50.0 110.689 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 52.6 t0 -140.56 135.42 31.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.838 -0.801 . . . . 50.0 108.838 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.86 -18.12 30.02 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.912 -0.715 . . . . 50.0 109.239 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -60.82 -45.36 94.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.499 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.719 ' HZ2' ' HE2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -86.28 161.7 18.63 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.336 -1.357 . . . . 50.0 107.336 176.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -117.82 136.9 53.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.058 -0.719 . . . . 16.66 109.058 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.759 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 5.6 m-85 -112.64 165.84 11.89 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 124.187 1.946 . . . . 50.0 115.591 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.746 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 109.324 -3.58 . . . . 16.66 103.944 176.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -132.7 123.22 3.45 Favored Glycine 0 C--N 1.319 -0.394 0 C-N-CA 117.928 -2.082 . . . . 16.66 114.709 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.391 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.14 108.8 0.16 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.895 -1.15 . . . . 16.66 107.895 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 22.6 t70 -64.92 -31.04 72.09 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.468 HH11 ' HG1' ' A' ' 59' ' ' THR . 19.4 ttm180 -109.08 -20.09 13.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.105 -1.407 . . . . 50.0 111.597 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -109.4 11.81 24.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.334 -0.947 . . . . 16.66 112.2 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 20.6 pt20 33.84 52.91 0.47 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.789 -0.187 . . . . 16.66 111.481 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.653 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -132.85 166.31 22.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.05 -0.26 . . . . 50.0 110.663 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.653 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -139.44 132.12 28.95 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 121.288 0.566 . . . . 16.66 112.238 -177.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.599 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -137.45 153.19 50.14 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.96 -0.564 . . . . 50.0 112.305 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.719 ' HE2' ' HZ2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -58.89 146.62 36.9 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 105.149 -2.167 . . . . 16.66 105.149 175.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.3 -48.55 33.2 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 119.247 -1.454 . . . . 16.66 111.008 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' C ' ' CD ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -76.91 -18.09 58.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 4.0 t -50.3 -31.65 14.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.645 -0.872 . . . . 16.66 108.645 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.59 14.77 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.972 -1.013 . . . . 16.66 110.798 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.74 46.15 70.18 Favored Glycine 0 N--CA 1.462 0.385 0 N-CA-C 111.569 -0.612 . . . . 16.66 111.569 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.2 167.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.211 0.529 . . . . 16.66 111.732 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.07 164.5 8.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.392 -0.822 . . . . 50.0 110.653 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.678 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.3 pt20 -79.86 -53.46 6.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.269 0.557 . . . . 25.0 110.059 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.681 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 74.5 m -63.98 -22.8 67.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.634 -0.876 . . . . 50.0 108.634 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.547 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.66 -19.46 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.26 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -69.62 -53.64 17.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.924 -1.034 . . . . 25.0 110.665 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' SER . 11.9 tm-20 -89.52 -43.46 10.8 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.105 1.52 . . . . 50.0 115.105 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 43' ' ' SER . 2.5 pp -54.72 -30.49 56.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.189 0.811 . . . . 16.66 113.189 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 2.6 pp -85.77 174.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.653 0.74 . . . . 25.0 109.467 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.15 -51.63 0.77 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.475 -1.239 . . . . 50.0 110.206 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -108.65 59.89 0.6 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 50.0 108.067 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.735 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.2 t80 -65.92 144.02 57.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.635 0.731 . . . . 16.66 110.357 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 5.6 t -123.98 156.3 31.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.443 -1.253 . . . . 50.0 109.058 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.391 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.7 p -85.8 160.52 52.72 Favored Pre-proline 0 N--CA 1.414 -2.239 0 CA-C-O 121.675 0.75 . . . . 16.66 110.685 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.1 Cg_endo -78.34 -22.75 9.32 Favored 'Trans proline' 0 C--N 1.278 -3.14 0 C-N-CA 122.061 1.841 . . . . 16.66 111.223 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -77.61 -31.09 52.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.382 -0.826 . . . . 50.0 108.963 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.59 -46.4 11.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.344 -0.844 . . . . 16.66 110.952 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' O ' ' A' ' 60' ' ' GLU . 12.1 pt20 -49.96 -22.9 1.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 50.0 110.928 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.2 m -53.08 -36.47 60.71 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.554 -0.458 . . . . 50.0 110.117 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.468 ' HG1' HH11 ' A' ' 28' ' ' ARG . 55.5 p -80.14 -23.27 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 50.0 110.882 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' GLN . 95.5 mt-10 -104.18 155.37 18.77 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.996 0.427 . . . . 50.0 110.93 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 47.76 44.68 18.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 50.0 110.642 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.033 -0.984 . . . . 50.0 110.607 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -53.45 142.22 59.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.728 2.285 . . . . 0.0 112.083 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.56 142.86 28.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.582 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 7' ' ' THR . . . -79.99 56.21 4.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.87 -0.892 . . . . 50.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 m -54.84 -33.74 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 50.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.0 -35.69 64.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 50.0 110.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 4' ' ' GLY . 30.8 p -119.19 164.37 15.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.439 . . . . 50.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -79.39 154.77 28.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 50.0 110.879 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.551 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -80.52 168.28 19.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 50.0 110.146 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.587 ' CD2' ' CD1' ' A' ' 32' ' ' TRP . 19.5 m-85 -105.32 -73.4 0.68 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 48.7 t -39.84 128.86 2.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.362 0.601 . . . . 16.66 111.916 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.5 pt -59.59 -7.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.128 -1.064 . . . . 50.0 108.128 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -77.42 2.14 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.716 -1.584 . . . . 16.66 110.928 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 42.0 mttm 69.34 54.81 0.4 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.189 -0.46 . . . . 25.0 111.773 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.67 125.18 2.49 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.537 -0.301 . . . . 50.0 110.258 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' N ' ' HB2' ' A' ' 9' ' ' LEU . 24.6 Cg_exo -56.02 176.47 0.18 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.677 2.252 . . . . 50.0 113.586 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -58.18 143.82 42.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.825 0.821 . . . . 50.0 111.402 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.5 m-20 -136.07 98.03 3.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.162 -1.381 . . . . 50.0 108.755 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -50.7 -14.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.266 0.555 . . . . 50.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 18' ' ' ASP . 24.3 m -80.77 -29.53 36.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.802 -1.184 . . . . 50.0 107.802 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 18' ' ' ASP . 25.3 tptt -100.12 130.09 46.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.62 -1.627 . . . . 50.0 107.636 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.521 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 43.9 p90 -97.0 142.14 29.31 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.078 -0.51 . . . . 16.66 111.091 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CD2' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -119.96 173.78 6.86 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 124.441 2.067 . . . . 50.0 115.151 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.827 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.13 123.5 60.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 108.994 -3.73 . . . . 16.66 104.623 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -89.21 126.34 8.18 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 119.478 -1.344 . . . . 16.66 115.656 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.438 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.16 121.17 3.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.359 -1.348 . . . . 16.66 107.359 176.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.4 t70 -68.3 -31.64 71.22 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.578 0.704 . . . . 25.0 109.216 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NE ' ' OG1' ' A' ' 59' ' ' THR . 32.9 ttt-85 -113.56 -26.46 8.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.588 -1.187 . . . . 50.0 111.81 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.283 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -95.26 12.58 28.49 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.8 -0.76 . . . . 16.66 112.607 -177.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 11.4 pt20 29.92 47.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.823 0.675 . . . . 16.66 112.823 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.56 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -131.36 164.1 26.41 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.069 -0.252 . . . . 50.0 110.544 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.587 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -134.39 125.6 27.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.907 -0.317 . . . . 16.66 111.832 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.649 ' OH ' ' CB ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -131.89 157.45 43.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 121.033 -0.267 . . . . 50.0 111.605 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.753 ' CD2' ' H ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.19 140.48 38.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.392 -1.336 . . . . 16.66 107.392 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.56 -42.57 20.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.379 -1.391 . . . . 16.66 110.615 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.27 -20.47 55.06 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.758 -0.46 . . . . 50.0 109.758 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.3 t -51.33 -32.49 25.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.799 -0.815 . . . . 16.66 108.799 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.5 11.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.028 -0.987 . . . . 16.66 110.988 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.96 45.57 50.37 Favored Glycine 0 N--CA 1.461 0.318 0 CA-C-N 115.934 -0.576 . . . . 16.66 111.837 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.512 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -106.55 163.81 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.89 0.376 . . . . 16.66 110.462 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.748 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.2 mm? -64.73 163.2 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 50.0 110.262 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -56.6 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.413 -0.812 . . . . 25.0 110.63 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.9 m -66.81 -14.64 62.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.151 -0.931 . . . . 50.0 109.164 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.987 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 3.0 tt0 -44.93 -44.47 9.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.523 -0.762 . . . . 50.0 111.056 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.12 -35.04 6.64 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.538 -0.465 . . . . 25.0 111.624 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -87.03 -52.64 5.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.796 0.665 . . . . 50.0 112.796 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 4.2 pp -71.95 4.98 2.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.372 -0.831 . . . . 16.66 111.452 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.987 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -107.34 130.62 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 119.695 -0.802 . . . . 25.0 111.21 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.88 -72.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.815 -1.084 . . . . 50.0 112.345 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.21 68.68 0.81 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.302 -0.629 . . . . 50.0 109.302 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.3 147.43 53.32 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.612 -0.722 . . . . 16.66 109.53 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.677 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.6 t -119.99 155.11 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.469 -0.787 . . . . 50.0 109.023 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.438 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -84.83 160.79 54.95 Favored Pre-proline 0 N--CA 1.412 -2.334 0 CA-C-N 115.596 -0.729 . . . . 16.66 110.944 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 39.0 Cg_endo -77.81 -26.34 6.91 Favored 'Trans proline' 0 C--N 1.279 -3.127 0 C-N-CA 122.251 1.967 . . . . 16.66 111.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.79 -34.05 71.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.193 -1.04 . . . . 50.0 108.193 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -86.12 -32.92 21.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.784 -1.098 . . . . 16.66 110.309 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -54.1 -35.7 62.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 50.0 111.579 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -53.94 -36.23 62.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 50.0 111.114 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.519 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 55.3 p -90.72 -8.69 49.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.4 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -112.6 155.73 23.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.924 0.393 . . . . 50.0 110.971 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.8 120.09 25.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 50.0 110.694 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.991 -1.004 . . . . 50.0 110.486 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.91 -22.75 25.12 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.694 2.262 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.9 mt -97.06 143.4 27.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.653 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.439 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -56.23 -29.17 55.95 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.016 -0.834 . . . . 50.0 111.016 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 4' ' ' GLY . 59.8 p 54.79 -150.4 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.754 0.312 . . . . 50.0 110.805 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.413 ' C ' ' OD1' ' A' ' 6' ' ' ASP . 52.6 p30 -91.92 8.18 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 50.0 111.166 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -121.62 160.93 23.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.447 -0.342 . . . . 50.0 110.459 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -89.4 -177.84 5.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 50.0 110.892 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 7.1 mt -113.68 142.92 45.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 50.0 111.419 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.654 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.0 m-85 -101.85 -67.34 0.87 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.498 -0.927 . . . . 25.0 108.498 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 4.6 t -41.43 114.71 0.54 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.957 -1.019 . . . . 16.66 110.638 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.3 pt -50.92 -8.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.575 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.946 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.68 6.72 10.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.832 -1.076 . . . . 16.66 110.7 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm 64.09 52.63 1.97 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.145 -0.48 . . . . 25.0 111.405 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.43 144.31 22.62 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 50.0 109.669 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.71 155.85 68.35 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.585 2.19 . . . . 50.0 112.408 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.705 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 30.6 t80 -58.24 148.48 27.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 50.0 109.833 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.649 ' H ' ' HH ' ' A' ' 23' ' ' TYR . 91.3 m-20 -140.57 111.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.763 -0.653 . . . . 50.0 111.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.84 -17.37 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 50.0 110.043 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.5 m -76.35 -29.27 57.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.585 -1.265 . . . . 50.0 107.585 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 18' ' ' ASP . 6.7 tptm -99.49 156.47 17.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.456 -1.702 . . . . 50.0 108.492 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 35.4 p90 -111.06 152.25 27.12 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.45 -0.5 . . . . 16.66 110.364 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.705 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 9.5 m-85 -130.46 168.83 16.38 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 123.42 1.581 . . . . 50.0 114.256 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.767 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.36 123.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 110.932 -2.849 . . . . 16.66 105.53 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.52 120.08 6.16 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.876 -1.154 . . . . 16.66 115.773 -174.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.439 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.21 107.6 0.13 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.273 -1.38 . . . . 16.66 107.273 175.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 89.7 m-20 -65.52 -34.08 77.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HE ' HG22 ' A' ' 59' ' ' THR . 37.4 ttt85 -92.71 -39.55 11.2 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.519 -1.673 . . . . 50.0 110.935 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.276 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.09 -28.4 27.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.918 -0.713 . . . . 16.66 111.49 -178.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.755 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER 76.13 28.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.486 0.921 . . . . 16.66 113.486 178.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.518 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.96 166.18 22.97 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 119.776 -0.77 . . . . 50.0 111.079 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 140.66 50.72 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.922 0.712 . . . . 16.66 112.922 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.69 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -133.62 144.38 49.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.454 -0.339 . . . . 50.0 111.061 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.721 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -56.34 139.31 48.88 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.395 -1.706 . . . . 16.66 106.395 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -42.8 -54.34 5.07 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.843 -1.17 . . . . 16.66 111.53 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.466 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.61 -20.28 62.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.486 -0.486 . . . . 50.0 109.784 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.5 -31.88 25.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.281 -0.637 . . . . 16.66 109.281 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.57 13.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.344 -0.844 . . . . 16.66 111.185 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.51 45.98 57.42 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.793 -0.523 . . . . 16.66 111.793 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.86 167.51 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.137 0.494 . . . . 16.66 111.363 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 42.4 mt -61.47 164.85 5.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.555 -0.748 . . . . 50.0 110.582 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.495 HE21 ' HB3' ' A' ' 42' ' ' GLN . 1.1 tt0 -77.92 -55.1 5.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 25.0 110.314 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.601 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 72.7 m -70.78 -15.24 62.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.507 -0.769 . . . . 50.0 109.441 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.552 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -41.97 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.564 -0.744 . . . . 50.0 110.755 -178.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.64 -45.5 58.65 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.939 -0.573 . . . . 25.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 43' ' ' SER . 97.1 mt-10 -88.93 -45.69 9.48 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.593 1.331 . . . . 50.0 114.593 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 43' ' ' SER . 1.8 pp -55.29 -29.28 57.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.948 0.721 . . . . 16.66 112.948 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.6 pp -86.06 174.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.803 0.811 . . . . 25.0 109.641 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -124.51 -69.74 0.79 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.261 -1.336 . . . . 50.0 110.91 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -101.31 70.57 1.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.916 -1.142 . . . . 50.0 107.916 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.3 t80 -65.74 140.12 58.42 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.433 -0.803 . . . . 16.66 110.728 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.72 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.5 t -120.29 155.16 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 114.458 -1.246 . . . . 50.0 108.556 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.439 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -87.28 160.21 49.03 Favored Pre-proline 0 N--CA 1.414 -2.275 0 CA-C-O 121.39 0.614 . . . . 16.66 110.491 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 24.8 Cg_endo -81.52 -25.24 3.86 Favored 'Trans proline' 0 C--N 1.279 -3.095 0 C-N-CA 122.085 1.857 . . . . 16.66 110.764 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -71.34 -35.67 71.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.095 -0.957 . . . . 50.0 108.565 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -70.39 -31.82 69.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.225 -0.898 . . . . 16.66 110.413 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -55.96 -29.86 60.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.924 0.392 . . . . 50.0 110.456 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.4 p -59.1 -24.62 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.031 -0.531 . . . . 50.0 110.867 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.458 HG22 ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -122.72 -16.71 7.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.925 -0.31 . . . . 50.0 111.794 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' CD ' ' C ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -57.0 139.59 51.69 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.256 -0.577 . . . . 50.0 110.429 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -107.74 151.58 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 50.0 110.672 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.957 -1.021 . . . . 50.0 110.406 179.905 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' GLY . 53.5 Cg_exo -48.88 -175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.803 2.335 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.9 tp -52.21 -38.76 58.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.265 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.38 163.67 29.21 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.07 -0.812 . . . . 50.0 111.07 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -29.37 70.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 50.0 110.825 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -74.38 122.04 22.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 50.0 110.87 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -123.62 176.52 6.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.909 -0.587 . . . . 50.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -70.1 -176.26 1.11 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -61.28 -178.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.851 -0.613 . . . . 50.0 110.303 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -69.46 -99.13 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.173 -0.676 . . . . 25.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 15.6 t -40.34 121.86 1.46 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.497 -0.774 . . . . 16.66 112.456 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 pt -59.09 -7.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.521 -1.218 . . . . 50.0 108.807 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.981 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.11 10.45 2.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.414 -1.266 . . . . 16.66 110.848 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.0 mttm 65.63 51.5 1.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.045 -0.525 . . . . 25.0 111.989 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 148.1 31.37 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.736 -0.385 . . . . 50.0 110.552 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.3 158.56 48.38 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.728 2.285 . . . . 50.0 111.8 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.2 t80 -58.31 144.84 39.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.662 -0.415 . . . . 50.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 92.5 m-20 -140.79 116.64 10.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.85 -0.614 . . . . 50.0 110.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.87 -12.86 4.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.389 -0.597 . . . . 50.0 109.389 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 m -79.33 -21.12 46.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.1 tptm -112.98 153.08 28.61 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.524 -1.671 . . . . 50.0 107.824 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 52.2 p90 -111.13 154.11 24.77 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.228 -0.589 . . . . 16.66 110.607 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.765 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.5 m-85 -127.8 169.8 13.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 123.779 1.752 . . . . 50.0 114.475 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.738 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.79 178.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.128 -3.214 . . . . 16.66 103.796 176.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.89 125.45 2.71 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 117.521 -2.275 . . . . 16.66 114.158 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.38 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 105.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.366 -1.346 . . . . 16.66 107.366 176.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' TYR . 84.5 m-20 -71.19 -19.95 62.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.607 HH21 ' CB ' ' A' ' 61' ' ' ASP . 6.9 tpt180 -111.61 -18.22 12.85 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.002 -1.454 . . . . 50.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.207 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -122.8 18.06 10.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.323 -0.951 . . . . 16.66 112.708 -178.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.569 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 19.3 pt20 32.93 54.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.202 0.445 . . . . 16.66 112.202 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.622 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -133.94 167.51 20.46 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 121.096 -0.242 . . . . 50.0 110.485 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.629 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -138.76 133.26 31.95 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.432 0.53 . . . . 16.66 112.432 -177.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.703 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -139.49 155.02 47.82 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.006 -0.543 . . . . 50.0 112.06 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.796 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -61.51 141.79 57.48 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 106.243 -1.762 . . . . 16.66 106.243 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.52 -58.53 4.0 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.633 -1.27 . . . . 16.66 111.518 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -20.95 66.05 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.5 t -51.72 -31.77 27.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.126 -0.63 . . . . 16.66 109.482 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.34 12.52 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.442 -0.799 . . . . 16.66 111.128 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.85 25.09 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 111.608 -0.597 . . . . 16.66 111.608 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.01 167.46 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.178 0.513 . . . . 16.66 112.038 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.49 164.15 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 50.0 110.432 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.638 ' HG2' ' H ' ' A' ' 43' ' ' SER . 7.9 pt20 -82.12 -49.38 10.24 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.963 ' O ' HD12 ' A' ' 47' ' ' LEU . 5.7 m -59.53 -39.0 82.5 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.422 -1.717 . . . . 50.0 107.459 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.718 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -40.15 -16.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.288 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -63.1 -61.65 2.23 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.249 -0.581 . . . . 25.0 111.649 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' A' ' 48' ' ' ILE . 47.4 mp0 -91.87 -47.35 7.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.857 1.799 . . . . 50.0 115.857 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 1.146 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -65.71 14.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.495 1.295 . . . . 16.66 114.495 -174.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 44' ' ' GLU . 2.5 pp -117.15 169.45 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 120.133 -0.627 . . . . 25.0 109.962 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 53.3 t0 -165.42 27.59 0.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.748 0.785 . . . . 50.0 109.935 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.46 16.09 0.52 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.248 -1.39 . . . . 50.0 107.248 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.634 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.3 t80 -67.37 147.61 52.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.802 -1.09 . . . . 16.66 110.511 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 25.2 t -137.26 157.57 34.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.888 -1.505 . . . . 50.0 108.917 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.38 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.0 p -80.03 158.21 72.71 Favored Pre-proline 0 N--CA 1.414 -2.254 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 11.0 Cg_endo -81.35 -27.94 2.57 Favored 'Trans proline' 0 C--N 1.273 -3.406 0 C-N-CA 121.842 1.694 . . . . 16.66 110.932 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -71.97 -33.83 68.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.461 -0.79 . . . . 50.0 108.877 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.151 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -65.43 -34.68 78.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.59 -0.732 . . . . 16.66 110.559 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -51.29 -36.99 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 50.0 110.34 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 p -78.62 -31.88 47.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.354 -0.384 . . . . 50.0 110.159 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 60' ' ' GLU . 33.3 m -71.87 -50.66 27.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.158 -0.473 . . . . 50.0 111.289 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 59' ' ' THR . 98.6 mt-10 12.01 59.99 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.325 0.391 . . . . 50.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.607 ' CB ' HH21 ' A' ' 28' ' ' ARG . 91.2 m-20 36.88 -88.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 50.0 111.049 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.029 -0.986 . . . . 50.0 110.52 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.482 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 50.0 Cg_endo -69.21 158.02 59.24 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.784 2.322 . . . . 0.0 111.987 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.7 mt -56.96 -32.75 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.72 -69.46 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.899 -0.88 . . . . 50.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.6 m -64.86 165.38 10.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 50.0 110.81 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -48.88 160.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 50.0 110.312 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 p -81.29 161.85 23.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.486 0.66 . . . . 50.0 111.556 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.674 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -151.45 -176.95 5.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.753 -1.112 . . . . 50.0 109.158 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.575 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 17.3 mt -83.75 137.44 33.74 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.924 -0.31 . . . . 50.0 110.714 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 2.7 m-85 -106.12 -6.26 18.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.364 0.602 . . . . 25.0 111.014 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -104.15 123.08 46.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.923 -1.035 . . . . 16.66 110.844 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' A' ' 33' ' ' TYR . 14.0 pt -59.96 -8.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.203 -1.406 . . . . 50.0 107.203 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.961 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -84.79 2.19 43.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.47 -1.696 . . . . 16.66 109.472 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mttp 67.78 64.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.553 -0.749 . . . . 25.0 112.246 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.43 HG23 ' HE2' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -155.3 141.64 13.13 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.709 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.98 158.73 52.66 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.657 2.238 . . . . 50.0 112.104 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.753 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 20.0 t80 -69.37 139.07 54.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.078 0.466 . . . . 50.0 110.936 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 11.5 t70 -140.58 128.62 22.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.593 -0.731 . . . . 50.0 109.47 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.6 -21.9 41.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.074 -0.512 . . . . 50.0 110.907 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -67.17 -33.79 76.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.744 -1.206 . . . . 50.0 107.744 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.644 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -85.41 152.49 23.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.259 -1.791 . . . . 50.0 109.114 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 22.0 p90 -114.17 140.6 48.4 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.32 -0.993 . . . . 16.66 108.32 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.753 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 28.5 m-85 -122.61 171.35 9.19 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 124.089 1.9 . . . . 50.0 115.621 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.79 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.28 118.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 109.513 -3.494 . . . . 16.66 103.977 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -90.42 125.64 8.01 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.58 -1.295 . . . . 16.66 116.279 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.415 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -46.64 108.45 0.14 Allowed 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.31 -1.367 . . . . 16.66 107.31 175.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 57.3 t0 -61.52 -29.3 69.9 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.018 -0.734 . . . . 25.0 109.018 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.42 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 13.6 ttt85 -113.72 -20.36 11.19 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.705 -1.134 . . . . 50.0 112.344 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.245 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -107.96 20.29 18.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.317 -0.953 . . . . 16.66 112.981 -177.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 29' ' ' CYS . 16.4 pt20 31.06 47.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.521 0.563 . . . . 16.66 112.521 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.529 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -131.54 159.79 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.748 -0.381 . . . . 50.0 110.703 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -135.74 122.87 21.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.727 0.299 . . . . 16.66 111.049 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.679 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -124.09 153.66 41.1 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.456 -0.307 . . . . 50.0 111.406 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.748 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -54.8 146.42 17.24 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.728 -1.953 . . . . 16.66 105.728 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -46.2 -53.18 9.52 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 119.461 -1.352 . . . . 16.66 111.505 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -73.7 -19.4 60.83 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.715 -0.476 . . . . 50.0 109.715 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.6 t -49.96 -31.29 12.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.77 9.45 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.203 -0.908 . . . . 16.66 110.3 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.79 45.83 20.16 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.395 -0.682 . . . . 16.66 111.395 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 ' CD1' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -117.3 167.53 10.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.91 0.386 . . . . 16.66 110.876 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 90.1 mt -65.64 163.24 16.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.338 0.589 . . . . 50.0 109.666 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.07 -54.88 5.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.937 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.0 t -70.32 -14.77 62.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.431 -0.804 . . . . 50.0 110.677 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.639 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.7 mt-10 -44.4 -30.1 0.79 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.648 -0.421 . . . . 50.0 111.159 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -37.66 88.11 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.07 -0.652 . . . . 25.0 110.53 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.3 mm-40 -87.89 -33.17 18.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.227 1.195 . . . . 50.0 114.227 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 3.7 pp -94.31 16.24 15.51 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 112.716 0.636 . . . . 16.66 112.716 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -120.17 146.87 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 C-N-CA 118.704 -1.198 . . . . 25.0 112.888 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -94.38 -81.22 0.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.074 -0.966 . . . . 50.0 111.792 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.27 69.89 1.03 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.585 -0.279 . . . . 50.0 110.449 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.617 ' CG ' ' HB ' ' A' ' 24' ' ' ILE . 5.1 t80 -67.28 138.85 57.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.476 -0.89 . . . . 16.66 108.802 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.6 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 23.9 t -119.38 150.81 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.722 -0.672 . . . . 50.0 109.315 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.415 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.8 p -80.99 160.91 64.94 Favored Pre-proline 0 N--CA 1.411 -2.395 0 CA-C-N 115.316 -0.857 . . . . 16.66 110.052 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 27.9 Cg_endo -80.43 -29.16 2.52 Favored 'Trans proline' 0 C--N 1.278 -3.177 0 C-N-CA 122.001 1.8 . . . . 16.66 111.405 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 58' ' ' SER . 8.8 tp-100 -70.83 -32.88 70.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 3.0 m -62.61 -39.69 94.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.789 -1.096 . . . . 16.66 110.34 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -55.01 -17.23 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 50.0 110.352 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 55' ' ' GLN . 23.1 m -54.51 -33.92 60.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 50.0 110.42 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.2 p -123.9 -17.03 6.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.903 0.335 . . . . 50.0 111.903 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 41.68 -114.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.738 -0.385 . . . . 50.0 110.679 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 54.5 p30 -67.81 175.15 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 50.0 110.406 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.983 -1.008 . . . . 50.0 110.55 -179.878 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 4' ' ' GLY . 35.8 Cg_exo -54.38 -29.07 56.67 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.022 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.404 ' CD1' ' C ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER 62.78 -77.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.392 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -84.81 -179.54 51.21 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.898 -0.881 . . . . 50.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.1 p -75.16 158.32 33.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.854 0.359 . . . . 50.0 110.593 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.76 120.64 27.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 50.0 110.41 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -81.39 165.04 21.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 50.0 110.481 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -130.33 158.07 40.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 50.0 110.655 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.751 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.1 -174.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.587 . . . . 50.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -59.55 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.389 0.614 . . . . 25.0 110.491 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 43.4 t -37.67 122.51 0.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.034 -0.985 . . . . 16.66 113.298 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' LYS . 8.8 pt -59.95 -13.98 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 114.862 -1.063 . . . . 50.0 108.138 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.965 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -72.25 4.5 3.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.811 -1.54 . . . . 16.66 110.137 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' ILE . 28.6 mtpt 65.85 50.29 1.54 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.488 -0.778 . . . . 25.0 112.065 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.462 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -141.23 123.51 9.41 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.01 156.66 12.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.346 2.031 . . . . 50.0 111.948 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 4.5 t80 -61.28 134.25 56.77 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.293 0.568 . . . . 50.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 20' ' ' SER . 88.1 m-20 -141.46 116.02 9.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.085 -0.961 . . . . 50.0 108.83 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -43.92 -13.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.627 -0.429 . . . . 50.0 110.481 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -62.84 -38.41 90.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.748 -0.834 . . . . 50.0 108.748 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.726 ' HZ2' ' NE2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -99.85 167.52 10.47 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.449 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 52.1 p90 -120.77 142.32 49.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.694 -0.684 . . . . 16.66 109.168 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 2.9 m-85 -114.03 155.49 25.82 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 123.791 1.758 . . . . 50.0 115.414 -175.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.725 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -121.92 126.43 74.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 110.2 -3.182 . . . . 16.66 105.123 176.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.66 123.68 7.41 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.556 -1.307 . . . . 16.66 115.054 -175.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -49.86 107.0 0.13 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.65 -1.275 . . . . 16.66 108.89 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 80.8 m-20 -56.88 -35.13 68.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.265 -0.574 . . . . 25.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HE ' ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -112.71 -12.71 13.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 50.0 111.873 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -110.21 12.58 23.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.323 -0.951 . . . . 16.66 111.57 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.5 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 10.0 pt20 29.92 53.43 0.12 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.941 0.4 . . . . 16.66 111.101 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.645 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 2.8 m-20 -132.45 166.64 21.54 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.31 -0.404 . . . . 50.0 110.189 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -141.36 132.8 26.81 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.333 -0.547 . . . . 16.66 111.676 -177.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.646 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -138.56 155.47 48.34 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 50.0 112.494 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.726 ' NE2' ' HZ2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -60.62 146.58 44.87 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 105.064 -2.198 . . . . 16.66 105.064 175.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.0 -51.27 25.37 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 119.136 -1.507 . . . . 16.66 110.831 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -18.48 60.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.712 -0.395 . . . . 50.0 109.953 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.0 t -50.39 -32.48 17.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.066 -0.716 . . . . 16.66 109.066 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.18 18.68 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.016 -0.993 . . . . 16.66 111.219 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.98 46.19 82.92 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 111.513 -0.635 . . . . 16.66 111.513 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.535 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.88 164.01 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.864 0.364 . . . . 16.66 110.934 -178.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.755 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 10.4 mp -58.0 164.76 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.245 0.545 . . . . 50.0 110.162 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -56.26 4.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.34 -0.845 . . . . 25.0 110.985 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' ALA . 67.4 m -71.23 -15.55 62.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.59 -0.732 . . . . 50.0 109.236 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.755 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 2.1 tt0 -43.36 -19.13 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.481 -0.781 . . . . 50.0 111.172 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -68.56 -47.01 67.92 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.432 -0.507 . . . . 25.0 111.19 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.25 -45.69 9.86 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.261 1.208 . . . . 50.0 114.261 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 48' ' ' ILE . 2.3 pp -55.15 -28.16 50.76 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.842 0.682 . . . . 16.66 112.842 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.6 pp -85.76 174.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.607 0.718 . . . . 25.0 109.349 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -137.46 -53.88 0.68 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.642 -1.163 . . . . 50.0 110.455 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -103.69 56.35 0.74 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.823 -1.177 . . . . 50.0 107.823 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.66 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.3 t80 -65.27 141.46 58.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.537 0.684 . . . . 16.66 109.876 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.1 t -126.06 154.83 35.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.375 -1.284 . . . . 50.0 109.288 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -82.21 159.51 64.84 Favored Pre-proline 0 N--CA 1.413 -2.289 0 CA-C-N 115.69 -0.686 . . . . 16.66 109.824 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 22.6 Cg_endo -81.28 -25.65 3.79 Favored 'Trans proline' 0 C--N 1.275 -3.297 0 C-N-CA 121.962 1.775 . . . . 16.66 111.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -74.79 -32.59 62.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.719 . . . . 50.0 109.101 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.145 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -65.92 -38.5 88.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 16.66 110.907 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -50.72 -40.19 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.802 -0.444 . . . . 50.0 109.802 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -72.76 -29.18 63.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 50.0 109.323 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -72.88 -54.84 7.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.633 -0.712 . . . . 50.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 95.5 mt-10 -128.37 155.22 45.03 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.861 0.362 . . . . 50.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -131.44 162.67 29.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.099 -0.501 . . . . 50.0 110.408 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' OXT' ' NH2' ' A' ' 28' ' ' ARG . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.094 -0.955 . . . . 50.0 110.638 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' H3 ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.456 ' HD2' ' H3 ' ' A' ' 1' ' ' GLY . 52.8 Cg_exo -52.0 142.34 44.17 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.455 2.104 . . . . 0.0 112.159 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.46 149.28 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.365 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.63 51.93 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.86 -0.896 . . . . 50.0 110.86 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' ASP . 28.7 p -79.54 5.4 13.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 50.0 110.601 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 52.8 p30 -56.25 -155.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.258 -0.428 . . . . 50.0 110.569 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 14.8 m -80.96 116.22 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.885 -0.326 . . . . 50.0 110.754 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 7' ' ' THR . 8.3 mtpt -145.69 -177.18 5.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.214 0.53 . . . . 50.0 110.771 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.2 158.91 24.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.799 . . . . 50.0 109.426 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.592 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.9 m-85 -94.04 -71.92 0.64 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.562 -0.533 . . . . 25.0 109.562 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 37.4 t -40.52 111.0 0.17 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.5 -0.773 . . . . 16.66 110.334 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 14' ' ' LYS . 18.8 pt -51.84 -7.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.918 -0.771 . . . . 50.0 108.918 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -83.49 30.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.484 -1.234 . . . . 16.66 109.392 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 12' ' ' ILE . 48.8 pttt 42.66 55.81 4.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.489 -0.778 . . . . 25.0 111.619 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 p -145.54 141.55 17.06 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.51 -0.314 . . . . 50.0 110.28 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.2 154.01 56.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.451 2.101 . . . . 50.0 111.482 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 17.5 t80 -57.81 138.71 55.37 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.05 -0.66 . . . . 50.0 109.84 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.5 m-20 -141.56 118.58 11.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.1 -0.955 . . . . 50.0 110.435 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -51.23 -22.9 2.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.055 -0.72 . . . . 50.0 109.055 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -63.45 -35.4 80.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.972 -1.121 . . . . 50.0 107.972 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -90.9 155.14 18.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 113.868 -1.514 . . . . 50.0 108.926 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' PHE . 46.0 p90 -118.39 123.34 45.02 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.03 0.919 . . . . 16.66 110.168 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 m-85 -103.03 162.55 12.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 123.769 1.747 . . . . 50.0 114.879 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.826 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -130.8 117.46 38.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 110.183 -3.189 . . . . 16.66 103.63 176.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.28 135.46 13.34 Favored Glycine 0 C--N 1.316 -0.543 0 N-CA-C 116.866 1.507 . . . . 16.66 116.866 -173.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.45 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.7 OUTLIER -46.86 117.78 1.8 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.946 -1.627 . . . . 16.66 108.503 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.625 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.9 t70 -51.71 -46.49 63.93 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.662 -0.815 . . . . 25.0 109.818 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -117.34 -5.94 11.27 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.212 0.819 . . . . 50.0 113.212 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.265 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -98.08 14.66 26.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 118.669 -1.212 . . . . 16.66 111.37 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.569 ' CD ' ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER 30.53 50.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.716 . . . . 16.66 111.963 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.552 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 10.2 m-20 -131.87 163.92 27.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.414 -0.357 . . . . 50.0 110.193 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.549 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -136.57 126.22 25.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.74 0.305 . . . . 16.66 110.832 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.647 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.8 141.82 51.85 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.796 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 6.6 p-80 -56.02 146.99 20.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.649 -1.612 . . . . 16.66 106.649 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -40.36 -60.7 1.95 Allowed Glycine 0 C--N 1.306 -1.111 0 C-N-CA 119.913 -1.137 . . . . 16.66 113.382 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.437 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.82 -20.36 64.31 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.221 0.534 . . . . 50.0 109.783 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -49.3 -25.9 2.69 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.343 -0.984 . . . . 16.66 108.343 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' A' ' 36' ' ' ARG . 17.7 m -124.32 7.8 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.184 -0.916 . . . . 16.66 111.345 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 79.35 46.38 8.14 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.824 -0.91 . . . . 16.66 110.824 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.457 HG21 ' O ' ' A' ' 41' ' ' LEU . 1.1 tp -106.0 155.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.019 0.437 . . . . 16.66 110.692 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' O ' HG21 ' A' ' 40' ' ' ILE . 2.7 mt -61.92 166.19 4.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.942 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -70.61 -53.55 15.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.76 -0.654 . . . . 25.0 109.362 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' ALA . 75.6 m -75.58 -14.65 60.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.218 -0.901 . . . . 50.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.984 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -43.11 -18.17 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.932 -0.576 . . . . 50.0 110.203 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.06 -43.55 64.72 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.519 -0.472 . . . . 25.0 110.969 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.683 ' C ' ' H ' ' A' ' 48' ' ' ILE . 97.4 mt-10 -87.6 -52.98 5.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.138 0.792 . . . . 50.0 113.138 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.67 9.08 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.049 -0.523 . . . . 16.66 110.63 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.984 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -112.62 135.66 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.282 -0.872 . . . . 25.0 112.146 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 59.5 t0 -91.59 -71.89 0.61 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.996 -1.002 . . . . 50.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' OE1' ' OD1' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -130.29 78.42 1.84 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.889 -0.782 . . . . 50.0 108.889 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.762 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.31 147.32 53.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.026 -0.731 . . . . 16.66 109.026 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.762 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 21.5 t -110.71 158.87 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.243 -0.583 . . . . 50.0 109.9 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.45 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -89.38 159.61 44.06 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 115.704 -0.68 . . . . 16.66 110.12 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 43.4 Cg_endo -79.28 -30.45 2.6 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 C-N-CA 121.746 1.631 . . . . 16.66 110.834 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.91 -32.99 73.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.588 -1.264 . . . . 50.0 107.588 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.115 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.1 m -60.73 -42.69 97.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.177 -1.374 . . . . 16.66 109.914 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' O ' ' A' ' 60' ' ' GLU . 93.1 mt-30 -57.73 -37.64 73.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.425 -0.807 . . . . 50.0 110.245 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.5 m -60.84 -38.93 87.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.312 -0.625 . . . . 50.0 109.312 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.405 ' HB ' ' OE1' ' A' ' 60' ' ' GLU . 28.4 m -77.83 -48.33 16.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.629 -0.714 . . . . 50.0 110.629 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 57' ' ' GLN . 51.9 mp0 -114.78 147.35 39.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.669 -0.412 . . . . 50.0 110.804 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 55.78 45.67 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 50.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.019 -0.991 . . . . 50.0 110.481 179.912 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.79 120.38 7.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.545 2.164 . . . . 0.0 111.93 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.86 -37.86 88.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.43 49.56 5.43 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.326 -0.71 . . . . 50.0 111.326 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 t -97.61 128.85 44.64 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.838 0.351 . . . . 50.0 110.315 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 7' ' ' THR . 33.7 p-10 -67.33 -39.62 85.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 50.0 111.476 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.534 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.5 p -149.39 -170.28 3.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.259 0.552 . . . . 50.0 111.559 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 17.7 mmmt -104.14 -177.6 3.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.373 -0.83 . . . . 50.0 111.082 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.58 144.45 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 50.0 110.894 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.8 m-85 -106.17 -67.35 0.94 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.7 t -41.63 116.53 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.27 -0.877 . . . . 16.66 110.742 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.3 pt -52.3 -7.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.18 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.947 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -79.85 3.08 20.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.662 -1.153 . . . . 16.66 110.671 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.1 mttp 67.94 55.17 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.187 -0.46 . . . . 25.0 111.786 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.492 ' CG2' ' HE2' ' A' ' 34' ' ' HIS . 0.6 OUTLIER -147.62 145.2 20.7 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 110.063 -0.347 . . . . 50.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.58 150.37 79.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.447 2.098 . . . . 50.0 111.874 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.741 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.0 t80 -54.26 146.24 15.82 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.49 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 91.2 m-20 -140.56 112.75 7.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.999 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.21 -17.6 7.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 50.0 109.934 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 t -72.11 -31.93 66.49 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.313 -1.366 . . . . 50.0 107.313 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -97.93 157.28 16.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.07 -1.877 . . . . 50.0 109.006 179.079 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 45.5 p90 -114.17 146.58 40.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.303 -0.559 . . . . 16.66 109.978 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.741 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 5.7 m-85 -122.83 165.22 16.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 123.355 1.55 . . . . 50.0 114.269 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.772 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -123.96 119.66 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 111.099 -2.773 . . . . 16.66 105.18 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -84.96 124.33 6.69 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.545 -1.312 . . . . 16.66 114.534 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.435 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -46.8 107.78 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.656 -1.609 . . . . 16.66 106.656 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 54.9 t0 -59.89 -29.82 68.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' NH2' ' OE2' ' A' ' 60' ' ' GLU . 13.6 tpp180 -113.89 -13.34 12.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.548 -1.205 . . . . 50.0 111.695 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.326 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -112.3 10.54 20.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 119.861 -0.735 . . . . 16.66 111.798 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.593 ' NE2' ' O ' ' A' ' 29' ' ' CYS . 3.8 pp0? 34.02 49.65 0.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.188 0.44 . . . . 16.66 112.188 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.697 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.1 m120 -132.25 166.19 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.946 -0.39 . . . . 50.0 109.946 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -134.53 133.04 39.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 120.801 -0.36 . . . . 16.66 111.936 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.77 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -132.94 143.58 49.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.012 178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.793 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -51.27 143.33 11.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.923 -1.51 . . . . 16.66 106.923 176.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.11 -59.59 2.91 Favored Glycine 0 C--N 1.318 -0.437 0 C-N-CA 119.885 -1.15 . . . . 16.66 111.396 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -19.06 63.99 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.762 -0.375 . . . . 50.0 110.394 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.08 -30.2 10.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.539 -0.911 . . . . 16.66 108.539 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.52 8.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.251 -0.886 . . . . 16.66 111.146 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.66 45.52 10.76 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.167 -0.54 . . . . 16.66 112.268 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.488 ' CG2' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -112.98 167.07 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.131 0.491 . . . . 16.66 110.923 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 6.5 mp -64.24 161.87 15.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 50.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -54.33 6.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.859 -0.793 . . . . 25.0 108.859 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.9 t -60.01 -12.52 8.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.707 -1.133 . . . . 50.0 109.07 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.821 ' CD ' ' N ' ' A' ' 45' ' ' ALA . 1.9 pp20? -40.49 -55.75 2.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.211 -0.904 . . . . 50.0 111.068 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.821 ' N ' ' CD ' ' A' ' 44' ' ' GLU . . . -56.55 -26.22 54.36 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.342 -0.844 . . . . 25.0 110.473 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' SER . 84.6 tt0 -86.77 -25.45 24.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.181 0.515 . . . . 50.0 111.965 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.451 ' H ' ' HG ' ' A' ' 47' ' ' LEU . 4.2 pp -117.92 11.51 13.48 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 115.599 -0.728 . . . . 16.66 112.35 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.789 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -119.15 145.39 25.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.097 -1.041 . . . . 25.0 111.864 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.505 ' N ' HD11 ' A' ' 48' ' ' ILE . 22.5 t70 -146.65 -42.62 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.163 -0.926 . . . . 50.0 111.628 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -94.21 24.88 4.09 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 2.7 t80 -65.28 141.74 58.51 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.47 -0.786 . . . . 16.66 109.061 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 4.9 t -129.32 157.77 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.822 -1.081 . . . . 50.0 108.423 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.435 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.3 p -79.62 158.92 72.84 Favored Pre-proline 0 N--CA 1.414 -2.265 0 CA-C-O 121.66 0.743 . . . . 16.66 110.693 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 23.8 Cg_endo -81.05 -15.75 10.24 Favored 'Trans proline' 0 C--N 1.278 -3.146 0 C-N-CA 122.15 1.9 . . . . 16.66 111.573 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.533 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 11.4 pt20 -87.53 -30.38 20.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 50.0 109.52 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.156 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -86.22 -39.16 16.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.924 -0.58 . . . . 16.66 111.023 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -49.61 -32.87 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.736 -0.386 . . . . 50.0 110.612 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.1 p -56.99 -31.84 65.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.006 -0.368 . . . . 50.0 110.006 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 56' ' ' CYS . 43.2 p -71.21 -37.97 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 50.0 110.33 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.561 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 23.8 pt-20 -174.71 -174.81 0.85 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.115 -0.493 . . . . 50.0 110.632 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 55.69 45.44 24.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 50.0 110.712 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.028 -0.987 . . . . 50.0 110.533 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 4' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.44 -64.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.659 2.239 . . . . 0.0 112.067 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.45 -36.52 82.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -103.66 134.86 12.08 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.05 -0.82 . . . . 50.0 111.05 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.8 t -128.45 142.51 51.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 50.0 110.583 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 46.5 p30 -148.62 104.14 3.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 50.0 110.652 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -121.82 161.0 23.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.473 . . . . 50.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -136.95 173.73 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.99 -0.55 . . . . 50.0 110.246 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.679 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.51 -176.1 0.1 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.694 -0.402 . . . . 50.0 110.461 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.616 ' CD2' ' CD1' ' A' ' 32' ' ' TRP . 2.6 m-85 -95.38 -75.49 0.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 120.107 -0.637 . . . . 25.0 112.04 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 11.4 t -38.39 118.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.428 0.632 . . . . 16.66 112.146 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 pt -53.31 -7.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.148 -0.933 . . . . 50.0 108.97 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.27 5.51 19.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.396 -1.274 . . . . 16.66 110.911 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 68.14 51.68 0.71 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.168 -0.469 . . . . 25.0 111.891 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.468 ' H ' HD22 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -150.27 124.96 4.67 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.932 -0.307 . . . . 50.0 110.792 179.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 38.1 Cg_exo -55.19 162.68 5.34 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.644 2.229 . . . . 50.0 112.654 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.87 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 11.4 t80 -63.3 138.39 58.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.538 0.685 . . . . 50.0 111.128 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.859 ' H ' ' HH ' ' A' ' 23' ' ' TYR . 70.8 m-20 -142.91 131.6 22.59 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.652 -1.158 . . . . 50.0 109.951 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.07 -20.74 62.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 50.0 110.395 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -63.11 -30.03 71.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.699 0.761 . . . . 50.0 109.1 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.716 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -106.09 158.35 16.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 114.378 -1.283 . . . . 50.0 107.685 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.417 ' CE2' ' HA3' ' A' ' 35' ' ' GLY . 45.8 p90 -119.38 137.91 53.43 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.082 -0.647 . . . . 16.66 109.288 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.87 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 2.2 m-85 -111.02 170.3 8.19 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 124.066 1.889 . . . . 50.0 115.331 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.825 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.32 118.72 24.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 109.747 -3.388 . . . . 16.66 105.07 177.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.63 124.8 6.99 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.037 1.175 . . . . 16.66 116.037 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.472 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -49.17 107.41 0.14 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.6 -1.259 . . . . 16.66 107.6 175.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 83.7 m-20 -61.4 -35.61 77.99 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.352 0.596 . . . . 25.0 109.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -19.56 14.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.103 -0.953 . . . . 50.0 111.327 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.315 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -94.39 -29.07 15.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.611 -0.835 . . . . 16.66 110.53 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.589 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 75.89 26.16 1.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.336 0.865 . . . . 16.66 113.336 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.708 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 14.7 p30 -132.63 167.41 20.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.859 -0.525 . . . . 50.0 110.091 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -121.31 145.04 48.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.429 0.899 . . . . 16.66 113.429 -176.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.708 ' OH ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -132.39 146.65 52.11 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.108 -0.496 . . . . 50.0 110.457 176.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.844 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -55.03 143.23 27.33 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.578 -1.638 . . . . 16.66 106.578 176.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -42.6 -58.3 3.57 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.0 -1.095 . . . . 16.66 111.697 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' H ' ' CD ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -71.61 -18.36 62.22 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.822 -0.351 . . . . 50.0 110.178 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.9 t -49.54 -31.47 10.4 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.799 -0.76 . . . . 16.66 109.003 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.96 12.27 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.229 -0.896 . . . . 16.66 111.066 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.79 45.44 58.11 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.811 -0.631 . . . . 16.66 111.709 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.04 167.66 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.161 0.505 . . . . 16.66 111.219 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.8 mt -62.76 164.5 7.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.584 -0.734 . . . . 50.0 110.911 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.1 -55.13 5.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.166 -0.925 . . . . 25.0 110.426 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.594 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.8 m -66.11 -15.78 63.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.863 -1.062 . . . . 50.0 109.625 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.501 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 0.7 OUTLIER -42.65 -32.88 0.63 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.267 0.556 . . . . 50.0 109.753 -179.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.05 -38.8 72.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.56 -0.745 . . . . 25.0 110.399 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' SER . 36.5 tp10 -88.31 -10.67 48.75 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.808 1.04 . . . . 50.0 113.808 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 43' ' ' SER . 4.1 pp -115.76 16.51 16.33 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.34 0.496 . . . . 16.66 112.34 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.55 HG13 ' H ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -124.7 160.08 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 118.45 -1.3 . . . . 25.0 113.763 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' H ' HG13 ' A' ' 48' ' ' ILE . 54.3 t0 -130.43 -44.8 1.11 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.163 -1.38 . . . . 50.0 111.027 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' C ' ' OD2' ' A' ' 27' ' ' ASP . 95.5 mt-10 -120.97 52.22 1.21 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.593 -0.276 . . . . 50.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.612 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 1.5 t80 -66.78 137.56 56.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.267 -0.973 . . . . 16.66 108.375 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.564 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 12.3 t -116.92 153.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.472 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -82.13 161.83 58.88 Favored Pre-proline 0 N--CA 1.409 -2.513 0 CA-C-N 115.217 -0.901 . . . . 16.66 110.859 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.4 Cg_endo -79.48 -26.47 4.86 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.113 1.876 . . . . 16.66 111.388 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -74.37 -30.96 62.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.194 -1.039 . . . . 50.0 108.194 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 2.5 m -68.34 -40.77 81.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.608 -1.178 . . . . 16.66 110.988 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 60' ' ' GLU . 96.5 mt-30 -50.56 -32.0 17.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 50.0 110.746 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -55.78 -39.78 71.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.36 -0.607 . . . . 50.0 109.36 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 m -70.75 -42.94 69.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.835 -0.621 . . . . 50.0 110.563 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.0 mt-10 -82.36 149.21 27.83 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.309 -0.405 . . . . 50.0 110.878 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 52.7 p30 -88.21 7.61 31.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 50.0 110.64 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.037 -0.982 . . . . 50.0 110.527 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.3 -13.69 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.973 2.449 . . . . 0.0 112.09 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 mt -82.32 135.86 35.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.53 -30.6 72.27 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 50.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 m 64.7 56.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 50.0 110.407 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.74 120.0 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 50.0 110.708 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' OG1' ' OH ' ' A' ' 10' ' ' TYR . 67.6 p -96.58 -175.82 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 50.0 110.848 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -70.83 -177.97 1.75 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 50.0 111.184 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.82 146.78 46.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.599 -0.728 . . . . 50.0 110.235 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.598 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.8 m-85 -99.71 -64.44 1.04 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.9 t -46.47 118.55 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.084 -0.962 . . . . 16.66 110.28 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.0 pt -53.62 -7.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.927 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -87.78 28.76 0.97 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.319 -1.309 . . . . 16.66 110.665 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.9 pttm 41.56 65.88 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 25.0 111.685 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 139.15 11.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.094 -0.503 . . . . 50.0 109.731 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.64 154.93 72.04 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.348 2.032 . . . . 50.0 112.049 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.747 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 25.6 t80 -55.43 147.3 17.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.034 0.445 . . . . 50.0 109.918 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 21' ' ' LYS . 91.1 m-20 -140.58 109.08 5.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.013 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.3 -14.7 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.1 m -76.65 -29.81 56.56 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -100.9 155.02 18.18 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.234 -1.803 . . . . 50.0 107.997 178.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 32.1 p90 -109.61 152.84 25.02 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.193 -0.603 . . . . 16.66 110.584 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.747 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.9 m-85 -128.24 162.05 27.9 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.46 1.6 . . . . 50.0 114.294 -177.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.835 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.11 117.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 110.883 -2.871 . . . . 16.66 104.188 176.049 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.81 131.17 10.4 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.953 -1.118 . . . . 16.66 115.685 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.411 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -47.36 108.03 0.14 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.481 -1.303 . . . . 16.66 107.481 176.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.62 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 51.2 t0 -61.13 -31.8 71.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.313 0.577 . . . . 25.0 109.704 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.575 HH21 ' N ' ' A' ' 61' ' ' ASP . 7.5 tpt180 -113.1 -16.15 12.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.09 -0.959 . . . . 50.0 112.023 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.192 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -112.15 14.01 20.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.174 -1.01 . . . . 16.66 112.569 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 21.1 pt20 39.29 44.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.282 1.586 . . . . 16.66 115.282 176.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.575 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -134.15 165.98 23.81 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.407 -0.917 . . . . 50.0 110.631 177.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -127.52 135.71 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 16.66 111.823 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.672 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -134.97 144.88 47.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.276 -0.42 . . . . 50.0 110.691 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.766 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -53.51 142.11 23.32 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.645 -1.613 . . . . 16.66 106.645 176.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.19 -56.34 4.0 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 119.784 -1.198 . . . . 16.66 111.547 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -18.51 61.96 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.45 -0.5 . . . . 50.0 110.203 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.23 -29.85 10.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.83 14.61 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.246 -0.888 . . . . 16.66 111.108 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.85 46.18 47.11 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.102 -0.571 . . . . 16.66 111.758 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.406 ' CD1' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -115.58 162.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 16.66 110.85 -179.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' A' ' 42' ' ' GLN . 2.0 tp -64.54 163.79 12.9 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 121.047 0.451 . . . . 50.0 109.992 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.813 ' HG2' ' H ' ' A' ' 43' ' ' SER . 4.2 pt20 -80.05 -53.44 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.009 -0.541 . . . . 25.0 110.075 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.813 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 29.6 t -64.98 -22.38 66.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 1.029 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.8 mt-10 -44.83 -17.45 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.555 ' N ' ' C ' ' A' ' 43' ' ' SER . . . -70.44 -45.11 66.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.479 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.712 ' C ' ' H ' ' A' ' 48' ' ' ILE . 96.4 mt-10 -88.5 -53.29 4.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.256 0.836 . . . . 50.0 113.256 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.593 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.73 11.56 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.144 0.497 . . . . 16.66 110.572 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 1.029 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -114.42 136.34 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.159 -0.928 . . . . 25.0 112.042 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.07 -73.64 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 50.0 111.818 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.53 71.95 1.24 Allowed 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.191 -0.67 . . . . 50.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.713 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.22 145.3 55.94 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.593 -0.73 . . . . 16.66 109.715 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.713 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 11.2 t -112.57 157.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.659 -0.701 . . . . 50.0 109.234 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.411 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.2 p -86.66 155.82 56.15 Favored Pre-proline 0 N--CA 1.409 -2.485 0 CA-C-N 115.572 -0.74 . . . . 16.66 110.546 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -67.97 -32.38 28.65 Favored 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 122.099 1.866 . . . . 16.66 111.093 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.38 -32.72 71.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 50.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -79.31 -21.98 45.21 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.422 -0.808 . . . . 16.66 111.4 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -52.38 -32.86 40.74 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.176 -0.61 . . . . 50.0 109.804 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.4 m -80.39 8.47 7.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.901 -0.777 . . . . 50.0 108.901 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 56' ' ' CYS . 20.9 p 57.61 94.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.145 -0.934 . . . . 50.0 110.795 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.483 ' C ' HH21 ' A' ' 28' ' ' ARG . 63.9 mm-40 -58.59 -28.05 65.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.483 -0.487 . . . . 50.0 110.674 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.684 ' OD1' ' N ' ' A' ' 62' ' ' ALA . 55.9 p30 -58.2 -31.52 67.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.339 . . . . 50.0 110.808 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.684 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.051 -0.976 . . . . 50.0 110.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.2 Cg_exo -54.16 -27.93 49.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.666 2.244 . . . . 0.0 111.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.08 -35.66 77.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.19 48.78 0.93 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.682 -0.967 . . . . 50.0 110.682 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -56.86 -36.85 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.627 0.251 . . . . 50.0 110.87 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.21 110.06 10.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.92 0.39 . . . . 50.0 111.105 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.422 ' OG1' ' CD1' ' A' ' 9' ' ' LEU . 45.1 p -131.02 174.36 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 50.0 110.148 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.638 ' NZ ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -71.33 102.98 2.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 50.0 110.661 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.519 ' HG ' ' C ' ' A' ' 8' ' ' LYS . 1.4 mt -142.12 152.71 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.356 -0.384 . . . . 50.0 110.247 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 1.6 m-85 -100.7 -70.89 0.72 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.0 t -41.22 116.18 0.71 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.195 -0.911 . . . . 16.66 111.034 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.1 pt -54.51 -8.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.533 -0.758 . . . . 50.0 109.265 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.971 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -80.67 8.03 8.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.698 -1.137 . . . . 16.66 110.694 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? 65.36 53.5 1.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 25.0 111.773 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 142.77 16.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.53 155.01 67.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.607 2.205 . . . . 50.0 112.643 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.708 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 14.6 t80 -63.09 140.85 58.91 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.243 -0.435 . . . . 50.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 45.2 t0 -140.57 126.32 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 50.0 110.299 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.77 -14.45 32.67 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.669 -0.696 . . . . 50.0 110.328 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -75.35 -30.15 60.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.35 -1.352 . . . . 50.0 107.35 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 8.2 tptp -99.92 153.95 18.76 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.316 -1.765 . . . . 50.0 108.159 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 45.8 p90 -110.55 152.01 26.92 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.315 -0.554 . . . . 16.66 110.582 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -129.21 165.46 21.31 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.422 1.582 . . . . 50.0 114.645 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.741 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -125.19 123.02 64.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 110.777 -2.92 . . . . 16.66 104.45 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -91.92 123.33 7.18 Favored Glycine 0 C--N 1.317 -0.472 0 C-N-CA 119.52 -1.324 . . . . 16.66 115.913 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.468 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.92 108.59 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.929 -1.508 . . . . 16.66 106.929 175.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 90.3 m-20 -66.67 -23.93 66.2 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 60' ' ' GLU . 44.6 ttm-85 -112.58 -22.59 10.7 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.085 -1.416 . . . . 50.0 111.634 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.261 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -106.66 12.85 28.82 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.677 -0.809 . . . . 16.66 111.762 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.509 ' HG2' ' C ' ' A' ' 29' ' ' CYS . 22.8 pt20 34.97 45.54 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.726 0.639 . . . . 16.66 112.726 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.54 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.5 t-20 -132.92 166.59 21.99 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.41 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -135.5 130.47 34.7 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 121.034 -0.267 . . . . 16.66 111.09 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.96 145.45 51.63 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.922 -0.311 . . . . 50.0 111.175 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.778 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -54.78 141.24 33.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.722 -1.585 . . . . 16.66 106.722 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.24 -59.79 2.9 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.433 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -20.27 66.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 50.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.0 t -50.94 -31.11 16.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.888 -0.782 . . . . 16.66 108.888 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.23 14.04 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.254 -0.885 . . . . 16.66 110.894 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.19 45.7 60.63 Favored Glycine 0 N--CA 1.46 0.287 0 CA-C-N 115.885 -0.598 . . . . 16.66 111.741 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.478 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -107.8 164.63 4.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.949 0.404 . . . . 16.66 110.538 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.792 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 74.2 mt -58.7 163.96 3.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.875 -0.602 . . . . 50.0 109.982 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.428 HE21 ' HB3' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -78.4 -55.44 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.295 -0.866 . . . . 25.0 110.996 -178.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -70.48 -15.82 62.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.506 -0.77 . . . . 50.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.792 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 1.3 mt-10 -45.77 -19.83 0.07 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.851 -0.613 . . . . 50.0 111.866 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.22 -48.06 77.32 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.931 -0.708 . . . . 25.0 111.334 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.57 -45.88 9.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.182 1.549 . . . . 50.0 115.182 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 1.9 pp -55.26 -32.61 62.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 114.208 1.188 . . . . 16.66 114.208 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.715 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.2 pp -86.0 171.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.532 -0.867 . . . . 25.0 109.913 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -162.99 9.62 0.06 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.89 -1.05 . . . . 50.0 109.631 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -145.44 30.63 1.11 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.661 -1.607 . . . . 50.0 106.661 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.697 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 9.6 t80 -66.12 147.56 53.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.225 -1.352 . . . . 16.66 110.873 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.697 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.4 t -132.55 156.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.053 -1.431 . . . . 50.0 108.652 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.468 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -79.53 156.65 75.56 Favored Pre-proline 0 N--CA 1.409 -2.521 0 CA-C-O 121.586 0.708 . . . . 16.66 110.003 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 86.1 Cg_endo -71.27 -28.12 18.84 Favored 'Trans proline' 0 C--N 1.273 -3.412 0 C-N-CA 121.835 1.69 . . . . 16.66 110.601 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -71.85 -35.97 70.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.27 -1.011 . . . . 50.0 108.27 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.243 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -85.44 -16.53 39.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.091 -0.958 . . . . 16.66 110.621 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 59' ' ' THR . 49.8 tt0 -48.14 -34.13 9.39 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.616 -0.434 . . . . 50.0 110.239 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.482 ' O ' ' OG1' ' A' ' 59' ' ' THR . 79.8 p -59.66 -9.01 2.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 56' ' ' CYS . 16.9 p 53.86 78.11 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.99 -1.005 . . . . 50.0 110.823 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' ASP . 78.8 mm-40 -66.87 142.14 57.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 50.0 110.296 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' GLU . 93.1 m-20 39.89 -164.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 50.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.968 -1.015 . . . . 50.0 110.585 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.33 -23.27 29.84 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.812 2.342 . . . . 0.0 112.063 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.7 mt -92.18 140.94 29.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.49 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.43 -173.42 49.64 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.909 -0.877 . . . . 50.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.3 m -77.31 -2.38 34.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 50.0 110.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.11 -35.78 71.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 50.0 110.481 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -81.71 169.06 17.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.019 -0.537 . . . . 50.0 110.721 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -74.45 -177.75 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 50.0 110.971 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.463 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -65.38 157.15 30.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 50.0 110.329 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.35 -68.72 0.79 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.119 0.485 . . . . 25.0 109.952 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.3 t -40.79 115.47 0.58 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 16.66 110.932 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.416 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 5.8 pt -52.75 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 50.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.999 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.67 4.22 16.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 16.66 110.333 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm 66.49 55.58 0.81 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.821 -0.627 . . . . 25.0 112.045 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.3 142.05 16.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.792 -0.447 . . . . 50.0 109.792 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.01 153.43 78.36 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.272 1.982 . . . . 50.0 112.292 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.5 t80 -58.05 146.2 33.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.538 -0.542 . . . . 50.0 109.538 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.515 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 96.0 m-20 -140.93 116.97 10.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.656 -0.702 . . . . 50.0 111.325 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.54 -16.7 26.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.059 -0.519 . . . . 50.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -76.36 -27.99 56.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 5.9 tptm -101.89 154.63 18.76 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.346 -1.752 . . . . 50.0 108.185 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 53.5 p90 -111.17 151.23 28.43 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.376 -0.529 . . . . 16.66 110.548 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.7 m-85 -128.9 168.26 16.22 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 123.314 1.531 . . . . 50.0 114.286 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.767 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.43 126.17 68.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 111.118 -2.764 . . . . 16.66 105.29 176.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.89 122.29 6.87 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.757 -1.211 . . . . 16.66 115.601 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.313 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -48.38 115.29 1.16 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.028 -1.086 . . . . 16.66 108.555 176.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.6 t70 -58.68 -34.02 70.8 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.355 -0.538 . . . . 25.0 109.871 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' NH1' ' OE2' ' A' ' 60' ' ' GLU . 1.4 ttm105 -113.32 -23.88 9.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.707 -0.678 . . . . 50.0 111.32 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.313 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -91.54 4.88 51.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.983 -0.687 . . . . 16.66 111.324 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.498 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 6.5 pt20 30.75 48.59 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.11 -0.496 . . . . 16.66 111.615 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.62 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -131.55 166.4 21.47 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.847 -0.427 . . . . 50.0 109.847 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.48 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.18 132.57 39.95 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.837 -0.345 . . . . 16.66 111.052 -178.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.02 144.97 51.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.779 -0.369 . . . . 50.0 111.327 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.753 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -56.47 140.06 47.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.392 -1.707 . . . . 16.66 106.392 176.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.12 -58.57 3.23 Favored Glycine 0 C--N 1.31 -0.899 0 C-N-CA 119.622 -1.275 . . . . 16.66 112.098 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -66.75 -21.3 66.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.58 -29.84 18.72 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.656 -0.702 . . . . 16.66 109.304 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.56 2.24 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.706 -0.679 . . . . 16.66 112.002 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.9 46.4 6.72 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.417 -0.673 . . . . 16.66 111.417 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.452 HG23 ' HG2' ' A' ' 44' ' ' GLU . 1.4 tt -118.69 159.92 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.05 0.453 . . . . 16.66 111.828 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.623 ' C ' ' HG3' ' A' ' 44' ' ' GLU . 4.1 mm? -46.91 169.61 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.58 -0.736 . . . . 50.0 110.991 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -56.33 4.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.702 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' ALA . 61.5 m -79.03 -16.07 57.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.637 -0.71 . . . . 50.0 111.446 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.765 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -43.34 -21.35 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.87 0.367 . . . . 50.0 110.166 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.505 ' N ' ' OE1' ' A' ' 44' ' ' GLU . . . -60.14 -51.52 69.24 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.037 -0.528 . . . . 25.0 111.418 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.77 -44.16 10.17 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.808 1.41 . . . . 50.0 114.808 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.632 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 3.1 pp -55.47 -28.09 52.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.661 0.985 . . . . 16.66 113.661 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.765 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.4 pp -85.71 172.48 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 119.862 -0.735 . . . . 25.0 110.028 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 48.6 t0 -156.35 0.48 0.14 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.571 -1.195 . . . . 50.0 109.982 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.33 33.67 2.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.413 -1.328 . . . . 50.0 107.413 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.1 t80 -65.94 145.88 55.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.197 -0.91 . . . . 16.66 110.032 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.691 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 20.3 t -133.73 155.73 40.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.058 -1.428 . . . . 50.0 108.991 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.998 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 7.2 p -81.72 154.42 70.78 Favored Pre-proline 0 N--CA 1.413 -2.287 0 CA-C-O 121.501 0.667 . . . . 16.66 109.98 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -74.4 -28.22 10.52 Favored 'Trans proline' 0 C--N 1.274 -3.379 0 C-N-CA 122.058 1.839 . . . . 16.66 110.947 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.416 ' NE2' ' CG2' ' A' ' 12' ' ' ILE . 96.2 mt-30 -70.32 -33.58 71.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.131 -1.063 . . . . 50.0 108.131 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.185 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.7 m -70.02 -33.87 72.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.767 -1.106 . . . . 16.66 110.277 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -55.75 -34.3 65.08 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.183 -0.462 . . . . 50.0 110.795 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -54.14 -39.44 66.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.3 m -71.24 -47.06 59.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 50.0 110.331 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.531 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 78.1 mm-40 -64.09 -33.08 74.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.25 -0.432 . . . . 50.0 110.618 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -82.73 119.44 24.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 50.0 110.717 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.058 -0.973 . . . . 50.0 110.586 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -53.91 -27.91 46.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.794 2.33 . . . . 0.0 112.046 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.83 141.84 32.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.41 34.41 40.52 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.638 -0.985 . . . . 50.0 110.638 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.508 ' O ' ' C ' ' A' ' 6' ' ' ASP . 22.7 t -56.14 -34.16 65.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.193 -0.203 . . . . 50.0 110.695 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' C ' ' O ' ' A' ' 5' ' ' SER . 47.2 p30 22.59 -138.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 50.0 111.488 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 20.6 p -124.11 163.71 20.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.978 0.418 . . . . 50.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -136.0 -174.5 3.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.983 -0.553 . . . . 50.0 110.015 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' N ' ' HG2' ' A' ' 8' ' ' LYS . 2.9 pp -58.13 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 50.0 111.082 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.3 m-85 -73.62 -103.21 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.951 -0.568 . . . . 25.0 110.993 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 18.7 t -37.87 120.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.819 0.818 . . . . 16.66 113.206 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.5 pt -59.29 -8.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.112 -1.404 . . . . 50.0 108.843 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.95 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.94 8.81 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.367 -1.288 . . . . 16.66 110.565 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.634 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 63.43 71.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.571 0.7 . . . . 25.0 110.086 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.03 124.67 1.12 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.939 -0.573 . . . . 50.0 110.757 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.45 154.9 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.287 1.991 . . . . 50.0 112.111 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -56.85 146.1 27.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.044 0.449 . . . . 50.0 110.074 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.2 m-20 -140.75 114.78 9.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.764 -0.653 . . . . 50.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.66 -10.81 2.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 18' ' ' ASP . 26.4 m -79.97 -24.8 40.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.358 -1.349 . . . . 50.0 107.358 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ASP . 4.7 tptm -107.56 153.56 22.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.59 -1.641 . . . . 50.0 107.94 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 39.2 p90 -110.13 153.47 24.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 120.11 -0.636 . . . . 16.66 111.011 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.742 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -126.59 164.0 22.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 123.504 1.621 . . . . 50.0 114.645 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.778 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.76 117.86 31.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 110.861 -2.881 . . . . 16.66 105.091 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -82.93 133.08 11.57 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 119.944 -1.122 . . . . 16.66 115.06 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -47.94 107.37 0.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.752 -1.224 . . . . 16.66 107.705 176.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.44 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 59.1 t0 -51.05 -41.43 59.87 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.85 -0.74 . . . . 25.0 110.23 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 56' ' ' CYS . 14.7 ptp180 -115.67 -4.51 12.19 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.83 0.678 . . . . 50.0 112.83 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.237 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -108.66 13.51 25.1 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 118.825 -1.15 . . . . 16.66 111.326 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER 33.69 52.33 0.42 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.268 -0.423 . . . . 16.66 110.72 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.608 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -132.57 166.44 22.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.189 -0.3 . . . . 50.0 110.189 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.658 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -139.89 132.14 28.24 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.004 0.742 . . . . 16.66 113.004 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.716 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -139.93 152.62 46.51 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.036 -0.529 . . . . 50.0 111.649 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.788 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -59.04 142.55 51.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.694 -1.595 . . . . 16.66 106.694 175.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.84 -60.31 2.98 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.058 -1.068 . . . . 16.66 111.713 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -20.12 65.91 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.324 -0.55 . . . . 50.0 110.183 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.7 t -51.19 -31.32 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.199 -0.667 . . . . 16.66 109.199 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.408 HG13 ' CD2' ' A' ' 33' ' ' TYR . 2.7 m -115.67 14.28 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.472 -0.786 . . . . 16.66 110.675 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.14 46.0 23.41 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 115.636 -0.711 . . . . 16.66 112.432 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.408 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.55 167.24 5.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.928 0.394 . . . . 16.66 110.581 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.61 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 85.6 mt -67.16 164.29 18.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.499 0.666 . . . . 50.0 110.662 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.415 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.6 OUTLIER -80.03 -54.96 5.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.034 -0.985 . . . . 25.0 111.086 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 m -65.81 -17.85 64.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 50.0 110.096 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.756 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.0 mt-10 -45.64 -38.28 6.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.353 -0.539 . . . . 50.0 110.658 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.37 -36.5 43.47 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.077 -0.649 . . . . 25.0 110.897 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -87.74 -44.46 11.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.601 0.963 . . . . 50.0 113.601 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' CG ' ' HA ' ' A' ' 44' ' ' GLU . 2.2 pp -86.46 17.13 3.98 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.285 -0.87 . . . . 16.66 112.013 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.756 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 4.1 tp -120.81 150.01 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 C-N-CA 119.056 -1.058 . . . . 25.0 112.984 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -170.17 29.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.614 -1.175 . . . . 50.0 110.411 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -161.03 9.02 0.08 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.671 -0.863 . . . . 50.0 108.671 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -67.22 147.63 52.8 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.54 -0.755 . . . . 16.66 109.35 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.589 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 14.8 t -126.03 157.76 35.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.143 -0.935 . . . . 50.0 109.43 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.9 p -79.84 156.87 74.71 Favored Pre-proline 0 N--CA 1.412 -2.353 0 CA-C-N 115.749 -0.66 . . . . 16.66 110.164 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 28.9 Cg_endo -80.25 -23.78 6.04 Favored 'Trans proline' 0 C--N 1.276 -3.239 0 C-N-CA 121.783 1.655 . . . . 16.66 110.786 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -72.64 -35.63 67.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.485 -0.932 . . . . 50.0 108.485 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.166 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -73.24 -33.69 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.03 -0.986 . . . . 16.66 110.609 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -49.83 -41.03 43.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.581 . . . . 50.0 110.653 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.616 ' O ' ' OG1' ' A' ' 59' ' ' THR . 90.6 p -65.37 -32.2 73.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.103 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 58' ' ' SER . 3.3 m 145.77 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.563 -0.744 . . . . 50.0 109.849 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 40.7 -109.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 50.0 110.624 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.19 117.46 21.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.36 -0.382 . . . . 50.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.93 -1.033 . . . . 50.0 110.593 -179.87 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 4' ' ' GLY . 69.5 Cg_endo -76.92 8.73 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.917 2.411 . . . . 0.0 112.12 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 3' ' ' LEU . 10.0 mp 45.09 -87.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.434 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -173.45 177.96 45.6 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.017 -0.833 . . . . 50.0 111.017 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.6 p -76.3 160.27 29.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 50.0 110.575 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -90.48 8.15 35.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 50.0 110.692 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -124.16 169.48 11.68 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.07 0.462 . . . . 50.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -109.4 -175.76 2.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.531 -0.759 . . . . 50.0 109.923 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.524 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -60.77 166.31 3.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 50.0 109.93 -179.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.6 m-85 -91.06 -71.34 0.64 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.411 -0.588 . . . . 25.0 109.411 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.1 t -41.38 113.41 0.4 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.653 -0.703 . . . . 16.66 110.772 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 pt -53.12 -7.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 50.0 109.414 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.972 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -81.25 6.72 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.729 -1.123 . . . . 16.66 110.892 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 66.97 56.12 0.68 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.13 -0.487 . . . . 25.0 111.916 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 135.94 10.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.91 -0.316 . . . . 50.0 110.352 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.48 156.72 39.98 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.321 2.014 . . . . 50.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.724 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.7 t80 -59.35 146.25 40.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.033 0.444 . . . . 50.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.503 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 95.4 m-20 -141.39 113.07 7.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.638 -0.71 . . . . 50.0 111.249 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.36 -20.87 13.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.968 0.413 . . . . 50.0 110.103 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.4 m -71.95 -30.99 65.87 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.582 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -99.05 150.37 22.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.265 -1.789 . . . . 50.0 107.954 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CE2' ' NH2' ' A' ' 36' ' ' ARG . 51.0 p90 -108.78 150.41 27.65 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.06 -0.656 . . . . 16.66 110.601 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.724 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.6 m-85 -127.76 166.0 19.02 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 123.362 1.553 . . . . 50.0 113.925 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.765 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.55 124.3 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 111.114 -2.766 . . . . 16.66 105.57 176.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -87.95 127.1 8.37 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.993 -1.099 . . . . 16.66 115.529 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.474 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -48.62 121.28 4.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.499 -1.297 . . . . 16.66 107.499 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -62.55 -34.21 76.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.507 0.67 . . . . 25.0 109.571 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -113.56 -27.85 7.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.841 -1.072 . . . . 50.0 111.477 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.293 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -89.91 8.23 33.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.945 -0.702 . . . . 16.66 111.81 -177.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.54 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 2.8 pt20 30.13 49.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 16.66 112.005 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.668 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -131.6 165.69 23.09 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.92 -0.4 . . . . 50.0 109.92 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -132.54 132.68 42.87 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.939 -0.304 . . . . 16.66 111.389 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.672 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.7 145.76 52.01 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.865 -0.334 . . . . 50.0 111.148 178.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.79 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -54.43 140.2 34.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.285 -1.746 . . . . 16.66 106.285 176.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.725 ' H ' HH21 ' A' ' 36' ' ' ARG . . . -42.29 -56.34 4.06 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 119.433 -1.365 . . . . 16.66 111.516 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.739 ' H ' ' NE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.55 -19.7 62.86 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.516 -0.474 . . . . 50.0 110.241 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.41 -30.94 13.62 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.866 -0.791 . . . . 16.66 108.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.71 13.58 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.117 -0.947 . . . . 16.66 110.631 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.34 46.25 50.35 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.345 -0.702 . . . . 16.66 111.345 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.38 167.93 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.124 0.488 . . . . 16.66 111.647 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 7.3 mp -62.38 163.64 8.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 50.0 110.446 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.587 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.1 pt20 -82.33 -46.56 13.44 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.18 -1.045 . . . . 25.0 108.18 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -63.8 -29.25 70.47 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.647 -1.615 . . . . 50.0 108.687 179.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.799 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.8 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.005 -0.739 . . . . 50.0 109.005 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -79.13 -41.93 27.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.298 -0.864 . . . . 25.0 110.538 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' SER . 48.5 mp0 -87.9 -52.13 5.45 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.696 1.369 . . . . 50.0 114.696 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.842 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.56 19.22 0.28 Allowed 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.481 0.658 . . . . 16.66 111.108 -177.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.799 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.3 tp -114.71 144.56 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 114.749 -1.114 . . . . 25.0 113.299 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -168.09 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.155 -1.384 . . . . 50.0 109.313 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -166.39 13.12 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.415 -0.957 . . . . 50.0 108.415 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -67.58 147.26 52.99 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.357 -0.838 . . . . 16.66 109.706 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.1 t -124.71 159.26 31.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.845 -1.071 . . . . 50.0 109.293 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.474 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -83.87 152.93 63.52 Favored Pre-proline 0 N--CA 1.411 -2.383 0 CA-C-O 121.611 0.72 . . . . 16.66 110.359 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.25 -27.61 16.32 Favored 'Trans proline' 0 C--N 1.274 -3.378 0 C-N-CA 121.892 1.728 . . . . 16.66 110.877 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -70.42 -33.67 71.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.31 -0.859 . . . . 50.0 108.827 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -76.38 -43.21 41.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.253 -0.885 . . . . 16.66 110.567 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -57.15 -26.83 61.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 50.0 111.035 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 m -48.58 -32.7 8.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.382 -0.372 . . . . 50.0 110.397 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -11.28 7.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.419 -0.355 . . . . 50.0 110.963 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -107.48 140.25 40.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.857 0.361 . . . . 50.0 110.912 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.6 140.75 46.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 50.0 110.316 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.044 -0.979 . . . . 50.0 110.588 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.08 144.85 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.693 2.262 . . . . 0.0 111.983 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 1.4 mm? -92.34 141.35 28.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.479 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.23 -126.52 5.83 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.659 -0.977 . . . . 50.0 110.659 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 46.8 m -62.77 155.16 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.793 0.33 . . . . 50.0 110.513 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 5' ' ' SER . 87.1 m-20 -136.29 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 50.0 110.507 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -81.5 162.38 23.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 50.0 110.182 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.653 ' HZ3' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -134.84 -177.4 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.28 0.562 . . . . 50.0 111.611 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.36 152.63 20.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.344 -0.843 . . . . 50.0 110.712 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.9 m-85 -95.53 -68.36 0.8 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.2 t -43.48 116.26 0.91 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.648 -0.705 . . . . 16.66 110.458 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.9 pt -51.95 -7.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.071 -0.714 . . . . 50.0 109.071 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -78.31 2.78 17.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.572 -1.195 . . . . 16.66 110.55 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.22 54.41 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.982 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.07 146.77 26.9 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.005 -0.369 . . . . 50.0 110.005 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 152.69 76.08 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.513 2.142 . . . . 50.0 111.941 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.6 t80 -55.97 146.06 23.41 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.759 -0.46 . . . . 50.0 109.759 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.0 m-20 -140.71 113.15 8.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.786 -0.643 . . . . 50.0 111.017 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.64 -17.76 9.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 50.0 109.842 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -71.58 -30.81 66.25 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.112 -1.44 . . . . 50.0 107.112 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 3.1 tptm -100.55 156.88 17.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 112.973 -1.922 . . . . 50.0 108.957 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 52.8 p90 -113.45 149.07 34.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 115.885 -0.598 . . . . 16.66 110.024 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 m-85 -127.15 166.75 17.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 123.379 1.561 . . . . 50.0 114.236 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.75 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.19 126.22 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 111.013 -2.812 . . . . 16.66 105.007 176.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.58 121.22 6.53 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.587 -1.292 . . . . 16.66 116.157 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.44 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.32 117.69 2.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.911 -1.145 . . . . 16.66 108.002 175.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 51' ' ' TYR . 87.3 m-20 -69.26 -30.18 68.24 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.652 0.739 . . . . 25.0 109.245 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 60' ' ' GLU . 45.3 ttm-85 -110.43 -23.15 11.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.597 -1.183 . . . . 50.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.292 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 9.93 40.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.888 -0.725 . . . . 16.66 111.683 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.547 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 8.9 pt20 30.37 48.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 16.66 112.405 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.653 HD22 ' HZ3' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -132.14 166.16 22.42 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 120.929 -0.308 . . . . 50.0 110.373 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -133.94 130.75 38.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.184 -0.206 . . . . 16.66 110.906 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -128.45 144.44 51.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.792 -0.363 . . . . 50.0 111.393 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.748 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.4 OUTLIER -54.19 140.59 32.04 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.28 -1.748 . . . . 16.66 106.28 176.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -41.9 -59.94 2.72 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.855 -1.164 . . . . 16.66 111.929 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -67.87 -19.79 65.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.458 -0.497 . . . . 50.0 109.971 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.1 t -50.4 -30.7 13.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.664 -0.865 . . . . 16.66 108.664 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.6 12.66 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.255 -0.884 . . . . 16.66 110.962 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.67 45.84 50.47 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.034 -0.603 . . . . 16.66 111.68 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.5 167.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.421 . . . . 16.66 111.495 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 8.0 mp -59.64 164.72 3.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 50.0 110.555 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.06 -55.39 5.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.515 -0.766 . . . . 25.0 110.523 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.516 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.4 m -70.86 -15.16 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 50.0 109.368 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.569 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -42.17 -20.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.467 -0.788 . . . . 50.0 110.938 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.34 -47.52 60.67 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.396 -0.522 . . . . 25.0 110.992 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -88.93 -43.46 11.15 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.745 1.387 . . . . 50.0 114.745 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 43' ' ' SER . 2.5 pp -55.39 -30.84 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.306 0.854 . . . . 16.66 113.306 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.3 pp -86.67 172.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.744 0.783 . . . . 25.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.35 13.2 0.14 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.403 -1.271 . . . . 50.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -155.54 36.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.753 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 18.5 t80 -65.96 145.88 55.37 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.674 -1.148 . . . . 16.66 111.014 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.753 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 11.7 t -129.71 157.55 42.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.942 -1.481 . . . . 50.0 108.608 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.44 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.2 p -86.35 158.36 54.99 Favored Pre-proline 0 N--CA 1.414 -2.236 0 CA-C-O 121.574 0.702 . . . . 16.66 110.578 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 29.8 Cg_endo -79.8 -22.7 7.44 Favored 'Trans proline' 0 C--N 1.278 -3.133 0 C-N-CA 121.97 1.78 . . . . 16.66 110.403 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -72.52 -35.76 68.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.062 -1.088 . . . . 50.0 108.062 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.17 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.34 -31.72 24.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.881 -1.054 . . . . 16.66 109.856 179.09 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -49.78 -31.59 11.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.83 -0.623 . . . . 50.0 110.753 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -50.19 -31.52 13.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.2 -0.455 . . . . 50.0 110.179 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -153.31 69.75 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 50.0 111.09 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 95.3 mt-10 -56.8 -30.43 63.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 50.0 110.055 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 61' ' ' ASP . 53.1 p30 -138.8 174.72 10.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.897 -0.592 . . . . 50.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.017 -0.992 . . . . 50.0 110.533 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.3 153.49 59.26 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.922 2.414 . . . . 0.0 111.917 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.8 mt -74.4 153.2 39.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.301 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.32 -174.81 35.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.966 -0.854 . . . . 50.0 110.966 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 m 56.65 51.23 11.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 50.0 110.44 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.27 150.76 39.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.525 . . . . 50.0 110.327 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -121.47 161.8 21.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 50.0 110.792 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 161.08 14.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.061 -0.518 . . . . 50.0 110.729 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.615 HD11 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -73.84 -179.69 3.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.619 -0.718 . . . . 50.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 32' ' ' TRP . 1.5 m-85 -87.16 -94.99 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.007 0.373 . . . . 25.0 112.007 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -37.45 132.72 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.69 0.757 . . . . 16.66 112.773 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.416 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -61.15 -7.75 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.671 -1.149 . . . . 50.0 108.692 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.59 4.95 14.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.001 -1.454 . . . . 16.66 110.852 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 67.31 47.6 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.269 -0.423 . . . . 25.0 111.038 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.466 ' H ' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -140.27 124.61 10.84 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.618 -0.264 . . . . 50.0 110.617 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.68 160.47 11.78 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.626 2.217 . . . . 50.0 112.878 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.751 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 10.4 t80 -66.3 138.51 57.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.047 -0.524 . . . . 50.0 111.104 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 54.3 t0 -140.54 127.01 20.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.653 -0.703 . . . . 50.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.92 -12.83 4.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.991 -0.549 . . . . 50.0 109.608 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 18' ' ' ASP . 19.4 m -75.64 -26.81 58.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HG2' ' CG ' ' A' ' 34' ' ' HIS . 15.5 tptt -101.5 152.17 21.09 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.489 -1.687 . . . . 50.0 108.129 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 55.3 p90 -113.08 147.21 37.75 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.182 -0.607 . . . . 16.66 110.154 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.0 m-85 -123.23 164.23 19.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 123.914 1.816 . . . . 50.0 115.538 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.795 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.68 117.96 21.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 109.953 -3.294 . . . . 16.66 104.286 176.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -89.73 129.87 9.92 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.778 -1.201 . . . . 16.66 115.455 -174.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.386 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 106.99 0.11 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.898 -1.519 . . . . 16.66 106.898 175.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -69.54 -20.01 63.69 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -112.86 -25.46 9.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.839 -1.528 . . . . 50.0 111.566 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.21 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -111.31 15.88 21.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.932 -0.707 . . . . 16.66 112.197 -178.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.515 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 30.96 54.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 16.66 111.87 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 5.5 m-20 -132.54 167.06 20.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.411 -0.359 . . . . 50.0 110.223 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.673 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -141.03 129.48 22.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.311 0.856 . . . . 16.66 113.311 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.662 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -141.43 158.34 44.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.873 -0.603 . . . . 50.0 111.771 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.645 ' CG ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.98 134.85 55.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.9 -1.889 . . . . 16.66 105.9 174.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -42.6 -44.85 5.44 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 119.502 -1.332 . . . . 16.66 111.545 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -68.53 -29.88 68.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.57 0.7 . . . . 50.0 109.238 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.933 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 4.2 t -51.6 -26.66 9.25 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.791 -1.095 . . . . 16.66 109.621 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.53 16.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.296 -0.866 . . . . 16.66 110.622 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.21 47.58 57.9 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.733 -0.667 . . . . 16.66 111.828 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -115.63 167.02 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.777 -0.369 . . . . 16.66 110.984 -178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.705 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.8 mm? -62.33 164.59 6.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.287 0.565 . . . . 50.0 110.412 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -56.05 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.13 -0.941 . . . . 25.0 110.911 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -69.35 -16.15 63.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.683 -0.689 . . . . 50.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.732 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 1.6 tt0 -48.22 -20.24 0.36 Allowed 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.488 -0.778 . . . . 50.0 111.464 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.0 -51.82 67.71 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.944 -0.702 . . . . 25.0 111.671 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 48' ' ' ILE . 78.2 mm-40 -90.1 -46.65 8.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.9 1.445 . . . . 50.0 114.9 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 3.1 pp -56.02 16.19 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.347 1.24 . . . . 16.66 114.347 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.732 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -134.48 171.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.406 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 46.0 t0 -173.36 36.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.82 -1.082 . . . . 50.0 108.994 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.03 20.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 2.4 t80 -66.82 148.68 51.62 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.547 -1.206 . . . . 16.66 110.522 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.646 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.3 t -129.87 152.26 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.302 -1.317 . . . . 50.0 109.43 178.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.386 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.3 p -78.95 162.45 64.71 Favored Pre-proline 0 N--CA 1.411 -2.391 0 CA-C-N 115.232 -0.894 . . . . 16.66 110.102 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 15.5 Cg_endo -81.23 -27.84 2.68 Favored 'Trans proline' 0 C--N 1.276 -3.279 0 C-N-CA 121.875 1.717 . . . . 16.66 110.848 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -67.93 -35.63 78.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.895 -1.15 . . . . 50.0 107.895 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.189 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -78.19 -44.26 26.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.892 -1.049 . . . . 16.66 109.552 179.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.492 ' NE2' ' OE1' ' A' ' 60' ' ' GLU . 60.6 tp60 -51.66 -38.25 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 50.0 109.747 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 18.4 m -60.3 -37.26 80.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 50.0 109.671 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 m -65.47 -40.03 92.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 50.0 110.43 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' OE1' ' NE2' ' A' ' 57' ' ' GLN . 96.8 mt-10 -59.56 -36.49 76.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.431 -0.349 . . . . 50.0 110.841 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 58' ' ' SER . 50.0 p30 -107.14 168.22 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.383 -0.371 . . . . 50.0 110.671 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.078 -0.963 . . . . 50.0 110.601 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.06 -22.8 32.7 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.174 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 mt -90.72 141.46 28.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.0 -168.91 42.03 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.076 -0.81 . . . . 50.0 111.076 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -62.86 170.91 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.188 -0.301 . . . . 50.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 60.24 60.85 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.952 0.406 . . . . 50.0 110.197 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -80.31 165.23 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 50.0 110.852 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -175.82 1.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.282 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -60.73 -174.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.311 -0.859 . . . . 50.0 110.242 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.661 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -82.28 -89.19 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 1.5 t -39.71 114.43 0.42 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.844 -0.617 . . . . 16.66 111.29 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -59.7 -8.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.16 -0.927 . . . . 50.0 109.588 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 1.137 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -71.21 7.34 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.425 -0.807 . . . . 16.66 109.923 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 12' ' ' ILE . 3.5 mtpm? 65.91 48.73 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.576 -0.738 . . . . 25.0 111.484 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.404 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -143.17 124.19 8.2 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.778 -0.369 . . . . 50.0 110.287 179.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.1 152.03 3.72 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.748 2.299 . . . . 50.0 112.801 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.7 t80 -67.57 145.02 55.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' LYS . 91.3 m-20 -140.82 116.68 10.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.831 -0.622 . . . . 50.0 110.355 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 -13.57 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.443 -0.577 . . . . 50.0 109.443 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -75.13 -25.69 58.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.513 -1.291 . . . . 50.0 107.513 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -101.39 155.3 18.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.433 -1.712 . . . . 50.0 108.113 178.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 51.8 p90 -110.25 153.21 25.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.889 -0.724 . . . . 16.66 110.588 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.3 m-85 -125.26 162.71 24.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.47 1.605 . . . . 50.0 114.534 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.805 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -131.58 117.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.803 -2.908 . . . . 16.66 104.601 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.77 131.96 11.03 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 119.782 -1.199 . . . . 16.66 116.025 -174.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.394 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -46.33 105.74 0.07 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.026 -1.472 . . . . 16.66 107.026 175.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 28' ' ' ARG . 43.4 p-10 -75.4 -11.4 60.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.568 -1.271 . . . . 25.0 107.568 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.483 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 23.4 ttm180 -113.7 -22.98 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.742 -1.572 . . . . 50.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.183 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -120.22 18.5 12.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 119.927 -0.709 . . . . 16.66 112.346 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.498 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 13.9 pt20 32.97 54.11 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.763 0.283 . . . . 16.66 111.763 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.614 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 4.8 m-20 -133.09 167.84 19.58 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 110.165 -0.309 . . . . 50.0 110.165 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.643 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -138.67 133.02 31.79 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.869 0.692 . . . . 16.66 112.869 -177.037 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.625 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -140.83 145.13 35.86 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.97 -0.559 . . . . 50.0 111.283 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.885 ' HD1' ' CB ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -55.89 150.03 13.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 106.368 -1.715 . . . . 16.66 106.368 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.08 -61.56 7.03 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 119.468 -1.348 . . . . 16.66 112.747 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -20.69 62.76 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.346 -0.541 . . . . 50.0 110.462 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 13.9 t -54.14 -29.24 44.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.488 -0.885 . . . . 16.66 108.941 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -112.61 11.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 16.66 110.34 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.06 46.96 20.15 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.862 -0.608 . . . . 16.66 111.774 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.64 167.58 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 16.66 111.546 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 7.4 mp -64.68 161.6 17.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.248 -0.887 . . . . 50.0 110.152 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.4 pt20 -82.12 -41.16 20.84 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.693 ' O ' HD12 ' A' ' 47' ' ' LEU . 69.6 m -60.88 -39.04 87.74 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 112.336 -2.211 . . . . 50.0 109.266 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.793 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -41.39 -17.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.935 -0.575 . . . . 50.0 110.037 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -76.4 -46.17 28.42 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.074 -0.512 . . . . 25.0 110.806 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.0 mm-40 -88.95 -51.23 5.73 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.069 1.507 . . . . 50.0 115.069 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.904 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.18 20.32 0.39 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.563 0.697 . . . . 16.66 111.761 -177.07 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.2 tp -111.43 139.04 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 25.0 111.915 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -116.19 -58.68 2.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.405 -1.27 . . . . 50.0 111.822 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 2.3 pm0 -118.83 59.48 0.82 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.166 -0.679 . . . . 50.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.0 t80 -66.37 142.07 57.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.175 -0.61 . . . . 16.66 109.368 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.684 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 6.7 t -117.33 152.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.543 -0.753 . . . . 50.0 109.716 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.394 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.4 p -83.99 157.85 62.54 Favored Pre-proline 0 N--CA 1.41 -2.45 0 CA-C-N 114.936 -1.029 . . . . 16.66 110.35 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.19 -25.69 5.69 Favored 'Trans proline' 0 C--N 1.278 -3.183 0 C-N-CA 121.92 1.746 . . . . 16.66 110.477 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -71.96 -33.49 68.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.945 -1.025 . . . . 50.0 108.936 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.168 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -69.08 -38.76 79.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.329 -0.85 . . . . 16.66 110.743 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -52.06 -36.51 50.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.633 -0.506 . . . . 50.0 109.633 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.2 p -75.24 -34.38 61.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 61' ' ' ASP . 26.0 m -72.88 -49.04 32.26 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HA ' HH11 ' A' ' 28' ' ' ARG . 85.6 mt-10 60.52 -5.47 0.1 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.407 -0.36 . . . . 50.0 111.039 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 59' ' ' THR . 85.6 m-20 56.08 46.62 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 50.0 110.672 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.027 -0.987 . . . . 50.0 110.569 179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.77 -25.34 78.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.913 2.408 . . . . 0.0 112.305 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.8 mt 44.37 85.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.55 103.02 0.75 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.007 -0.837 . . . . 50.0 111.007 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m -130.66 153.59 48.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 50.0 110.525 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.1 146.16 39.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.361 . . . . 50.0 110.097 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 4.6 m -81.68 109.7 16.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.799 -0.361 . . . . 50.0 110.932 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.601 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 8.7 mtpt -149.98 -177.07 5.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 50.0 109.894 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.72 139.38 51.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.726 -0.39 . . . . 50.0 110.025 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 8' ' ' LYS . 4.9 m-85 -103.03 -69.96 0.78 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.849 -0.34 . . . . 25.0 110.106 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 35.7 t -41.6 130.61 3.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 16.66 110.719 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.9 pt -57.74 -7.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.269 -1.011 . . . . 50.0 108.269 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.74 -5.85 56.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.899 -1.501 . . . . 16.66 110.897 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 22.1 mtmm 72.18 52.8 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.186 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.68 139.33 23.97 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 109.906 -0.405 . . . . 50.0 109.906 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.66 153.96 74.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.453 2.102 . . . . 50.0 112.331 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -63.05 140.29 58.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.13 0.491 . . . . 50.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.623 ' H ' ' HH ' ' A' ' 23' ' ' TYR . 82.1 m-20 -141.8 119.86 12.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.487 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.81 -22.34 9.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.95 -0.389 . . . . 50.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 m -68.79 -34.11 74.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.528 -1.286 . . . . 50.0 107.528 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 4.6 ttmt -93.33 139.3 30.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.304 -1.771 . . . . 50.0 107.584 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 45.1 p90 -105.13 143.01 33.9 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.134 -0.627 . . . . 16.66 110.173 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -122.13 173.19 7.73 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 123.941 1.829 . . . . 50.0 114.78 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.78 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.69 179.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 109.685 -3.416 . . . . 16.66 104.018 176.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.06 124.14 2.48 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 117.658 -2.211 . . . . 16.66 114.36 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 1.447 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -48.04 110.65 0.35 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.052 -1.074 . . . . 16.66 108.739 177.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.502 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 57.2 t0 -46.57 -41.95 15.22 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.081 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD3' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.39 -13.81 11.0 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 112.407 0.521 . . . . 50.0 112.407 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 1.347 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -88.49 0.17 56.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.937 -1.105 . . . . 16.66 111.272 -178.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.443 HE21 ' C ' ' A' ' 28' ' ' ARG . 8.9 mm-40 40.85 45.98 2.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.551 -0.295 . . . . 16.66 110.347 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.575 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -132.31 166.28 22.27 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.755 -0.378 . . . . 50.0 110.604 -177.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -140.82 127.77 20.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.56 -0.456 . . . . 16.66 111.428 -178.445 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.74 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -127.67 156.43 42.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.94 -0.573 . . . . 50.0 110.866 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.532 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -61.46 141.0 57.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.154 -1.795 . . . . 16.66 106.154 176.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 34' ' ' HIS . . . -43.4 -48.48 6.96 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 119.42 -1.371 . . . . 16.66 111.261 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -19.76 59.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.349 -0.54 . . . . 50.0 110.037 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.92 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -51.6 -30.71 22.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.562 -0.855 . . . . 16.66 109.241 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.43 8.59 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.487 -0.779 . . . . 16.66 111.427 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.57 45.86 7.68 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.124 -0.56 . . . . 16.66 112.204 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.15 167.34 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.222 0.534 . . . . 16.66 111.608 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' CB ' ' OE1' ' A' ' 44' ' ' GLU . 4.0 mm? -67.02 164.58 17.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.481 -0.781 . . . . 50.0 110.46 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.713 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.8 pt20 -80.55 -54.26 5.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 25.0 110.902 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.713 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 49.5 m -60.35 -28.26 68.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.063 -1.088 . . . . 50.0 108.063 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.944 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -43.67 -17.03 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.305 -1.316 . . . . 50.0 109.928 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.27 -48.16 58.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.98 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.731 ' C ' ' H ' ' A' ' 48' ' ' ILE . 84.8 tt0 -87.66 -52.91 5.06 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.096 0.776 . . . . 50.0 113.096 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.593 ' CD1' ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -57.78 5.6 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.385 0.612 . . . . 16.66 110.516 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.944 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -105.15 133.02 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.714 -177.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -87.7 -74.38 0.45 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.995 -1.002 . . . . 50.0 111.522 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 27' ' ' ASP . 80.7 tt0 -122.08 74.0 1.13 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.73 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.09 146.6 54.47 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.774 -0.648 . . . . 16.66 109.324 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 43.7 t -117.09 159.24 17.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.805 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 1.447 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -87.5 161.11 46.38 Favored Pre-proline 0 N--CA 1.415 -2.177 0 CA-C-O 121.425 0.631 . . . . 16.66 110.22 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 34.6 Cg_endo -80.33 -32.55 1.27 Allowed 'Trans proline' 0 C--N 1.28 -3.059 0 C-N-CA 121.862 1.708 . . . . 16.66 111.741 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -72.96 -28.81 62.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 1.104 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 61.4 m -57.59 -42.83 83.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.121 -1.4 . . . . 16.66 111.0 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -56.16 -34.33 66.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.813 -0.63 . . . . 50.0 110.196 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 59' ' ' THR . 52.4 p -79.66 -1.21 37.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.303 -0.628 . . . . 50.0 109.303 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.569 ' CB ' ' O ' ' A' ' 58' ' ' SER . 2.7 m 97.46 80.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.205 -0.907 . . . . 50.0 110.356 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 44.81 -87.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.286 -0.416 . . . . 50.0 110.664 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 59' ' ' THR . 60.1 t0 -132.89 131.13 40.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.277 -0.42 . . . . 50.0 110.432 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.984 -1.008 . . . . 50.0 110.596 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 110.236 -0.283 . . . . 50.0 110.236 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -97.8 -72.77 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.168 -0.613 . . . . 25.0 111.528 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 6.2 t -39.01 112.04 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 16.66 111.597 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.615 HG23 ' CD1' ' A' ' 33' ' ' TYR . 9.1 pt -48.02 -8.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.541 -0.754 . . . . 50.0 109.682 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.969 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -86.02 30.52 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.742 -1.117 . . . . 16.66 110.343 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 14.0 pttp 43.4 58.87 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.77 -0.65 . . . . 25.0 112.144 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.433 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -156.32 124.34 2.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 110.022 -0.362 . . . . 50.0 110.022 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 25.0 Cg_exo -57.22 164.17 7.07 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.614 2.209 . . . . 50.0 113.352 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.737 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 16.1 t80 -60.23 145.78 46.04 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.517 -0.765 . . . . 50.0 110.74 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' LYS . 92.6 m-20 -141.46 111.84 6.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.03 -0.986 . . . . 50.0 110.848 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.51 -22.45 8.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 50.0 110.448 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -71.11 -30.38 66.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.633 -1.247 . . . . 50.0 107.633 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -100.26 149.36 23.66 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.165 -1.834 . . . . 50.0 108.034 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 39.5 p90 -108.62 151.72 25.75 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.865 -0.734 . . . . 16.66 110.296 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.3 m-85 -126.86 165.44 19.34 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 123.152 1.454 . . . . 50.0 113.943 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.039 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.52 118.71 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 111.242 -2.708 . . . . 16.66 105.25 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -83.32 127.0 7.78 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.039 -1.077 . . . . 16.66 115.563 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.43 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -48.21 107.27 0.12 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.875 -1.162 . . . . 16.66 107.928 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.666 ' HB2' HG22 ' A' ' 52' ' ' VAL . 76.6 m-20 -51.08 -37.27 44.69 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.993 -0.683 . . . . 25.0 110.53 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.654 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -114.29 -14.56 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.042 0.386 . . . . 50.0 112.042 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.256 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.9 14.2 32.52 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.472 -0.891 . . . . 16.66 111.865 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.443 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 14.3 pt20 30.35 48.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.893 0.701 . . . . 16.66 112.893 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.636 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.13 166.11 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.971 -0.381 . . . . 50.0 109.971 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.488 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.61 130.98 37.27 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.868 -0.333 . . . . 16.66 111.279 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.2 144.99 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.05 -0.26 . . . . 50.0 111.024 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.828 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -52.03 143.02 14.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.714 -1.588 . . . . 16.66 106.714 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.577 ' C ' HG22 ' A' ' 40' ' ' ILE . . . -42.18 -60.31 2.72 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.432 -1.366 . . . . 16.66 111.478 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -69.19 -18.24 63.89 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.565 -0.454 . . . . 50.0 110.44 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.09 -30.67 11.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.656 -0.818 . . . . 16.66 108.814 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 33' ' ' TYR . 5.5 m -116.8 4.16 7.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.411 -0.813 . . . . 16.66 111.637 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.72 46.08 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.366 -0.694 . . . . 16.66 111.366 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 41' ' ' LEU . 3.5 tt -119.17 167.73 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 16.66 111.885 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 40' ' ' ILE . 42.0 mt -68.69 164.48 21.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.168 -0.923 . . . . 50.0 110.646 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.582 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 36.8 mt-30 -80.56 -43.97 19.78 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.965 -1.494 . . . . 25.0 106.965 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.773 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -62.76 -41.13 99.08 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 112.378 -2.192 . . . . 50.0 107.714 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.824 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.3 mm-40 -43.63 -16.35 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -78.93 -44.47 22.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.427 -0.806 . . . . 25.0 110.468 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 43' ' ' SER . 96.4 mt-10 -87.94 -51.91 5.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.583 1.327 . . . . 50.0 114.583 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.084 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.68 20.38 0.24 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.795 0.807 . . . . 16.66 111.03 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.824 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.5 tp -110.44 143.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.272 -1.331 . . . . 25.0 112.9 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -165.98 29.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.381 -1.281 . . . . 50.0 109.448 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -166.33 11.43 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.593 -0.892 . . . . 50.0 108.593 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -67.09 146.9 53.81 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 16.66 109.761 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 27' ' ' ASP . 21.7 t -125.16 156.95 34.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.912 -1.04 . . . . 50.0 110.016 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.43 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.5 p -78.57 157.23 77.51 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-N 115.592 -0.731 . . . . 16.66 110.078 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 41.5 Cg_endo -77.84 -30.13 3.94 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 121.963 1.776 . . . . 16.66 111.585 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -72.26 -29.59 64.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.99 -1.115 . . . . 50.0 107.99 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.2 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 114.324 -1.307 . . . . 16.66 110.735 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.522 -0.123 0 N-CA-C 109.483 -0.562 . . . . 50.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.14 -69.1 0.77 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.385 -0.526 . . . . 25.0 110.463 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -41.59 129.37 3.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 16.66 111.133 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 12' ' ' ILE . 9.1 pt -58.16 -7.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -82.39 -1.87 51.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.844 -1.525 . . . . 16.66 110.985 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 46.2 mttm 70.95 56.76 0.22 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.463 -0.335 . . . . 25.0 111.299 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.651 ' OG1' ' CE1' ' A' ' 34' ' ' HIS . 23.0 p -141.1 147.74 48.82 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.409 -0.36 . . . . 50.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.32 150.93 47.82 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.411 2.074 . . . . 50.0 111.846 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.723 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 22.2 t80 -62.65 139.98 58.67 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.11 0.481 . . . . 50.0 110.075 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 21' ' ' LYS . 87.4 m-20 -141.32 120.47 12.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.5 -0.773 . . . . 50.0 110.286 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.1 -17.08 6.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -70.21 -32.07 69.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.558 ' HG2' ' CG ' ' A' ' 34' ' ' HIS . 11.3 tptt -95.8 150.21 20.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.782 -2.008 . . . . 50.0 108.165 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 31.6 p90 -111.0 149.15 31.1 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.589 -0.523 . . . . 16.66 109.589 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 11.8 m-85 -128.73 169.78 14.09 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 123.703 1.716 . . . . 50.0 115.374 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.031 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.84 118.39 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 110.167 -3.197 . . . . 16.66 104.464 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.64 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -87.12 123.15 6.43 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 119.636 -1.269 . . . . 16.66 115.147 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.421 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -53.41 106.98 0.2 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.488 -1.356 . . . . 16.66 108.154 176.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB2' HG22 ' A' ' 52' ' ' VAL . 92.8 m-20 -61.04 -34.96 75.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.474 0.654 . . . . 25.0 109.394 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -101.28 -34.51 9.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.891 -1.05 . . . . 50.0 111.632 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.238 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -92.54 5.82 49.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.826 -0.75 . . . . 16.66 112.148 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.562 ' HG2' ' C ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 38.95 36.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.751 1.019 . . . . 16.66 113.751 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.556 ' OD1' ' HB2' ' A' ' 26' ' ' CYS . 1.9 p30 -132.83 166.87 21.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.988 0.813 . . . . 50.0 110.449 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.64 ' HE3' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -128.66 138.18 52.03 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.218 0.822 . . . . 16.66 113.218 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' OH ' ' HB2' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -133.63 151.71 51.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.324 -0.398 . . . . 50.0 110.94 177.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.651 ' CE1' ' OG1' ' A' ' 15' ' ' THR . 0.3 OUTLIER -58.17 140.19 53.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.589 -1.634 . . . . 16.66 106.589 176.084 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.583 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.81 -54.3 5.09 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.159 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.646 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.76 -20.3 64.36 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.53 -0.468 . . . . 50.0 110.309 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.2 t -51.32 -31.77 22.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 119.682 -0.807 . . . . 16.66 108.944 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.52 14.92 7.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.183 -0.917 . . . . 16.66 111.358 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.21 46.26 43.83 Favored Glycine 0 N--CA 1.463 0.47 0 C-N-CA 121.254 -0.498 . . . . 16.66 112.039 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.583 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -118.48 167.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 16.66 111.381 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.6 mp -61.23 164.69 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.755 -0.657 . . . . 50.0 110.566 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -78.35 -55.37 5.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.45 -0.796 . . . . 25.0 110.364 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.589 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.3 m -69.5 -15.47 63.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 50.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.852 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.6 -19.8 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.322 -0.854 . . . . 50.0 111.115 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HA ' HG22 ' A' ' 24' ' ' ILE . . . -74.44 -45.13 48.38 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.463 -0.495 . . . . 25.0 111.514 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.05 -45.31 10.29 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.247 1.203 . . . . 50.0 114.247 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.1 pp -55.78 -30.79 61.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.051 0.76 . . . . 16.66 113.051 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.892 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 pp -86.52 172.38 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.931 -0.708 . . . . 25.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.3 28.18 0.17 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.642 -1.163 . . . . 50.0 109.901 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.57 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.166 -1.42 . . . . 50.0 107.166 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.9 t80 -66.7 145.58 55.39 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.799 -1.091 . . . . 16.66 111.121 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.632 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 22.3 t -133.37 154.11 38.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 113.848 -1.524 . . . . 50.0 108.575 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.421 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 5.8 p -79.92 161.99 63.98 Favored Pre-proline 0 N--CA 1.411 -2.405 0 CA-C-O 121.318 0.58 . . . . 16.66 110.005 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 19.3 Cg_endo -82.67 -27.46 2.11 Favored 'Trans proline' 0 C--N 1.28 -3.043 0 C-N-CA 121.997 1.798 . . . . 16.66 111.625 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -74.28 -30.39 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.087 -1.079 . . . . 50.0 108.087 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.6 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 114.43 -1.259 . . . . 16.66 110.675 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.909 0.385 . . . . 50.0 110.644 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.801 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.39 -79.04 0.47 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 34.9 t -41.04 128.43 2.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.27 . . . . 16.66 112.464 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.777 HG23 ' CD2' ' A' ' 33' ' ' TYR . 13.0 pt -62.9 -10.3 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 1.047 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -76.69 -0.76 24.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.59 -1.641 . . . . 16.66 110.375 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 62.84 53.22 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.376 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.82 125.33 11.68 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.4 -0.364 . . . . 50.0 110.097 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.03 146.64 8.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.165 1.91 . . . . 50.0 112.08 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 9.9 t80 -64.76 137.49 57.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.166 0.508 . . . . 50.0 110.689 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 52.6 t0 -140.56 135.42 31.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.838 -0.801 . . . . 50.0 108.838 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.86 -18.12 30.02 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.912 -0.715 . . . . 50.0 109.239 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -60.82 -45.36 94.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.499 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.598 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -86.28 161.7 18.63 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.336 -1.357 . . . . 50.0 107.336 176.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 45.3 p90 -117.82 136.9 53.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.058 -0.719 . . . . 16.66 109.058 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.759 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 5.6 m-85 -112.64 165.84 11.89 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 124.187 1.946 . . . . 50.0 115.591 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.02 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 109.324 -3.58 . . . . 16.66 103.944 176.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -132.7 123.22 3.45 Favored Glycine 0 C--N 1.319 -0.394 0 C-N-CA 117.928 -2.082 . . . . 16.66 114.709 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.391 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.14 108.8 0.16 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.895 -1.15 . . . . 16.66 107.895 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 22.6 t70 -64.92 -31.04 72.09 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -109.08 -20.09 13.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.105 -1.407 . . . . 50.0 111.597 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -109.4 11.81 24.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.334 -0.947 . . . . 16.66 112.2 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.598 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 20.6 pt20 33.84 52.91 0.47 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.789 -0.187 . . . . 16.66 111.481 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.653 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -132.85 166.31 22.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.05 -0.26 . . . . 50.0 110.663 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.653 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -139.44 132.12 28.95 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 121.288 0.566 . . . . 16.66 112.238 -177.201 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -137.45 153.19 50.14 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.96 -0.564 . . . . 50.0 112.305 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.735 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -58.89 146.62 36.9 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 105.149 -2.167 . . . . 16.66 105.149 175.356 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -49.3 -48.55 33.2 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 119.247 -1.454 . . . . 16.66 111.008 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -76.91 -18.09 58.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 4.0 t -50.3 -31.65 14.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.645 -0.872 . . . . 16.66 108.645 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.59 14.77 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.972 -1.013 . . . . 16.66 110.798 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 67.74 46.15 70.18 Favored Glycine 0 N--CA 1.462 0.385 0 N-CA-C 111.569 -0.612 . . . . 16.66 111.569 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -113.2 167.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.211 0.529 . . . . 16.66 111.732 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 40' ' ' ILE . 21.8 mt -63.07 164.5 8.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.392 -0.822 . . . . 50.0 110.653 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.689 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.3 pt20 -79.86 -53.46 6.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.269 0.557 . . . . 25.0 110.059 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.7 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 74.5 m -63.98 -22.8 67.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.634 -0.876 . . . . 50.0 108.634 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.876 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.66 -19.46 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.26 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -69.62 -53.64 17.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.924 -1.034 . . . . 25.0 110.665 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' SER . 11.9 tm-20 -89.52 -43.46 10.8 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.105 1.52 . . . . 50.0 115.105 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.059 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.5 pp -54.72 -30.49 56.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.189 0.811 . . . . 16.66 113.189 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.059 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -85.77 174.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.653 0.74 . . . . 25.0 109.467 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.15 -51.63 0.77 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.475 -1.239 . . . . 50.0 110.206 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -108.65 59.89 0.6 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 50.0 108.067 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.735 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.2 t80 -65.92 144.02 57.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.635 0.731 . . . . 16.66 110.357 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 5.6 t -123.98 156.3 31.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.443 -1.253 . . . . 50.0 109.058 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.391 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.7 p -85.8 160.52 52.72 Favored Pre-proline 0 N--CA 1.414 -2.239 0 CA-C-O 121.675 0.75 . . . . 16.66 110.685 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.1 Cg_endo -78.34 -22.75 9.32 Favored 'Trans proline' 0 C--N 1.278 -3.14 0 C-N-CA 122.061 1.841 . . . . 16.66 111.223 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' HG22 ' A' ' 12' ' ' ILE . 97.0 mt-30 -77.61 -31.09 52.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.382 -0.826 . . . . 50.0 108.963 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.188 0 CA-C-N 115.344 -0.844 . . . . 16.66 110.952 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.847 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 110.146 -0.316 . . . . 50.0 110.146 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.659 ' N ' HD22 ' A' ' 9' ' ' LEU . 19.5 m-85 -105.32 -73.4 0.68 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 48.7 t -39.84 128.86 2.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.362 0.601 . . . . 16.66 111.916 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.682 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -59.59 -7.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.128 -1.064 . . . . 50.0 108.128 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -77.42 2.14 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.716 -1.584 . . . . 16.66 110.928 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 42.0 mttm 69.34 54.81 0.4 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.189 -0.46 . . . . 25.0 111.773 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.433 HG23 ' HB3' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -158.67 125.18 2.49 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.537 -0.301 . . . . 50.0 110.258 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' N ' ' HB2' ' A' ' 9' ' ' LEU . 24.6 Cg_exo -56.02 176.47 0.18 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.677 2.252 . . . . 50.0 113.586 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -58.18 143.82 42.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.825 0.821 . . . . 50.0 111.402 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.5 m-20 -136.07 98.03 3.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.162 -1.381 . . . . 50.0 108.755 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -50.7 -14.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.266 0.555 . . . . 50.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.466 ' N ' ' C ' ' A' ' 18' ' ' ASP . 24.3 m -80.77 -29.53 36.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.802 -1.184 . . . . 50.0 107.802 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 18' ' ' ASP . 25.3 tptt -100.12 130.09 46.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.62 -1.627 . . . . 50.0 107.636 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.521 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 43.9 p90 -97.0 142.14 29.31 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.078 -0.51 . . . . 16.66 111.091 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CD2' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -119.96 173.78 6.86 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 124.441 2.067 . . . . 50.0 115.151 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.995 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.13 123.5 60.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 108.994 -3.73 . . . . 16.66 104.623 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.546 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -89.21 126.34 8.18 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 119.478 -1.344 . . . . 16.66 115.656 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.438 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.16 121.17 3.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.359 -1.348 . . . . 16.66 107.359 176.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.459 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.4 t70 -68.3 -31.64 71.22 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.578 0.704 . . . . 25.0 109.216 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -113.56 -26.46 8.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.588 -1.187 . . . . 50.0 111.81 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.283 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -95.26 12.58 28.49 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.8 -0.76 . . . . 16.66 112.607 -177.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.5 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 11.4 pt20 29.92 47.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.823 0.675 . . . . 16.66 112.823 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.56 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -131.36 164.1 26.41 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.069 -0.252 . . . . 50.0 110.544 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.587 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -134.39 125.6 27.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.907 -0.317 . . . . 16.66 111.832 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -131.89 157.45 43.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 121.033 -0.267 . . . . 50.0 111.605 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -55.19 140.48 38.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.392 -1.336 . . . . 16.66 107.392 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -47.56 -42.57 20.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.379 -1.391 . . . . 16.66 110.615 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -77.27 -20.47 55.06 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.758 -0.46 . . . . 50.0 109.758 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.3 t -51.33 -32.49 25.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.799 -0.815 . . . . 16.66 108.799 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.5 11.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.028 -0.987 . . . . 16.66 110.988 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.96 45.57 50.37 Favored Glycine 0 N--CA 1.461 0.318 0 CA-C-N 115.934 -0.576 . . . . 16.66 111.837 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.526 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -106.55 163.81 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.89 0.376 . . . . 16.66 110.462 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.748 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.2 mm? -64.73 163.2 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 50.0 110.262 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -80.27 -56.6 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.413 -0.812 . . . . 25.0 110.63 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.9 m -66.81 -14.64 62.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.151 -0.931 . . . . 50.0 109.164 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.006 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 3.0 tt0 -44.93 -44.47 9.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.523 -0.762 . . . . 50.0 111.056 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.12 -35.04 6.64 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.538 -0.465 . . . . 25.0 111.624 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -87.03 -52.64 5.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.796 0.665 . . . . 50.0 112.796 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.2 pp -71.95 4.98 2.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.372 -0.831 . . . . 16.66 111.452 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.006 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -107.34 130.62 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 119.695 -0.802 . . . . 25.0 111.21 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.88 -72.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.815 -1.084 . . . . 50.0 112.345 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.21 68.68 0.81 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.302 -0.629 . . . . 50.0 109.302 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.3 147.43 53.32 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.612 -0.722 . . . . 16.66 109.53 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.677 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.6 t -119.99 155.11 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.469 -0.787 . . . . 50.0 109.023 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.438 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -84.83 160.79 54.95 Favored Pre-proline 0 N--CA 1.412 -2.334 0 CA-C-N 115.596 -0.729 . . . . 16.66 110.944 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 39.0 Cg_endo -77.81 -26.34 6.91 Favored 'Trans proline' 0 C--N 1.279 -3.127 0 C-N-CA 122.251 1.967 . . . . 16.66 111.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.79 -34.05 71.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.193 -1.04 . . . . 50.0 108.193 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 114.784 -1.098 . . . . 16.66 110.309 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.707 0.289 . . . . 50.0 111.419 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.0 m-85 -101.85 -67.34 0.87 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.498 -0.927 . . . . 25.0 108.498 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 4.6 t -41.43 114.71 0.54 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.957 -1.019 . . . . 16.66 110.638 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.626 HG23 ' CD1' ' A' ' 33' ' ' TYR . 4.3 pt -50.92 -8.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.575 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.946 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.68 6.72 10.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.832 -1.076 . . . . 16.66 110.7 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm 64.09 52.63 1.97 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.145 -0.48 . . . . 25.0 111.405 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.43 144.31 22.62 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 50.0 109.669 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.71 155.85 68.35 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.585 2.19 . . . . 50.0 112.408 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.705 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 30.6 t80 -58.24 148.48 27.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 50.0 109.833 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.491 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 91.3 m-20 -140.57 111.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.763 -0.653 . . . . 50.0 111.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.84 -17.37 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 50.0 110.043 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.5 m -76.35 -29.27 57.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.585 -1.265 . . . . 50.0 107.585 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 6.7 tptm -99.49 156.47 17.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.456 -1.702 . . . . 50.0 108.492 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 35.4 p90 -111.06 152.25 27.12 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.45 -0.5 . . . . 16.66 110.364 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.705 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 9.5 m-85 -130.46 168.83 16.38 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 123.42 1.581 . . . . 50.0 114.256 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.03 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.36 123.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 110.932 -2.849 . . . . 16.66 105.53 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.52 120.08 6.16 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.876 -1.154 . . . . 16.66 115.773 -174.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.439 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.21 107.6 0.13 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.273 -1.38 . . . . 16.66 107.273 175.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 89.7 m-20 -65.52 -34.08 77.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -92.71 -39.55 11.2 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.519 -1.673 . . . . 50.0 110.935 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.276 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.09 -28.4 27.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.918 -0.713 . . . . 16.66 111.49 -178.316 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.779 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER 76.13 28.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.486 0.921 . . . . 16.66 113.486 178.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.523 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.96 166.18 22.97 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 119.776 -0.77 . . . . 50.0 111.079 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 140.66 50.72 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.922 0.712 . . . . 16.66 112.922 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.69 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -133.62 144.38 49.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.454 -0.339 . . . . 50.0 111.061 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.814 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.7 OUTLIER -56.34 139.31 48.88 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.395 -1.706 . . . . 16.66 106.395 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.499 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.8 -54.34 5.07 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.843 -1.17 . . . . 16.66 111.53 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.61 -20.28 62.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.486 -0.486 . . . . 50.0 109.784 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.5 -31.88 25.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.281 -0.637 . . . . 16.66 109.281 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.57 13.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.344 -0.844 . . . . 16.66 111.185 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.51 45.98 57.42 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.793 -0.523 . . . . 16.66 111.793 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.499 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -113.86 167.51 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.137 0.494 . . . . 16.66 111.363 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 40' ' ' ILE . 42.4 mt -61.47 164.85 5.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.555 -0.748 . . . . 50.0 110.582 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -77.92 -55.1 5.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 25.0 110.314 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.62 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 72.7 m -70.78 -15.24 62.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.507 -0.769 . . . . 50.0 109.441 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.872 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -41.97 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.564 -0.744 . . . . 50.0 110.755 -178.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.64 -45.5 58.65 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.939 -0.573 . . . . 25.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 43' ' ' SER . 97.1 mt-10 -88.93 -45.69 9.48 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.593 1.331 . . . . 50.0 114.593 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 48' ' ' ILE . 1.8 pp -55.29 -29.28 57.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.948 0.721 . . . . 16.66 112.948 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.053 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -86.06 174.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.803 0.811 . . . . 25.0 109.641 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -124.51 -69.74 0.79 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.261 -1.336 . . . . 50.0 110.91 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -101.31 70.57 1.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.916 -1.142 . . . . 50.0 107.916 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.3 t80 -65.74 140.12 58.42 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.433 -0.803 . . . . 16.66 110.728 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.72 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.5 t -120.29 155.16 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 114.458 -1.246 . . . . 50.0 108.556 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.439 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -87.28 160.21 49.03 Favored Pre-proline 0 N--CA 1.414 -2.275 0 CA-C-O 121.39 0.614 . . . . 16.66 110.491 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 24.8 Cg_endo -81.52 -25.24 3.86 Favored 'Trans proline' 0 C--N 1.279 -3.095 0 C-N-CA 122.085 1.857 . . . . 16.66 110.764 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -71.34 -35.67 71.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.095 -0.957 . . . . 50.0 108.565 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-N 115.225 -0.898 . . . . 16.66 110.413 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.725 0.297 . . . . 50.0 110.303 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.643 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 4.9 m-85 -69.46 -99.13 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.173 -0.676 . . . . 25.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 15.6 t -40.34 121.86 1.46 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.497 -0.774 . . . . 16.66 112.456 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.729 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.2 pt -59.09 -7.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.521 -1.218 . . . . 50.0 108.807 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.981 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.11 10.45 2.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.414 -1.266 . . . . 16.66 110.848 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.0 mttm 65.63 51.5 1.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.045 -0.525 . . . . 25.0 111.989 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 148.1 31.37 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.736 -0.385 . . . . 50.0 110.552 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.3 158.56 48.38 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.728 2.285 . . . . 50.0 111.8 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.2 t80 -58.31 144.84 39.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.662 -0.415 . . . . 50.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 92.5 m-20 -140.79 116.64 10.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.85 -0.614 . . . . 50.0 110.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.87 -12.86 4.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.389 -0.597 . . . . 50.0 109.389 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 m -79.33 -21.12 46.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.541 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.1 tptm -112.98 153.08 28.61 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.524 -1.671 . . . . 50.0 107.824 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.2 p90 -111.13 154.11 24.77 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.228 -0.589 . . . . 16.66 110.607 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.765 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.5 m-85 -127.8 169.8 13.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 123.779 1.752 . . . . 50.0 114.475 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.049 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.79 178.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.128 -3.214 . . . . 16.66 103.796 176.092 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.89 125.45 2.71 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 117.521 -2.275 . . . . 16.66 114.158 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.38 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 105.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.366 -1.346 . . . . 16.66 107.366 176.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' TYR . 84.5 m-20 -71.19 -19.95 62.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -111.61 -18.22 12.85 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.002 -1.454 . . . . 50.0 110.908 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.207 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -122.8 18.06 10.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.323 -0.951 . . . . 16.66 112.708 -178.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.594 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 19.3 pt20 32.93 54.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.202 0.445 . . . . 16.66 112.202 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.622 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -133.94 167.51 20.46 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 121.096 -0.242 . . . . 50.0 110.485 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.642 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -138.76 133.26 31.95 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.432 0.53 . . . . 16.66 112.432 -177.262 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.729 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -139.49 155.02 47.82 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.006 -0.543 . . . . 50.0 112.06 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.891 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.51 141.79 57.48 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 106.243 -1.762 . . . . 16.66 106.243 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.537 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -43.52 -58.53 4.0 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.633 -1.27 . . . . 16.66 111.518 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.426 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -66.79 -20.95 66.05 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.5 t -51.72 -31.77 27.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.126 -0.63 . . . . 16.66 109.482 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.34 12.52 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.442 -0.799 . . . . 16.66 111.128 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.85 25.09 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 111.608 -0.597 . . . . 16.66 111.608 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -122.01 167.46 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.178 0.513 . . . . 16.66 112.038 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.4 mm? -62.49 164.15 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 50.0 110.432 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.661 ' HG2' ' H ' ' A' ' 43' ' ' SER . 7.9 pt20 -82.12 -49.38 10.24 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.905 ' C ' HD21 ' A' ' 47' ' ' LEU . 5.7 m -59.53 -39.0 82.5 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.422 -1.717 . . . . 50.0 107.459 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.757 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -40.15 -16.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.288 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -63.1 -61.65 2.23 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.249 -0.581 . . . . 25.0 111.649 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mp0 -91.87 -47.35 7.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.857 1.799 . . . . 50.0 115.857 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.155 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -65.71 14.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.495 1.295 . . . . 16.66 114.495 -174.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 44' ' ' GLU . 2.5 pp -117.15 169.45 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 120.133 -0.627 . . . . 25.0 109.962 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 53.3 t0 -165.42 27.59 0.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.748 0.785 . . . . 50.0 109.935 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.46 16.09 0.52 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.248 -1.39 . . . . 50.0 107.248 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.634 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.3 t80 -67.37 147.61 52.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.802 -1.09 . . . . 16.66 110.511 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 25.2 t -137.26 157.57 34.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.888 -1.505 . . . . 50.0 108.917 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.38 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.0 p -80.03 158.21 72.71 Favored Pre-proline 0 N--CA 1.414 -2.254 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 11.0 Cg_endo -81.35 -27.94 2.57 Favored 'Trans proline' 0 C--N 1.273 -3.406 0 C-N-CA 121.842 1.694 . . . . 16.66 110.932 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -71.97 -33.83 68.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.461 -0.79 . . . . 50.0 108.877 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.151 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-N 115.59 -0.732 . . . . 16.66 110.559 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.602 0.239 . . . . 50.0 110.714 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 2.7 m-85 -106.12 -6.26 18.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.364 0.602 . . . . 25.0 111.014 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -104.15 123.08 46.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.923 -1.035 . . . . 16.66 110.844 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.692 HG23 ' CD2' ' A' ' 33' ' ' TYR . 14.0 pt -59.96 -8.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.203 -1.406 . . . . 50.0 107.203 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.961 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -84.79 2.19 43.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.47 -1.696 . . . . 16.66 109.472 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mttp 67.78 64.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.553 -0.749 . . . . 25.0 112.246 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.3 141.64 13.13 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.709 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.98 158.73 52.66 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.657 2.238 . . . . 50.0 112.104 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.753 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 20.0 t80 -69.37 139.07 54.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.078 0.466 . . . . 50.0 110.936 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 11.5 t70 -140.58 128.62 22.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.593 -0.731 . . . . 50.0 109.47 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.6 -21.9 41.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.074 -0.512 . . . . 50.0 110.907 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -67.17 -33.79 76.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.744 -1.206 . . . . 50.0 107.744 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -85.41 152.49 23.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.259 -1.791 . . . . 50.0 109.114 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 22.0 p90 -114.17 140.6 48.4 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.32 -0.993 . . . . 16.66 108.32 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.753 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 28.5 m-85 -122.61 171.35 9.19 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 124.089 1.9 . . . . 50.0 115.621 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.041 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.28 118.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 109.513 -3.494 . . . . 16.66 103.977 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -90.42 125.64 8.01 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.58 -1.295 . . . . 16.66 116.279 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.415 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -46.64 108.45 0.14 Allowed 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.31 -1.367 . . . . 16.66 107.31 175.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.673 ' HB3' HG22 ' A' ' 52' ' ' VAL . 57.3 t0 -61.52 -29.3 69.9 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.018 -0.734 . . . . 25.0 109.018 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.42 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 13.6 ttt85 -113.72 -20.36 11.19 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.705 -1.134 . . . . 50.0 112.344 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.245 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -107.96 20.29 18.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.317 -0.953 . . . . 16.66 112.981 -177.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 29' ' ' CYS . 16.4 pt20 31.06 47.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.521 0.563 . . . . 16.66 112.521 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.529 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 3.6 m-20 -131.54 159.79 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.748 -0.381 . . . . 50.0 110.703 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -135.74 122.87 21.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.727 0.299 . . . . 16.66 111.049 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.692 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -124.09 153.66 41.1 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.456 -0.307 . . . . 50.0 111.406 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.839 ' CE1' ' HG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -54.8 146.42 17.24 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.728 -1.953 . . . . 16.66 105.728 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.543 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -46.2 -53.18 9.52 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 119.461 -1.352 . . . . 16.66 111.505 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -73.7 -19.4 60.83 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.715 -0.476 . . . . 50.0 109.715 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.6 t -49.96 -31.29 12.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 33' ' ' TYR . 4.0 m -115.77 9.45 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.203 -0.908 . . . . 16.66 110.3 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.79 45.83 20.16 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.395 -0.682 . . . . 16.66 111.395 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.543 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -117.3 167.53 10.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.91 0.386 . . . . 16.66 110.876 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 40' ' ' ILE . 90.1 mt -65.64 163.24 16.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.338 0.589 . . . . 50.0 109.666 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -78.07 -54.88 5.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.937 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.0 t -70.32 -14.77 62.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.431 -0.804 . . . . 50.0 110.677 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.68 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.7 mt-10 -44.4 -30.1 0.79 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.648 -0.421 . . . . 50.0 111.159 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -37.66 88.11 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.07 -0.652 . . . . 25.0 110.53 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.3 mm-40 -87.89 -33.17 18.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.227 1.195 . . . . 50.0 114.227 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.666 HD11 ' HA ' ' A' ' 44' ' ' GLU . 3.7 pp -94.31 16.24 15.51 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 112.716 0.636 . . . . 16.66 112.716 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -120.17 146.87 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 C-N-CA 118.704 -1.198 . . . . 25.0 112.888 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -94.38 -81.22 0.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.074 -0.966 . . . . 50.0 111.792 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.27 69.89 1.03 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.585 -0.279 . . . . 50.0 110.449 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.637 ' CG ' ' HB ' ' A' ' 24' ' ' ILE . 5.1 t80 -67.28 138.85 57.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.476 -0.89 . . . . 16.66 108.802 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 27' ' ' ASP . 23.9 t -119.38 150.81 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.722 -0.672 . . . . 50.0 109.315 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.415 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.8 p -80.99 160.91 64.94 Favored Pre-proline 0 N--CA 1.411 -2.395 0 CA-C-N 115.316 -0.857 . . . . 16.66 110.052 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 27.9 Cg_endo -80.43 -29.16 2.52 Favored 'Trans proline' 0 C--N 1.278 -3.177 0 C-N-CA 122.001 1.8 . . . . 16.66 111.405 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -70.83 -32.88 70.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.789 -1.096 . . . . 16.66 110.34 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.795 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 110.453 -0.203 . . . . 50.0 110.453 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -59.55 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.389 0.614 . . . . 25.0 110.491 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 43.4 t -37.67 122.51 0.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.034 -0.985 . . . . 16.66 113.298 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.753 HG23 ' CD2' ' A' ' 33' ' ' TYR . 8.8 pt -59.95 -13.98 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 114.862 -1.063 . . . . 50.0 108.138 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.965 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -72.25 4.5 3.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.811 -1.54 . . . . 16.66 110.137 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt 65.85 50.29 1.54 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.488 -0.778 . . . . 25.0 112.065 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.23 123.51 9.41 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.01 156.66 12.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.346 2.031 . . . . 50.0 111.948 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 4.5 t80 -61.28 134.25 56.77 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.293 0.568 . . . . 50.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 20' ' ' SER . 88.1 m-20 -141.46 116.02 9.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.085 -0.961 . . . . 50.0 108.83 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -43.92 -13.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.627 -0.429 . . . . 50.0 110.481 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -62.84 -38.41 90.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.748 -0.834 . . . . 50.0 108.748 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -99.85 167.52 10.47 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.1 p90 -120.77 142.32 49.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.694 -0.684 . . . . 16.66 109.168 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 2.9 m-85 -114.03 155.49 25.82 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 123.791 1.758 . . . . 50.0 115.414 -175.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.01 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -121.92 126.43 74.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 110.2 -3.182 . . . . 16.66 105.123 176.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.66 123.68 7.41 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.556 -1.307 . . . . 16.66 115.054 -175.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -49.86 107.0 0.13 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.65 -1.275 . . . . 16.66 108.89 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.635 ' HB2' HG22 ' A' ' 52' ' ' VAL . 80.8 m-20 -56.88 -35.13 68.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.265 -0.574 . . . . 25.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.71 -12.71 13.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 50.0 111.873 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -110.21 12.58 23.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.323 -0.951 . . . . 16.66 111.57 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.52 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 10.0 pt20 29.92 53.43 0.12 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.941 0.4 . . . . 16.66 111.101 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.645 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 2.8 m-20 -132.45 166.64 21.54 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.31 -0.404 . . . . 50.0 110.189 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -141.36 132.8 26.81 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.333 -0.547 . . . . 16.66 111.676 -177.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.753 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -138.56 155.47 48.34 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 50.0 112.494 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.824 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -60.62 146.58 44.87 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 105.064 -2.198 . . . . 16.66 105.064 175.142 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.0 -51.27 25.37 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 119.136 -1.507 . . . . 16.66 110.831 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.84 -18.48 60.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.712 -0.395 . . . . 50.0 109.953 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.0 t -50.39 -32.48 17.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.066 -0.716 . . . . 16.66 109.066 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.18 18.68 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.016 -0.993 . . . . 16.66 111.219 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.98 46.19 82.92 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 111.513 -0.635 . . . . 16.66 111.513 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.88 164.01 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.864 0.364 . . . . 16.66 110.934 -178.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.755 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 10.4 mp -58.0 164.76 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.245 0.545 . . . . 50.0 110.162 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -78.63 -56.26 4.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.34 -0.845 . . . . 25.0 110.985 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.494 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 67.4 m -71.23 -15.55 62.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.59 -0.732 . . . . 50.0 109.236 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.779 ' HA ' HD11 ' A' ' 47' ' ' LEU . 2.1 tt0 -43.36 -19.13 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.481 -0.781 . . . . 50.0 111.172 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -68.56 -47.01 67.92 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.432 -0.507 . . . . 25.0 111.19 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.25 -45.69 9.86 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.261 1.208 . . . . 50.0 114.261 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.089 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.3 pp -55.15 -28.16 50.76 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.842 0.682 . . . . 16.66 112.842 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.089 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -85.76 174.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.607 0.718 . . . . 25.0 109.349 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -137.46 -53.88 0.68 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.642 -1.163 . . . . 50.0 110.455 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -103.69 56.35 0.74 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.823 -1.177 . . . . 50.0 107.823 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.66 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.3 t80 -65.27 141.46 58.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.537 0.684 . . . . 16.66 109.876 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.1 t -126.06 154.83 35.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.375 -1.284 . . . . 50.0 109.288 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -82.21 159.51 64.84 Favored Pre-proline 0 N--CA 1.413 -2.289 0 CA-C-N 115.69 -0.686 . . . . 16.66 109.824 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 22.6 Cg_endo -81.28 -25.65 3.79 Favored 'Trans proline' 0 C--N 1.275 -3.297 0 C-N-CA 121.962 1.775 . . . . 16.66 111.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -74.79 -32.59 62.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.719 . . . . 50.0 109.101 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.145 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 16.66 110.907 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.9 m-85 -94.04 -71.92 0.64 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.562 -0.533 . . . . 25.0 109.562 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 37.4 t -40.52 111.0 0.17 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.5 -0.773 . . . . 16.66 110.334 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.696 HG23 ' CD2' ' A' ' 33' ' ' TYR . 18.8 pt -51.84 -7.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.918 -0.771 . . . . 50.0 108.918 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -83.49 30.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.484 -1.234 . . . . 16.66 109.392 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 12' ' ' ILE . 48.8 pttt 42.66 55.81 4.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.489 -0.778 . . . . 25.0 111.619 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 p -145.54 141.55 17.06 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.51 -0.314 . . . . 50.0 110.28 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.2 154.01 56.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.451 2.101 . . . . 50.0 111.482 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 17.5 t80 -57.81 138.71 55.37 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.05 -0.66 . . . . 50.0 109.84 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.5 m-20 -141.56 118.58 11.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.1 -0.955 . . . . 50.0 110.435 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -51.23 -22.9 2.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.055 -0.72 . . . . 50.0 109.055 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -63.45 -35.4 80.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.972 -1.121 . . . . 50.0 107.972 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -90.9 155.14 18.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 113.868 -1.514 . . . . 50.0 108.926 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 46.0 p90 -118.39 123.34 45.02 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.03 0.919 . . . . 16.66 110.168 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 m-85 -103.03 162.55 12.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 123.769 1.747 . . . . 50.0 114.879 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.057 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -130.8 117.46 38.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 110.183 -3.189 . . . . 16.66 103.63 176.288 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.28 135.46 13.34 Favored Glycine 0 C--N 1.316 -0.543 0 N-CA-C 116.866 1.507 . . . . 16.66 116.866 -173.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.45 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.7 OUTLIER -46.86 117.78 1.8 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.946 -1.627 . . . . 16.66 108.503 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.704 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.9 t70 -51.71 -46.49 63.93 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.662 -0.815 . . . . 25.0 109.818 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.526 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -117.34 -5.94 11.27 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.212 0.819 . . . . 50.0 113.212 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.265 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -98.08 14.66 26.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 118.669 -1.212 . . . . 16.66 111.37 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.569 ' CD ' ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER 30.53 50.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.716 . . . . 16.66 111.963 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.567 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 10.2 m-20 -131.87 163.92 27.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.414 -0.357 . . . . 50.0 110.193 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.549 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -136.57 126.22 25.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.74 0.305 . . . . 16.66 110.832 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.696 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -124.8 141.82 51.85 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.796 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 6.6 p-80 -56.02 146.99 20.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.649 -1.612 . . . . 16.66 106.649 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.51 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -40.36 -60.7 1.95 Allowed Glycine 0 C--N 1.306 -1.111 0 C-N-CA 119.913 -1.137 . . . . 16.66 113.382 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.524 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.82 -20.36 64.31 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.221 0.534 . . . . 50.0 109.783 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -49.3 -25.9 2.69 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.343 -0.984 . . . . 16.66 108.343 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 33' ' ' TYR . 17.7 m -124.32 7.8 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.184 -0.916 . . . . 16.66 111.345 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 79.35 46.38 8.14 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.824 -0.91 . . . . 16.66 110.824 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 41' ' ' LEU . 1.1 tp -106.0 155.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.019 0.437 . . . . 16.66 110.692 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.7 mt -61.92 166.19 4.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.942 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -70.61 -53.55 15.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.76 -0.654 . . . . 25.0 109.362 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' ALA . 75.6 m -75.58 -14.65 60.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.218 -0.901 . . . . 50.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.995 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -43.11 -18.17 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.932 -0.576 . . . . 50.0 110.203 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.06 -43.55 64.72 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.519 -0.472 . . . . 25.0 110.969 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.67 ' C ' ' H ' ' A' ' 48' ' ' ILE . 97.4 mt-10 -87.6 -52.98 5.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.138 0.792 . . . . 50.0 113.138 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.817 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.67 9.08 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.049 -0.523 . . . . 16.66 110.63 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.995 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -112.62 135.66 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.282 -0.872 . . . . 25.0 112.146 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 59.5 t0 -91.59 -71.89 0.61 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.996 -1.002 . . . . 50.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' OE1' ' OD1' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -130.29 78.42 1.84 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.889 -0.782 . . . . 50.0 108.889 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.762 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.31 147.32 53.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.026 -0.731 . . . . 16.66 109.026 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.762 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 21.5 t -110.71 158.87 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.243 -0.583 . . . . 50.0 109.9 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.45 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -89.38 159.61 44.06 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 115.704 -0.68 . . . . 16.66 110.12 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 43.4 Cg_endo -79.28 -30.45 2.6 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 C-N-CA 121.746 1.631 . . . . 16.66 110.834 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -68.91 -32.99 73.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.588 -1.264 . . . . 50.0 107.588 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.115 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.1 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 114.177 -1.374 . . . . 16.66 109.914 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.498 0.19 . . . . 50.0 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.8 m-85 -106.17 -67.35 0.94 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.7 t -41.63 116.53 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.27 -0.877 . . . . 16.66 110.742 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' CD1' ' A' ' 33' ' ' TYR . 11.3 pt -52.3 -7.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.18 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.947 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -79.85 3.08 20.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.662 -1.153 . . . . 16.66 110.671 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.1 mttp 67.94 55.17 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.187 -0.46 . . . . 25.0 111.786 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.412 ' CG2' ' NE2' ' A' ' 34' ' ' HIS . 0.6 OUTLIER -147.62 145.2 20.7 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 110.063 -0.347 . . . . 50.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.58 150.37 79.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.447 2.098 . . . . 50.0 111.874 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.741 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.0 t80 -54.26 146.24 15.82 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.49 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 91.2 m-20 -140.56 112.75 7.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.999 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.21 -17.6 7.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 50.0 109.934 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 t -72.11 -31.93 66.49 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.313 -1.366 . . . . 50.0 107.313 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -97.93 157.28 16.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.07 -1.877 . . . . 50.0 109.006 179.079 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 45.5 p90 -114.17 146.58 40.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.303 -0.559 . . . . 16.66 109.978 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.741 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 5.7 m-85 -122.83 165.22 16.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 123.355 1.55 . . . . 50.0 114.269 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.008 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -123.96 119.66 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 111.099 -2.773 . . . . 16.66 105.18 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -84.96 124.33 6.69 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.545 -1.312 . . . . 16.66 114.534 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.435 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -46.8 107.78 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.656 -1.609 . . . . 16.66 106.656 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 54.9 t0 -59.89 -29.82 68.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -113.89 -13.34 12.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.548 -1.205 . . . . 50.0 111.695 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.326 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -112.3 10.54 20.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 119.861 -0.735 . . . . 16.66 111.798 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.593 ' NE2' ' O ' ' A' ' 29' ' ' CYS . 3.8 pp0? 34.02 49.65 0.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.188 0.44 . . . . 16.66 112.188 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.705 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 9.8 m-20 -132.25 166.19 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.946 -0.39 . . . . 50.0 109.946 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -134.53 133.04 39.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 120.801 -0.36 . . . . 16.66 111.936 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.77 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -132.94 143.58 49.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.012 178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.883 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -51.27 143.33 11.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.923 -1.51 . . . . 16.66 106.923 176.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.11 -59.59 2.91 Favored Glycine 0 C--N 1.318 -0.437 0 C-N-CA 119.885 -1.15 . . . . 16.66 111.396 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.18 -19.06 63.99 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.762 -0.375 . . . . 50.0 110.394 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.08 -30.2 10.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.539 -0.911 . . . . 16.66 108.539 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 33' ' ' TYR . 6.7 m -117.52 8.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.251 -0.886 . . . . 16.66 111.146 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 77.66 45.52 10.76 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.167 -0.54 . . . . 16.66 112.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.491 ' CG2' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -112.98 167.07 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.131 0.491 . . . . 16.66 110.923 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 41' ' ' LEU . 6.5 mp -64.24 161.87 15.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 50.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -79.1 -54.33 6.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.859 -0.793 . . . . 25.0 108.859 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.9 t -60.01 -12.52 8.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.707 -1.133 . . . . 50.0 109.07 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.821 ' CD ' ' N ' ' A' ' 45' ' ' ALA . 1.9 pp20? -40.49 -55.75 2.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.211 -0.904 . . . . 50.0 111.068 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.821 ' N ' ' CD ' ' A' ' 44' ' ' GLU . . . -56.55 -26.22 54.36 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.342 -0.844 . . . . 25.0 110.473 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' SER . 84.6 tt0 -86.77 -25.45 24.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.181 0.515 . . . . 50.0 111.965 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 47' ' ' LEU . 4.2 pp -117.92 11.51 13.48 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 115.599 -0.728 . . . . 16.66 112.35 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.809 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -119.15 145.39 25.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.097 -1.041 . . . . 25.0 111.864 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.617 ' H ' HD13 ' A' ' 48' ' ' ILE . 22.5 t70 -146.65 -42.62 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.163 -0.926 . . . . 50.0 111.628 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -94.21 24.88 4.09 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 2.7 t80 -65.28 141.74 58.51 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.47 -0.786 . . . . 16.66 109.061 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' H ' ' A' ' 27' ' ' ASP . 4.9 t -129.32 157.77 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.822 -1.081 . . . . 50.0 108.423 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.435 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.3 p -79.62 158.92 72.84 Favored Pre-proline 0 N--CA 1.414 -2.265 0 CA-C-O 121.66 0.743 . . . . 16.66 110.693 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 23.8 Cg_endo -81.05 -15.75 10.24 Favored 'Trans proline' 0 C--N 1.278 -3.146 0 C-N-CA 122.15 1.9 . . . . 16.66 111.573 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' OE1' ' ND2' ' A' ' 31' ' ' ASN . 2.0 pt20 -87.53 -30.38 20.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 50.0 109.52 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.156 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-N 115.924 -0.58 . . . . 16.66 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.719 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 110.461 -0.2 . . . . 50.0 110.461 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.616 ' CD2' ' CD1' ' A' ' 32' ' ' TRP . 2.6 m-85 -95.38 -75.49 0.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 120.107 -0.637 . . . . 25.0 112.04 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 11.4 t -38.39 118.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.428 0.632 . . . . 16.66 112.146 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.508 HG23 ' CD1' ' A' ' 33' ' ' TYR . 6.6 pt -53.31 -7.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.148 -0.933 . . . . 50.0 108.97 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.27 5.51 19.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.396 -1.274 . . . . 16.66 110.911 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 68.14 51.68 0.71 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.168 -0.469 . . . . 25.0 111.891 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 124.96 4.67 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.932 -0.307 . . . . 50.0 110.792 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 38.1 Cg_exo -55.19 162.68 5.34 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.644 2.229 . . . . 50.0 112.654 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.87 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 11.4 t80 -63.3 138.39 58.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.538 0.685 . . . . 50.0 111.128 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.546 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 70.8 m-20 -142.91 131.6 22.59 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.652 -1.158 . . . . 50.0 109.951 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.07 -20.74 62.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 50.0 110.395 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -63.11 -30.03 71.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.699 0.761 . . . . 50.0 109.1 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.735 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -106.09 158.35 16.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 114.378 -1.283 . . . . 50.0 107.685 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE2' ' HA3' ' A' ' 35' ' ' GLY . 45.8 p90 -119.38 137.91 53.43 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.082 -0.647 . . . . 16.66 109.288 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.87 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 2.2 m-85 -111.02 170.3 8.19 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 124.066 1.889 . . . . 50.0 115.331 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.03 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.32 118.72 24.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 109.747 -3.388 . . . . 16.66 105.07 177.459 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.63 124.8 6.99 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.037 1.175 . . . . 16.66 116.037 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.472 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -49.17 107.41 0.14 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.6 -1.259 . . . . 16.66 107.6 175.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.687 ' HB2' HG22 ' A' ' 52' ' ' VAL . 83.7 m-20 -61.4 -35.61 77.99 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.352 0.596 . . . . 25.0 109.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -19.56 14.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.103 -0.953 . . . . 50.0 111.327 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.315 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -94.39 -29.07 15.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.611 -0.835 . . . . 16.66 110.53 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.607 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 75.89 26.16 1.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.336 0.865 . . . . 16.66 113.336 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.708 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 14.7 p30 -132.63 167.41 20.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.859 -0.525 . . . . 50.0 110.091 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -121.31 145.04 48.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.429 0.899 . . . . 16.66 113.429 -176.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.708 ' OH ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -132.39 146.65 52.11 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.108 -0.496 . . . . 50.0 110.457 176.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.891 ' CE1' ' HG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -55.03 143.23 27.33 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.578 -1.638 . . . . 16.66 106.578 176.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -42.6 -58.3 3.57 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.0 -1.095 . . . . 16.66 111.697 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -71.61 -18.36 62.22 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.822 -0.351 . . . . 50.0 110.178 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.9 t -49.54 -31.47 10.4 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.799 -0.76 . . . . 16.66 109.003 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 33' ' ' TYR . 4.5 m -117.96 12.27 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.229 -0.896 . . . . 16.66 111.066 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 69.79 45.44 58.11 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.811 -0.631 . . . . 16.66 111.709 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -109.04 167.66 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.161 0.505 . . . . 16.66 111.219 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 40' ' ' ILE . 43.8 mt -62.76 164.5 7.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.584 -0.734 . . . . 50.0 110.911 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -80.1 -55.13 5.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.166 -0.925 . . . . 25.0 110.426 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.61 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.8 m -66.11 -15.78 63.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.863 -1.062 . . . . 50.0 109.625 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.709 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -42.65 -32.88 0.63 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.267 0.556 . . . . 50.0 109.753 -179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.05 -38.8 72.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.56 -0.745 . . . . 25.0 110.399 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' SER . 36.5 tp10 -88.31 -10.67 48.75 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.808 1.04 . . . . 50.0 113.808 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.709 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -115.76 16.51 16.33 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.34 0.496 . . . . 16.66 112.34 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -124.7 160.08 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 118.45 -1.3 . . . . 25.0 113.763 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' H ' HG13 ' A' ' 48' ' ' ILE . 54.3 t0 -130.43 -44.8 1.11 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.163 -1.38 . . . . 50.0 111.027 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' C ' ' OD2' ' A' ' 27' ' ' ASP . 95.5 mt-10 -120.97 52.22 1.21 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.593 -0.276 . . . . 50.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.612 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 1.5 t80 -66.78 137.56 56.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.267 -0.973 . . . . 16.66 108.375 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 27' ' ' ASP . 12.3 t -116.92 153.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.472 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -82.13 161.83 58.88 Favored Pre-proline 0 N--CA 1.409 -2.513 0 CA-C-N 115.217 -0.901 . . . . 16.66 110.859 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.4 Cg_endo -79.48 -26.47 4.86 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.113 1.876 . . . . 16.66 111.388 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -74.37 -30.96 62.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.194 -1.039 . . . . 50.0 108.194 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 2.5 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 114.608 -1.178 . . . . 16.66 110.988 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.235 -0.283 . . . . 50.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.8 m-85 -99.71 -64.44 1.04 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.9 t -46.47 118.55 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.084 -0.962 . . . . 16.66 110.28 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.704 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.0 pt -53.62 -7.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.927 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -87.78 28.76 0.97 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.319 -1.309 . . . . 16.66 110.665 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 13' ' ' CYS . 19.9 pttm 41.56 65.88 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 25.0 111.685 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 139.15 11.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.094 -0.503 . . . . 50.0 109.731 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.64 154.93 72.04 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.348 2.032 . . . . 50.0 112.049 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.747 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 25.6 t80 -55.43 147.3 17.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.034 0.445 . . . . 50.0 109.918 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 21' ' ' LYS . 91.1 m-20 -140.58 109.08 5.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.013 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.3 -14.7 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.1 m -76.65 -29.81 56.56 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -100.9 155.02 18.18 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.234 -1.803 . . . . 50.0 107.997 178.321 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 32.1 p90 -109.61 152.84 25.02 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.193 -0.603 . . . . 16.66 110.584 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.747 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.9 m-85 -128.24 162.05 27.9 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.46 1.6 . . . . 50.0 114.294 -177.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.032 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.11 117.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 110.883 -2.871 . . . . 16.66 104.188 176.049 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.81 131.17 10.4 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.953 -1.118 . . . . 16.66 115.685 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.411 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -47.36 108.03 0.14 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.481 -1.303 . . . . 16.66 107.481 176.047 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.715 ' HB3' HG22 ' A' ' 52' ' ' VAL . 51.2 t0 -61.13 -31.8 71.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.313 0.577 . . . . 25.0 109.704 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 7.5 tpt180 -113.1 -16.15 12.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.09 -0.959 . . . . 50.0 112.023 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.192 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -112.15 14.01 20.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.174 -1.01 . . . . 16.66 112.569 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.549 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 21.1 pt20 39.29 44.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.282 1.586 . . . . 16.66 115.282 176.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.595 ' H ' ' CB ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -134.15 165.98 23.81 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.407 -0.917 . . . . 50.0 110.631 177.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -127.52 135.71 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 16.66 111.823 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.704 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -134.97 144.88 47.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.276 -0.42 . . . . 50.0 110.691 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.813 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -53.51 142.11 23.32 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.645 -1.613 . . . . 16.66 106.645 176.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.19 -56.34 4.0 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 119.784 -1.198 . . . . 16.66 111.547 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -18.51 61.96 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.45 -0.5 . . . . 50.0 110.203 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.23 -29.85 10.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 33' ' ' TYR . 4.5 m -119.83 14.61 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.246 -0.888 . . . . 16.66 111.108 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.85 46.18 47.11 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.102 -0.571 . . . . 16.66 111.758 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.488 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -115.58 162.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 16.66 110.85 -179.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.0 tp -64.54 163.79 12.9 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 121.047 0.451 . . . . 50.0 109.992 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.824 ' HG2' ' H ' ' A' ' 43' ' ' SER . 4.2 pt20 -80.05 -53.44 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.009 -0.541 . . . . 25.0 110.075 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.824 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 29.6 t -64.98 -22.38 66.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 1.044 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.8 mt-10 -44.83 -17.45 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.555 ' N ' ' C ' ' A' ' 43' ' ' SER . . . -70.44 -45.11 66.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.479 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.711 ' C ' ' H ' ' A' ' 48' ' ' ILE . 96.4 mt-10 -88.5 -53.29 4.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.256 0.836 . . . . 50.0 113.256 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.868 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.73 11.56 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.144 0.497 . . . . 16.66 110.572 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.044 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -114.42 136.34 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.159 -0.928 . . . . 25.0 112.042 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.07 -73.64 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 50.0 111.818 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.53 71.95 1.24 Allowed 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.191 -0.67 . . . . 50.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.713 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.22 145.3 55.94 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.593 -0.73 . . . . 16.66 109.715 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' A' ' 27' ' ' ASP . 11.2 t -112.57 157.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.659 -0.701 . . . . 50.0 109.234 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.411 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.2 p -86.66 155.82 56.15 Favored Pre-proline 0 N--CA 1.409 -2.485 0 CA-C-N 115.572 -0.74 . . . . 16.66 110.546 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD3' ' OH ' ' A' ' 51' ' ' TYR . 84.2 Cg_endo -67.97 -32.38 28.65 Favored 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 122.099 1.866 . . . . 16.66 111.093 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.38 -32.72 71.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 50.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.238 0 CA-C-N 115.422 -0.808 . . . . 16.66 111.4 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.232 0.154 0 N-CA-C 110.247 -0.279 . . . . 50.0 110.247 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.6 m-85 -100.7 -70.89 0.72 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.0 t -41.22 116.18 0.71 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.195 -0.911 . . . . 16.66 111.034 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.649 HG23 ' CD1' ' A' ' 33' ' ' TYR . 5.1 pt -54.51 -8.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.533 -0.758 . . . . 50.0 109.265 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.971 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -80.67 8.03 8.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.698 -1.137 . . . . 16.66 110.694 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? 65.36 53.5 1.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 25.0 111.773 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 142.77 16.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.53 155.01 67.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.607 2.205 . . . . 50.0 112.643 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.708 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 14.6 t80 -63.09 140.85 58.91 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.243 -0.435 . . . . 50.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 45.2 t0 -140.57 126.32 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 50.0 110.299 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.77 -14.45 32.67 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.669 -0.696 . . . . 50.0 110.328 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -75.35 -30.15 60.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.35 -1.352 . . . . 50.0 107.35 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.568 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 8.2 tptp -99.92 153.95 18.76 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.316 -1.765 . . . . 50.0 108.159 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 45.8 p90 -110.55 152.01 26.92 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.315 -0.554 . . . . 16.66 110.582 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -129.21 165.46 21.31 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.422 1.582 . . . . 50.0 114.645 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.007 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -125.19 123.02 64.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 110.777 -2.92 . . . . 16.66 104.45 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -91.92 123.33 7.18 Favored Glycine 0 C--N 1.317 -0.472 0 C-N-CA 119.52 -1.324 . . . . 16.66 115.913 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.468 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.92 108.59 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.929 -1.508 . . . . 16.66 106.929 175.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 90.3 m-20 -66.67 -23.93 66.2 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -112.58 -22.59 10.7 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.085 -1.416 . . . . 50.0 111.634 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.261 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -106.66 12.85 28.82 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.677 -0.809 . . . . 16.66 111.762 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HG2' ' C ' ' A' ' 29' ' ' CYS . 22.8 pt20 34.97 45.54 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.726 0.639 . . . . 16.66 112.726 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.5 t-20 -132.92 166.59 21.99 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.41 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -135.5 130.47 34.7 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 121.034 -0.267 . . . . 16.66 111.09 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.96 145.45 51.63 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.922 -0.311 . . . . 50.0 111.175 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.845 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -54.78 141.24 33.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.722 -1.585 . . . . 16.66 106.722 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.24 -59.79 2.9 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.433 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -20.27 66.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 50.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.0 t -50.94 -31.11 16.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.888 -0.782 . . . . 16.66 108.888 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 33' ' ' TYR . 2.5 m -120.23 14.04 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.254 -0.885 . . . . 16.66 110.894 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.19 45.7 60.63 Favored Glycine 0 N--CA 1.46 0.287 0 CA-C-N 115.885 -0.598 . . . . 16.66 111.741 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.473 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -107.8 164.63 4.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.949 0.404 . . . . 16.66 110.538 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.792 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 74.2 mt -58.7 163.96 3.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.875 -0.602 . . . . 50.0 109.982 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -78.4 -55.44 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.295 -0.866 . . . . 25.0 110.996 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -70.48 -15.82 62.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.506 -0.77 . . . . 50.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.794 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.3 mt-10 -45.77 -19.83 0.07 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.851 -0.613 . . . . 50.0 111.866 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -64.22 -48.06 77.32 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.931 -0.708 . . . . 25.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.57 -45.88 9.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.182 1.549 . . . . 50.0 115.182 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.794 HD11 ' HA ' ' A' ' 44' ' ' GLU . 1.9 pp -55.26 -32.61 62.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 114.208 1.188 . . . . 16.66 114.208 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.2 pp -86.0 171.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.532 -0.867 . . . . 25.0 109.913 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -162.99 9.62 0.06 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.89 -1.05 . . . . 50.0 109.631 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -145.44 30.63 1.11 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.661 -1.607 . . . . 50.0 106.661 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.697 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 9.6 t80 -66.12 147.56 53.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.225 -1.352 . . . . 16.66 110.873 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.697 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.4 t -132.55 156.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.053 -1.431 . . . . 50.0 108.652 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.468 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -79.53 156.65 75.56 Favored Pre-proline 0 N--CA 1.409 -2.521 0 CA-C-O 121.586 0.708 . . . . 16.66 110.003 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 86.1 Cg_endo -71.27 -28.12 18.84 Favored 'Trans proline' 0 C--N 1.273 -3.412 0 C-N-CA 121.835 1.69 . . . . 16.66 110.601 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -71.85 -35.97 70.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.27 -1.011 . . . . 50.0 108.27 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.243 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.176 0 CA-C-N 115.091 -0.958 . . . . 16.66 110.621 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 110.329 -0.249 . . . . 50.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.35 -68.72 0.79 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.119 0.485 . . . . 25.0 109.952 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.3 t -40.79 115.47 0.58 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 16.66 110.932 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.634 HG22 ' NE2' ' A' ' 55' ' ' GLN . 5.8 pt -52.75 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 50.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.999 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.67 4.22 16.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 16.66 110.333 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm 66.49 55.58 0.81 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.821 -0.627 . . . . 25.0 112.045 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -147.3 142.05 16.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.792 -0.447 . . . . 50.0 109.792 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 15' ' ' THR . 15.8 Cg_exo -65.01 153.43 78.36 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.272 1.982 . . . . 50.0 112.292 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.5 t80 -58.05 146.2 33.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.538 -0.542 . . . . 50.0 109.538 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.515 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 96.0 m-20 -140.93 116.97 10.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.656 -0.702 . . . . 50.0 111.325 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.54 -16.7 26.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.059 -0.519 . . . . 50.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -76.36 -27.99 56.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 5.9 tptm -101.89 154.63 18.76 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.346 -1.752 . . . . 50.0 108.185 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 53.5 p90 -111.17 151.23 28.43 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.376 -0.529 . . . . 16.66 110.548 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.7 m-85 -128.9 168.26 16.22 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 123.314 1.531 . . . . 50.0 114.286 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.011 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.43 126.17 68.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 111.118 -2.764 . . . . 16.66 105.29 176.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.89 122.29 6.87 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.757 -1.211 . . . . 16.66 115.601 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.313 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -48.38 115.29 1.16 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.028 -1.086 . . . . 16.66 108.555 176.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.6 t70 -58.68 -34.02 70.8 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.355 -0.538 . . . . 25.0 109.871 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -113.32 -23.88 9.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.707 -0.678 . . . . 50.0 111.32 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.313 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -91.54 4.88 51.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.983 -0.687 . . . . 16.66 111.324 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.527 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 6.5 pt20 30.75 48.59 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.11 -0.496 . . . . 16.66 111.615 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.63 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -131.55 166.4 21.47 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.847 -0.427 . . . . 50.0 109.847 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.48 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.18 132.57 39.95 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.837 -0.345 . . . . 16.66 111.052 -178.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.02 144.97 51.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.779 -0.369 . . . . 50.0 111.327 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.815 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -56.47 140.06 47.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.392 -1.707 . . . . 16.66 106.392 176.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.12 -58.57 3.23 Favored Glycine 0 C--N 1.31 -0.899 0 C-N-CA 119.622 -1.275 . . . . 16.66 112.098 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -66.75 -21.3 66.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.58 -29.84 18.72 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.656 -0.702 . . . . 16.66 109.304 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.56 2.24 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.706 -0.679 . . . . 16.66 112.002 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.9 46.4 6.72 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.417 -0.673 . . . . 16.66 111.417 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.57 HG22 ' CA ' ' A' ' 35' ' ' GLY . 1.4 tt -118.69 159.92 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.05 0.453 . . . . 16.66 111.828 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.661 ' C ' ' HG3' ' A' ' 44' ' ' GLU . 4.1 mm? -46.91 169.61 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.58 -0.736 . . . . 50.0 110.991 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -82.09 -56.33 4.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.702 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' ALA . 61.5 m -79.03 -16.07 57.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.637 -0.71 . . . . 50.0 111.446 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.878 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -43.34 -21.35 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.87 0.367 . . . . 50.0 110.166 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.505 ' N ' ' OE1' ' A' ' 44' ' ' GLU . . . -60.14 -51.52 69.24 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.037 -0.528 . . . . 25.0 111.418 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.77 -44.16 10.17 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.808 1.41 . . . . 50.0 114.808 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.965 HD12 ' N ' ' A' ' 48' ' ' ILE . 3.1 pp -55.47 -28.09 52.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.661 0.985 . . . . 16.66 113.661 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.965 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 pp -85.71 172.48 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 119.862 -0.735 . . . . 25.0 110.028 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 48.6 t0 -156.35 0.48 0.14 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.571 -1.195 . . . . 50.0 109.982 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.33 33.67 2.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.413 -1.328 . . . . 50.0 107.413 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.1 t80 -65.94 145.88 55.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.197 -0.91 . . . . 16.66 110.032 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.691 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 20.3 t -133.73 155.73 40.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.058 -1.428 . . . . 50.0 108.991 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.998 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 7.2 p -81.72 154.42 70.78 Favored Pre-proline 0 N--CA 1.413 -2.287 0 CA-C-O 121.501 0.667 . . . . 16.66 109.98 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 50.7 Cg_endo -74.4 -28.22 10.52 Favored 'Trans proline' 0 C--N 1.274 -3.379 0 C-N-CA 122.058 1.839 . . . . 16.66 110.947 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.634 ' NE2' HG22 ' A' ' 12' ' ' ILE . 96.2 mt-30 -70.32 -33.58 71.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.131 -1.063 . . . . 50.0 108.131 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.185 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 114.767 -1.106 . . . . 16.66 110.277 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 9' ' ' LEU . 2.9 pp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.94 0.4 . . . . 50.0 111.082 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -73.62 -103.21 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.951 -0.568 . . . . 25.0 110.993 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 18.7 t -37.87 120.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.819 0.818 . . . . 16.66 113.206 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 33' ' ' TYR . 7.5 pt -59.29 -8.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.112 -1.404 . . . . 50.0 108.843 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.95 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.94 8.81 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.367 -1.288 . . . . 16.66 110.565 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.634 ' CG ' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 63.43 71.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.571 0.7 . . . . 25.0 110.086 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.03 124.67 1.12 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.939 -0.573 . . . . 50.0 110.757 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.45 154.9 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.287 1.991 . . . . 50.0 112.111 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -56.85 146.1 27.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.044 0.449 . . . . 50.0 110.074 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.2 m-20 -140.75 114.78 9.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.764 -0.653 . . . . 50.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.66 -10.81 2.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.419 ' N ' ' C ' ' A' ' 18' ' ' ASP . 26.4 m -79.97 -24.8 40.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.358 -1.349 . . . . 50.0 107.358 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.7 tptm -107.56 153.56 22.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.59 -1.641 . . . . 50.0 107.94 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 39.2 p90 -110.13 153.47 24.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 120.11 -0.636 . . . . 16.66 111.011 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.742 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -126.59 164.0 22.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 123.504 1.621 . . . . 50.0 114.645 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.104 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.76 117.86 31.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 110.861 -2.881 . . . . 16.66 105.091 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -82.93 133.08 11.57 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 119.944 -1.122 . . . . 16.66 115.06 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -47.94 107.37 0.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.752 -1.224 . . . . 16.66 107.705 176.433 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.596 ' HB3' HG22 ' A' ' 52' ' ' VAL . 59.1 t0 -51.05 -41.43 59.87 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.85 -0.74 . . . . 25.0 110.23 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.633 ' HG3' ' HB3' ' A' ' 56' ' ' CYS . 14.7 ptp180 -115.67 -4.51 12.19 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.83 0.678 . . . . 50.0 112.83 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.237 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -108.66 13.51 25.1 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 118.825 -1.15 . . . . 16.66 111.326 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER 33.69 52.33 0.42 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.268 -0.423 . . . . 16.66 110.72 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.608 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 1.3 t30 -132.57 166.44 22.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.189 -0.3 . . . . 50.0 110.189 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.674 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -139.89 132.14 28.24 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.004 0.742 . . . . 16.66 113.004 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.741 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -139.93 152.62 46.51 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.036 -0.529 . . . . 50.0 111.649 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.921 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -59.04 142.55 51.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.694 -1.595 . . . . 16.66 106.694 175.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.84 -60.31 2.98 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.058 -1.068 . . . . 16.66 111.713 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -20.12 65.91 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.324 -0.55 . . . . 50.0 110.183 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.7 t -51.19 -31.32 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.199 -0.667 . . . . 16.66 109.199 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 33' ' ' TYR . 2.7 m -115.67 14.28 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.472 -0.786 . . . . 16.66 110.675 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.14 46.0 23.41 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 115.636 -0.711 . . . . 16.66 112.432 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -112.55 167.24 5.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.928 0.394 . . . . 16.66 110.581 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.584 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 85.6 mt -67.16 164.29 18.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.499 0.666 . . . . 50.0 110.662 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -80.03 -54.96 5.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.034 -0.985 . . . . 25.0 111.086 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 m -65.81 -17.85 64.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 50.0 110.096 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.792 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.0 mt-10 -45.64 -38.28 6.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.353 -0.539 . . . . 50.0 110.658 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.607 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -51.37 -36.5 43.47 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.077 -0.649 . . . . 25.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -87.74 -44.46 11.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.601 0.963 . . . . 50.0 113.601 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 44' ' ' GLU . 2.2 pp -86.46 17.13 3.98 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.285 -0.87 . . . . 16.66 112.013 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.792 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 4.1 tp -120.81 150.01 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 C-N-CA 119.056 -1.058 . . . . 25.0 112.984 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -170.17 29.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.614 -1.175 . . . . 50.0 110.411 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -161.03 9.02 0.08 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.671 -0.863 . . . . 50.0 108.671 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -67.22 147.63 52.8 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.54 -0.755 . . . . 16.66 109.35 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 27' ' ' ASP . 14.8 t -126.03 157.76 35.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.143 -0.935 . . . . 50.0 109.43 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.9 p -79.84 156.87 74.71 Favored Pre-proline 0 N--CA 1.412 -2.353 0 CA-C-N 115.749 -0.66 . . . . 16.66 110.164 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 28.9 Cg_endo -80.25 -23.78 6.04 Favored 'Trans proline' 0 C--N 1.276 -3.239 0 C-N-CA 121.783 1.655 . . . . 16.66 110.786 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -72.64 -35.63 67.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.485 -0.932 . . . . 50.0 108.485 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.166 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.03 -0.986 . . . . 16.66 110.609 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 N-CA-C 109.93 -0.396 . . . . 50.0 109.93 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.6 m-85 -91.06 -71.34 0.64 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.411 -0.588 . . . . 25.0 109.411 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.1 t -41.38 113.41 0.4 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.653 -0.703 . . . . 16.66 110.772 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.696 HG22 ' NE2' ' A' ' 55' ' ' GLN . 6.5 pt -53.12 -7.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 50.0 109.414 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.972 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -81.25 6.72 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.729 -1.123 . . . . 16.66 110.892 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 66.97 56.12 0.68 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.13 -0.487 . . . . 25.0 111.916 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 135.94 10.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.91 -0.316 . . . . 50.0 110.352 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.48 156.72 39.98 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.321 2.014 . . . . 50.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.724 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.7 t80 -59.35 146.25 40.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.033 0.444 . . . . 50.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.503 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 95.4 m-20 -141.39 113.07 7.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.638 -0.71 . . . . 50.0 111.249 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.36 -20.87 13.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.968 0.413 . . . . 50.0 110.103 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.4 m -71.95 -30.99 65.87 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.602 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -99.05 150.37 22.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.265 -1.789 . . . . 50.0 107.954 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 51.0 p90 -108.78 150.41 27.65 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.06 -0.656 . . . . 16.66 110.601 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.724 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.6 m-85 -127.76 166.0 19.02 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 123.362 1.553 . . . . 50.0 113.925 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.058 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.55 124.3 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 111.114 -2.766 . . . . 16.66 105.57 176.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -87.95 127.1 8.37 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.993 -1.099 . . . . 16.66 115.529 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.474 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -48.62 121.28 4.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.499 -1.297 . . . . 16.66 107.499 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.554 ' HB2' HG22 ' A' ' 52' ' ' VAL . 60.5 t0 -62.55 -34.21 76.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.507 0.67 . . . . 25.0 109.571 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -113.56 -27.85 7.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.841 -1.072 . . . . 50.0 111.477 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.293 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -89.91 8.23 33.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.945 -0.702 . . . . 16.66 111.81 -177.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.566 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 2.8 pt20 30.13 49.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 16.66 112.005 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.673 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -131.6 165.69 23.09 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.92 -0.4 . . . . 50.0 109.92 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -132.54 132.68 42.87 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.939 -0.304 . . . . 16.66 111.389 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.672 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.7 145.76 52.01 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.865 -0.334 . . . . 50.0 111.148 178.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.834 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -54.43 140.2 34.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.285 -1.746 . . . . 16.66 106.285 176.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.745 ' H ' HH21 ' A' ' 36' ' ' ARG . . . -42.29 -56.34 4.06 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 119.433 -1.365 . . . . 16.66 111.516 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.781 ' H ' ' NE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.55 -19.7 62.86 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.516 -0.474 . . . . 50.0 110.241 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.41 -30.94 13.62 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.866 -0.791 . . . . 16.66 108.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.71 13.58 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.117 -0.947 . . . . 16.66 110.631 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 70.34 46.25 50.35 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.345 -0.702 . . . . 16.66 111.345 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.569 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -115.38 167.93 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.124 0.488 . . . . 16.66 111.647 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.3 mp -62.38 163.64 8.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 50.0 110.446 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.587 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.1 pt20 -82.33 -46.56 13.44 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.18 -1.045 . . . . 25.0 108.18 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.948 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -63.8 -29.25 70.47 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.647 -1.615 . . . . 50.0 108.687 179.151 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.81 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.8 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.005 -0.739 . . . . 50.0 109.005 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 22' ' ' PHE . . . -79.13 -41.93 27.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.298 -0.864 . . . . 25.0 110.538 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' SER . 48.5 mp0 -87.9 -52.13 5.45 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.696 1.369 . . . . 50.0 114.696 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.032 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.56 19.22 0.28 Allowed 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.481 0.658 . . . . 16.66 111.108 -177.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.81 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.3 tp -114.71 144.56 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 114.749 -1.114 . . . . 25.0 113.299 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -168.09 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.155 -1.384 . . . . 50.0 109.313 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -166.39 13.12 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.415 -0.957 . . . . 50.0 108.415 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -67.58 147.26 52.99 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.357 -0.838 . . . . 16.66 109.706 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.1 t -124.71 159.26 31.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.845 -1.071 . . . . 50.0 109.293 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.474 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -83.87 152.93 63.52 Favored Pre-proline 0 N--CA 1.411 -2.383 0 CA-C-O 121.611 0.72 . . . . 16.66 110.359 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.25 -27.61 16.32 Favored 'Trans proline' 0 C--N 1.274 -3.378 0 C-N-CA 121.892 1.728 . . . . 16.66 110.877 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.696 ' NE2' HG22 ' A' ' 12' ' ' ILE . 95.0 mt-30 -70.42 -33.67 71.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.31 -0.859 . . . . 50.0 108.827 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.253 -0.885 . . . . 16.66 110.567 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.37 0.128 . . . . 50.0 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 m-85 -95.53 -68.36 0.8 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.2 t -43.48 116.26 0.91 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.648 -0.705 . . . . 16.66 110.458 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.631 HG23 ' CD1' ' A' ' 33' ' ' TYR . 9.9 pt -51.95 -7.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.071 -0.714 . . . . 50.0 109.071 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -78.31 2.78 17.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.572 -1.195 . . . . 16.66 110.55 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.22 54.41 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.982 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.07 146.77 26.9 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.005 -0.369 . . . . 50.0 110.005 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 152.69 76.08 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.513 2.142 . . . . 50.0 111.941 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.6 t80 -55.97 146.06 23.41 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.759 -0.46 . . . . 50.0 109.759 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.0 m-20 -140.71 113.15 8.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.786 -0.643 . . . . 50.0 111.017 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.64 -17.76 9.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 50.0 109.842 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -71.58 -30.81 66.25 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.112 -1.44 . . . . 50.0 107.112 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 3.1 tptm -100.55 156.88 17.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 112.973 -1.922 . . . . 50.0 108.957 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.8 p90 -113.45 149.07 34.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 115.885 -0.598 . . . . 16.66 110.024 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 m-85 -127.15 166.75 17.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 123.379 1.561 . . . . 50.0 114.236 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.02 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.19 126.22 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 111.013 -2.812 . . . . 16.66 105.007 176.641 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.58 121.22 6.53 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.587 -1.292 . . . . 16.66 116.157 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.44 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.32 117.69 2.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.911 -1.145 . . . . 16.66 108.002 175.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 51' ' ' TYR . 87.3 m-20 -69.26 -30.18 68.24 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.652 0.739 . . . . 25.0 109.245 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -110.43 -23.15 11.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.597 -1.183 . . . . 50.0 111.452 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.292 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 9.93 40.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.888 -0.725 . . . . 16.66 111.683 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.573 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 8.9 pt20 30.37 48.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 16.66 112.405 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.586 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.14 166.16 22.42 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 120.929 -0.308 . . . . 50.0 110.373 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -133.94 130.75 38.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.184 -0.206 . . . . 16.66 110.906 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -128.45 144.44 51.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.792 -0.363 . . . . 50.0 111.393 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.75 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -54.19 140.59 32.04 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.28 -1.748 . . . . 16.66 106.28 176.083 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -41.9 -59.94 2.72 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.855 -1.164 . . . . 16.66 111.929 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.47 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -67.87 -19.79 65.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.458 -0.497 . . . . 50.0 109.971 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.1 t -50.4 -30.7 13.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.664 -0.865 . . . . 16.66 108.664 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.6 12.66 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.255 -0.884 . . . . 16.66 110.962 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 70.67 45.84 50.47 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.034 -0.603 . . . . 16.66 111.68 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.504 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -112.5 167.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.421 . . . . 16.66 111.495 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 41' ' ' LEU . 8.0 mp -59.64 164.72 3.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 50.0 110.555 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -78.06 -55.39 5.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.515 -0.766 . . . . 25.0 110.523 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.4 m -70.86 -15.16 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 50.0 109.368 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.744 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -42.17 -20.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.467 -0.788 . . . . 50.0 110.938 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.34 -47.52 60.67 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.396 -0.522 . . . . 25.0 110.992 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -88.93 -43.46 11.15 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.745 1.387 . . . . 50.0 114.745 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.0 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.5 pp -55.39 -30.84 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.306 0.854 . . . . 16.66 113.306 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.0 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.3 pp -86.67 172.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.744 0.783 . . . . 25.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.35 13.2 0.14 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.403 -1.271 . . . . 50.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -155.54 36.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.753 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 18.5 t80 -65.96 145.88 55.37 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.674 -1.148 . . . . 16.66 111.014 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.753 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 11.7 t -129.71 157.55 42.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.942 -1.481 . . . . 50.0 108.608 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.44 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.2 p -86.35 158.36 54.99 Favored Pre-proline 0 N--CA 1.414 -2.236 0 CA-C-O 121.574 0.702 . . . . 16.66 110.578 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 29.8 Cg_endo -79.8 -22.7 7.44 Favored 'Trans proline' 0 C--N 1.278 -3.133 0 C-N-CA 121.97 1.78 . . . . 16.66 110.403 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -72.52 -35.76 68.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.062 -1.088 . . . . 50.0 108.062 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.17 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 CA-C-N 114.881 -1.054 . . . . 16.66 109.856 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.333 -0.247 . . . . 50.0 110.333 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.726 ' N ' HD22 ' A' ' 9' ' ' LEU . 1.5 m-85 -87.16 -94.99 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.007 0.373 . . . . 25.0 112.007 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -37.45 132.72 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.69 0.757 . . . . 16.66 112.773 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.751 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -61.15 -7.75 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.671 -1.149 . . . . 50.0 108.692 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.59 4.95 14.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.001 -1.454 . . . . 16.66 110.852 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 67.31 47.6 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.269 -0.423 . . . . 25.0 111.038 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.27 124.61 10.84 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.618 -0.264 . . . . 50.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.68 160.47 11.78 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.626 2.217 . . . . 50.0 112.878 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.751 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 10.4 t80 -66.3 138.51 57.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.047 -0.524 . . . . 50.0 111.104 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 54.3 t0 -140.54 127.01 20.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.653 -0.703 . . . . 50.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.92 -12.83 4.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.991 -0.549 . . . . 50.0 109.608 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -75.64 -26.81 58.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.681 ' HG2' ' CG ' ' A' ' 34' ' ' HIS . 15.5 tptt -101.5 152.17 21.09 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.489 -1.687 . . . . 50.0 108.129 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 55.3 p90 -113.08 147.21 37.75 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.182 -0.607 . . . . 16.66 110.154 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.0 m-85 -123.23 164.23 19.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 123.914 1.816 . . . . 50.0 115.538 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.123 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.68 117.96 21.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 109.953 -3.294 . . . . 16.66 104.286 176.431 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -89.73 129.87 9.92 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.778 -1.201 . . . . 16.66 115.455 -174.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.386 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 106.99 0.11 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.898 -1.519 . . . . 16.66 106.898 175.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -69.54 -20.01 63.69 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -112.86 -25.46 9.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.839 -1.528 . . . . 50.0 111.566 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.21 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -111.31 15.88 21.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.932 -0.707 . . . . 16.66 112.197 -178.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.539 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 30.96 54.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 16.66 111.87 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 5.5 m-20 -132.54 167.06 20.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.411 -0.359 . . . . 50.0 110.223 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.692 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -141.03 129.48 22.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.311 0.856 . . . . 16.66 113.311 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.751 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -141.43 158.34 44.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.873 -0.603 . . . . 50.0 111.771 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.681 ' CG ' ' HG2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -63.98 134.85 55.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.9 -1.889 . . . . 16.66 105.9 174.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.6 -44.85 5.44 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 119.502 -1.332 . . . . 16.66 111.545 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 17.9 mtt180 -68.53 -29.88 68.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.57 0.7 . . . . 50.0 109.238 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.933 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 4.2 t -51.6 -26.66 9.25 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.791 -1.095 . . . . 16.66 109.621 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.53 16.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.296 -0.866 . . . . 16.66 110.622 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.21 47.58 57.9 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.733 -0.667 . . . . 16.66 111.828 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -115.63 167.02 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.777 -0.369 . . . . 16.66 110.984 -178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.705 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.8 mm? -62.33 164.59 6.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.287 0.565 . . . . 50.0 110.412 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -78.31 -56.05 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.13 -0.941 . . . . 25.0 110.911 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -69.35 -16.15 63.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.683 -0.689 . . . . 50.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.81 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.6 tt0 -48.22 -20.24 0.36 Allowed 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.488 -0.778 . . . . 50.0 111.464 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.699 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -57.0 -51.82 67.71 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.944 -0.702 . . . . 25.0 111.671 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 48' ' ' ILE . 78.2 mm-40 -90.1 -46.65 8.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.9 1.445 . . . . 50.0 114.9 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 44' ' ' GLU . 3.1 pp -56.02 16.19 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.347 1.24 . . . . 16.66 114.347 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -134.48 171.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.406 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 46.0 t0 -173.36 36.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.82 -1.082 . . . . 50.0 108.994 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.03 20.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 2.4 t80 -66.82 148.68 51.62 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.547 -1.206 . . . . 16.66 110.522 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.646 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.3 t -129.87 152.26 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.302 -1.317 . . . . 50.0 109.43 178.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.386 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.3 p -78.95 162.45 64.71 Favored Pre-proline 0 N--CA 1.411 -2.391 0 CA-C-N 115.232 -0.894 . . . . 16.66 110.102 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 15.5 Cg_endo -81.23 -27.84 2.68 Favored 'Trans proline' 0 C--N 1.276 -3.279 0 C-N-CA 121.875 1.717 . . . . 16.66 110.848 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -67.93 -35.63 78.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.895 -1.15 . . . . 50.0 107.895 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.189 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 114.892 -1.049 . . . . 16.66 109.552 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD22 ' N ' ' A' ' 15' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.662 ' HB3' ' O ' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -82.28 -89.19 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 1.5 t -39.71 114.43 0.42 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.844 -0.617 . . . . 16.66 111.29 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.833 HD13 ' N ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -59.7 -8.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.16 -0.927 . . . . 50.0 109.588 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 1.137 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -71.21 7.34 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.425 -0.807 . . . . 16.66 109.923 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HB3' ' HZ2' ' A' ' 14' ' ' LYS . 3.5 mtpm? 65.91 48.73 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.576 -0.738 . . . . 25.0 111.484 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.539 ' N ' HD22 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -143.17 124.19 8.2 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.778 -0.369 . . . . 50.0 110.287 179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.1 152.03 3.72 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.748 2.299 . . . . 50.0 112.801 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.7 t80 -67.57 145.02 55.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 91.3 m-20 -140.82 116.68 10.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.831 -0.622 . . . . 50.0 110.355 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 -13.57 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.443 -0.577 . . . . 50.0 109.443 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -75.13 -25.69 58.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.513 -1.291 . . . . 50.0 107.513 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -101.39 155.3 18.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.433 -1.712 . . . . 50.0 108.113 178.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 51.8 p90 -110.25 153.21 25.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.889 -0.724 . . . . 16.66 110.588 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.3 m-85 -125.26 162.71 24.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.47 1.605 . . . . 50.0 114.534 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.035 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -131.58 117.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.803 -2.908 . . . . 16.66 104.601 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.77 131.96 11.03 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 119.782 -1.199 . . . . 16.66 116.025 -174.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.394 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -46.33 105.74 0.07 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.026 -1.472 . . . . 16.66 107.026 175.403 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.742 ' CG ' HG22 ' A' ' 52' ' ' VAL . 43.4 p-10 -75.4 -11.4 60.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.568 -1.271 . . . . 25.0 107.568 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.483 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 23.4 ttm180 -113.7 -22.98 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.742 -1.572 . . . . 50.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.183 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -120.22 18.5 12.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 119.927 -0.709 . . . . 16.66 112.346 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.519 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 13.9 pt20 32.97 54.11 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.763 0.283 . . . . 16.66 111.763 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.614 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 4.8 m-20 -133.09 167.84 19.58 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 110.165 -0.309 . . . . 50.0 110.165 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.662 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -138.67 133.02 31.79 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.869 0.692 . . . . 16.66 112.869 -177.037 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.646 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -140.83 145.13 35.86 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.97 -0.559 . . . . 50.0 111.283 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.931 ' HD1' ' CB ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -55.89 150.03 13.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 106.368 -1.715 . . . . 16.66 106.368 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.545 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -54.08 -61.56 7.03 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 119.468 -1.348 . . . . 16.66 112.747 -177.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HD3' ' HZ1' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.57 -20.69 62.76 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.346 -0.541 . . . . 50.0 110.462 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 13.9 t -54.14 -29.24 44.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.488 -0.885 . . . . 16.66 108.941 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -112.61 11.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 16.66 110.34 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.06 46.96 20.15 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.862 -0.608 . . . . 16.66 111.774 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -116.64 167.58 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 16.66 111.546 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.4 mp -64.68 161.6 17.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.248 -0.887 . . . . 50.0 110.152 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.4 pt20 -82.12 -41.16 20.84 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.779 ' C ' HD21 ' A' ' 47' ' ' LEU . 69.6 m -60.88 -39.04 87.74 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 112.336 -2.211 . . . . 50.0 109.266 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.809 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -41.39 -17.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.935 -0.575 . . . . 50.0 110.037 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -76.4 -46.17 28.42 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.074 -0.512 . . . . 25.0 110.806 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.0 mm-40 -88.95 -51.23 5.73 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.069 1.507 . . . . 50.0 115.069 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.09 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.18 20.32 0.39 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.563 0.697 . . . . 16.66 111.761 -177.07 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.809 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.2 tp -111.43 139.04 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 25.0 111.915 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -116.19 -58.68 2.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.405 -1.27 . . . . 50.0 111.822 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 2.3 pm0 -118.83 59.48 0.82 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.166 -0.679 . . . . 50.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.0 t80 -66.37 142.07 57.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.175 -0.61 . . . . 16.66 109.368 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.742 HG22 ' CG ' ' A' ' 27' ' ' ASP . 6.7 t -117.33 152.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.543 -0.753 . . . . 50.0 109.716 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.394 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.4 p -83.99 157.85 62.54 Favored Pre-proline 0 N--CA 1.41 -2.45 0 CA-C-N 114.936 -1.029 . . . . 16.66 110.35 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -79.19 -25.69 5.69 Favored 'Trans proline' 0 C--N 1.278 -3.183 0 C-N-CA 121.92 1.746 . . . . 16.66 110.477 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -71.96 -33.49 68.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.945 -1.025 . . . . 50.0 108.936 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.168 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.148 0 CA-C-N 115.329 -0.85 . . . . 16.66 110.743 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.025 -0.361 . . . . 50.0 110.025 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.9 m-85 -103.03 -69.96 0.78 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.849 -0.34 . . . . 25.0 110.106 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 35.7 t -41.6 130.61 3.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 16.66 110.719 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.611 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.9 pt -57.74 -7.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.269 -1.011 . . . . 50.0 108.269 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.74 -5.85 56.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.899 -1.501 . . . . 16.66 110.897 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 22.1 mtmm 72.18 52.8 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.186 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.68 139.33 23.97 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 109.906 -0.405 . . . . 50.0 109.906 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.66 153.96 74.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.453 2.102 . . . . 50.0 112.331 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -63.05 140.29 58.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.13 0.491 . . . . 50.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 21' ' ' LYS . 82.1 m-20 -141.8 119.86 12.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.487 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.81 -22.34 9.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.95 -0.389 . . . . 50.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 m -68.79 -34.11 74.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.528 -1.286 . . . . 50.0 107.528 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.564 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 4.6 ttmt -93.33 139.3 30.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.304 -1.771 . . . . 50.0 107.584 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 45.1 p90 -105.13 143.01 33.9 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.134 -0.627 . . . . 16.66 110.173 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -122.13 173.19 7.73 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 123.941 1.829 . . . . 50.0 114.78 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.029 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.69 179.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 109.685 -3.416 . . . . 16.66 104.018 176.237 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.06 124.14 2.48 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 117.658 -2.211 . . . . 16.66 114.36 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 1.447 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -48.04 110.65 0.35 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.052 -1.074 . . . . 16.66 108.739 177.25 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.696 ' HB2' HG22 ' A' ' 52' ' ' VAL . 57.2 t0 -46.57 -41.95 15.22 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.081 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.566 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.39 -13.81 11.0 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 112.407 0.521 . . . . 50.0 112.407 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 1.347 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -88.49 0.17 56.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.937 -1.105 . . . . 16.66 111.272 -178.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 40.85 45.98 2.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.551 -0.295 . . . . 16.66 110.347 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.581 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -132.31 166.28 22.27 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.755 -0.378 . . . . 50.0 110.604 -177.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -140.82 127.77 20.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.56 -0.456 . . . . 16.66 111.428 -178.445 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.74 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -127.67 156.43 42.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.94 -0.573 . . . . 50.0 110.866 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.564 ' CE1' ' HD2' ' A' ' 21' ' ' LYS . 1.3 m-70 -61.46 141.0 57.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.154 -1.795 . . . . 16.66 106.154 176.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.593 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -43.4 -48.48 6.96 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 119.42 -1.371 . . . . 16.66 111.261 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -75.06 -19.76 59.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.349 -0.54 . . . . 50.0 110.037 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.92 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -51.6 -30.71 22.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.562 -0.855 . . . . 16.66 109.241 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.43 8.59 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.487 -0.779 . . . . 16.66 111.427 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.57 45.86 7.68 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.124 -0.56 . . . . 16.66 112.204 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.593 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -123.15 167.34 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.222 0.534 . . . . 16.66 111.608 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 40' ' ' ILE . 4.0 mm? -67.02 164.58 17.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.481 -0.781 . . . . 50.0 110.46 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.708 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.8 pt20 -80.55 -54.26 5.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 25.0 110.902 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.708 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 49.5 m -60.35 -28.26 68.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.063 -1.088 . . . . 50.0 108.063 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.958 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -43.67 -17.03 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.305 -1.316 . . . . 50.0 109.928 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.27 -48.16 58.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.98 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.734 ' C ' ' H ' ' A' ' 48' ' ' ILE . 84.8 tt0 -87.66 -52.91 5.06 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.096 0.776 . . . . 50.0 113.096 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.886 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -57.78 5.6 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.385 0.612 . . . . 16.66 110.516 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.958 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -105.15 133.02 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.714 -177.423 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -87.7 -74.38 0.45 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.995 -1.002 . . . . 50.0 111.522 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 27' ' ' ASP . 80.7 tt0 -122.08 74.0 1.13 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.73 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.09 146.6 54.47 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.774 -0.648 . . . . 16.66 109.324 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 43.7 t -117.09 159.24 17.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.805 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 1.447 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -87.5 161.11 46.38 Favored Pre-proline 0 N--CA 1.415 -2.177 0 CA-C-O 121.425 0.631 . . . . 16.66 110.22 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 34.6 Cg_endo -80.33 -32.55 1.27 Allowed 'Trans proline' 0 C--N 1.28 -3.059 0 C-N-CA 121.862 1.708 . . . . 16.66 111.741 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.427 ' OE1' HG22 ' A' ' 12' ' ' ILE . 43.1 mt-30 -72.96 -28.81 62.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 1.104 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 61.4 m . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 114.121 -1.4 . . . . 16.66 111.0 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -53.62 147.96 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.756 2.304 . . . . 0.0 112.053 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.1 mt -58.07 -35.0 70.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.402 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.72 174.69 47.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.937 -0.865 . . . . 50.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.4 t -147.87 146.76 29.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 50.0 110.709 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.3 157.39 31.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 50.0 110.227 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -81.09 174.93 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.254 0.55 . . . . 50.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -128.75 179.89 5.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.338 -0.847 . . . . 50.0 111.119 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.98 176.55 0.69 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 50.0 110.236 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -97.8 -72.77 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.168 -0.613 . . . . 25.0 111.528 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 6.2 t -39.01 112.04 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 16.66 111.597 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.615 HG23 ' CD1' ' A' ' 33' ' ' TYR . 9.1 pt -48.02 -8.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.541 -0.754 . . . . 50.0 109.682 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.969 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -86.02 30.52 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.742 -1.117 . . . . 16.66 110.343 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 14.0 pttp 43.4 58.87 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.77 -0.65 . . . . 25.0 112.144 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.433 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -156.32 124.34 2.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 110.022 -0.362 . . . . 50.0 110.022 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 25.0 Cg_exo -57.22 164.17 7.07 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.614 2.209 . . . . 50.0 113.352 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.737 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 16.1 t80 -60.23 145.78 46.04 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.517 -0.765 . . . . 50.0 110.74 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' LYS . 92.6 m-20 -141.46 111.84 6.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.03 -0.986 . . . . 50.0 110.848 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.51 -22.45 8.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 50.0 110.448 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -71.11 -30.38 66.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.633 -1.247 . . . . 50.0 107.633 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -100.26 149.36 23.66 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.165 -1.834 . . . . 50.0 108.034 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 39.5 p90 -108.62 151.72 25.75 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.865 -0.734 . . . . 16.66 110.296 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.3 m-85 -126.86 165.44 19.34 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 123.152 1.454 . . . . 50.0 113.943 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.039 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.52 118.71 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 111.242 -2.708 . . . . 16.66 105.25 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -83.32 127.0 7.78 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.039 -1.077 . . . . 16.66 115.563 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.43 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -48.21 107.27 0.12 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.875 -1.162 . . . . 16.66 107.928 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.666 ' HB2' HG22 ' A' ' 52' ' ' VAL . 76.6 m-20 -51.08 -37.27 44.69 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.993 -0.683 . . . . 25.0 110.53 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.654 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -114.29 -14.56 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.042 0.386 . . . . 50.0 112.042 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.256 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.9 14.2 32.52 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.472 -0.891 . . . . 16.66 111.865 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.443 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 14.3 pt20 30.35 48.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.893 0.701 . . . . 16.66 112.893 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.636 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.13 166.11 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.971 -0.381 . . . . 50.0 109.971 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.488 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.61 130.98 37.27 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.868 -0.333 . . . . 16.66 111.279 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.2 144.99 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.05 -0.26 . . . . 50.0 111.024 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.828 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -52.03 143.02 14.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.714 -1.588 . . . . 16.66 106.714 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.577 ' C ' HG22 ' A' ' 40' ' ' ILE . . . -42.18 -60.31 2.72 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.432 -1.366 . . . . 16.66 111.478 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -69.19 -18.24 63.89 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.565 -0.454 . . . . 50.0 110.44 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.09 -30.67 11.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.656 -0.818 . . . . 16.66 108.814 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 33' ' ' TYR . 5.5 m -116.8 4.16 7.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.411 -0.813 . . . . 16.66 111.637 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.72 46.08 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.366 -0.694 . . . . 16.66 111.366 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 41' ' ' LEU . 3.5 tt -119.17 167.73 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 16.66 111.885 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 40' ' ' ILE . 42.0 mt -68.69 164.48 21.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.168 -0.923 . . . . 50.0 110.646 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.582 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 36.8 mt-30 -80.56 -43.97 19.78 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.965 -1.494 . . . . 25.0 106.965 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.773 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -62.76 -41.13 99.08 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 112.378 -2.192 . . . . 50.0 107.714 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.824 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.3 mm-40 -43.63 -16.35 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -78.93 -44.47 22.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.427 -0.806 . . . . 25.0 110.468 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 43' ' ' SER . 96.4 mt-10 -87.94 -51.91 5.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.583 1.327 . . . . 50.0 114.583 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.084 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.68 20.38 0.24 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.795 0.807 . . . . 16.66 111.03 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.824 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.5 tp -110.44 143.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.272 -1.331 . . . . 25.0 112.9 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -165.98 29.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.381 -1.281 . . . . 50.0 109.448 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -166.33 11.43 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.593 -0.892 . . . . 50.0 108.593 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -67.09 146.9 53.81 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 16.66 109.761 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 27' ' ' ASP . 21.7 t -125.16 156.95 34.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.912 -1.04 . . . . 50.0 110.016 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.43 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.5 p -78.57 157.23 77.51 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-N 115.592 -0.731 . . . . 16.66 110.078 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 41.5 Cg_endo -77.84 -30.13 3.94 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 121.963 1.776 . . . . 16.66 111.585 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -72.26 -29.59 64.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.99 -1.115 . . . . 50.0 107.99 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.2 m -62.76 -45.42 92.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.324 -1.307 . . . . 16.66 110.735 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -52.61 -36.71 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.677 -0.692 . . . . 50.0 110.566 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -37.04 79.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.514 -0.55 . . . . 50.0 109.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 60' ' ' GLU . 72.8 p -83.83 -34.94 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.753 -0.658 . . . . 50.0 111.319 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 59' ' ' THR . 66.6 mm-40 -38.27 -68.29 0.16 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.947 -0.301 . . . . 50.0 111.121 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 52.1 p30 -152.57 170.06 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 50.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.999 -1.001 . . . . 50.0 110.534 -179.93 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 4' ' ' GLY . 34.8 Cg_endo -65.66 -27.02 53.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.765 2.31 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 3' ' ' LEU . 10.6 mp 39.01 23.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -110.3 128.57 8.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.031 -0.828 . . . . 50.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.1 p -169.74 -149.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.226 -0.287 . . . . 50.0 110.226 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -74.09 105.76 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.882 -0.414 . . . . 50.0 109.882 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -127.36 165.56 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.228 0.537 . . . . 50.0 111.262 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -104.57 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.359 -0.837 . . . . 50.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.9 mt -61.26 151.19 32.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.483 -0.562 . . . . 50.0 109.483 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.14 -69.1 0.77 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.385 -0.526 . . . . 25.0 110.463 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -41.59 129.37 3.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 16.66 111.133 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 12' ' ' ILE . 9.1 pt -58.16 -7.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -82.39 -1.87 51.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.844 -1.525 . . . . 16.66 110.985 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 46.2 mttm 70.95 56.76 0.22 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.463 -0.335 . . . . 25.0 111.299 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.651 ' OG1' ' CE1' ' A' ' 34' ' ' HIS . 23.0 p -141.1 147.74 48.82 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.409 -0.36 . . . . 50.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.32 150.93 47.82 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.411 2.074 . . . . 50.0 111.846 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.723 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 22.2 t80 -62.65 139.98 58.67 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.11 0.481 . . . . 50.0 110.075 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 21' ' ' LYS . 87.4 m-20 -141.32 120.47 12.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.5 -0.773 . . . . 50.0 110.286 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.1 -17.08 6.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -70.21 -32.07 69.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.558 ' HG2' ' CG ' ' A' ' 34' ' ' HIS . 11.3 tptt -95.8 150.21 20.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.782 -2.008 . . . . 50.0 108.165 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 31.6 p90 -111.0 149.15 31.1 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.589 -0.523 . . . . 16.66 109.589 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 11.8 m-85 -128.73 169.78 14.09 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 123.703 1.716 . . . . 50.0 115.374 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.031 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.84 118.39 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 110.167 -3.197 . . . . 16.66 104.464 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.64 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -87.12 123.15 6.43 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 119.636 -1.269 . . . . 16.66 115.147 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.421 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -53.41 106.98 0.2 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.488 -1.356 . . . . 16.66 108.154 176.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB2' HG22 ' A' ' 52' ' ' VAL . 92.8 m-20 -61.04 -34.96 75.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.474 0.654 . . . . 25.0 109.394 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -101.28 -34.51 9.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.891 -1.05 . . . . 50.0 111.632 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.238 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -92.54 5.82 49.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.826 -0.75 . . . . 16.66 112.148 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.562 ' HG2' ' C ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 38.95 36.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.751 1.019 . . . . 16.66 113.751 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.556 ' OD1' ' HB2' ' A' ' 26' ' ' CYS . 1.9 p30 -132.83 166.87 21.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.988 0.813 . . . . 50.0 110.449 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.64 ' HE3' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -128.66 138.18 52.03 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.218 0.822 . . . . 16.66 113.218 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' OH ' ' HB2' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -133.63 151.71 51.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.324 -0.398 . . . . 50.0 110.94 177.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.651 ' CE1' ' OG1' ' A' ' 15' ' ' THR . 0.3 OUTLIER -58.17 140.19 53.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.589 -1.634 . . . . 16.66 106.589 176.084 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.583 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.81 -54.3 5.09 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.159 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.646 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.76 -20.3 64.36 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.53 -0.468 . . . . 50.0 110.309 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.2 t -51.32 -31.77 22.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 119.682 -0.807 . . . . 16.66 108.944 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.52 14.92 7.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.183 -0.917 . . . . 16.66 111.358 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.21 46.26 43.83 Favored Glycine 0 N--CA 1.463 0.47 0 C-N-CA 121.254 -0.498 . . . . 16.66 112.039 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.583 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -118.48 167.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 16.66 111.381 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.6 mp -61.23 164.69 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.755 -0.657 . . . . 50.0 110.566 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -78.35 -55.37 5.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.45 -0.796 . . . . 25.0 110.364 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.589 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.3 m -69.5 -15.47 63.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 50.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.852 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.6 -19.8 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.322 -0.854 . . . . 50.0 111.115 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HA ' HG22 ' A' ' 24' ' ' ILE . . . -74.44 -45.13 48.38 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.463 -0.495 . . . . 25.0 111.514 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.05 -45.31 10.29 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.247 1.203 . . . . 50.0 114.247 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.1 pp -55.78 -30.79 61.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.051 0.76 . . . . 16.66 113.051 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.892 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 pp -86.52 172.38 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.931 -0.708 . . . . 25.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.3 28.18 0.17 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.642 -1.163 . . . . 50.0 109.901 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.57 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.166 -1.42 . . . . 50.0 107.166 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.9 t80 -66.7 145.58 55.39 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.799 -1.091 . . . . 16.66 111.121 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.632 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 22.3 t -133.37 154.11 38.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 113.848 -1.524 . . . . 50.0 108.575 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.421 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 5.8 p -79.92 161.99 63.98 Favored Pre-proline 0 N--CA 1.411 -2.405 0 CA-C-O 121.318 0.58 . . . . 16.66 110.005 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 19.3 Cg_endo -82.67 -27.46 2.11 Favored 'Trans proline' 0 C--N 1.28 -3.043 0 C-N-CA 121.997 1.798 . . . . 16.66 111.625 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -74.28 -30.39 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.087 -1.079 . . . . 50.0 108.087 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.6 m -61.67 -43.42 98.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.43 -1.259 . . . . 16.66 110.675 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.446 ' OE1' ' OE1' ' A' ' 60' ' ' GLU . 26.5 mm100 -53.07 -36.43 60.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 50.0 110.722 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.1 m -61.83 -38.58 88.71 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.742 -0.383 . . . . 50.0 110.456 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.6 p -98.84 -22.45 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.284 -0.416 . . . . 50.0 111.358 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' CYS . 74.7 tt0 -56.58 -33.98 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.851 -0.339 . . . . 50.0 110.451 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 53.3 p30 -74.25 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 50.0 110.685 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.053 -0.975 . . . . 50.0 110.481 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.74 -21.81 26.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.816 2.344 . . . . 0.0 111.978 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 3' ' ' LEU . 2.3 mm? -88.16 142.37 27.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.301 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.0 -175.2 35.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.925 -0.87 . . . . 50.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 7' ' ' THR . 56.5 m -154.31 -116.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.32 . . . . 50.0 110.579 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 5' ' ' SER . 4.6 p-10 43.43 24.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 50.0 110.781 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 5' ' ' SER . 34.1 p -130.43 167.12 19.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 50.0 110.592 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.56 -177.23 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.834 -0.621 . . . . 50.0 110.463 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.888 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -75.35 174.81 9.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 50.0 110.644 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.801 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.39 -79.04 0.47 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 34.9 t -41.04 128.43 2.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.27 . . . . 16.66 112.464 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.777 HG23 ' CD2' ' A' ' 33' ' ' TYR . 13.0 pt -62.9 -10.3 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 1.047 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -76.69 -0.76 24.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.59 -1.641 . . . . 16.66 110.375 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 62.84 53.22 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.376 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.82 125.33 11.68 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.4 -0.364 . . . . 50.0 110.097 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.03 146.64 8.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.165 1.91 . . . . 50.0 112.08 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 9.9 t80 -64.76 137.49 57.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.166 0.508 . . . . 50.0 110.689 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 52.6 t0 -140.56 135.42 31.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.838 -0.801 . . . . 50.0 108.838 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.86 -18.12 30.02 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.912 -0.715 . . . . 50.0 109.239 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -60.82 -45.36 94.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.499 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.598 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -86.28 161.7 18.63 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.336 -1.357 . . . . 50.0 107.336 176.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 45.3 p90 -117.82 136.9 53.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.058 -0.719 . . . . 16.66 109.058 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.759 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 5.6 m-85 -112.64 165.84 11.89 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 124.187 1.946 . . . . 50.0 115.591 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.02 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 109.324 -3.58 . . . . 16.66 103.944 176.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -132.7 123.22 3.45 Favored Glycine 0 C--N 1.319 -0.394 0 C-N-CA 117.928 -2.082 . . . . 16.66 114.709 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.391 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.14 108.8 0.16 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.895 -1.15 . . . . 16.66 107.895 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 22.6 t70 -64.92 -31.04 72.09 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -109.08 -20.09 13.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.105 -1.407 . . . . 50.0 111.597 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -109.4 11.81 24.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.334 -0.947 . . . . 16.66 112.2 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.598 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 20.6 pt20 33.84 52.91 0.47 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.789 -0.187 . . . . 16.66 111.481 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.653 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -132.85 166.31 22.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.05 -0.26 . . . . 50.0 110.663 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.653 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -139.44 132.12 28.95 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 121.288 0.566 . . . . 16.66 112.238 -177.201 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -137.45 153.19 50.14 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.96 -0.564 . . . . 50.0 112.305 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.735 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -58.89 146.62 36.9 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 105.149 -2.167 . . . . 16.66 105.149 175.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -49.3 -48.55 33.2 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 119.247 -1.454 . . . . 16.66 111.008 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -76.91 -18.09 58.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 4.0 t -50.3 -31.65 14.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.645 -0.872 . . . . 16.66 108.645 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.59 14.77 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.972 -1.013 . . . . 16.66 110.798 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 67.74 46.15 70.18 Favored Glycine 0 N--CA 1.462 0.385 0 N-CA-C 111.569 -0.612 . . . . 16.66 111.569 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -113.2 167.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.211 0.529 . . . . 16.66 111.732 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 40' ' ' ILE . 21.8 mt -63.07 164.5 8.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.392 -0.822 . . . . 50.0 110.653 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.689 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.3 pt20 -79.86 -53.46 6.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.269 0.557 . . . . 25.0 110.059 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.7 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 74.5 m -63.98 -22.8 67.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.634 -0.876 . . . . 50.0 108.634 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.876 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.66 -19.46 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.26 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -69.62 -53.64 17.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.924 -1.034 . . . . 25.0 110.665 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' SER . 11.9 tm-20 -89.52 -43.46 10.8 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.105 1.52 . . . . 50.0 115.105 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.059 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.5 pp -54.72 -30.49 56.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.189 0.811 . . . . 16.66 113.189 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.059 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -85.77 174.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.653 0.74 . . . . 25.0 109.467 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.15 -51.63 0.77 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.475 -1.239 . . . . 50.0 110.206 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -108.65 59.89 0.6 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 50.0 108.067 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.735 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.2 t80 -65.92 144.02 57.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.635 0.731 . . . . 16.66 110.357 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 5.6 t -123.98 156.3 31.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.443 -1.253 . . . . 50.0 109.058 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.391 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.7 p -85.8 160.52 52.72 Favored Pre-proline 0 N--CA 1.414 -2.239 0 CA-C-O 121.675 0.75 . . . . 16.66 110.685 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.1 Cg_endo -78.34 -22.75 9.32 Favored 'Trans proline' 0 C--N 1.278 -3.14 0 C-N-CA 122.061 1.841 . . . . 16.66 111.223 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' HG22 ' A' ' 12' ' ' ILE . 97.0 mt-30 -77.61 -31.09 52.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.382 -0.826 . . . . 50.0 108.963 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.59 -46.4 11.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.344 -0.844 . . . . 16.66 110.952 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' O ' ' A' ' 60' ' ' GLU . 12.1 pt20 -49.96 -22.9 1.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 50.0 110.928 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.2 m -53.08 -36.47 60.71 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.554 -0.458 . . . . 50.0 110.117 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.5 p -80.14 -23.27 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 50.0 110.882 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' GLN . 95.5 mt-10 -104.18 155.37 18.77 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.996 0.427 . . . . 50.0 110.93 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 47.76 44.68 18.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 50.0 110.642 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.033 -0.984 . . . . 50.0 110.607 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -53.45 142.22 59.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.728 2.285 . . . . 0.0 112.083 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.7 mp -96.56 142.86 28.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.582 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 7' ' ' THR . . . -79.99 56.21 4.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.87 -0.892 . . . . 50.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 m -54.84 -33.74 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 50.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.0 -35.69 64.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 50.0 110.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 4' ' ' GLY . 30.8 p -119.19 164.37 15.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.439 . . . . 50.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -79.39 154.77 28.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 50.0 110.879 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.847 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -80.52 168.28 19.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 50.0 110.146 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.659 ' N ' HD22 ' A' ' 9' ' ' LEU . 19.5 m-85 -105.32 -73.4 0.68 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 48.7 t -39.84 128.86 2.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.362 0.601 . . . . 16.66 111.916 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.682 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -59.59 -7.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.128 -1.064 . . . . 50.0 108.128 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -77.42 2.14 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.716 -1.584 . . . . 16.66 110.928 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 42.0 mttm 69.34 54.81 0.4 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.189 -0.46 . . . . 25.0 111.773 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.433 HG23 ' HB3' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -158.67 125.18 2.49 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.537 -0.301 . . . . 50.0 110.258 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' N ' ' HB2' ' A' ' 9' ' ' LEU . 24.6 Cg_exo -56.02 176.47 0.18 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.677 2.252 . . . . 50.0 113.586 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -58.18 143.82 42.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.825 0.821 . . . . 50.0 111.402 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.5 m-20 -136.07 98.03 3.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.162 -1.381 . . . . 50.0 108.755 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -50.7 -14.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.266 0.555 . . . . 50.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.466 ' N ' ' C ' ' A' ' 18' ' ' ASP . 24.3 m -80.77 -29.53 36.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.802 -1.184 . . . . 50.0 107.802 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 18' ' ' ASP . 25.3 tptt -100.12 130.09 46.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.62 -1.627 . . . . 50.0 107.636 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.521 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 43.9 p90 -97.0 142.14 29.31 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.078 -0.51 . . . . 16.66 111.091 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CD2' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -119.96 173.78 6.86 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 124.441 2.067 . . . . 50.0 115.151 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.995 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.13 123.5 60.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 108.994 -3.73 . . . . 16.66 104.623 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.546 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -89.21 126.34 8.18 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 119.478 -1.344 . . . . 16.66 115.656 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.438 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.16 121.17 3.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.359 -1.348 . . . . 16.66 107.359 176.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.459 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.4 t70 -68.3 -31.64 71.22 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.578 0.704 . . . . 25.0 109.216 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NE ' ' OG1' ' A' ' 59' ' ' THR . 32.9 ttt-85 -113.56 -26.46 8.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.588 -1.187 . . . . 50.0 111.81 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.283 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -95.26 12.58 28.49 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.8 -0.76 . . . . 16.66 112.607 -177.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.5 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 11.4 pt20 29.92 47.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.823 0.675 . . . . 16.66 112.823 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.56 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -131.36 164.1 26.41 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.069 -0.252 . . . . 50.0 110.544 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.587 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -134.39 125.6 27.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.907 -0.317 . . . . 16.66 111.832 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -131.89 157.45 43.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 121.033 -0.267 . . . . 50.0 111.605 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -55.19 140.48 38.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.392 -1.336 . . . . 16.66 107.392 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -47.56 -42.57 20.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.379 -1.391 . . . . 16.66 110.615 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -77.27 -20.47 55.06 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.758 -0.46 . . . . 50.0 109.758 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.3 t -51.33 -32.49 25.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.799 -0.815 . . . . 16.66 108.799 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.5 11.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.028 -0.987 . . . . 16.66 110.988 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.96 45.57 50.37 Favored Glycine 0 N--CA 1.461 0.318 0 CA-C-N 115.934 -0.576 . . . . 16.66 111.837 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.526 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -106.55 163.81 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.89 0.376 . . . . 16.66 110.462 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.748 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.2 mm? -64.73 163.2 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 50.0 110.262 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -80.27 -56.6 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.413 -0.812 . . . . 25.0 110.63 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.9 m -66.81 -14.64 62.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.151 -0.931 . . . . 50.0 109.164 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.006 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 3.0 tt0 -44.93 -44.47 9.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.523 -0.762 . . . . 50.0 111.056 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.12 -35.04 6.64 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.538 -0.465 . . . . 25.0 111.624 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -87.03 -52.64 5.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.796 0.665 . . . . 50.0 112.796 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.2 pp -71.95 4.98 2.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.372 -0.831 . . . . 16.66 111.452 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.006 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -107.34 130.62 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 119.695 -0.802 . . . . 25.0 111.21 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.88 -72.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.815 -1.084 . . . . 50.0 112.345 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.21 68.68 0.81 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.302 -0.629 . . . . 50.0 109.302 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.3 147.43 53.32 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.612 -0.722 . . . . 16.66 109.53 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.677 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.6 t -119.99 155.11 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.469 -0.787 . . . . 50.0 109.023 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.438 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -84.83 160.79 54.95 Favored Pre-proline 0 N--CA 1.412 -2.334 0 CA-C-N 115.596 -0.729 . . . . 16.66 110.944 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 39.0 Cg_endo -77.81 -26.34 6.91 Favored 'Trans proline' 0 C--N 1.279 -3.127 0 C-N-CA 122.251 1.967 . . . . 16.66 111.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.79 -34.05 71.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.193 -1.04 . . . . 50.0 108.193 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -86.12 -32.92 21.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.784 -1.098 . . . . 16.66 110.309 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -54.1 -35.7 62.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 50.0 111.579 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -53.94 -36.23 62.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 50.0 111.114 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.519 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 55.3 p -90.72 -8.69 49.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.4 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -112.6 155.73 23.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.924 0.393 . . . . 50.0 110.971 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.8 120.09 25.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 50.0 110.694 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.991 -1.004 . . . . 50.0 110.486 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.91 -22.75 25.12 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.694 2.262 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.9 mt -97.06 143.4 27.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.653 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.23 -29.17 55.95 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.016 -0.834 . . . . 50.0 111.016 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p 54.79 -150.4 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.754 0.312 . . . . 50.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.776 ' OD1' HG23 ' A' ' 7' ' ' THR . 52.6 p30 -91.92 8.18 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 50.0 111.166 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.776 HG23 ' OD1' ' A' ' 6' ' ' ASP . 68.8 p -121.62 160.93 23.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.447 -0.342 . . . . 50.0 110.459 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -89.4 -177.84 5.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 50.0 110.892 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 7.1 mt -113.68 142.92 45.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 50.0 111.419 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.0 m-85 -101.85 -67.34 0.87 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.498 -0.927 . . . . 25.0 108.498 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 4.6 t -41.43 114.71 0.54 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.957 -1.019 . . . . 16.66 110.638 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.626 HG23 ' CD1' ' A' ' 33' ' ' TYR . 4.3 pt -50.92 -8.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.575 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.946 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.68 6.72 10.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.832 -1.076 . . . . 16.66 110.7 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm 64.09 52.63 1.97 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.145 -0.48 . . . . 25.0 111.405 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.43 144.31 22.62 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 50.0 109.669 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.71 155.85 68.35 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.585 2.19 . . . . 50.0 112.408 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.705 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 30.6 t80 -58.24 148.48 27.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 50.0 109.833 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.491 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 91.3 m-20 -140.57 111.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.763 -0.653 . . . . 50.0 111.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.84 -17.37 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 50.0 110.043 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.5 m -76.35 -29.27 57.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.585 -1.265 . . . . 50.0 107.585 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 6.7 tptm -99.49 156.47 17.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.456 -1.702 . . . . 50.0 108.492 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 35.4 p90 -111.06 152.25 27.12 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.45 -0.5 . . . . 16.66 110.364 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.705 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 9.5 m-85 -130.46 168.83 16.38 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 123.42 1.581 . . . . 50.0 114.256 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.03 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.36 123.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 110.932 -2.849 . . . . 16.66 105.53 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.52 120.08 6.16 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.876 -1.154 . . . . 16.66 115.773 -174.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.439 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.21 107.6 0.13 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.273 -1.38 . . . . 16.66 107.273 175.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 89.7 m-20 -65.52 -34.08 77.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HE ' HG23 ' A' ' 59' ' ' THR . 37.4 ttt85 -92.71 -39.55 11.2 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.519 -1.673 . . . . 50.0 110.935 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.276 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.09 -28.4 27.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.918 -0.713 . . . . 16.66 111.49 -178.316 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.779 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER 76.13 28.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.486 0.921 . . . . 16.66 113.486 178.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.523 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.96 166.18 22.97 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 119.776 -0.77 . . . . 50.0 111.079 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 140.66 50.72 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.922 0.712 . . . . 16.66 112.922 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.69 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -133.62 144.38 49.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.454 -0.339 . . . . 50.0 111.061 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.814 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.7 OUTLIER -56.34 139.31 48.88 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.395 -1.706 . . . . 16.66 106.395 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.499 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.8 -54.34 5.07 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.843 -1.17 . . . . 16.66 111.53 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.61 -20.28 62.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.486 -0.486 . . . . 50.0 109.784 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.5 -31.88 25.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.281 -0.637 . . . . 16.66 109.281 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.57 13.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.344 -0.844 . . . . 16.66 111.185 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.51 45.98 57.42 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.793 -0.523 . . . . 16.66 111.793 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.499 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -113.86 167.51 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.137 0.494 . . . . 16.66 111.363 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 40' ' ' ILE . 42.4 mt -61.47 164.85 5.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.555 -0.748 . . . . 50.0 110.582 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -77.92 -55.1 5.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 25.0 110.314 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.62 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 72.7 m -70.78 -15.24 62.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.507 -0.769 . . . . 50.0 109.441 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.872 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -41.97 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.564 -0.744 . . . . 50.0 110.755 -178.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.64 -45.5 58.65 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.939 -0.573 . . . . 25.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 43' ' ' SER . 97.1 mt-10 -88.93 -45.69 9.48 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.593 1.331 . . . . 50.0 114.593 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 48' ' ' ILE . 1.8 pp -55.29 -29.28 57.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.948 0.721 . . . . 16.66 112.948 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.053 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -86.06 174.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.803 0.811 . . . . 25.0 109.641 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -124.51 -69.74 0.79 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.261 -1.336 . . . . 50.0 110.91 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -101.31 70.57 1.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.916 -1.142 . . . . 50.0 107.916 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.3 t80 -65.74 140.12 58.42 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.433 -0.803 . . . . 16.66 110.728 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.72 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.5 t -120.29 155.16 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 114.458 -1.246 . . . . 50.0 108.556 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.439 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -87.28 160.21 49.03 Favored Pre-proline 0 N--CA 1.414 -2.275 0 CA-C-O 121.39 0.614 . . . . 16.66 110.491 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 24.8 Cg_endo -81.52 -25.24 3.86 Favored 'Trans proline' 0 C--N 1.279 -3.095 0 C-N-CA 122.085 1.857 . . . . 16.66 110.764 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -71.34 -35.67 71.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.095 -0.957 . . . . 50.0 108.565 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -70.39 -31.82 69.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.225 -0.898 . . . . 16.66 110.413 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 53' ' ' CYS . 94.3 mt-30 -55.96 -29.86 60.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.924 0.392 . . . . 50.0 110.456 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.4 p -59.1 -24.62 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.031 -0.531 . . . . 50.0 110.867 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.521 HG23 ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -122.72 -16.71 7.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.925 -0.31 . . . . 50.0 111.794 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' C ' ' CD ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -57.0 139.59 51.69 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.256 -0.577 . . . . 50.0 110.429 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 87.7 m-20 -107.74 151.58 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 50.0 110.672 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 61' ' ' ASP . . . . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.957 -1.021 . . . . 50.0 110.406 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' GLY . 53.5 Cg_exo -48.88 -175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.803 2.335 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.9 tp -52.21 -38.76 58.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.265 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.38 163.67 29.21 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.07 -0.812 . . . . 50.0 111.07 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -29.37 70.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 50.0 110.825 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -74.38 122.04 22.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 50.0 110.87 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -123.62 176.52 6.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.909 -0.587 . . . . 50.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -70.1 -176.26 1.11 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.837 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -61.28 -178.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.851 -0.613 . . . . 50.0 110.303 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.643 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 4.9 m-85 -69.46 -99.13 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.173 -0.676 . . . . 25.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 15.6 t -40.34 121.86 1.46 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.497 -0.774 . . . . 16.66 112.456 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.729 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.2 pt -59.09 -7.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.521 -1.218 . . . . 50.0 108.807 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.981 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.11 10.45 2.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.414 -1.266 . . . . 16.66 110.848 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.0 mttm 65.63 51.5 1.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.045 -0.525 . . . . 25.0 111.989 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 148.1 31.37 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.736 -0.385 . . . . 50.0 110.552 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.3 158.56 48.38 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.728 2.285 . . . . 50.0 111.8 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.2 t80 -58.31 144.84 39.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.662 -0.415 . . . . 50.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 92.5 m-20 -140.79 116.64 10.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.85 -0.614 . . . . 50.0 110.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.87 -12.86 4.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.389 -0.597 . . . . 50.0 109.389 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 m -79.33 -21.12 46.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.541 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.1 tptm -112.98 153.08 28.61 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.524 -1.671 . . . . 50.0 107.824 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.2 p90 -111.13 154.11 24.77 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.228 -0.589 . . . . 16.66 110.607 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.765 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.5 m-85 -127.8 169.8 13.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 123.779 1.752 . . . . 50.0 114.475 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.049 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.79 178.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.128 -3.214 . . . . 16.66 103.796 176.092 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.89 125.45 2.71 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 117.521 -2.275 . . . . 16.66 114.158 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.38 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 105.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.366 -1.346 . . . . 16.66 107.366 176.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' TYR . 84.5 m-20 -71.19 -19.95 62.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.622 HH21 ' CB ' ' A' ' 61' ' ' ASP . 6.9 tpt180 -111.61 -18.22 12.85 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.002 -1.454 . . . . 50.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.207 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -122.8 18.06 10.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.323 -0.951 . . . . 16.66 112.708 -178.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.594 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 19.3 pt20 32.93 54.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.202 0.445 . . . . 16.66 112.202 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.622 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -133.94 167.51 20.46 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 121.096 -0.242 . . . . 50.0 110.485 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.642 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -138.76 133.26 31.95 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.432 0.53 . . . . 16.66 112.432 -177.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.729 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -139.49 155.02 47.82 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.006 -0.543 . . . . 50.0 112.06 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.891 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.51 141.79 57.48 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 106.243 -1.762 . . . . 16.66 106.243 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.537 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -43.52 -58.53 4.0 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.633 -1.27 . . . . 16.66 111.518 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.426 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -66.79 -20.95 66.05 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.5 t -51.72 -31.77 27.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.126 -0.63 . . . . 16.66 109.482 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.34 12.52 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.442 -0.799 . . . . 16.66 111.128 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.85 25.09 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 111.608 -0.597 . . . . 16.66 111.608 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -122.01 167.46 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.178 0.513 . . . . 16.66 112.038 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.4 mm? -62.49 164.15 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 50.0 110.432 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.661 ' HG2' ' H ' ' A' ' 43' ' ' SER . 7.9 pt20 -82.12 -49.38 10.24 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.905 ' C ' HD21 ' A' ' 47' ' ' LEU . 5.7 m -59.53 -39.0 82.5 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.422 -1.717 . . . . 50.0 107.459 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.757 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -40.15 -16.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.288 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -63.1 -61.65 2.23 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.249 -0.581 . . . . 25.0 111.649 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mp0 -91.87 -47.35 7.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.857 1.799 . . . . 50.0 115.857 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.155 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -65.71 14.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.495 1.295 . . . . 16.66 114.495 -174.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 44' ' ' GLU . 2.5 pp -117.15 169.45 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 120.133 -0.627 . . . . 25.0 109.962 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 53.3 t0 -165.42 27.59 0.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.748 0.785 . . . . 50.0 109.935 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.46 16.09 0.52 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.248 -1.39 . . . . 50.0 107.248 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.634 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.3 t80 -67.37 147.61 52.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.802 -1.09 . . . . 16.66 110.511 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 25.2 t -137.26 157.57 34.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.888 -1.505 . . . . 50.0 108.917 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.38 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.0 p -80.03 158.21 72.71 Favored Pre-proline 0 N--CA 1.414 -2.254 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 11.0 Cg_endo -81.35 -27.94 2.57 Favored 'Trans proline' 0 C--N 1.273 -3.406 0 C-N-CA 121.842 1.694 . . . . 16.66 110.932 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -71.97 -33.83 68.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.461 -0.79 . . . . 50.0 108.877 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.151 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -65.43 -34.68 78.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.59 -0.732 . . . . 16.66 110.559 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -51.29 -36.99 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 50.0 110.34 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 p -78.62 -31.88 47.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.354 -0.384 . . . . 50.0 110.159 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 60' ' ' GLU . 33.3 m -71.87 -50.66 27.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.158 -0.473 . . . . 50.0 111.289 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 59' ' ' THR . 98.6 mt-10 12.01 59.99 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.325 0.391 . . . . 50.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.622 ' CB ' HH21 ' A' ' 28' ' ' ARG . 91.2 m-20 36.88 -88.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 50.0 111.049 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.029 -0.986 . . . . 50.0 110.52 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.482 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 50.0 Cg_endo -69.21 158.02 59.24 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.784 2.322 . . . . 0.0 111.987 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.7 mt -56.96 -32.75 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.72 -69.46 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.899 -0.88 . . . . 50.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.6 m -64.86 165.38 10.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 50.0 110.81 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -48.88 160.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 50.0 110.312 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.454 HG22 ' HB3' ' A' ' 2' ' ' PRO . 50.5 p -81.29 161.85 23.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.486 0.66 . . . . 50.0 111.556 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.674 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -151.45 -176.95 5.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.753 -1.112 . . . . 50.0 109.158 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.575 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 17.3 mt -83.75 137.44 33.74 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.924 -0.31 . . . . 50.0 110.714 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 2.7 m-85 -106.12 -6.26 18.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.364 0.602 . . . . 25.0 111.014 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -104.15 123.08 46.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.923 -1.035 . . . . 16.66 110.844 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.692 HG23 ' CD2' ' A' ' 33' ' ' TYR . 14.0 pt -59.96 -8.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.203 -1.406 . . . . 50.0 107.203 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.961 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -84.79 2.19 43.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.47 -1.696 . . . . 16.66 109.472 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mttp 67.78 64.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.553 -0.749 . . . . 25.0 112.246 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.3 141.64 13.13 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.709 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.98 158.73 52.66 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.657 2.238 . . . . 50.0 112.104 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.753 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 20.0 t80 -69.37 139.07 54.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.078 0.466 . . . . 50.0 110.936 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 11.5 t70 -140.58 128.62 22.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.593 -0.731 . . . . 50.0 109.47 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.6 -21.9 41.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.074 -0.512 . . . . 50.0 110.907 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -67.17 -33.79 76.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.744 -1.206 . . . . 50.0 107.744 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -85.41 152.49 23.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.259 -1.791 . . . . 50.0 109.114 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 22.0 p90 -114.17 140.6 48.4 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.32 -0.993 . . . . 16.66 108.32 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.753 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 28.5 m-85 -122.61 171.35 9.19 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 124.089 1.9 . . . . 50.0 115.621 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.041 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.28 118.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 109.513 -3.494 . . . . 16.66 103.977 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -90.42 125.64 8.01 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.58 -1.295 . . . . 16.66 116.279 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.415 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -46.64 108.45 0.14 Allowed 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.31 -1.367 . . . . 16.66 107.31 175.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.673 ' HB3' HG22 ' A' ' 52' ' ' VAL . 57.3 t0 -61.52 -29.3 69.9 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.018 -0.734 . . . . 25.0 109.018 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.42 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 13.6 ttt85 -113.72 -20.36 11.19 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.705 -1.134 . . . . 50.0 112.344 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.245 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -107.96 20.29 18.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.317 -0.953 . . . . 16.66 112.981 -177.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 29' ' ' CYS . 16.4 pt20 31.06 47.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.521 0.563 . . . . 16.66 112.521 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.529 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 3.6 m-20 -131.54 159.79 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.748 -0.381 . . . . 50.0 110.703 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -135.74 122.87 21.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.727 0.299 . . . . 16.66 111.049 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.692 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -124.09 153.66 41.1 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.456 -0.307 . . . . 50.0 111.406 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.839 ' CE1' ' HG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -54.8 146.42 17.24 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.728 -1.953 . . . . 16.66 105.728 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.543 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -46.2 -53.18 9.52 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 119.461 -1.352 . . . . 16.66 111.505 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -73.7 -19.4 60.83 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.715 -0.476 . . . . 50.0 109.715 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.6 t -49.96 -31.29 12.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 33' ' ' TYR . 4.0 m -115.77 9.45 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.203 -0.908 . . . . 16.66 110.3 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.79 45.83 20.16 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.395 -0.682 . . . . 16.66 111.395 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.543 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -117.3 167.53 10.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.91 0.386 . . . . 16.66 110.876 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 40' ' ' ILE . 90.1 mt -65.64 163.24 16.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.338 0.589 . . . . 50.0 109.666 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -78.07 -54.88 5.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.937 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.0 t -70.32 -14.77 62.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.431 -0.804 . . . . 50.0 110.677 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.68 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.7 mt-10 -44.4 -30.1 0.79 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.648 -0.421 . . . . 50.0 111.159 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -37.66 88.11 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.07 -0.652 . . . . 25.0 110.53 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.3 mm-40 -87.89 -33.17 18.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.227 1.195 . . . . 50.0 114.227 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.666 HD11 ' HA ' ' A' ' 44' ' ' GLU . 3.7 pp -94.31 16.24 15.51 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 112.716 0.636 . . . . 16.66 112.716 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -120.17 146.87 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 C-N-CA 118.704 -1.198 . . . . 25.0 112.888 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -94.38 -81.22 0.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.074 -0.966 . . . . 50.0 111.792 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.27 69.89 1.03 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.585 -0.279 . . . . 50.0 110.449 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.637 ' CG ' ' HB ' ' A' ' 24' ' ' ILE . 5.1 t80 -67.28 138.85 57.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.476 -0.89 . . . . 16.66 108.802 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 27' ' ' ASP . 23.9 t -119.38 150.81 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.722 -0.672 . . . . 50.0 109.315 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.415 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.8 p -80.99 160.91 64.94 Favored Pre-proline 0 N--CA 1.411 -2.395 0 CA-C-N 115.316 -0.857 . . . . 16.66 110.052 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 27.9 Cg_endo -80.43 -29.16 2.52 Favored 'Trans proline' 0 C--N 1.278 -3.177 0 C-N-CA 122.001 1.8 . . . . 16.66 111.405 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -70.83 -32.88 70.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 3.0 m -62.61 -39.69 94.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.789 -1.096 . . . . 16.66 110.34 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -55.01 -17.23 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 50.0 110.352 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 m -54.51 -33.92 60.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 50.0 110.42 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.2 p -123.9 -17.03 6.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.903 0.335 . . . . 50.0 111.903 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 41.68 -114.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.738 -0.385 . . . . 50.0 110.679 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 54.5 p30 -67.81 175.15 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 50.0 110.406 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.983 -1.008 . . . . 50.0 110.55 -179.878 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 4' ' ' GLY . 35.8 Cg_exo -54.38 -29.07 56.67 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.022 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' C ' HD13 ' A' ' 3' ' ' LEU . 0.2 OUTLIER 62.78 -77.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.392 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -84.81 -179.54 51.21 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.898 -0.881 . . . . 50.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.1 p -75.16 158.32 33.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.854 0.359 . . . . 50.0 110.593 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.76 120.64 27.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 50.0 110.41 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -81.39 165.04 21.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 50.0 110.481 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' NZ ' HG22 ' A' ' 12' ' ' ILE . 3.2 ptmt -130.33 158.07 40.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 50.0 110.655 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.83 ' CD1' ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.1 -174.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.587 . . . . 50.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -59.55 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.389 0.614 . . . . 25.0 110.491 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 43.4 t -37.67 122.51 0.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.034 -0.985 . . . . 16.66 113.298 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.753 HG23 ' CD2' ' A' ' 33' ' ' TYR . 8.8 pt -59.95 -13.98 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 114.862 -1.063 . . . . 50.0 108.138 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.965 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -72.25 4.5 3.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.811 -1.54 . . . . 16.66 110.137 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt 65.85 50.29 1.54 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.488 -0.778 . . . . 25.0 112.065 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.23 123.51 9.41 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.01 156.66 12.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.346 2.031 . . . . 50.0 111.948 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 4.5 t80 -61.28 134.25 56.77 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.293 0.568 . . . . 50.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 20' ' ' SER . 88.1 m-20 -141.46 116.02 9.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.085 -0.961 . . . . 50.0 108.83 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -43.92 -13.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.627 -0.429 . . . . 50.0 110.481 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -62.84 -38.41 90.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.748 -0.834 . . . . 50.0 108.748 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -99.85 167.52 10.47 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.1 p90 -120.77 142.32 49.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.694 -0.684 . . . . 16.66 109.168 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 2.9 m-85 -114.03 155.49 25.82 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 123.791 1.758 . . . . 50.0 115.414 -175.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.01 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -121.92 126.43 74.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 110.2 -3.182 . . . . 16.66 105.123 176.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.66 123.68 7.41 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.556 -1.307 . . . . 16.66 115.054 -175.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -49.86 107.0 0.13 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.65 -1.275 . . . . 16.66 108.89 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.635 ' HB2' HG22 ' A' ' 52' ' ' VAL . 80.8 m-20 -56.88 -35.13 68.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.265 -0.574 . . . . 25.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.497 ' HE ' ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -112.71 -12.71 13.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 50.0 111.873 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -110.21 12.58 23.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.323 -0.951 . . . . 16.66 111.57 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.52 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 10.0 pt20 29.92 53.43 0.12 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.941 0.4 . . . . 16.66 111.101 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.645 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 2.8 m-20 -132.45 166.64 21.54 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.31 -0.404 . . . . 50.0 110.189 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -141.36 132.8 26.81 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.333 -0.547 . . . . 16.66 111.676 -177.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.753 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -138.56 155.47 48.34 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 50.0 112.494 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.824 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -60.62 146.58 44.87 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 105.064 -2.198 . . . . 16.66 105.064 175.142 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.0 -51.27 25.37 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 119.136 -1.507 . . . . 16.66 110.831 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.84 -18.48 60.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.712 -0.395 . . . . 50.0 109.953 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.0 t -50.39 -32.48 17.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.066 -0.716 . . . . 16.66 109.066 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.18 18.68 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.016 -0.993 . . . . 16.66 111.219 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.98 46.19 82.92 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 111.513 -0.635 . . . . 16.66 111.513 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.88 164.01 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.864 0.364 . . . . 16.66 110.934 -178.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.755 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 10.4 mp -58.0 164.76 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.245 0.545 . . . . 50.0 110.162 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -78.63 -56.26 4.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.34 -0.845 . . . . 25.0 110.985 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.494 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 67.4 m -71.23 -15.55 62.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.59 -0.732 . . . . 50.0 109.236 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.779 ' HA ' HD11 ' A' ' 47' ' ' LEU . 2.1 tt0 -43.36 -19.13 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.481 -0.781 . . . . 50.0 111.172 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -68.56 -47.01 67.92 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.432 -0.507 . . . . 25.0 111.19 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.25 -45.69 9.86 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.261 1.208 . . . . 50.0 114.261 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.089 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.3 pp -55.15 -28.16 50.76 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.842 0.682 . . . . 16.66 112.842 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.089 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -85.76 174.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.607 0.718 . . . . 25.0 109.349 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -137.46 -53.88 0.68 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.642 -1.163 . . . . 50.0 110.455 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -103.69 56.35 0.74 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.823 -1.177 . . . . 50.0 107.823 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.66 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.3 t80 -65.27 141.46 58.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.537 0.684 . . . . 16.66 109.876 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.1 t -126.06 154.83 35.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.375 -1.284 . . . . 50.0 109.288 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -82.21 159.51 64.84 Favored Pre-proline 0 N--CA 1.413 -2.289 0 CA-C-N 115.69 -0.686 . . . . 16.66 109.824 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 22.6 Cg_endo -81.28 -25.65 3.79 Favored 'Trans proline' 0 C--N 1.275 -3.297 0 C-N-CA 121.962 1.775 . . . . 16.66 111.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -74.79 -32.59 62.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.719 . . . . 50.0 109.101 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.145 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -65.92 -38.5 88.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 16.66 110.907 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -50.72 -40.19 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.802 -0.444 . . . . 50.0 109.802 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -72.76 -29.18 63.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 50.0 109.323 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -72.88 -54.84 7.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.633 -0.712 . . . . 50.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.497 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 95.5 mt-10 -128.37 155.22 45.03 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.861 0.362 . . . . 50.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -131.44 162.67 29.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.099 -0.501 . . . . 50.0 110.408 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' OXT' ' NH2' ' A' ' 28' ' ' ARG . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.094 -0.955 . . . . 50.0 110.638 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.0 142.34 44.17 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.455 2.104 . . . . 0.0 112.159 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.9 mp -95.46 149.28 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.365 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.63 51.93 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.86 -0.896 . . . . 50.0 110.86 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' ASP . 28.7 p -79.54 5.4 13.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 50.0 110.601 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 52.8 p30 -56.25 -155.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.258 -0.428 . . . . 50.0 110.569 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 14.8 m -80.96 116.22 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.885 -0.326 . . . . 50.0 110.754 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 7' ' ' THR . 8.3 mtpt -145.69 -177.18 5.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.214 0.53 . . . . 50.0 110.771 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.685 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.2 158.91 24.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.799 . . . . 50.0 109.426 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.9 m-85 -94.04 -71.92 0.64 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.562 -0.533 . . . . 25.0 109.562 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 37.4 t -40.52 111.0 0.17 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.5 -0.773 . . . . 16.66 110.334 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.696 HG23 ' CD2' ' A' ' 33' ' ' TYR . 18.8 pt -51.84 -7.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.918 -0.771 . . . . 50.0 108.918 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -83.49 30.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.484 -1.234 . . . . 16.66 109.392 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 12' ' ' ILE . 48.8 pttt 42.66 55.81 4.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.489 -0.778 . . . . 25.0 111.619 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 p -145.54 141.55 17.06 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.51 -0.314 . . . . 50.0 110.28 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.2 154.01 56.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.451 2.101 . . . . 50.0 111.482 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 17.5 t80 -57.81 138.71 55.37 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.05 -0.66 . . . . 50.0 109.84 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.5 m-20 -141.56 118.58 11.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.1 -0.955 . . . . 50.0 110.435 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -51.23 -22.9 2.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.055 -0.72 . . . . 50.0 109.055 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -63.45 -35.4 80.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.972 -1.121 . . . . 50.0 107.972 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -90.9 155.14 18.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 113.868 -1.514 . . . . 50.0 108.926 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 46.0 p90 -118.39 123.34 45.02 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.03 0.919 . . . . 16.66 110.168 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 m-85 -103.03 162.55 12.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 123.769 1.747 . . . . 50.0 114.879 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.057 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -130.8 117.46 38.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 110.183 -3.189 . . . . 16.66 103.63 176.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.28 135.46 13.34 Favored Glycine 0 C--N 1.316 -0.543 0 N-CA-C 116.866 1.507 . . . . 16.66 116.866 -173.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.45 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.7 OUTLIER -46.86 117.78 1.8 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.946 -1.627 . . . . 16.66 108.503 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.704 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.9 t70 -51.71 -46.49 63.93 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.662 -0.815 . . . . 25.0 109.818 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.526 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -117.34 -5.94 11.27 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.212 0.819 . . . . 50.0 113.212 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.265 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -98.08 14.66 26.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 118.669 -1.212 . . . . 16.66 111.37 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.569 ' CD ' ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER 30.53 50.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.716 . . . . 16.66 111.963 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.567 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 10.2 m-20 -131.87 163.92 27.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.414 -0.357 . . . . 50.0 110.193 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.549 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -136.57 126.22 25.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.74 0.305 . . . . 16.66 110.832 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.696 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -124.8 141.82 51.85 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.796 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 6.6 p-80 -56.02 146.99 20.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.649 -1.612 . . . . 16.66 106.649 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.51 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -40.36 -60.7 1.95 Allowed Glycine 0 C--N 1.306 -1.111 0 C-N-CA 119.913 -1.137 . . . . 16.66 113.382 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.524 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.82 -20.36 64.31 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.221 0.534 . . . . 50.0 109.783 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -49.3 -25.9 2.69 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.343 -0.984 . . . . 16.66 108.343 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 33' ' ' TYR . 17.7 m -124.32 7.8 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.184 -0.916 . . . . 16.66 111.345 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 79.35 46.38 8.14 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.824 -0.91 . . . . 16.66 110.824 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 41' ' ' LEU . 1.1 tp -106.0 155.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.019 0.437 . . . . 16.66 110.692 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.7 mt -61.92 166.19 4.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.942 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -70.61 -53.55 15.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.76 -0.654 . . . . 25.0 109.362 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' ALA . 75.6 m -75.58 -14.65 60.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.218 -0.901 . . . . 50.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.995 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -43.11 -18.17 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.932 -0.576 . . . . 50.0 110.203 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.06 -43.55 64.72 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.519 -0.472 . . . . 25.0 110.969 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.67 ' C ' ' H ' ' A' ' 48' ' ' ILE . 97.4 mt-10 -87.6 -52.98 5.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.138 0.792 . . . . 50.0 113.138 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.817 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.67 9.08 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.049 -0.523 . . . . 16.66 110.63 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.995 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -112.62 135.66 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.282 -0.872 . . . . 25.0 112.146 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 59.5 t0 -91.59 -71.89 0.61 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.996 -1.002 . . . . 50.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' OE1' ' OD1' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -130.29 78.42 1.84 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.889 -0.782 . . . . 50.0 108.889 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.762 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.31 147.32 53.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.026 -0.731 . . . . 16.66 109.026 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.762 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 21.5 t -110.71 158.87 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.243 -0.583 . . . . 50.0 109.9 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.45 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -89.38 159.61 44.06 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 115.704 -0.68 . . . . 16.66 110.12 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 43.4 Cg_endo -79.28 -30.45 2.6 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 C-N-CA 121.746 1.631 . . . . 16.66 110.834 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -68.91 -32.99 73.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.588 -1.264 . . . . 50.0 107.588 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.115 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.1 m -60.73 -42.69 97.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.177 -1.374 . . . . 16.66 109.914 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' O ' ' A' ' 60' ' ' GLU . 93.1 mt-30 -57.73 -37.64 73.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.425 -0.807 . . . . 50.0 110.245 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.5 m -60.84 -38.93 87.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.312 -0.625 . . . . 50.0 109.312 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.427 HG22 ' OE2' ' A' ' 60' ' ' GLU . 28.4 m -77.83 -48.33 16.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.629 -0.714 . . . . 50.0 110.629 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 57' ' ' GLN . 51.9 mp0 -114.78 147.35 39.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.669 -0.412 . . . . 50.0 110.804 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 55.78 45.67 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 50.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.019 -0.991 . . . . 50.0 110.481 179.912 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.79 120.38 7.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.545 2.164 . . . . 0.0 111.93 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.701 ' O ' HD23 ' A' ' 3' ' ' LEU . 7.6 tt -63.86 -37.86 88.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.43 49.56 5.43 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.326 -0.71 . . . . 50.0 111.326 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.427 ' HB2' HD22 ' A' ' 3' ' ' LEU . 34.6 t -97.61 128.85 44.64 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.838 0.351 . . . . 50.0 110.315 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 7' ' ' THR . 33.7 p-10 -67.33 -39.62 85.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 50.0 111.476 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.534 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.5 p -149.39 -170.28 3.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.259 0.552 . . . . 50.0 111.559 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 17.7 mmmt -104.14 -177.6 3.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.373 -0.83 . . . . 50.0 111.082 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.58 144.45 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 50.0 110.894 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.8 m-85 -106.17 -67.35 0.94 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.7 t -41.63 116.53 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.27 -0.877 . . . . 16.66 110.742 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' CD1' ' A' ' 33' ' ' TYR . 11.3 pt -52.3 -7.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.18 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.947 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -79.85 3.08 20.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.662 -1.153 . . . . 16.66 110.671 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.1 mttp 67.94 55.17 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.187 -0.46 . . . . 25.0 111.786 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.412 ' CG2' ' NE2' ' A' ' 34' ' ' HIS . 0.6 OUTLIER -147.62 145.2 20.7 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 110.063 -0.347 . . . . 50.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.58 150.37 79.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.447 2.098 . . . . 50.0 111.874 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.741 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.0 t80 -54.26 146.24 15.82 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.49 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 91.2 m-20 -140.56 112.75 7.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.999 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.21 -17.6 7.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 50.0 109.934 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 t -72.11 -31.93 66.49 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.313 -1.366 . . . . 50.0 107.313 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -97.93 157.28 16.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.07 -1.877 . . . . 50.0 109.006 179.079 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 45.5 p90 -114.17 146.58 40.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.303 -0.559 . . . . 16.66 109.978 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.741 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 5.7 m-85 -122.83 165.22 16.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 123.355 1.55 . . . . 50.0 114.269 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.008 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -123.96 119.66 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 111.099 -2.773 . . . . 16.66 105.18 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -84.96 124.33 6.69 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.545 -1.312 . . . . 16.66 114.534 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.435 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -46.8 107.78 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.656 -1.609 . . . . 16.66 106.656 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 54.9 t0 -59.89 -29.82 68.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' NH2' ' OE2' ' A' ' 60' ' ' GLU . 13.6 tpp180 -113.89 -13.34 12.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.548 -1.205 . . . . 50.0 111.695 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.326 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -112.3 10.54 20.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 119.861 -0.735 . . . . 16.66 111.798 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.593 ' NE2' ' O ' ' A' ' 29' ' ' CYS . 3.8 pp0? 34.02 49.65 0.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.188 0.44 . . . . 16.66 112.188 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.705 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 9.8 m-20 -132.25 166.19 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.946 -0.39 . . . . 50.0 109.946 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -134.53 133.04 39.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 120.801 -0.36 . . . . 16.66 111.936 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.77 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -132.94 143.58 49.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.012 178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.883 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -51.27 143.33 11.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.923 -1.51 . . . . 16.66 106.923 176.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.11 -59.59 2.91 Favored Glycine 0 C--N 1.318 -0.437 0 C-N-CA 119.885 -1.15 . . . . 16.66 111.396 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.18 -19.06 63.99 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.762 -0.375 . . . . 50.0 110.394 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.08 -30.2 10.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.539 -0.911 . . . . 16.66 108.539 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 33' ' ' TYR . 6.7 m -117.52 8.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.251 -0.886 . . . . 16.66 111.146 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 77.66 45.52 10.76 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.167 -0.54 . . . . 16.66 112.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.491 ' CG2' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -112.98 167.07 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.131 0.491 . . . . 16.66 110.923 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 41' ' ' LEU . 6.5 mp -64.24 161.87 15.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 50.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -79.1 -54.33 6.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.859 -0.793 . . . . 25.0 108.859 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.9 t -60.01 -12.52 8.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.707 -1.133 . . . . 50.0 109.07 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.821 ' CD ' ' N ' ' A' ' 45' ' ' ALA . 1.9 pp20? -40.49 -55.75 2.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.211 -0.904 . . . . 50.0 111.068 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.821 ' N ' ' CD ' ' A' ' 44' ' ' GLU . . . -56.55 -26.22 54.36 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.342 -0.844 . . . . 25.0 110.473 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' SER . 84.6 tt0 -86.77 -25.45 24.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.181 0.515 . . . . 50.0 111.965 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 47' ' ' LEU . 4.2 pp -117.92 11.51 13.48 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 115.599 -0.728 . . . . 16.66 112.35 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.809 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -119.15 145.39 25.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.097 -1.041 . . . . 25.0 111.864 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.617 ' H ' HD13 ' A' ' 48' ' ' ILE . 22.5 t70 -146.65 -42.62 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.163 -0.926 . . . . 50.0 111.628 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -94.21 24.88 4.09 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 2.7 t80 -65.28 141.74 58.51 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.47 -0.786 . . . . 16.66 109.061 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' H ' ' A' ' 27' ' ' ASP . 4.9 t -129.32 157.77 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.822 -1.081 . . . . 50.0 108.423 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.435 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.3 p -79.62 158.92 72.84 Favored Pre-proline 0 N--CA 1.414 -2.265 0 CA-C-O 121.66 0.743 . . . . 16.66 110.693 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 23.8 Cg_endo -81.05 -15.75 10.24 Favored 'Trans proline' 0 C--N 1.278 -3.146 0 C-N-CA 122.15 1.9 . . . . 16.66 111.573 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' OE1' ' ND2' ' A' ' 31' ' ' ASN . 2.0 pt20 -87.53 -30.38 20.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 50.0 109.52 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.156 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -86.22 -39.16 16.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.924 -0.58 . . . . 16.66 111.023 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -49.61 -32.87 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.736 -0.386 . . . . 50.0 110.612 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.1 p -56.99 -31.84 65.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.006 -0.368 . . . . 50.0 110.006 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.2 p -71.21 -37.97 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 50.0 110.33 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.561 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 23.8 pt-20 -174.71 -174.81 0.85 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.115 -0.493 . . . . 50.0 110.632 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 55.69 45.44 24.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 50.0 110.712 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.028 -0.987 . . . . 50.0 110.533 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 4' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.44 -64.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.659 2.239 . . . . 0.0 112.067 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.45 -36.52 82.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -103.66 134.86 12.08 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.05 -0.82 . . . . 50.0 111.05 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.8 t -128.45 142.51 51.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 50.0 110.583 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 46.5 p30 -148.62 104.14 3.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 50.0 110.652 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -121.82 161.0 23.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.473 . . . . 50.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -136.95 173.73 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.99 -0.55 . . . . 50.0 110.246 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.759 ' CD1' ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.51 -176.1 0.1 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.694 -0.402 . . . . 50.0 110.461 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.616 ' CD2' ' CD1' ' A' ' 32' ' ' TRP . 2.6 m-85 -95.38 -75.49 0.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 120.107 -0.637 . . . . 25.0 112.04 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 11.4 t -38.39 118.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.428 0.632 . . . . 16.66 112.146 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.508 HG23 ' CD1' ' A' ' 33' ' ' TYR . 6.6 pt -53.31 -7.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.148 -0.933 . . . . 50.0 108.97 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.27 5.51 19.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.396 -1.274 . . . . 16.66 110.911 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 68.14 51.68 0.71 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.168 -0.469 . . . . 25.0 111.891 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 124.96 4.67 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.932 -0.307 . . . . 50.0 110.792 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 38.1 Cg_exo -55.19 162.68 5.34 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.644 2.229 . . . . 50.0 112.654 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.87 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 11.4 t80 -63.3 138.39 58.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.538 0.685 . . . . 50.0 111.128 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.546 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 70.8 m-20 -142.91 131.6 22.59 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.652 -1.158 . . . . 50.0 109.951 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.07 -20.74 62.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 50.0 110.395 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -63.11 -30.03 71.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.699 0.761 . . . . 50.0 109.1 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.735 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -106.09 158.35 16.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 114.378 -1.283 . . . . 50.0 107.685 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE2' ' HA3' ' A' ' 35' ' ' GLY . 45.8 p90 -119.38 137.91 53.43 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.082 -0.647 . . . . 16.66 109.288 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.87 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 2.2 m-85 -111.02 170.3 8.19 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 124.066 1.889 . . . . 50.0 115.331 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.03 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.32 118.72 24.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 109.747 -3.388 . . . . 16.66 105.07 177.459 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.63 124.8 6.99 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.037 1.175 . . . . 16.66 116.037 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.472 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -49.17 107.41 0.14 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.6 -1.259 . . . . 16.66 107.6 175.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.687 ' HB2' HG22 ' A' ' 52' ' ' VAL . 83.7 m-20 -61.4 -35.61 77.99 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.352 0.596 . . . . 25.0 109.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -19.56 14.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.103 -0.953 . . . . 50.0 111.327 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.315 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -94.39 -29.07 15.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.611 -0.835 . . . . 16.66 110.53 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.607 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 75.89 26.16 1.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.336 0.865 . . . . 16.66 113.336 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.708 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 14.7 p30 -132.63 167.41 20.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.859 -0.525 . . . . 50.0 110.091 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -121.31 145.04 48.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.429 0.899 . . . . 16.66 113.429 -176.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.708 ' OH ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -132.39 146.65 52.11 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.108 -0.496 . . . . 50.0 110.457 176.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.891 ' CE1' ' HG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -55.03 143.23 27.33 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.578 -1.638 . . . . 16.66 106.578 176.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -42.6 -58.3 3.57 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.0 -1.095 . . . . 16.66 111.697 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -71.61 -18.36 62.22 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.822 -0.351 . . . . 50.0 110.178 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.9 t -49.54 -31.47 10.4 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.799 -0.76 . . . . 16.66 109.003 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 33' ' ' TYR . 4.5 m -117.96 12.27 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.229 -0.896 . . . . 16.66 111.066 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 69.79 45.44 58.11 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.811 -0.631 . . . . 16.66 111.709 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -109.04 167.66 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.161 0.505 . . . . 16.66 111.219 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 40' ' ' ILE . 43.8 mt -62.76 164.5 7.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.584 -0.734 . . . . 50.0 110.911 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -80.1 -55.13 5.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.166 -0.925 . . . . 25.0 110.426 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.61 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.8 m -66.11 -15.78 63.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.863 -1.062 . . . . 50.0 109.625 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.709 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -42.65 -32.88 0.63 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.267 0.556 . . . . 50.0 109.753 -179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.05 -38.8 72.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.56 -0.745 . . . . 25.0 110.399 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' SER . 36.5 tp10 -88.31 -10.67 48.75 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.808 1.04 . . . . 50.0 113.808 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.709 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -115.76 16.51 16.33 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.34 0.496 . . . . 16.66 112.34 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -124.7 160.08 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 118.45 -1.3 . . . . 25.0 113.763 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' H ' HG13 ' A' ' 48' ' ' ILE . 54.3 t0 -130.43 -44.8 1.11 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.163 -1.38 . . . . 50.0 111.027 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' C ' ' OD2' ' A' ' 27' ' ' ASP . 95.5 mt-10 -120.97 52.22 1.21 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.593 -0.276 . . . . 50.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.612 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 1.5 t80 -66.78 137.56 56.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.267 -0.973 . . . . 16.66 108.375 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 27' ' ' ASP . 12.3 t -116.92 153.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.472 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -82.13 161.83 58.88 Favored Pre-proline 0 N--CA 1.409 -2.513 0 CA-C-N 115.217 -0.901 . . . . 16.66 110.859 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.4 Cg_endo -79.48 -26.47 4.86 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.113 1.876 . . . . 16.66 111.388 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -74.37 -30.96 62.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.194 -1.039 . . . . 50.0 108.194 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 2.5 m -68.34 -40.77 81.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.608 -1.178 . . . . 16.66 110.988 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 60' ' ' GLU . 96.5 mt-30 -50.56 -32.0 17.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 50.0 110.746 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -55.78 -39.78 71.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.36 -0.607 . . . . 50.0 109.36 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 m -70.75 -42.94 69.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.835 -0.621 . . . . 50.0 110.563 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.0 mt-10 -82.36 149.21 27.83 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.309 -0.405 . . . . 50.0 110.878 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 52.7 p30 -88.21 7.61 31.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 50.0 110.64 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.037 -0.982 . . . . 50.0 110.527 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.3 -13.69 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.973 2.449 . . . . 0.0 112.09 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 mt -82.32 135.86 35.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.53 -30.6 72.27 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 50.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 m 64.7 56.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 50.0 110.407 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.74 120.0 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 50.0 110.708 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.429 ' OG1' ' OH ' ' A' ' 10' ' ' TYR . 67.6 p -96.58 -175.82 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 50.0 110.848 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -70.83 -177.97 1.75 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 50.0 111.184 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.82 146.78 46.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.599 -0.728 . . . . 50.0 110.235 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.8 m-85 -99.71 -64.44 1.04 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.9 t -46.47 118.55 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.084 -0.962 . . . . 16.66 110.28 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.704 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.0 pt -53.62 -7.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.927 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -87.78 28.76 0.97 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.319 -1.309 . . . . 16.66 110.665 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 13' ' ' CYS . 19.9 pttm 41.56 65.88 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 25.0 111.685 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 139.15 11.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.094 -0.503 . . . . 50.0 109.731 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.64 154.93 72.04 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.348 2.032 . . . . 50.0 112.049 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.747 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 25.6 t80 -55.43 147.3 17.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.034 0.445 . . . . 50.0 109.918 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 21' ' ' LYS . 91.1 m-20 -140.58 109.08 5.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.013 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.3 -14.7 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.1 m -76.65 -29.81 56.56 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -100.9 155.02 18.18 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.234 -1.803 . . . . 50.0 107.997 178.321 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 32.1 p90 -109.61 152.84 25.02 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.193 -0.603 . . . . 16.66 110.584 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.747 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.9 m-85 -128.24 162.05 27.9 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.46 1.6 . . . . 50.0 114.294 -177.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.032 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.11 117.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 110.883 -2.871 . . . . 16.66 104.188 176.049 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.81 131.17 10.4 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.953 -1.118 . . . . 16.66 115.685 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.411 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -47.36 108.03 0.14 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.481 -1.303 . . . . 16.66 107.481 176.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.715 ' HB3' HG22 ' A' ' 52' ' ' VAL . 51.2 t0 -61.13 -31.8 71.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.313 0.577 . . . . 25.0 109.704 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.587 HH21 ' N ' ' A' ' 61' ' ' ASP . 7.5 tpt180 -113.1 -16.15 12.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.09 -0.959 . . . . 50.0 112.023 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.192 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -112.15 14.01 20.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.174 -1.01 . . . . 16.66 112.569 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.549 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 21.1 pt20 39.29 44.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.282 1.586 . . . . 16.66 115.282 176.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.595 ' H ' ' CB ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -134.15 165.98 23.81 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.407 -0.917 . . . . 50.0 110.631 177.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -127.52 135.71 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 16.66 111.823 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.704 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -134.97 144.88 47.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.276 -0.42 . . . . 50.0 110.691 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.813 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -53.51 142.11 23.32 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.645 -1.613 . . . . 16.66 106.645 176.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.19 -56.34 4.0 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 119.784 -1.198 . . . . 16.66 111.547 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -18.51 61.96 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.45 -0.5 . . . . 50.0 110.203 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.23 -29.85 10.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 33' ' ' TYR . 4.5 m -119.83 14.61 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.246 -0.888 . . . . 16.66 111.108 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.85 46.18 47.11 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.102 -0.571 . . . . 16.66 111.758 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.488 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -115.58 162.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 16.66 110.85 -179.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.0 tp -64.54 163.79 12.9 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 121.047 0.451 . . . . 50.0 109.992 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.824 ' HG2' ' H ' ' A' ' 43' ' ' SER . 4.2 pt20 -80.05 -53.44 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.009 -0.541 . . . . 25.0 110.075 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.824 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 29.6 t -64.98 -22.38 66.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 1.044 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.8 mt-10 -44.83 -17.45 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.555 ' N ' ' C ' ' A' ' 43' ' ' SER . . . -70.44 -45.11 66.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.479 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.711 ' C ' ' H ' ' A' ' 48' ' ' ILE . 96.4 mt-10 -88.5 -53.29 4.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.256 0.836 . . . . 50.0 113.256 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.868 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.73 11.56 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.144 0.497 . . . . 16.66 110.572 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.044 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -114.42 136.34 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.159 -0.928 . . . . 25.0 112.042 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.07 -73.64 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 50.0 111.818 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.53 71.95 1.24 Allowed 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.191 -0.67 . . . . 50.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.713 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.22 145.3 55.94 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.593 -0.73 . . . . 16.66 109.715 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' A' ' 27' ' ' ASP . 11.2 t -112.57 157.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.659 -0.701 . . . . 50.0 109.234 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.411 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.2 p -86.66 155.82 56.15 Favored Pre-proline 0 N--CA 1.409 -2.485 0 CA-C-N 115.572 -0.74 . . . . 16.66 110.546 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD3' ' OH ' ' A' ' 51' ' ' TYR . 84.2 Cg_endo -67.97 -32.38 28.65 Favored 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 122.099 1.866 . . . . 16.66 111.093 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.38 -32.72 71.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 50.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -79.31 -21.98 45.21 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.422 -0.808 . . . . 16.66 111.4 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -52.38 -32.86 40.74 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.176 -0.61 . . . . 50.0 109.804 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.4 m -80.39 8.47 7.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.901 -0.777 . . . . 50.0 108.901 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 56' ' ' CYS . 20.9 p 57.61 94.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.145 -0.934 . . . . 50.0 110.795 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.502 ' C ' HH21 ' A' ' 28' ' ' ARG . 63.9 mm-40 -58.59 -28.05 65.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.483 -0.487 . . . . 50.0 110.674 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.684 ' OD1' ' N ' ' A' ' 62' ' ' ALA . 55.9 p30 -58.2 -31.52 67.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.339 . . . . 50.0 110.808 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.684 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.051 -0.976 . . . . 50.0 110.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.2 Cg_exo -54.16 -27.93 49.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.666 2.244 . . . . 0.0 111.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.08 -35.66 77.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.19 48.78 0.93 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.682 -0.967 . . . . 50.0 110.682 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -56.86 -36.85 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.627 0.251 . . . . 50.0 110.87 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.21 110.06 10.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.92 0.39 . . . . 50.0 111.105 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.75 ' OG1' HD11 ' A' ' 9' ' ' LEU . 45.1 p -131.02 174.36 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 50.0 110.148 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.629 ' NZ ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -71.33 102.98 2.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 50.0 110.661 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.75 HD11 ' OG1' ' A' ' 7' ' ' THR . 1.4 mt -142.12 152.71 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.356 -0.384 . . . . 50.0 110.247 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.6 m-85 -100.7 -70.89 0.72 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.0 t -41.22 116.18 0.71 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.195 -0.911 . . . . 16.66 111.034 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.649 HG23 ' CD1' ' A' ' 33' ' ' TYR . 5.1 pt -54.51 -8.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.533 -0.758 . . . . 50.0 109.265 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.971 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -80.67 8.03 8.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.698 -1.137 . . . . 16.66 110.694 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? 65.36 53.5 1.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 25.0 111.773 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 142.77 16.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.53 155.01 67.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.607 2.205 . . . . 50.0 112.643 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.708 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 14.6 t80 -63.09 140.85 58.91 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.243 -0.435 . . . . 50.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 45.2 t0 -140.57 126.32 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 50.0 110.299 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.77 -14.45 32.67 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.669 -0.696 . . . . 50.0 110.328 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -75.35 -30.15 60.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.35 -1.352 . . . . 50.0 107.35 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.568 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 8.2 tptp -99.92 153.95 18.76 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.316 -1.765 . . . . 50.0 108.159 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 45.8 p90 -110.55 152.01 26.92 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.315 -0.554 . . . . 16.66 110.582 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -129.21 165.46 21.31 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.422 1.582 . . . . 50.0 114.645 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.007 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -125.19 123.02 64.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 110.777 -2.92 . . . . 16.66 104.45 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -91.92 123.33 7.18 Favored Glycine 0 C--N 1.317 -0.472 0 C-N-CA 119.52 -1.324 . . . . 16.66 115.913 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.468 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.92 108.59 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.929 -1.508 . . . . 16.66 106.929 175.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 90.3 m-20 -66.67 -23.93 66.2 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 60' ' ' GLU . 44.6 ttm-85 -112.58 -22.59 10.7 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.085 -1.416 . . . . 50.0 111.634 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.261 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -106.66 12.85 28.82 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.677 -0.809 . . . . 16.66 111.762 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HG2' ' C ' ' A' ' 29' ' ' CYS . 22.8 pt20 34.97 45.54 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.726 0.639 . . . . 16.66 112.726 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.5 t-20 -132.92 166.59 21.99 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.41 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -135.5 130.47 34.7 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 121.034 -0.267 . . . . 16.66 111.09 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.96 145.45 51.63 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.922 -0.311 . . . . 50.0 111.175 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.841 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -54.78 141.24 33.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.722 -1.585 . . . . 16.66 106.722 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.24 -59.79 2.9 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.433 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -20.27 66.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 50.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.0 t -50.94 -31.11 16.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.888 -0.782 . . . . 16.66 108.888 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 33' ' ' TYR . 2.5 m -120.23 14.04 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.254 -0.885 . . . . 16.66 110.894 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.19 45.7 60.63 Favored Glycine 0 N--CA 1.46 0.287 0 CA-C-N 115.885 -0.598 . . . . 16.66 111.741 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.473 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -107.8 164.63 4.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.949 0.404 . . . . 16.66 110.538 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.792 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 74.2 mt -58.7 163.96 3.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.875 -0.602 . . . . 50.0 109.982 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -78.4 -55.44 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.295 -0.866 . . . . 25.0 110.996 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -70.48 -15.82 62.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.506 -0.77 . . . . 50.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.794 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.3 mt-10 -45.77 -19.83 0.07 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.851 -0.613 . . . . 50.0 111.866 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -64.22 -48.06 77.32 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.931 -0.708 . . . . 25.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.57 -45.88 9.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.182 1.549 . . . . 50.0 115.182 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.794 HD11 ' HA ' ' A' ' 44' ' ' GLU . 1.9 pp -55.26 -32.61 62.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 114.208 1.188 . . . . 16.66 114.208 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.2 pp -86.0 171.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.532 -0.867 . . . . 25.0 109.913 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -162.99 9.62 0.06 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.89 -1.05 . . . . 50.0 109.631 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -145.44 30.63 1.11 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.661 -1.607 . . . . 50.0 106.661 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.697 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 9.6 t80 -66.12 147.56 53.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.225 -1.352 . . . . 16.66 110.873 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.697 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.4 t -132.55 156.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.053 -1.431 . . . . 50.0 108.652 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.468 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -79.53 156.65 75.56 Favored Pre-proline 0 N--CA 1.409 -2.521 0 CA-C-O 121.586 0.708 . . . . 16.66 110.003 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 86.1 Cg_endo -71.27 -28.12 18.84 Favored 'Trans proline' 0 C--N 1.273 -3.412 0 C-N-CA 121.835 1.69 . . . . 16.66 110.601 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -71.85 -35.97 70.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.27 -1.011 . . . . 50.0 108.27 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.243 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -85.44 -16.53 39.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.091 -0.958 . . . . 16.66 110.621 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.451 ' C ' ' H ' ' A' ' 59' ' ' THR . 49.8 tt0 -48.14 -34.13 9.39 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.616 -0.434 . . . . 50.0 110.239 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.482 ' O ' ' OG1' ' A' ' 59' ' ' THR . 79.8 p -59.66 -9.01 2.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 56' ' ' CYS . 16.9 p 53.86 78.11 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.99 -1.005 . . . . 50.0 110.823 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' ASP . 78.8 mm-40 -66.87 142.14 57.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 50.0 110.296 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' GLU . 93.1 m-20 39.89 -164.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 50.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.968 -1.015 . . . . 50.0 110.585 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.33 -23.27 29.84 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.812 2.342 . . . . 0.0 112.063 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.7 mt -92.18 140.94 29.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.49 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.43 -173.42 49.64 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.909 -0.877 . . . . 50.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.3 m -77.31 -2.38 34.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 50.0 110.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.11 -35.78 71.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 50.0 110.481 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -81.71 169.06 17.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.019 -0.537 . . . . 50.0 110.721 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -74.45 -177.75 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 50.0 110.971 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.691 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -65.38 157.15 30.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 50.0 110.329 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.35 -68.72 0.79 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.119 0.485 . . . . 25.0 109.952 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.3 t -40.79 115.47 0.58 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 16.66 110.932 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.634 HG22 ' NE2' ' A' ' 55' ' ' GLN . 5.8 pt -52.75 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 50.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.999 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.67 4.22 16.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 16.66 110.333 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm 66.49 55.58 0.81 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.821 -0.627 . . . . 25.0 112.045 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -147.3 142.05 16.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.792 -0.447 . . . . 50.0 109.792 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 15' ' ' THR . 15.8 Cg_exo -65.01 153.43 78.36 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.272 1.982 . . . . 50.0 112.292 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.5 t80 -58.05 146.2 33.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.538 -0.542 . . . . 50.0 109.538 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.515 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 96.0 m-20 -140.93 116.97 10.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.656 -0.702 . . . . 50.0 111.325 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.54 -16.7 26.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.059 -0.519 . . . . 50.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -76.36 -27.99 56.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 5.9 tptm -101.89 154.63 18.76 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.346 -1.752 . . . . 50.0 108.185 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 53.5 p90 -111.17 151.23 28.43 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.376 -0.529 . . . . 16.66 110.548 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.7 m-85 -128.9 168.26 16.22 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 123.314 1.531 . . . . 50.0 114.286 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.011 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.43 126.17 68.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 111.118 -2.764 . . . . 16.66 105.29 176.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.89 122.29 6.87 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.757 -1.211 . . . . 16.66 115.601 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.313 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -48.38 115.29 1.16 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.028 -1.086 . . . . 16.66 108.555 176.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.6 t70 -58.68 -34.02 70.8 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.355 -0.538 . . . . 25.0 109.871 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' NH1' ' OE2' ' A' ' 60' ' ' GLU . 1.4 ttm105 -113.32 -23.88 9.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.707 -0.678 . . . . 50.0 111.32 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.313 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -91.54 4.88 51.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.983 -0.687 . . . . 16.66 111.324 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.527 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 6.5 pt20 30.75 48.59 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.11 -0.496 . . . . 16.66 111.615 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.63 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -131.55 166.4 21.47 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.847 -0.427 . . . . 50.0 109.847 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.48 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.18 132.57 39.95 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.837 -0.345 . . . . 16.66 111.052 -178.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.02 144.97 51.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.779 -0.369 . . . . 50.0 111.327 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.815 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -56.47 140.06 47.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.392 -1.707 . . . . 16.66 106.392 176.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.12 -58.57 3.23 Favored Glycine 0 C--N 1.31 -0.899 0 C-N-CA 119.622 -1.275 . . . . 16.66 112.098 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -66.75 -21.3 66.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.58 -29.84 18.72 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.656 -0.702 . . . . 16.66 109.304 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.56 2.24 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.706 -0.679 . . . . 16.66 112.002 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.9 46.4 6.72 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.417 -0.673 . . . . 16.66 111.417 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.57 HG22 ' CA ' ' A' ' 35' ' ' GLY . 1.4 tt -118.69 159.92 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.05 0.453 . . . . 16.66 111.828 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.661 ' C ' ' HG3' ' A' ' 44' ' ' GLU . 4.1 mm? -46.91 169.61 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.58 -0.736 . . . . 50.0 110.991 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -82.09 -56.33 4.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.702 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' ALA . 61.5 m -79.03 -16.07 57.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.637 -0.71 . . . . 50.0 111.446 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.878 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -43.34 -21.35 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.87 0.367 . . . . 50.0 110.166 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.505 ' N ' ' OE1' ' A' ' 44' ' ' GLU . . . -60.14 -51.52 69.24 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.037 -0.528 . . . . 25.0 111.418 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.77 -44.16 10.17 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.808 1.41 . . . . 50.0 114.808 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.965 HD12 ' N ' ' A' ' 48' ' ' ILE . 3.1 pp -55.47 -28.09 52.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.661 0.985 . . . . 16.66 113.661 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.965 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 pp -85.71 172.48 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 119.862 -0.735 . . . . 25.0 110.028 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 48.6 t0 -156.35 0.48 0.14 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.571 -1.195 . . . . 50.0 109.982 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.33 33.67 2.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.413 -1.328 . . . . 50.0 107.413 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.1 t80 -65.94 145.88 55.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.197 -0.91 . . . . 16.66 110.032 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.691 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 20.3 t -133.73 155.73 40.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.058 -1.428 . . . . 50.0 108.991 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.998 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 7.2 p -81.72 154.42 70.78 Favored Pre-proline 0 N--CA 1.413 -2.287 0 CA-C-O 121.501 0.667 . . . . 16.66 109.98 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 50.7 Cg_endo -74.4 -28.22 10.52 Favored 'Trans proline' 0 C--N 1.274 -3.379 0 C-N-CA 122.058 1.839 . . . . 16.66 110.947 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.634 ' NE2' HG22 ' A' ' 12' ' ' ILE . 96.2 mt-30 -70.32 -33.58 71.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.131 -1.063 . . . . 50.0 108.131 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.185 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.7 m -70.02 -33.87 72.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.767 -1.106 . . . . 16.66 110.277 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -55.75 -34.3 65.08 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.183 -0.462 . . . . 50.0 110.795 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -54.14 -39.44 66.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.3 m -71.24 -47.06 59.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 50.0 110.331 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.531 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 78.1 mm-40 -64.09 -33.08 74.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.25 -0.432 . . . . 50.0 110.618 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -82.73 119.44 24.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 50.0 110.717 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.058 -0.973 . . . . 50.0 110.586 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -53.91 -27.91 46.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.794 2.33 . . . . 0.0 112.046 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.83 141.84 32.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.41 34.41 40.52 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.638 -0.985 . . . . 50.0 110.638 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.508 ' O ' ' C ' ' A' ' 6' ' ' ASP . 22.7 t -56.14 -34.16 65.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.193 -0.203 . . . . 50.0 110.695 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' C ' ' O ' ' A' ' 5' ' ' SER . 47.2 p30 22.59 -138.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 50.0 111.488 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 20.6 p -124.11 163.71 20.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.978 0.418 . . . . 50.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -136.0 -174.5 3.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.983 -0.553 . . . . 50.0 110.015 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 9' ' ' LEU . 2.9 pp -58.13 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 50.0 111.082 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -73.62 -103.21 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.951 -0.568 . . . . 25.0 110.993 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 18.7 t -37.87 120.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.819 0.818 . . . . 16.66 113.206 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 33' ' ' TYR . 7.5 pt -59.29 -8.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.112 -1.404 . . . . 50.0 108.843 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.95 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.94 8.81 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.367 -1.288 . . . . 16.66 110.565 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.634 ' CG ' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 63.43 71.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.571 0.7 . . . . 25.0 110.086 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.03 124.67 1.12 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.939 -0.573 . . . . 50.0 110.757 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.45 154.9 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.287 1.991 . . . . 50.0 112.111 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -56.85 146.1 27.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.044 0.449 . . . . 50.0 110.074 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.2 m-20 -140.75 114.78 9.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.764 -0.653 . . . . 50.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.66 -10.81 2.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.419 ' N ' ' C ' ' A' ' 18' ' ' ASP . 26.4 m -79.97 -24.8 40.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.358 -1.349 . . . . 50.0 107.358 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.7 tptm -107.56 153.56 22.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.59 -1.641 . . . . 50.0 107.94 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 39.2 p90 -110.13 153.47 24.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 120.11 -0.636 . . . . 16.66 111.011 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.742 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -126.59 164.0 22.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 123.504 1.621 . . . . 50.0 114.645 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.104 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.76 117.86 31.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 110.861 -2.881 . . . . 16.66 105.091 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -82.93 133.08 11.57 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 119.944 -1.122 . . . . 16.66 115.06 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -47.94 107.37 0.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.752 -1.224 . . . . 16.66 107.705 176.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.596 ' HB3' HG22 ' A' ' 52' ' ' VAL . 59.1 t0 -51.05 -41.43 59.87 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.85 -0.74 . . . . 25.0 110.23 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.633 ' HG3' ' HB3' ' A' ' 56' ' ' CYS . 14.7 ptp180 -115.67 -4.51 12.19 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.83 0.678 . . . . 50.0 112.83 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.237 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -108.66 13.51 25.1 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 118.825 -1.15 . . . . 16.66 111.326 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER 33.69 52.33 0.42 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.268 -0.423 . . . . 16.66 110.72 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.608 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -132.57 166.44 22.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.189 -0.3 . . . . 50.0 110.189 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.674 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -139.89 132.14 28.24 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.004 0.742 . . . . 16.66 113.004 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.741 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -139.93 152.62 46.51 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.036 -0.529 . . . . 50.0 111.649 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.921 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -59.04 142.55 51.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.694 -1.595 . . . . 16.66 106.694 175.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.84 -60.31 2.98 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.058 -1.068 . . . . 16.66 111.713 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -20.12 65.91 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.324 -0.55 . . . . 50.0 110.183 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.7 t -51.19 -31.32 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.199 -0.667 . . . . 16.66 109.199 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 33' ' ' TYR . 2.7 m -115.67 14.28 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.472 -0.786 . . . . 16.66 110.675 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.14 46.0 23.41 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 115.636 -0.711 . . . . 16.66 112.432 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -112.55 167.24 5.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.928 0.394 . . . . 16.66 110.581 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.584 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 85.6 mt -67.16 164.29 18.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.499 0.666 . . . . 50.0 110.662 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -80.03 -54.96 5.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.034 -0.985 . . . . 25.0 111.086 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 m -65.81 -17.85 64.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 50.0 110.096 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.792 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.0 mt-10 -45.64 -38.28 6.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.353 -0.539 . . . . 50.0 110.658 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.607 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -51.37 -36.5 43.47 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.077 -0.649 . . . . 25.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -87.74 -44.46 11.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.601 0.963 . . . . 50.0 113.601 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 44' ' ' GLU . 2.2 pp -86.46 17.13 3.98 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.285 -0.87 . . . . 16.66 112.013 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.792 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 4.1 tp -120.81 150.01 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 C-N-CA 119.056 -1.058 . . . . 25.0 112.984 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -170.17 29.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.614 -1.175 . . . . 50.0 110.411 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -161.03 9.02 0.08 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.671 -0.863 . . . . 50.0 108.671 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -67.22 147.63 52.8 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.54 -0.755 . . . . 16.66 109.35 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 27' ' ' ASP . 14.8 t -126.03 157.76 35.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.143 -0.935 . . . . 50.0 109.43 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.9 p -79.84 156.87 74.71 Favored Pre-proline 0 N--CA 1.412 -2.353 0 CA-C-N 115.749 -0.66 . . . . 16.66 110.164 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 28.9 Cg_endo -80.25 -23.78 6.04 Favored 'Trans proline' 0 C--N 1.276 -3.239 0 C-N-CA 121.783 1.655 . . . . 16.66 110.786 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -72.64 -35.63 67.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.485 -0.932 . . . . 50.0 108.485 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.166 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -73.24 -33.69 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.03 -0.986 . . . . 16.66 110.609 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -49.83 -41.03 43.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.581 . . . . 50.0 110.653 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.616 ' O ' ' OG1' ' A' ' 59' ' ' THR . 90.6 p -65.37 -32.2 73.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.103 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 58' ' ' SER . 3.3 m 145.77 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.563 -0.744 . . . . 50.0 109.849 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 40.7 -109.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 50.0 110.624 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.19 117.46 21.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.36 -0.382 . . . . 50.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.93 -1.033 . . . . 50.0 110.593 -179.87 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 4' ' ' GLY . 69.5 Cg_endo -76.92 8.73 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.917 2.411 . . . . 0.0 112.12 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 3' ' ' LEU . 10.0 mp 45.09 -87.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.434 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -173.45 177.96 45.6 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.017 -0.833 . . . . 50.0 111.017 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.6 p -76.3 160.27 29.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 50.0 110.575 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.512 ' OD1' HG23 ' A' ' 7' ' ' THR . 33.4 p-10 -90.48 8.15 35.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 50.0 110.692 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.512 HG23 ' OD1' ' A' ' 6' ' ' ASP . 37.3 p -124.16 169.48 11.68 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.07 0.462 . . . . 50.0 110.914 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.442 ' H ' ' HG3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -109.4 -175.76 2.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.531 -0.759 . . . . 50.0 109.923 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -60.77 166.31 3.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 50.0 109.93 -179.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.6 m-85 -91.06 -71.34 0.64 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.411 -0.588 . . . . 25.0 109.411 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.1 t -41.38 113.41 0.4 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.653 -0.703 . . . . 16.66 110.772 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.696 HG22 ' NE2' ' A' ' 55' ' ' GLN . 6.5 pt -53.12 -7.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 50.0 109.414 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.972 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -81.25 6.72 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.729 -1.123 . . . . 16.66 110.892 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 66.97 56.12 0.68 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.13 -0.487 . . . . 25.0 111.916 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 135.94 10.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.91 -0.316 . . . . 50.0 110.352 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.48 156.72 39.98 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.321 2.014 . . . . 50.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.724 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.7 t80 -59.35 146.25 40.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.033 0.444 . . . . 50.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.503 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 95.4 m-20 -141.39 113.07 7.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.638 -0.71 . . . . 50.0 111.249 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.36 -20.87 13.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.968 0.413 . . . . 50.0 110.103 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.4 m -71.95 -30.99 65.87 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.602 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -99.05 150.37 22.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.265 -1.789 . . . . 50.0 107.954 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 51.0 p90 -108.78 150.41 27.65 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.06 -0.656 . . . . 16.66 110.601 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.724 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.6 m-85 -127.76 166.0 19.02 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 123.362 1.553 . . . . 50.0 113.925 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.058 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.55 124.3 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 111.114 -2.766 . . . . 16.66 105.57 176.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -87.95 127.1 8.37 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.993 -1.099 . . . . 16.66 115.529 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.474 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -48.62 121.28 4.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.499 -1.297 . . . . 16.66 107.499 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.554 ' HB2' HG22 ' A' ' 52' ' ' VAL . 60.5 t0 -62.55 -34.21 76.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.507 0.67 . . . . 25.0 109.571 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -113.56 -27.85 7.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.841 -1.072 . . . . 50.0 111.477 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.293 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -89.91 8.23 33.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.945 -0.702 . . . . 16.66 111.81 -177.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.566 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 2.8 pt20 30.13 49.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 16.66 112.005 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.673 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -131.6 165.69 23.09 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.92 -0.4 . . . . 50.0 109.92 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -132.54 132.68 42.87 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.939 -0.304 . . . . 16.66 111.389 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.672 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.7 145.76 52.01 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.865 -0.334 . . . . 50.0 111.148 178.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.834 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -54.43 140.2 34.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.285 -1.746 . . . . 16.66 106.285 176.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.745 ' H ' HH21 ' A' ' 36' ' ' ARG . . . -42.29 -56.34 4.06 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 119.433 -1.365 . . . . 16.66 111.516 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.781 ' H ' ' NE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.55 -19.7 62.86 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.516 -0.474 . . . . 50.0 110.241 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.41 -30.94 13.62 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.866 -0.791 . . . . 16.66 108.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.71 13.58 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.117 -0.947 . . . . 16.66 110.631 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 70.34 46.25 50.35 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.345 -0.702 . . . . 16.66 111.345 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.569 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -115.38 167.93 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.124 0.488 . . . . 16.66 111.647 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.3 mp -62.38 163.64 8.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 50.0 110.446 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.587 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.1 pt20 -82.33 -46.56 13.44 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.18 -1.045 . . . . 25.0 108.18 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.948 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -63.8 -29.25 70.47 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.647 -1.615 . . . . 50.0 108.687 179.151 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.81 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.8 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.005 -0.739 . . . . 50.0 109.005 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 22' ' ' PHE . . . -79.13 -41.93 27.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.298 -0.864 . . . . 25.0 110.538 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' SER . 48.5 mp0 -87.9 -52.13 5.45 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.696 1.369 . . . . 50.0 114.696 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.032 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.56 19.22 0.28 Allowed 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.481 0.658 . . . . 16.66 111.108 -177.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.81 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.3 tp -114.71 144.56 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 114.749 -1.114 . . . . 25.0 113.299 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -168.09 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.155 -1.384 . . . . 50.0 109.313 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -166.39 13.12 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.415 -0.957 . . . . 50.0 108.415 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -67.58 147.26 52.99 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.357 -0.838 . . . . 16.66 109.706 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.1 t -124.71 159.26 31.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.845 -1.071 . . . . 50.0 109.293 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.474 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -83.87 152.93 63.52 Favored Pre-proline 0 N--CA 1.411 -2.383 0 CA-C-O 121.611 0.72 . . . . 16.66 110.359 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.25 -27.61 16.32 Favored 'Trans proline' 0 C--N 1.274 -3.378 0 C-N-CA 121.892 1.728 . . . . 16.66 110.877 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.696 ' NE2' HG22 ' A' ' 12' ' ' ILE . 95.0 mt-30 -70.42 -33.67 71.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.31 -0.859 . . . . 50.0 108.827 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -76.38 -43.21 41.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.253 -0.885 . . . . 16.66 110.567 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -57.15 -26.83 61.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 50.0 111.035 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 m -48.58 -32.7 8.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.382 -0.372 . . . . 50.0 110.397 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -11.28 7.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.419 -0.355 . . . . 50.0 110.963 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -107.48 140.25 40.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.857 0.361 . . . . 50.0 110.912 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.6 140.75 46.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 50.0 110.316 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.044 -0.979 . . . . 50.0 110.588 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.08 144.85 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.693 2.262 . . . . 0.0 111.983 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.849 HD22 ' N ' ' A' ' 3' ' ' LEU . 1.4 mm? -92.34 141.35 28.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.479 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.23 -126.52 5.83 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.659 -0.977 . . . . 50.0 110.659 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 46.8 m -62.77 155.16 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.793 0.33 . . . . 50.0 110.513 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 5' ' ' SER . 87.1 m-20 -136.29 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 50.0 110.507 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -81.5 162.38 23.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 50.0 110.182 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -134.84 -177.4 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.28 0.562 . . . . 50.0 111.611 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.36 152.63 20.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.344 -0.843 . . . . 50.0 110.712 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 m-85 -95.53 -68.36 0.8 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.2 t -43.48 116.26 0.91 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.648 -0.705 . . . . 16.66 110.458 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.631 HG23 ' CD1' ' A' ' 33' ' ' TYR . 9.9 pt -51.95 -7.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.071 -0.714 . . . . 50.0 109.071 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -78.31 2.78 17.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.572 -1.195 . . . . 16.66 110.55 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.22 54.41 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.982 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.07 146.77 26.9 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.005 -0.369 . . . . 50.0 110.005 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 152.69 76.08 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.513 2.142 . . . . 50.0 111.941 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.6 t80 -55.97 146.06 23.41 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.759 -0.46 . . . . 50.0 109.759 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.0 m-20 -140.71 113.15 8.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.786 -0.643 . . . . 50.0 111.017 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.64 -17.76 9.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 50.0 109.842 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -71.58 -30.81 66.25 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.112 -1.44 . . . . 50.0 107.112 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 3.1 tptm -100.55 156.88 17.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 112.973 -1.922 . . . . 50.0 108.957 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.8 p90 -113.45 149.07 34.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 115.885 -0.598 . . . . 16.66 110.024 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 m-85 -127.15 166.75 17.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 123.379 1.561 . . . . 50.0 114.236 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.02 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.19 126.22 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 111.013 -2.812 . . . . 16.66 105.007 176.641 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.58 121.22 6.53 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.587 -1.292 . . . . 16.66 116.157 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.44 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.32 117.69 2.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.911 -1.145 . . . . 16.66 108.002 175.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 51' ' ' TYR . 87.3 m-20 -69.26 -30.18 68.24 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.652 0.739 . . . . 25.0 109.245 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 60' ' ' GLU . 45.3 ttm-85 -110.43 -23.15 11.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.597 -1.183 . . . . 50.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.292 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 9.93 40.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.888 -0.725 . . . . 16.66 111.683 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.573 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 8.9 pt20 30.37 48.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 16.66 112.405 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.586 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 4.9 t30 -132.14 166.16 22.42 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 120.929 -0.308 . . . . 50.0 110.373 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -133.94 130.75 38.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.184 -0.206 . . . . 16.66 110.906 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -128.45 144.44 51.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.792 -0.363 . . . . 50.0 111.393 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.75 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -54.19 140.59 32.04 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.28 -1.748 . . . . 16.66 106.28 176.083 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -41.9 -59.94 2.72 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.855 -1.164 . . . . 16.66 111.929 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.47 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -67.87 -19.79 65.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.458 -0.497 . . . . 50.0 109.971 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.1 t -50.4 -30.7 13.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.664 -0.865 . . . . 16.66 108.664 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.6 12.66 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.255 -0.884 . . . . 16.66 110.962 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 70.67 45.84 50.47 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.034 -0.603 . . . . 16.66 111.68 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.504 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -112.5 167.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.421 . . . . 16.66 111.495 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 41' ' ' LEU . 8.0 mp -59.64 164.72 3.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 50.0 110.555 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -78.06 -55.39 5.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.515 -0.766 . . . . 25.0 110.523 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.4 m -70.86 -15.16 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 50.0 109.368 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.744 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -42.17 -20.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.467 -0.788 . . . . 50.0 110.938 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.34 -47.52 60.67 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.396 -0.522 . . . . 25.0 110.992 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -88.93 -43.46 11.15 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.745 1.387 . . . . 50.0 114.745 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.0 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.5 pp -55.39 -30.84 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.306 0.854 . . . . 16.66 113.306 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.0 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.3 pp -86.67 172.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.744 0.783 . . . . 25.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.35 13.2 0.14 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.403 -1.271 . . . . 50.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -155.54 36.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.753 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 18.5 t80 -65.96 145.88 55.37 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.674 -1.148 . . . . 16.66 111.014 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.753 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 11.7 t -129.71 157.55 42.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.942 -1.481 . . . . 50.0 108.608 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.44 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.2 p -86.35 158.36 54.99 Favored Pre-proline 0 N--CA 1.414 -2.236 0 CA-C-O 121.574 0.702 . . . . 16.66 110.578 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 29.8 Cg_endo -79.8 -22.7 7.44 Favored 'Trans proline' 0 C--N 1.278 -3.133 0 C-N-CA 121.97 1.78 . . . . 16.66 110.403 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -72.52 -35.76 68.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.062 -1.088 . . . . 50.0 108.062 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.17 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.34 -31.72 24.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.881 -1.054 . . . . 16.66 109.856 179.09 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -49.78 -31.59 11.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.83 -0.623 . . . . 50.0 110.753 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -50.19 -31.52 13.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.2 -0.455 . . . . 50.0 110.179 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.31 69.75 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 50.0 111.09 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 95.3 mt-10 -56.8 -30.43 63.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 50.0 110.055 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 61' ' ' ASP . 53.1 p30 -138.8 174.72 10.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.897 -0.592 . . . . 50.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.017 -0.992 . . . . 50.0 110.533 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.3 153.49 59.26 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.922 2.414 . . . . 0.0 111.917 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.8 mt -74.4 153.2 39.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.301 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.32 -174.81 35.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.966 -0.854 . . . . 50.0 110.966 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 m 56.65 51.23 11.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 50.0 110.44 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.27 150.76 39.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.525 . . . . 50.0 110.327 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -121.47 161.8 21.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 50.0 110.792 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.45 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -94.66 161.08 14.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.061 -0.518 . . . . 50.0 110.729 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -73.84 -179.69 3.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.619 -0.718 . . . . 50.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.726 ' N ' HD22 ' A' ' 9' ' ' LEU . 1.5 m-85 -87.16 -94.99 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.007 0.373 . . . . 25.0 112.007 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -37.45 132.72 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.69 0.757 . . . . 16.66 112.773 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.751 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -61.15 -7.75 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.671 -1.149 . . . . 50.0 108.692 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.59 4.95 14.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.001 -1.454 . . . . 16.66 110.852 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 67.31 47.6 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.269 -0.423 . . . . 25.0 111.038 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.27 124.61 10.84 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.618 -0.264 . . . . 50.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.68 160.47 11.78 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.626 2.217 . . . . 50.0 112.878 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.751 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 10.4 t80 -66.3 138.51 57.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.047 -0.524 . . . . 50.0 111.104 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 54.3 t0 -140.54 127.01 20.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.653 -0.703 . . . . 50.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.92 -12.83 4.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.991 -0.549 . . . . 50.0 109.608 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -75.64 -26.81 58.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.681 ' HG2' ' CG ' ' A' ' 34' ' ' HIS . 15.5 tptt -101.5 152.17 21.09 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.489 -1.687 . . . . 50.0 108.129 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 55.3 p90 -113.08 147.21 37.75 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.182 -0.607 . . . . 16.66 110.154 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.0 m-85 -123.23 164.23 19.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 123.914 1.816 . . . . 50.0 115.538 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.123 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.68 117.96 21.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 109.953 -3.294 . . . . 16.66 104.286 176.431 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -89.73 129.87 9.92 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.778 -1.201 . . . . 16.66 115.455 -174.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.386 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 106.99 0.11 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.898 -1.519 . . . . 16.66 106.898 175.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -69.54 -20.01 63.69 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -112.86 -25.46 9.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.839 -1.528 . . . . 50.0 111.566 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.21 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -111.31 15.88 21.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.932 -0.707 . . . . 16.66 112.197 -178.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.539 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 30.96 54.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 16.66 111.87 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 5.5 m-20 -132.54 167.06 20.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.411 -0.359 . . . . 50.0 110.223 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.692 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -141.03 129.48 22.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.311 0.856 . . . . 16.66 113.311 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.751 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -141.43 158.34 44.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.873 -0.603 . . . . 50.0 111.771 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.681 ' CG ' ' HG2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -63.98 134.85 55.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.9 -1.889 . . . . 16.66 105.9 174.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.6 -44.85 5.44 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 119.502 -1.332 . . . . 16.66 111.545 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 17.9 mtt180 -68.53 -29.88 68.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.57 0.7 . . . . 50.0 109.238 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.933 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 4.2 t -51.6 -26.66 9.25 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.791 -1.095 . . . . 16.66 109.621 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.53 16.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.296 -0.866 . . . . 16.66 110.622 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.21 47.58 57.9 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.733 -0.667 . . . . 16.66 111.828 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -115.63 167.02 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.777 -0.369 . . . . 16.66 110.984 -178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.705 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.8 mm? -62.33 164.59 6.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.287 0.565 . . . . 50.0 110.412 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -78.31 -56.05 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.13 -0.941 . . . . 25.0 110.911 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -69.35 -16.15 63.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.683 -0.689 . . . . 50.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.81 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.6 tt0 -48.22 -20.24 0.36 Allowed 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.488 -0.778 . . . . 50.0 111.464 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.699 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -57.0 -51.82 67.71 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.944 -0.702 . . . . 25.0 111.671 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 48' ' ' ILE . 78.2 mm-40 -90.1 -46.65 8.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.9 1.445 . . . . 50.0 114.9 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 44' ' ' GLU . 3.1 pp -56.02 16.19 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.347 1.24 . . . . 16.66 114.347 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -134.48 171.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.406 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 46.0 t0 -173.36 36.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.82 -1.082 . . . . 50.0 108.994 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.03 20.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 2.4 t80 -66.82 148.68 51.62 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.547 -1.206 . . . . 16.66 110.522 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.646 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.3 t -129.87 152.26 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.302 -1.317 . . . . 50.0 109.43 178.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.386 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.3 p -78.95 162.45 64.71 Favored Pre-proline 0 N--CA 1.411 -2.391 0 CA-C-N 115.232 -0.894 . . . . 16.66 110.102 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 15.5 Cg_endo -81.23 -27.84 2.68 Favored 'Trans proline' 0 C--N 1.276 -3.279 0 C-N-CA 121.875 1.717 . . . . 16.66 110.848 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -67.93 -35.63 78.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.895 -1.15 . . . . 50.0 107.895 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.189 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -78.19 -44.26 26.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.892 -1.049 . . . . 16.66 109.552 179.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -51.66 -38.25 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 50.0 109.747 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 18.4 m -60.3 -37.26 80.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 50.0 109.671 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 m -65.47 -40.03 92.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 50.0 110.43 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.56 -36.49 76.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.431 -0.349 . . . . 50.0 110.841 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 58' ' ' SER . 50.0 p30 -107.14 168.22 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.383 -0.371 . . . . 50.0 110.671 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.078 -0.963 . . . . 50.0 110.601 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.06 -22.8 32.7 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.174 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 mt -90.72 141.46 28.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.0 -168.91 42.03 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.076 -0.81 . . . . 50.0 111.076 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -62.86 170.91 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.188 -0.301 . . . . 50.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 60.24 60.85 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.952 0.406 . . . . 50.0 110.197 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -80.31 165.23 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 50.0 110.852 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -175.82 1.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.282 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD22 ' N ' ' A' ' 15' ' ' THR . 0.2 OUTLIER -60.73 -174.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.311 -0.859 . . . . 50.0 110.242 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.662 ' HB3' ' O ' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -82.28 -89.19 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 1.5 t -39.71 114.43 0.42 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.844 -0.617 . . . . 16.66 111.29 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.833 HD13 ' N ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -59.7 -8.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.16 -0.927 . . . . 50.0 109.588 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 1.137 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -71.21 7.34 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.425 -0.807 . . . . 16.66 109.923 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HB3' ' HZ2' ' A' ' 14' ' ' LYS . 3.5 mtpm? 65.91 48.73 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.576 -0.738 . . . . 25.0 111.484 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.539 ' N ' HD22 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -143.17 124.19 8.2 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.778 -0.369 . . . . 50.0 110.287 179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.1 152.03 3.72 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.748 2.299 . . . . 50.0 112.801 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.7 t80 -67.57 145.02 55.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 91.3 m-20 -140.82 116.68 10.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.831 -0.622 . . . . 50.0 110.355 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 -13.57 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.443 -0.577 . . . . 50.0 109.443 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -75.13 -25.69 58.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.513 -1.291 . . . . 50.0 107.513 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -101.39 155.3 18.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.433 -1.712 . . . . 50.0 108.113 178.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 51.8 p90 -110.25 153.21 25.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.889 -0.724 . . . . 16.66 110.588 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.3 m-85 -125.26 162.71 24.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.47 1.605 . . . . 50.0 114.534 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.035 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -131.58 117.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.803 -2.908 . . . . 16.66 104.601 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.77 131.96 11.03 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 119.782 -1.199 . . . . 16.66 116.025 -174.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.394 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -46.33 105.74 0.07 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.026 -1.472 . . . . 16.66 107.026 175.403 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.742 ' CG ' HG22 ' A' ' 52' ' ' VAL . 43.4 p-10 -75.4 -11.4 60.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.568 -1.271 . . . . 25.0 107.568 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.483 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 23.4 ttm180 -113.7 -22.98 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.742 -1.572 . . . . 50.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.183 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -120.22 18.5 12.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 119.927 -0.709 . . . . 16.66 112.346 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.519 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 13.9 pt20 32.97 54.11 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.763 0.283 . . . . 16.66 111.763 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.614 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 4.8 m-20 -133.09 167.84 19.58 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 110.165 -0.309 . . . . 50.0 110.165 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.662 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -138.67 133.02 31.79 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.869 0.692 . . . . 16.66 112.869 -177.037 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.646 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -140.83 145.13 35.86 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.97 -0.559 . . . . 50.0 111.283 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.931 ' HD1' ' CB ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -55.89 150.03 13.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 106.368 -1.715 . . . . 16.66 106.368 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.545 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -54.08 -61.56 7.03 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 119.468 -1.348 . . . . 16.66 112.747 -177.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HD3' ' HZ1' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.57 -20.69 62.76 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.346 -0.541 . . . . 50.0 110.462 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 13.9 t -54.14 -29.24 44.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.488 -0.885 . . . . 16.66 108.941 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -112.61 11.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 16.66 110.34 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.06 46.96 20.15 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.862 -0.608 . . . . 16.66 111.774 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -116.64 167.58 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 16.66 111.546 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.4 mp -64.68 161.6 17.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.248 -0.887 . . . . 50.0 110.152 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.4 pt20 -82.12 -41.16 20.84 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.779 ' C ' HD21 ' A' ' 47' ' ' LEU . 69.6 m -60.88 -39.04 87.74 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 112.336 -2.211 . . . . 50.0 109.266 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.809 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -41.39 -17.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.935 -0.575 . . . . 50.0 110.037 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -76.4 -46.17 28.42 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.074 -0.512 . . . . 25.0 110.806 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.0 mm-40 -88.95 -51.23 5.73 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.069 1.507 . . . . 50.0 115.069 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.09 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.18 20.32 0.39 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.563 0.697 . . . . 16.66 111.761 -177.07 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.809 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.2 tp -111.43 139.04 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 25.0 111.915 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -116.19 -58.68 2.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.405 -1.27 . . . . 50.0 111.822 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 2.3 pm0 -118.83 59.48 0.82 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.166 -0.679 . . . . 50.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.0 t80 -66.37 142.07 57.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.175 -0.61 . . . . 16.66 109.368 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.742 HG22 ' CG ' ' A' ' 27' ' ' ASP . 6.7 t -117.33 152.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.543 -0.753 . . . . 50.0 109.716 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.394 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.4 p -83.99 157.85 62.54 Favored Pre-proline 0 N--CA 1.41 -2.45 0 CA-C-N 114.936 -1.029 . . . . 16.66 110.35 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -79.19 -25.69 5.69 Favored 'Trans proline' 0 C--N 1.278 -3.183 0 C-N-CA 121.92 1.746 . . . . 16.66 110.477 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -71.96 -33.49 68.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.945 -1.025 . . . . 50.0 108.936 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.168 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -69.08 -38.76 79.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.329 -0.85 . . . . 16.66 110.743 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -52.06 -36.51 50.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.633 -0.506 . . . . 50.0 109.633 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.2 p -75.24 -34.38 61.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 61' ' ' ASP . 26.0 m -72.88 -49.04 32.26 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HA ' HH11 ' A' ' 28' ' ' ARG . 85.6 mt-10 60.52 -5.47 0.1 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.407 -0.36 . . . . 50.0 111.039 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 59' ' ' THR . 85.6 m-20 56.08 46.62 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 50.0 110.672 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.027 -0.987 . . . . 50.0 110.569 179.973 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.77 -25.34 78.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.913 2.408 . . . . 0.0 112.305 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.8 mt 44.37 85.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.55 103.02 0.75 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.007 -0.837 . . . . 50.0 111.007 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m -130.66 153.59 48.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 50.0 110.525 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.1 146.16 39.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.361 . . . . 50.0 110.097 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 4.6 m -81.68 109.7 16.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.799 -0.361 . . . . 50.0 110.932 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.601 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 8.7 mtpt -149.98 -177.07 5.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 50.0 109.894 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.72 139.38 51.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.726 -0.39 . . . . 50.0 110.025 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 8' ' ' LYS . 4.9 m-85 -103.03 -69.96 0.78 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.849 -0.34 . . . . 25.0 110.106 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 35.7 t -41.6 130.61 3.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 16.66 110.719 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.611 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.9 pt -57.74 -7.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.269 -1.011 . . . . 50.0 108.269 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.74 -5.85 56.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.899 -1.501 . . . . 16.66 110.897 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 22.1 mtmm 72.18 52.8 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.186 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.68 139.33 23.97 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 109.906 -0.405 . . . . 50.0 109.906 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.66 153.96 74.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.453 2.102 . . . . 50.0 112.331 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -63.05 140.29 58.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.13 0.491 . . . . 50.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 21' ' ' LYS . 82.1 m-20 -141.8 119.86 12.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.487 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.81 -22.34 9.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.95 -0.389 . . . . 50.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 m -68.79 -34.11 74.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.528 -1.286 . . . . 50.0 107.528 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.564 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 4.6 ttmt -93.33 139.3 30.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.304 -1.771 . . . . 50.0 107.584 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 45.1 p90 -105.13 143.01 33.9 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.134 -0.627 . . . . 16.66 110.173 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -122.13 173.19 7.73 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 123.941 1.829 . . . . 50.0 114.78 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.029 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.69 179.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 109.685 -3.416 . . . . 16.66 104.018 176.237 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.06 124.14 2.48 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 117.658 -2.211 . . . . 16.66 114.36 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 1.447 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -48.04 110.65 0.35 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.052 -1.074 . . . . 16.66 108.739 177.25 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.696 ' HB2' HG22 ' A' ' 52' ' ' VAL . 57.2 t0 -46.57 -41.95 15.22 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.081 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.566 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.39 -13.81 11.0 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 112.407 0.521 . . . . 50.0 112.407 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 1.347 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -88.49 0.17 56.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.937 -1.105 . . . . 16.66 111.272 -178.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 40.85 45.98 2.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.551 -0.295 . . . . 16.66 110.347 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.581 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -132.31 166.28 22.27 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.755 -0.378 . . . . 50.0 110.604 -177.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -140.82 127.77 20.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.56 -0.456 . . . . 16.66 111.428 -178.445 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.74 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -127.67 156.43 42.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.94 -0.573 . . . . 50.0 110.866 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.564 ' CE1' ' HD2' ' A' ' 21' ' ' LYS . 1.3 m-70 -61.46 141.0 57.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.154 -1.795 . . . . 16.66 106.154 176.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.593 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -43.4 -48.48 6.96 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 119.42 -1.371 . . . . 16.66 111.261 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -75.06 -19.76 59.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.349 -0.54 . . . . 50.0 110.037 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.92 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -51.6 -30.71 22.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.562 -0.855 . . . . 16.66 109.241 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.43 8.59 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.487 -0.779 . . . . 16.66 111.427 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.57 45.86 7.68 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.124 -0.56 . . . . 16.66 112.204 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.593 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -123.15 167.34 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.222 0.534 . . . . 16.66 111.608 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 40' ' ' ILE . 4.0 mm? -67.02 164.58 17.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.481 -0.781 . . . . 50.0 110.46 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.708 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.8 pt20 -80.55 -54.26 5.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 25.0 110.902 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.708 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 49.5 m -60.35 -28.26 68.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.063 -1.088 . . . . 50.0 108.063 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.958 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -43.67 -17.03 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.305 -1.316 . . . . 50.0 109.928 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.27 -48.16 58.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.98 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.734 ' C ' ' H ' ' A' ' 48' ' ' ILE . 84.8 tt0 -87.66 -52.91 5.06 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.096 0.776 . . . . 50.0 113.096 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.886 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -57.78 5.6 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.385 0.612 . . . . 16.66 110.516 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.958 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -105.15 133.02 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.714 -177.423 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -87.7 -74.38 0.45 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.995 -1.002 . . . . 50.0 111.522 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 27' ' ' ASP . 80.7 tt0 -122.08 74.0 1.13 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.73 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.09 146.6 54.47 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.774 -0.648 . . . . 16.66 109.324 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 43.7 t -117.09 159.24 17.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.805 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 1.447 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -87.5 161.11 46.38 Favored Pre-proline 0 N--CA 1.415 -2.177 0 CA-C-O 121.425 0.631 . . . . 16.66 110.22 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 34.6 Cg_endo -80.33 -32.55 1.27 Allowed 'Trans proline' 0 C--N 1.28 -3.059 0 C-N-CA 121.862 1.708 . . . . 16.66 111.741 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.427 ' OE1' HG22 ' A' ' 12' ' ' ILE . 43.1 mt-30 -72.96 -28.81 62.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 1.104 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 61.4 m -57.59 -42.83 83.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.121 -1.4 . . . . 16.66 111.0 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -56.16 -34.33 66.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.813 -0.63 . . . . 50.0 110.196 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 59' ' ' THR . 52.4 p -79.66 -1.21 37.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.303 -0.628 . . . . 50.0 109.303 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.569 ' CB ' ' O ' ' A' ' 58' ' ' SER . 2.7 m 97.46 80.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.205 -0.907 . . . . 50.0 110.356 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 44.81 -87.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.286 -0.416 . . . . 50.0 110.664 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 59' ' ' THR . 60.1 t0 -132.89 131.13 40.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.277 -0.42 . . . . 50.0 110.432 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.984 -1.008 . . . . 50.0 110.596 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 110.236 -0.283 . . . . 50.0 110.236 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -97.8 -72.77 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.168 -0.613 . . . . 25.0 111.528 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 6.2 t -39.01 112.04 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 16.66 111.597 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.615 HG23 ' CD1' ' A' ' 33' ' ' TYR . 9.1 pt -48.02 -8.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.541 -0.754 . . . . 50.0 109.682 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.969 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -86.02 30.52 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.742 -1.117 . . . . 16.66 110.343 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 14.0 pttp 43.4 58.87 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.77 -0.65 . . . . 25.0 112.144 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.433 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -156.32 124.34 2.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 110.022 -0.362 . . . . 50.0 110.022 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 25.0 Cg_exo -57.22 164.17 7.07 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.614 2.209 . . . . 50.0 113.352 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.737 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 16.1 t80 -60.23 145.78 46.04 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.517 -0.765 . . . . 50.0 110.74 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' LYS . 92.6 m-20 -141.46 111.84 6.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.03 -0.986 . . . . 50.0 110.848 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.51 -22.45 8.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 50.0 110.448 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -71.11 -30.38 66.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.633 -1.247 . . . . 50.0 107.633 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -100.26 149.36 23.66 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.165 -1.834 . . . . 50.0 108.034 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 39.5 p90 -108.62 151.72 25.75 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.865 -0.734 . . . . 16.66 110.296 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.3 m-85 -126.86 165.44 19.34 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 123.152 1.454 . . . . 50.0 113.943 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.039 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.52 118.71 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 111.242 -2.708 . . . . 16.66 105.25 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -83.32 127.0 7.78 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.039 -1.077 . . . . 16.66 115.563 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.43 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -48.21 107.27 0.12 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.875 -1.162 . . . . 16.66 107.928 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.666 ' HB2' HG22 ' A' ' 52' ' ' VAL . 76.6 m-20 -51.08 -37.27 44.69 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.993 -0.683 . . . . 25.0 110.53 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.654 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -114.29 -14.56 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.042 0.386 . . . . 50.0 112.042 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.256 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.9 14.2 32.52 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.472 -0.891 . . . . 16.66 111.865 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.443 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 14.3 pt20 30.35 48.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.893 0.701 . . . . 16.66 112.893 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.636 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.13 166.11 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.971 -0.381 . . . . 50.0 109.971 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.488 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.61 130.98 37.27 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.868 -0.333 . . . . 16.66 111.279 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.2 144.99 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.05 -0.26 . . . . 50.0 111.024 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.828 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -52.03 143.02 14.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.714 -1.588 . . . . 16.66 106.714 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.577 ' C ' HG22 ' A' ' 40' ' ' ILE . . . -42.18 -60.31 2.72 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.432 -1.366 . . . . 16.66 111.478 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -69.19 -18.24 63.89 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.565 -0.454 . . . . 50.0 110.44 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.09 -30.67 11.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.656 -0.818 . . . . 16.66 108.814 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 33' ' ' TYR . 5.5 m -116.8 4.16 7.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.411 -0.813 . . . . 16.66 111.637 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.72 46.08 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.366 -0.694 . . . . 16.66 111.366 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 41' ' ' LEU . 3.5 tt -119.17 167.73 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 16.66 111.885 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 40' ' ' ILE . 42.0 mt -68.69 164.48 21.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.168 -0.923 . . . . 50.0 110.646 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.582 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 36.8 mt-30 -80.56 -43.97 19.78 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.965 -1.494 . . . . 25.0 106.965 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.773 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -62.76 -41.13 99.08 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 112.378 -2.192 . . . . 50.0 107.714 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.824 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.3 mm-40 -43.63 -16.35 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -78.93 -44.47 22.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.427 -0.806 . . . . 25.0 110.468 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 43' ' ' SER . 96.4 mt-10 -87.94 -51.91 5.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.583 1.327 . . . . 50.0 114.583 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.084 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.68 20.38 0.24 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.795 0.807 . . . . 16.66 111.03 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.824 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.5 tp -110.44 143.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.272 -1.331 . . . . 25.0 112.9 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -165.98 29.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.381 -1.281 . . . . 50.0 109.448 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -166.33 11.43 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.593 -0.892 . . . . 50.0 108.593 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -67.09 146.9 53.81 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 16.66 109.761 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 27' ' ' ASP . 21.7 t -125.16 156.95 34.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.912 -1.04 . . . . 50.0 110.016 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.43 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.5 p -78.57 157.23 77.51 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-N 115.592 -0.731 . . . . 16.66 110.078 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 41.5 Cg_endo -77.84 -30.13 3.94 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 121.963 1.776 . . . . 16.66 111.585 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -72.26 -29.59 64.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.99 -1.115 . . . . 50.0 107.99 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.2 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 114.324 -1.307 . . . . 16.66 110.735 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.522 -0.123 0 N-CA-C 109.483 -0.562 . . . . 50.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.14 -69.1 0.77 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.385 -0.526 . . . . 25.0 110.463 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -41.59 129.37 3.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 16.66 111.133 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 12' ' ' ILE . 9.1 pt -58.16 -7.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -82.39 -1.87 51.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.844 -1.525 . . . . 16.66 110.985 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 46.2 mttm 70.95 56.76 0.22 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.463 -0.335 . . . . 25.0 111.299 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.506 ' OG1' ' CE1' ' A' ' 34' ' ' HIS . 23.0 p -141.1 147.74 48.82 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.409 -0.36 . . . . 50.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.32 150.93 47.82 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.411 2.074 . . . . 50.0 111.846 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.723 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 22.2 t80 -62.65 139.98 58.67 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.11 0.481 . . . . 50.0 110.075 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 21' ' ' LYS . 87.4 m-20 -141.32 120.47 12.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.5 -0.773 . . . . 50.0 110.286 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.1 -17.08 6.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -70.21 -32.07 69.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.572 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 11.3 tptt -95.8 150.21 20.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.782 -2.008 . . . . 50.0 108.165 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 31.6 p90 -111.0 149.15 31.1 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.589 -0.523 . . . . 16.66 109.589 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 11.8 m-85 -128.73 169.78 14.09 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 123.703 1.716 . . . . 50.0 115.374 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.031 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.84 118.39 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 110.167 -3.197 . . . . 16.66 104.464 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.64 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -87.12 123.15 6.43 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 119.636 -1.269 . . . . 16.66 115.147 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.421 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -53.41 106.98 0.2 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.488 -1.356 . . . . 16.66 108.154 176.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB2' HG22 ' A' ' 52' ' ' VAL . 92.8 m-20 -61.04 -34.96 75.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.474 0.654 . . . . 25.0 109.394 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.53 ' C ' ' NE2' ' A' ' 30' ' ' GLN . 11.6 tpt180 -101.28 -34.51 9.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.891 -1.05 . . . . 50.0 111.632 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.238 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -92.54 5.82 49.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.826 -0.75 . . . . 16.66 112.148 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.869 ' H ' HE21 ' A' ' 30' ' ' GLN . 0.0 OUTLIER 38.95 36.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.751 1.019 . . . . 16.66 113.751 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.556 ' OD1' ' HB2' ' A' ' 26' ' ' CYS . 1.9 p30 -132.83 166.87 21.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.988 0.813 . . . . 50.0 110.449 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.64 ' HE3' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -128.66 138.18 52.03 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.218 0.822 . . . . 16.66 113.218 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' OH ' ' HB2' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -133.63 151.71 51.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.324 -0.398 . . . . 50.0 110.94 177.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.595 ' H ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -58.17 140.19 53.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.589 -1.634 . . . . 16.66 106.589 176.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.583 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.81 -54.3 5.09 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.159 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.646 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.76 -20.3 64.36 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.53 -0.468 . . . . 50.0 110.309 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.2 t -51.32 -31.77 22.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 119.682 -0.807 . . . . 16.66 108.944 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.52 14.92 7.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.183 -0.917 . . . . 16.66 111.358 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.21 46.26 43.83 Favored Glycine 0 N--CA 1.463 0.47 0 C-N-CA 121.254 -0.498 . . . . 16.66 112.039 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.583 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -118.48 167.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 16.66 111.381 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.6 mp -61.23 164.69 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.755 -0.657 . . . . 50.0 110.566 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.35 -55.37 5.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.45 -0.796 . . . . 25.0 110.364 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.589 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.3 m -69.5 -15.47 63.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 50.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.852 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.6 -19.8 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.322 -0.854 . . . . 50.0 111.115 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HA ' HG22 ' A' ' 24' ' ' ILE . . . -74.44 -45.13 48.38 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.463 -0.495 . . . . 25.0 111.514 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.05 -45.31 10.29 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.247 1.203 . . . . 50.0 114.247 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.1 pp -55.78 -30.79 61.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.051 0.76 . . . . 16.66 113.051 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.892 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 pp -86.52 172.38 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.931 -0.708 . . . . 25.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.3 28.18 0.17 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.642 -1.163 . . . . 50.0 109.901 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.57 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.166 -1.42 . . . . 50.0 107.166 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.9 t80 -66.7 145.58 55.39 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.799 -1.091 . . . . 16.66 111.121 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.632 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 22.3 t -133.37 154.11 38.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 113.848 -1.524 . . . . 50.0 108.575 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.421 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 5.8 p -79.92 161.99 63.98 Favored Pre-proline 0 N--CA 1.411 -2.405 0 CA-C-O 121.318 0.58 . . . . 16.66 110.005 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 19.3 Cg_endo -82.67 -27.46 2.11 Favored 'Trans proline' 0 C--N 1.28 -3.043 0 C-N-CA 121.997 1.798 . . . . 16.66 111.625 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -74.28 -30.39 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.087 -1.079 . . . . 50.0 108.087 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.6 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 114.43 -1.259 . . . . 16.66 110.675 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.909 0.385 . . . . 50.0 110.644 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.801 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.39 -79.04 0.47 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 34.9 t -41.04 128.43 2.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.27 . . . . 16.66 112.464 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.777 HG23 ' CD2' ' A' ' 33' ' ' TYR . 13.0 pt -62.9 -10.3 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 1.047 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -76.69 -0.76 24.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.59 -1.641 . . . . 16.66 110.375 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 62.84 53.22 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.376 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.82 125.33 11.68 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.4 -0.364 . . . . 50.0 110.097 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.03 146.64 8.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.165 1.91 . . . . 50.0 112.08 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 9.9 t80 -64.76 137.49 57.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.166 0.508 . . . . 50.0 110.689 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 52.6 t0 -140.56 135.42 31.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.838 -0.801 . . . . 50.0 108.838 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.86 -18.12 30.02 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.912 -0.715 . . . . 50.0 109.239 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -60.82 -45.36 94.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.499 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.598 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -86.28 161.7 18.63 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.336 -1.357 . . . . 50.0 107.336 176.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 45.3 p90 -117.82 136.9 53.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.058 -0.719 . . . . 16.66 109.058 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.759 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 5.6 m-85 -112.64 165.84 11.89 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 124.187 1.946 . . . . 50.0 115.591 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.02 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 109.324 -3.58 . . . . 16.66 103.944 176.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -132.7 123.22 3.45 Favored Glycine 0 C--N 1.319 -0.394 0 C-N-CA 117.928 -2.082 . . . . 16.66 114.709 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.391 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.14 108.8 0.16 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.895 -1.15 . . . . 16.66 107.895 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 22.6 t70 -64.92 -31.04 72.09 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -109.08 -20.09 13.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.105 -1.407 . . . . 50.0 111.597 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -109.4 11.81 24.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.334 -0.947 . . . . 16.66 112.2 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.598 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 20.6 pt20 33.84 52.91 0.47 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.789 -0.187 . . . . 16.66 111.481 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.653 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -132.85 166.31 22.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.05 -0.26 . . . . 50.0 110.663 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.653 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -139.44 132.12 28.95 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 121.288 0.566 . . . . 16.66 112.238 -177.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -137.45 153.19 50.14 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.96 -0.564 . . . . 50.0 112.305 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.735 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -58.89 146.62 36.9 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 105.149 -2.167 . . . . 16.66 105.149 175.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -49.3 -48.55 33.2 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 119.247 -1.454 . . . . 16.66 111.008 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -76.91 -18.09 58.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 4.0 t -50.3 -31.65 14.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.645 -0.872 . . . . 16.66 108.645 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.59 14.77 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.972 -1.013 . . . . 16.66 110.798 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 67.74 46.15 70.18 Favored Glycine 0 N--CA 1.462 0.385 0 N-CA-C 111.569 -0.612 . . . . 16.66 111.569 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -113.2 167.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.211 0.529 . . . . 16.66 111.732 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 40' ' ' ILE . 21.8 mt -63.07 164.5 8.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.392 -0.822 . . . . 50.0 110.653 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.689 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.3 pt20 -79.86 -53.46 6.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.269 0.557 . . . . 25.0 110.059 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.7 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 74.5 m -63.98 -22.8 67.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.634 -0.876 . . . . 50.0 108.634 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.876 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.66 -19.46 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.26 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -69.62 -53.64 17.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.924 -1.034 . . . . 25.0 110.665 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' SER . 11.9 tm-20 -89.52 -43.46 10.8 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.105 1.52 . . . . 50.0 115.105 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.059 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.5 pp -54.72 -30.49 56.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.189 0.811 . . . . 16.66 113.189 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.059 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -85.77 174.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.653 0.74 . . . . 25.0 109.467 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.15 -51.63 0.77 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.475 -1.239 . . . . 50.0 110.206 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -108.65 59.89 0.6 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 50.0 108.067 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.735 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.2 t80 -65.92 144.02 57.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.635 0.731 . . . . 16.66 110.357 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 5.6 t -123.98 156.3 31.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.443 -1.253 . . . . 50.0 109.058 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.391 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.7 p -85.8 160.52 52.72 Favored Pre-proline 0 N--CA 1.414 -2.239 0 CA-C-O 121.675 0.75 . . . . 16.66 110.685 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.1 Cg_endo -78.34 -22.75 9.32 Favored 'Trans proline' 0 C--N 1.278 -3.14 0 C-N-CA 122.061 1.841 . . . . 16.66 111.223 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' HG22 ' A' ' 12' ' ' ILE . 97.0 mt-30 -77.61 -31.09 52.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.382 -0.826 . . . . 50.0 108.963 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.188 0 CA-C-N 115.344 -0.844 . . . . 16.66 110.952 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.847 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 110.146 -0.316 . . . . 50.0 110.146 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.659 ' N ' HD22 ' A' ' 9' ' ' LEU . 19.5 m-85 -105.32 -73.4 0.68 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 48.7 t -39.84 128.86 2.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.362 0.601 . . . . 16.66 111.916 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.682 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -59.59 -7.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.128 -1.064 . . . . 50.0 108.128 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -77.42 2.14 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.716 -1.584 . . . . 16.66 110.928 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 42.0 mttm 69.34 54.81 0.4 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.189 -0.46 . . . . 25.0 111.773 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.433 HG23 ' HB3' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -158.67 125.18 2.49 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.537 -0.301 . . . . 50.0 110.258 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' N ' ' HB2' ' A' ' 9' ' ' LEU . 24.6 Cg_exo -56.02 176.47 0.18 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.677 2.252 . . . . 50.0 113.586 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -58.18 143.82 42.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.825 0.821 . . . . 50.0 111.402 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.5 m-20 -136.07 98.03 3.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.162 -1.381 . . . . 50.0 108.755 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -50.7 -14.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.266 0.555 . . . . 50.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.466 ' N ' ' C ' ' A' ' 18' ' ' ASP . 24.3 m -80.77 -29.53 36.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.802 -1.184 . . . . 50.0 107.802 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 18' ' ' ASP . 25.3 tptt -100.12 130.09 46.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.62 -1.627 . . . . 50.0 107.636 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.521 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 43.9 p90 -97.0 142.14 29.31 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.078 -0.51 . . . . 16.66 111.091 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CD2' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -119.96 173.78 6.86 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 124.441 2.067 . . . . 50.0 115.151 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.995 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.13 123.5 60.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 108.994 -3.73 . . . . 16.66 104.623 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.546 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -89.21 126.34 8.18 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 119.478 -1.344 . . . . 16.66 115.656 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.438 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.16 121.17 3.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.359 -1.348 . . . . 16.66 107.359 176.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.459 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.4 t70 -68.3 -31.64 71.22 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.578 0.704 . . . . 25.0 109.216 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -113.56 -26.46 8.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.588 -1.187 . . . . 50.0 111.81 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.283 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -95.26 12.58 28.49 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.8 -0.76 . . . . 16.66 112.607 -177.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.5 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 11.4 pt20 29.92 47.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.823 0.675 . . . . 16.66 112.823 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.56 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -131.36 164.1 26.41 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.069 -0.252 . . . . 50.0 110.544 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.587 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -134.39 125.6 27.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.907 -0.317 . . . . 16.66 111.832 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.682 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -131.89 157.45 43.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 121.033 -0.267 . . . . 50.0 111.605 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.811 ' H ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.19 140.48 38.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.392 -1.336 . . . . 16.66 107.392 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -47.56 -42.57 20.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.379 -1.391 . . . . 16.66 110.615 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -77.27 -20.47 55.06 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.758 -0.46 . . . . 50.0 109.758 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.3 t -51.33 -32.49 25.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.799 -0.815 . . . . 16.66 108.799 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.5 11.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.028 -0.987 . . . . 16.66 110.988 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.96 45.57 50.37 Favored Glycine 0 N--CA 1.461 0.318 0 CA-C-N 115.934 -0.576 . . . . 16.66 111.837 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.526 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -106.55 163.81 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.89 0.376 . . . . 16.66 110.462 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.748 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.2 mm? -64.73 163.2 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 50.0 110.262 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -56.6 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.413 -0.812 . . . . 25.0 110.63 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.9 m -66.81 -14.64 62.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.151 -0.931 . . . . 50.0 109.164 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.006 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 3.0 tt0 -44.93 -44.47 9.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.523 -0.762 . . . . 50.0 111.056 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.12 -35.04 6.64 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.538 -0.465 . . . . 25.0 111.624 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -87.03 -52.64 5.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.796 0.665 . . . . 50.0 112.796 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.2 pp -71.95 4.98 2.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.372 -0.831 . . . . 16.66 111.452 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.006 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -107.34 130.62 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 119.695 -0.802 . . . . 25.0 111.21 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.88 -72.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.815 -1.084 . . . . 50.0 112.345 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.21 68.68 0.81 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.302 -0.629 . . . . 50.0 109.302 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.3 147.43 53.32 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.612 -0.722 . . . . 16.66 109.53 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.677 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.6 t -119.99 155.11 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.469 -0.787 . . . . 50.0 109.023 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.438 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -84.83 160.79 54.95 Favored Pre-proline 0 N--CA 1.412 -2.334 0 CA-C-N 115.596 -0.729 . . . . 16.66 110.944 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 39.0 Cg_endo -77.81 -26.34 6.91 Favored 'Trans proline' 0 C--N 1.279 -3.127 0 C-N-CA 122.251 1.967 . . . . 16.66 111.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.79 -34.05 71.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.193 -1.04 . . . . 50.0 108.193 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 114.784 -1.098 . . . . 16.66 110.309 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.707 0.289 . . . . 50.0 111.419 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.0 m-85 -101.85 -67.34 0.87 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.498 -0.927 . . . . 25.0 108.498 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 4.6 t -41.43 114.71 0.54 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.957 -1.019 . . . . 16.66 110.638 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.626 HG23 ' CD1' ' A' ' 33' ' ' TYR . 4.3 pt -50.92 -8.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.575 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.946 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.68 6.72 10.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.832 -1.076 . . . . 16.66 110.7 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm 64.09 52.63 1.97 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.145 -0.48 . . . . 25.0 111.405 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.43 144.31 22.62 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 50.0 109.669 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.71 155.85 68.35 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.585 2.19 . . . . 50.0 112.408 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.705 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 30.6 t80 -58.24 148.48 27.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 50.0 109.833 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.491 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 91.3 m-20 -140.57 111.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.763 -0.653 . . . . 50.0 111.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.84 -17.37 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 50.0 110.043 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.5 m -76.35 -29.27 57.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.585 -1.265 . . . . 50.0 107.585 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 6.7 tptm -99.49 156.47 17.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.456 -1.702 . . . . 50.0 108.492 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 35.4 p90 -111.06 152.25 27.12 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.45 -0.5 . . . . 16.66 110.364 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.705 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 9.5 m-85 -130.46 168.83 16.38 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 123.42 1.581 . . . . 50.0 114.256 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.03 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.36 123.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 110.932 -2.849 . . . . 16.66 105.53 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.52 120.08 6.16 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.876 -1.154 . . . . 16.66 115.773 -174.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.439 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.21 107.6 0.13 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.273 -1.38 . . . . 16.66 107.273 175.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 89.7 m-20 -65.52 -34.08 77.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -92.71 -39.55 11.2 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.519 -1.673 . . . . 50.0 110.935 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.276 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.09 -28.4 27.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.918 -0.713 . . . . 16.66 111.49 -178.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.779 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER 76.13 28.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.486 0.921 . . . . 16.66 113.486 178.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.523 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.96 166.18 22.97 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 119.776 -0.77 . . . . 50.0 111.079 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 140.66 50.72 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.922 0.712 . . . . 16.66 112.922 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.69 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -133.62 144.38 49.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.454 -0.339 . . . . 50.0 111.061 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.814 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.7 OUTLIER -56.34 139.31 48.88 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.395 -1.706 . . . . 16.66 106.395 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.499 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.8 -54.34 5.07 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.843 -1.17 . . . . 16.66 111.53 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.61 -20.28 62.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.486 -0.486 . . . . 50.0 109.784 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.5 -31.88 25.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.281 -0.637 . . . . 16.66 109.281 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.57 13.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.344 -0.844 . . . . 16.66 111.185 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.51 45.98 57.42 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.793 -0.523 . . . . 16.66 111.793 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.499 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -113.86 167.51 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.137 0.494 . . . . 16.66 111.363 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 40' ' ' ILE . 42.4 mt -61.47 164.85 5.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.555 -0.748 . . . . 50.0 110.582 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.514 ' HB3' HE21 ' A' ' 42' ' ' GLN . 1.1 tt0 -77.92 -55.1 5.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 25.0 110.314 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.62 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 72.7 m -70.78 -15.24 62.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.507 -0.769 . . . . 50.0 109.441 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.872 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -41.97 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.564 -0.744 . . . . 50.0 110.755 -178.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.64 -45.5 58.65 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.939 -0.573 . . . . 25.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 43' ' ' SER . 97.1 mt-10 -88.93 -45.69 9.48 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.593 1.331 . . . . 50.0 114.593 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 48' ' ' ILE . 1.8 pp -55.29 -29.28 57.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.948 0.721 . . . . 16.66 112.948 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.053 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -86.06 174.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.803 0.811 . . . . 25.0 109.641 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -124.51 -69.74 0.79 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.261 -1.336 . . . . 50.0 110.91 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -101.31 70.57 1.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.916 -1.142 . . . . 50.0 107.916 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.3 t80 -65.74 140.12 58.42 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.433 -0.803 . . . . 16.66 110.728 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.72 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.5 t -120.29 155.16 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 114.458 -1.246 . . . . 50.0 108.556 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.439 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -87.28 160.21 49.03 Favored Pre-proline 0 N--CA 1.414 -2.275 0 CA-C-O 121.39 0.614 . . . . 16.66 110.491 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 24.8 Cg_endo -81.52 -25.24 3.86 Favored 'Trans proline' 0 C--N 1.279 -3.095 0 C-N-CA 122.085 1.857 . . . . 16.66 110.764 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -71.34 -35.67 71.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.095 -0.957 . . . . 50.0 108.565 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-N 115.225 -0.898 . . . . 16.66 110.413 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.725 0.297 . . . . 50.0 110.303 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.643 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 4.9 m-85 -69.46 -99.13 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.173 -0.676 . . . . 25.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 15.6 t -40.34 121.86 1.46 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.497 -0.774 . . . . 16.66 112.456 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.729 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.2 pt -59.09 -7.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.521 -1.218 . . . . 50.0 108.807 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.981 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.11 10.45 2.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.414 -1.266 . . . . 16.66 110.848 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.0 mttm 65.63 51.5 1.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.045 -0.525 . . . . 25.0 111.989 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 148.1 31.37 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.736 -0.385 . . . . 50.0 110.552 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.3 158.56 48.38 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.728 2.285 . . . . 50.0 111.8 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.2 t80 -58.31 144.84 39.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.662 -0.415 . . . . 50.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 92.5 m-20 -140.79 116.64 10.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.85 -0.614 . . . . 50.0 110.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.87 -12.86 4.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.389 -0.597 . . . . 50.0 109.389 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 m -79.33 -21.12 46.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.541 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.1 tptm -112.98 153.08 28.61 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.524 -1.671 . . . . 50.0 107.824 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.2 p90 -111.13 154.11 24.77 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.228 -0.589 . . . . 16.66 110.607 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.765 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.5 m-85 -127.8 169.8 13.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 123.779 1.752 . . . . 50.0 114.475 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.049 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.79 178.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.128 -3.214 . . . . 16.66 103.796 176.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.89 125.45 2.71 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 117.521 -2.275 . . . . 16.66 114.158 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.38 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 105.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.366 -1.346 . . . . 16.66 107.366 176.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' TYR . 84.5 m-20 -71.19 -19.95 62.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -111.61 -18.22 12.85 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.002 -1.454 . . . . 50.0 110.908 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.207 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -122.8 18.06 10.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.323 -0.951 . . . . 16.66 112.708 -178.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.594 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 19.3 pt20 32.93 54.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.202 0.445 . . . . 16.66 112.202 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.622 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -133.94 167.51 20.46 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 121.096 -0.242 . . . . 50.0 110.485 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.642 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -138.76 133.26 31.95 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.432 0.53 . . . . 16.66 112.432 -177.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.729 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -139.49 155.02 47.82 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.006 -0.543 . . . . 50.0 112.06 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.891 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.51 141.79 57.48 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 106.243 -1.762 . . . . 16.66 106.243 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.537 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -43.52 -58.53 4.0 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.633 -1.27 . . . . 16.66 111.518 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.426 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -66.79 -20.95 66.05 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.5 t -51.72 -31.77 27.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.126 -0.63 . . . . 16.66 109.482 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.34 12.52 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.442 -0.799 . . . . 16.66 111.128 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.85 25.09 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 111.608 -0.597 . . . . 16.66 111.608 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -122.01 167.46 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.178 0.513 . . . . 16.66 112.038 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.4 mm? -62.49 164.15 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 50.0 110.432 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.661 ' HG2' ' H ' ' A' ' 43' ' ' SER . 7.9 pt20 -82.12 -49.38 10.24 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.905 ' C ' HD21 ' A' ' 47' ' ' LEU . 5.7 m -59.53 -39.0 82.5 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.422 -1.717 . . . . 50.0 107.459 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.757 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -40.15 -16.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.288 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -63.1 -61.65 2.23 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.249 -0.581 . . . . 25.0 111.649 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mp0 -91.87 -47.35 7.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.857 1.799 . . . . 50.0 115.857 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.155 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -65.71 14.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.495 1.295 . . . . 16.66 114.495 -174.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 44' ' ' GLU . 2.5 pp -117.15 169.45 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 120.133 -0.627 . . . . 25.0 109.962 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 53.3 t0 -165.42 27.59 0.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.748 0.785 . . . . 50.0 109.935 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.46 16.09 0.52 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.248 -1.39 . . . . 50.0 107.248 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.634 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.3 t80 -67.37 147.61 52.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.802 -1.09 . . . . 16.66 110.511 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 25.2 t -137.26 157.57 34.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.888 -1.505 . . . . 50.0 108.917 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.38 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.0 p -80.03 158.21 72.71 Favored Pre-proline 0 N--CA 1.414 -2.254 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 11.0 Cg_endo -81.35 -27.94 2.57 Favored 'Trans proline' 0 C--N 1.273 -3.406 0 C-N-CA 121.842 1.694 . . . . 16.66 110.932 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -71.97 -33.83 68.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.461 -0.79 . . . . 50.0 108.877 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.151 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-N 115.59 -0.732 . . . . 16.66 110.559 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.602 0.239 . . . . 50.0 110.714 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 2.7 m-85 -106.12 -6.26 18.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.364 0.602 . . . . 25.0 111.014 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -104.15 123.08 46.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.923 -1.035 . . . . 16.66 110.844 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.692 HG23 ' CD2' ' A' ' 33' ' ' TYR . 14.0 pt -59.96 -8.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.203 -1.406 . . . . 50.0 107.203 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.961 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -84.79 2.19 43.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.47 -1.696 . . . . 16.66 109.472 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mttp 67.78 64.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.553 -0.749 . . . . 25.0 112.246 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.3 141.64 13.13 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.709 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.98 158.73 52.66 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.657 2.238 . . . . 50.0 112.104 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.753 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 20.0 t80 -69.37 139.07 54.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.078 0.466 . . . . 50.0 110.936 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 11.5 t70 -140.58 128.62 22.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.593 -0.731 . . . . 50.0 109.47 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.6 -21.9 41.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.074 -0.512 . . . . 50.0 110.907 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -67.17 -33.79 76.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.744 -1.206 . . . . 50.0 107.744 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -85.41 152.49 23.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.259 -1.791 . . . . 50.0 109.114 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 22.0 p90 -114.17 140.6 48.4 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.32 -0.993 . . . . 16.66 108.32 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.753 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 28.5 m-85 -122.61 171.35 9.19 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 124.089 1.9 . . . . 50.0 115.621 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.041 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.28 118.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 109.513 -3.494 . . . . 16.66 103.977 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -90.42 125.64 8.01 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.58 -1.295 . . . . 16.66 116.279 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.415 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -46.64 108.45 0.14 Allowed 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.31 -1.367 . . . . 16.66 107.31 175.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.673 ' HB3' HG22 ' A' ' 52' ' ' VAL . 57.3 t0 -61.52 -29.3 69.9 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.018 -0.734 . . . . 25.0 109.018 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.42 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 13.6 ttt85 -113.72 -20.36 11.19 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.705 -1.134 . . . . 50.0 112.344 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.245 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -107.96 20.29 18.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.317 -0.953 . . . . 16.66 112.981 -177.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 29' ' ' CYS . 16.4 pt20 31.06 47.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.521 0.563 . . . . 16.66 112.521 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.529 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -131.54 159.79 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.748 -0.381 . . . . 50.0 110.703 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -135.74 122.87 21.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.727 0.299 . . . . 16.66 111.049 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.692 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -124.09 153.66 41.1 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.456 -0.307 . . . . 50.0 111.406 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.839 ' CE1' ' HG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -54.8 146.42 17.24 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.728 -1.953 . . . . 16.66 105.728 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.543 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -46.2 -53.18 9.52 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 119.461 -1.352 . . . . 16.66 111.505 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -73.7 -19.4 60.83 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.715 -0.476 . . . . 50.0 109.715 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.6 t -49.96 -31.29 12.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 33' ' ' TYR . 4.0 m -115.77 9.45 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.203 -0.908 . . . . 16.66 110.3 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.79 45.83 20.16 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.395 -0.682 . . . . 16.66 111.395 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.543 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -117.3 167.53 10.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.91 0.386 . . . . 16.66 110.876 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 40' ' ' ILE . 90.1 mt -65.64 163.24 16.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.338 0.589 . . . . 50.0 109.666 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.07 -54.88 5.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.937 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.0 t -70.32 -14.77 62.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.431 -0.804 . . . . 50.0 110.677 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.68 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.7 mt-10 -44.4 -30.1 0.79 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.648 -0.421 . . . . 50.0 111.159 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -37.66 88.11 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.07 -0.652 . . . . 25.0 110.53 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.3 mm-40 -87.89 -33.17 18.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.227 1.195 . . . . 50.0 114.227 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.666 HD11 ' HA ' ' A' ' 44' ' ' GLU . 3.7 pp -94.31 16.24 15.51 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 112.716 0.636 . . . . 16.66 112.716 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -120.17 146.87 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 C-N-CA 118.704 -1.198 . . . . 25.0 112.888 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -94.38 -81.22 0.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.074 -0.966 . . . . 50.0 111.792 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.27 69.89 1.03 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.585 -0.279 . . . . 50.0 110.449 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.637 ' CG ' ' HB ' ' A' ' 24' ' ' ILE . 5.1 t80 -67.28 138.85 57.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.476 -0.89 . . . . 16.66 108.802 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 27' ' ' ASP . 23.9 t -119.38 150.81 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.722 -0.672 . . . . 50.0 109.315 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.415 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.8 p -80.99 160.91 64.94 Favored Pre-proline 0 N--CA 1.411 -2.395 0 CA-C-N 115.316 -0.857 . . . . 16.66 110.052 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 27.9 Cg_endo -80.43 -29.16 2.52 Favored 'Trans proline' 0 C--N 1.278 -3.177 0 C-N-CA 122.001 1.8 . . . . 16.66 111.405 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -70.83 -32.88 70.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.789 -1.096 . . . . 16.66 110.34 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.795 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 110.453 -0.203 . . . . 50.0 110.453 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -59.55 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.389 0.614 . . . . 25.0 110.491 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 43.4 t -37.67 122.51 0.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.034 -0.985 . . . . 16.66 113.298 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.753 HG23 ' CD2' ' A' ' 33' ' ' TYR . 8.8 pt -59.95 -13.98 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 114.862 -1.063 . . . . 50.0 108.138 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.965 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -72.25 4.5 3.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.811 -1.54 . . . . 16.66 110.137 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt 65.85 50.29 1.54 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.488 -0.778 . . . . 25.0 112.065 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.23 123.51 9.41 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.01 156.66 12.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.346 2.031 . . . . 50.0 111.948 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 4.5 t80 -61.28 134.25 56.77 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.293 0.568 . . . . 50.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 20' ' ' SER . 88.1 m-20 -141.46 116.02 9.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.085 -0.961 . . . . 50.0 108.83 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -43.92 -13.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.627 -0.429 . . . . 50.0 110.481 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -62.84 -38.41 90.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.748 -0.834 . . . . 50.0 108.748 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -99.85 167.52 10.47 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.1 p90 -120.77 142.32 49.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.694 -0.684 . . . . 16.66 109.168 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 2.9 m-85 -114.03 155.49 25.82 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 123.791 1.758 . . . . 50.0 115.414 -175.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.01 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -121.92 126.43 74.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 110.2 -3.182 . . . . 16.66 105.123 176.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.66 123.68 7.41 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.556 -1.307 . . . . 16.66 115.054 -175.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -49.86 107.0 0.13 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.65 -1.275 . . . . 16.66 108.89 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.635 ' HB2' HG22 ' A' ' 52' ' ' VAL . 80.8 m-20 -56.88 -35.13 68.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.265 -0.574 . . . . 25.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.71 -12.71 13.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 50.0 111.873 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -110.21 12.58 23.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.323 -0.951 . . . . 16.66 111.57 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.52 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 10.0 pt20 29.92 53.43 0.12 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.941 0.4 . . . . 16.66 111.101 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.645 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 2.8 m-20 -132.45 166.64 21.54 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.31 -0.404 . . . . 50.0 110.189 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -141.36 132.8 26.81 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.333 -0.547 . . . . 16.66 111.676 -177.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.753 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -138.56 155.47 48.34 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 50.0 112.494 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.824 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -60.62 146.58 44.87 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 105.064 -2.198 . . . . 16.66 105.064 175.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.0 -51.27 25.37 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 119.136 -1.507 . . . . 16.66 110.831 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.84 -18.48 60.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.712 -0.395 . . . . 50.0 109.953 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.0 t -50.39 -32.48 17.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.066 -0.716 . . . . 16.66 109.066 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.18 18.68 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.016 -0.993 . . . . 16.66 111.219 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.98 46.19 82.92 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 111.513 -0.635 . . . . 16.66 111.513 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.88 164.01 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.864 0.364 . . . . 16.66 110.934 -178.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.755 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 10.4 mp -58.0 164.76 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.245 0.545 . . . . 50.0 110.162 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -56.26 4.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.34 -0.845 . . . . 25.0 110.985 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.494 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 67.4 m -71.23 -15.55 62.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.59 -0.732 . . . . 50.0 109.236 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.779 ' HA ' HD11 ' A' ' 47' ' ' LEU . 2.1 tt0 -43.36 -19.13 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.481 -0.781 . . . . 50.0 111.172 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -68.56 -47.01 67.92 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.432 -0.507 . . . . 25.0 111.19 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.25 -45.69 9.86 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.261 1.208 . . . . 50.0 114.261 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.089 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.3 pp -55.15 -28.16 50.76 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.842 0.682 . . . . 16.66 112.842 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.089 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -85.76 174.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.607 0.718 . . . . 25.0 109.349 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -137.46 -53.88 0.68 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.642 -1.163 . . . . 50.0 110.455 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -103.69 56.35 0.74 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.823 -1.177 . . . . 50.0 107.823 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.66 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.3 t80 -65.27 141.46 58.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.537 0.684 . . . . 16.66 109.876 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.1 t -126.06 154.83 35.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.375 -1.284 . . . . 50.0 109.288 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -82.21 159.51 64.84 Favored Pre-proline 0 N--CA 1.413 -2.289 0 CA-C-N 115.69 -0.686 . . . . 16.66 109.824 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 22.6 Cg_endo -81.28 -25.65 3.79 Favored 'Trans proline' 0 C--N 1.275 -3.297 0 C-N-CA 121.962 1.775 . . . . 16.66 111.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -74.79 -32.59 62.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.719 . . . . 50.0 109.101 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.145 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 16.66 110.907 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.9 m-85 -94.04 -71.92 0.64 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.562 -0.533 . . . . 25.0 109.562 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 37.4 t -40.52 111.0 0.17 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.5 -0.773 . . . . 16.66 110.334 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.696 HG23 ' CD2' ' A' ' 33' ' ' TYR . 18.8 pt -51.84 -7.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.918 -0.771 . . . . 50.0 108.918 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -83.49 30.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.484 -1.234 . . . . 16.66 109.392 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 12' ' ' ILE . 48.8 pttt 42.66 55.81 4.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.489 -0.778 . . . . 25.0 111.619 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 p -145.54 141.55 17.06 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.51 -0.314 . . . . 50.0 110.28 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.2 154.01 56.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.451 2.101 . . . . 50.0 111.482 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 17.5 t80 -57.81 138.71 55.37 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.05 -0.66 . . . . 50.0 109.84 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.5 m-20 -141.56 118.58 11.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.1 -0.955 . . . . 50.0 110.435 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -51.23 -22.9 2.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.055 -0.72 . . . . 50.0 109.055 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -63.45 -35.4 80.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.972 -1.121 . . . . 50.0 107.972 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -90.9 155.14 18.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 113.868 -1.514 . . . . 50.0 108.926 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 46.0 p90 -118.39 123.34 45.02 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.03 0.919 . . . . 16.66 110.168 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 m-85 -103.03 162.55 12.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 123.769 1.747 . . . . 50.0 114.879 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.057 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -130.8 117.46 38.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 110.183 -3.189 . . . . 16.66 103.63 176.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.28 135.46 13.34 Favored Glycine 0 C--N 1.316 -0.543 0 N-CA-C 116.866 1.507 . . . . 16.66 116.866 -173.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.45 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.7 OUTLIER -46.86 117.78 1.8 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.946 -1.627 . . . . 16.66 108.503 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.704 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.9 t70 -51.71 -46.49 63.93 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.662 -0.815 . . . . 25.0 109.818 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.526 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -117.34 -5.94 11.27 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.212 0.819 . . . . 50.0 113.212 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.265 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -98.08 14.66 26.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 118.669 -1.212 . . . . 16.66 111.37 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.569 ' CD ' ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER 30.53 50.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.716 . . . . 16.66 111.963 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.567 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 10.2 m-20 -131.87 163.92 27.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.414 -0.357 . . . . 50.0 110.193 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.549 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -136.57 126.22 25.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.74 0.305 . . . . 16.66 110.832 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.696 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -124.8 141.82 51.85 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.796 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 6.6 p-80 -56.02 146.99 20.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.649 -1.612 . . . . 16.66 106.649 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.51 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -40.36 -60.7 1.95 Allowed Glycine 0 C--N 1.306 -1.111 0 C-N-CA 119.913 -1.137 . . . . 16.66 113.382 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.524 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.82 -20.36 64.31 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.221 0.534 . . . . 50.0 109.783 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -49.3 -25.9 2.69 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.343 -0.984 . . . . 16.66 108.343 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 33' ' ' TYR . 17.7 m -124.32 7.8 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.184 -0.916 . . . . 16.66 111.345 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 79.35 46.38 8.14 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.824 -0.91 . . . . 16.66 110.824 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 41' ' ' LEU . 1.1 tp -106.0 155.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.019 0.437 . . . . 16.66 110.692 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.7 mt -61.92 166.19 4.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.942 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -70.61 -53.55 15.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.76 -0.654 . . . . 25.0 109.362 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' ALA . 75.6 m -75.58 -14.65 60.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.218 -0.901 . . . . 50.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.995 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -43.11 -18.17 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.932 -0.576 . . . . 50.0 110.203 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.06 -43.55 64.72 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.519 -0.472 . . . . 25.0 110.969 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.67 ' C ' ' H ' ' A' ' 48' ' ' ILE . 97.4 mt-10 -87.6 -52.98 5.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.138 0.792 . . . . 50.0 113.138 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.817 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.67 9.08 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.049 -0.523 . . . . 16.66 110.63 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.995 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -112.62 135.66 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.282 -0.872 . . . . 25.0 112.146 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 59.5 t0 -91.59 -71.89 0.61 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.996 -1.002 . . . . 50.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' OE1' ' OD1' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -130.29 78.42 1.84 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.889 -0.782 . . . . 50.0 108.889 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.762 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.31 147.32 53.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.026 -0.731 . . . . 16.66 109.026 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.762 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 21.5 t -110.71 158.87 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.243 -0.583 . . . . 50.0 109.9 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.45 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -89.38 159.61 44.06 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 115.704 -0.68 . . . . 16.66 110.12 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 43.4 Cg_endo -79.28 -30.45 2.6 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 C-N-CA 121.746 1.631 . . . . 16.66 110.834 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.91 -32.99 73.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.588 -1.264 . . . . 50.0 107.588 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.115 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.1 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 114.177 -1.374 . . . . 16.66 109.914 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.498 0.19 . . . . 50.0 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.8 m-85 -106.17 -67.35 0.94 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.7 t -41.63 116.53 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.27 -0.877 . . . . 16.66 110.742 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' CD1' ' A' ' 33' ' ' TYR . 11.3 pt -52.3 -7.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.18 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.947 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -79.85 3.08 20.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.662 -1.153 . . . . 16.66 110.671 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.1 mttp 67.94 55.17 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.187 -0.46 . . . . 25.0 111.786 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.412 ' CG2' ' NE2' ' A' ' 34' ' ' HIS . 0.6 OUTLIER -147.62 145.2 20.7 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 110.063 -0.347 . . . . 50.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.58 150.37 79.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.447 2.098 . . . . 50.0 111.874 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.741 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.0 t80 -54.26 146.24 15.82 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.49 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 91.2 m-20 -140.56 112.75 7.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.999 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.21 -17.6 7.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 50.0 109.934 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 t -72.11 -31.93 66.49 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.313 -1.366 . . . . 50.0 107.313 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -97.93 157.28 16.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.07 -1.877 . . . . 50.0 109.006 179.079 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 45.5 p90 -114.17 146.58 40.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.303 -0.559 . . . . 16.66 109.978 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.741 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 5.7 m-85 -122.83 165.22 16.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 123.355 1.55 . . . . 50.0 114.269 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.008 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -123.96 119.66 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 111.099 -2.773 . . . . 16.66 105.18 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -84.96 124.33 6.69 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.545 -1.312 . . . . 16.66 114.534 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.435 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -46.8 107.78 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.656 -1.609 . . . . 16.66 106.656 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 54.9 t0 -59.89 -29.82 68.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -113.89 -13.34 12.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.548 -1.205 . . . . 50.0 111.695 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.326 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -112.3 10.54 20.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 119.861 -0.735 . . . . 16.66 111.798 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.593 ' NE2' ' O ' ' A' ' 29' ' ' CYS . 3.8 pp0? 34.02 49.65 0.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.188 0.44 . . . . 16.66 112.188 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.705 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.1 m120 -132.25 166.19 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.946 -0.39 . . . . 50.0 109.946 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -134.53 133.04 39.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 120.801 -0.36 . . . . 16.66 111.936 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.77 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -132.94 143.58 49.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.012 178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.883 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -51.27 143.33 11.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.923 -1.51 . . . . 16.66 106.923 176.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.11 -59.59 2.91 Favored Glycine 0 C--N 1.318 -0.437 0 C-N-CA 119.885 -1.15 . . . . 16.66 111.396 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.18 -19.06 63.99 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.762 -0.375 . . . . 50.0 110.394 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.08 -30.2 10.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.539 -0.911 . . . . 16.66 108.539 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 33' ' ' TYR . 6.7 m -117.52 8.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.251 -0.886 . . . . 16.66 111.146 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 77.66 45.52 10.76 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.167 -0.54 . . . . 16.66 112.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.491 ' CG2' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -112.98 167.07 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.131 0.491 . . . . 16.66 110.923 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 41' ' ' LEU . 6.5 mp -64.24 161.87 15.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 50.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -54.33 6.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.859 -0.793 . . . . 25.0 108.859 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.9 t -60.01 -12.52 8.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.707 -1.133 . . . . 50.0 109.07 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.821 ' CD ' ' N ' ' A' ' 45' ' ' ALA . 1.9 pp20? -40.49 -55.75 2.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.211 -0.904 . . . . 50.0 111.068 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.821 ' N ' ' CD ' ' A' ' 44' ' ' GLU . . . -56.55 -26.22 54.36 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.342 -0.844 . . . . 25.0 110.473 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' SER . 84.6 tt0 -86.77 -25.45 24.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.181 0.515 . . . . 50.0 111.965 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 47' ' ' LEU . 4.2 pp -117.92 11.51 13.48 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 115.599 -0.728 . . . . 16.66 112.35 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.809 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -119.15 145.39 25.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.097 -1.041 . . . . 25.0 111.864 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.617 ' H ' HD13 ' A' ' 48' ' ' ILE . 22.5 t70 -146.65 -42.62 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.163 -0.926 . . . . 50.0 111.628 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -94.21 24.88 4.09 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 2.7 t80 -65.28 141.74 58.51 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.47 -0.786 . . . . 16.66 109.061 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' H ' ' A' ' 27' ' ' ASP . 4.9 t -129.32 157.77 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.822 -1.081 . . . . 50.0 108.423 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.435 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.3 p -79.62 158.92 72.84 Favored Pre-proline 0 N--CA 1.414 -2.265 0 CA-C-O 121.66 0.743 . . . . 16.66 110.693 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 23.8 Cg_endo -81.05 -15.75 10.24 Favored 'Trans proline' 0 C--N 1.278 -3.146 0 C-N-CA 122.15 1.9 . . . . 16.66 111.573 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.533 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 11.4 pt20 -87.53 -30.38 20.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 50.0 109.52 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.156 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-N 115.924 -0.58 . . . . 16.66 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.719 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 110.461 -0.2 . . . . 50.0 110.461 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.616 ' CD2' ' CD1' ' A' ' 32' ' ' TRP . 2.6 m-85 -95.38 -75.49 0.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 120.107 -0.637 . . . . 25.0 112.04 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 11.4 t -38.39 118.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.428 0.632 . . . . 16.66 112.146 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.508 HG23 ' CD1' ' A' ' 33' ' ' TYR . 6.6 pt -53.31 -7.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.148 -0.933 . . . . 50.0 108.97 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.27 5.51 19.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.396 -1.274 . . . . 16.66 110.911 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 68.14 51.68 0.71 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.168 -0.469 . . . . 25.0 111.891 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 124.96 4.67 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.932 -0.307 . . . . 50.0 110.792 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 38.1 Cg_exo -55.19 162.68 5.34 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.644 2.229 . . . . 50.0 112.654 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.87 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 11.4 t80 -63.3 138.39 58.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.538 0.685 . . . . 50.0 111.128 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.546 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 70.8 m-20 -142.91 131.6 22.59 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.652 -1.158 . . . . 50.0 109.951 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.07 -20.74 62.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 50.0 110.395 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -63.11 -30.03 71.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.699 0.761 . . . . 50.0 109.1 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.735 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -106.09 158.35 16.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 114.378 -1.283 . . . . 50.0 107.685 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE2' ' HA3' ' A' ' 35' ' ' GLY . 45.8 p90 -119.38 137.91 53.43 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.082 -0.647 . . . . 16.66 109.288 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.87 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 2.2 m-85 -111.02 170.3 8.19 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 124.066 1.889 . . . . 50.0 115.331 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.03 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.32 118.72 24.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 109.747 -3.388 . . . . 16.66 105.07 177.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.63 124.8 6.99 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.037 1.175 . . . . 16.66 116.037 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.472 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -49.17 107.41 0.14 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.6 -1.259 . . . . 16.66 107.6 175.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.687 ' HB2' HG22 ' A' ' 52' ' ' VAL . 83.7 m-20 -61.4 -35.61 77.99 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.352 0.596 . . . . 25.0 109.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -19.56 14.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.103 -0.953 . . . . 50.0 111.327 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.315 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -94.39 -29.07 15.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.611 -0.835 . . . . 16.66 110.53 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.607 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 75.89 26.16 1.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.336 0.865 . . . . 16.66 113.336 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.708 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 14.7 p30 -132.63 167.41 20.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.859 -0.525 . . . . 50.0 110.091 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -121.31 145.04 48.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.429 0.899 . . . . 16.66 113.429 -176.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.708 ' OH ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -132.39 146.65 52.11 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.108 -0.496 . . . . 50.0 110.457 176.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.891 ' CE1' ' HG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -55.03 143.23 27.33 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.578 -1.638 . . . . 16.66 106.578 176.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -42.6 -58.3 3.57 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.0 -1.095 . . . . 16.66 111.697 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -71.61 -18.36 62.22 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.822 -0.351 . . . . 50.0 110.178 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.9 t -49.54 -31.47 10.4 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.799 -0.76 . . . . 16.66 109.003 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 33' ' ' TYR . 4.5 m -117.96 12.27 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.229 -0.896 . . . . 16.66 111.066 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 69.79 45.44 58.11 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.811 -0.631 . . . . 16.66 111.709 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -109.04 167.66 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.161 0.505 . . . . 16.66 111.219 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 40' ' ' ILE . 43.8 mt -62.76 164.5 7.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.584 -0.734 . . . . 50.0 110.911 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' CA ' HE21 ' A' ' 42' ' ' GLN . 0.4 OUTLIER -80.1 -55.13 5.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.166 -0.925 . . . . 25.0 110.426 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.61 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.8 m -66.11 -15.78 63.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.863 -1.062 . . . . 50.0 109.625 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.709 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -42.65 -32.88 0.63 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.267 0.556 . . . . 50.0 109.753 -179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.05 -38.8 72.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.56 -0.745 . . . . 25.0 110.399 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' SER . 36.5 tp10 -88.31 -10.67 48.75 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.808 1.04 . . . . 50.0 113.808 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.709 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -115.76 16.51 16.33 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.34 0.496 . . . . 16.66 112.34 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -124.7 160.08 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 118.45 -1.3 . . . . 25.0 113.763 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' H ' HG13 ' A' ' 48' ' ' ILE . 54.3 t0 -130.43 -44.8 1.11 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.163 -1.38 . . . . 50.0 111.027 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' C ' ' OD2' ' A' ' 27' ' ' ASP . 95.5 mt-10 -120.97 52.22 1.21 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.593 -0.276 . . . . 50.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.612 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 1.5 t80 -66.78 137.56 56.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.267 -0.973 . . . . 16.66 108.375 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 27' ' ' ASP . 12.3 t -116.92 153.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.472 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -82.13 161.83 58.88 Favored Pre-proline 0 N--CA 1.409 -2.513 0 CA-C-N 115.217 -0.901 . . . . 16.66 110.859 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.4 Cg_endo -79.48 -26.47 4.86 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.113 1.876 . . . . 16.66 111.388 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -74.37 -30.96 62.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.194 -1.039 . . . . 50.0 108.194 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 2.5 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 114.608 -1.178 . . . . 16.66 110.988 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.235 -0.283 . . . . 50.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.8 m-85 -99.71 -64.44 1.04 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.9 t -46.47 118.55 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.084 -0.962 . . . . 16.66 110.28 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.704 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.0 pt -53.62 -7.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.927 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -87.78 28.76 0.97 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.319 -1.309 . . . . 16.66 110.665 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 13' ' ' CYS . 19.9 pttm 41.56 65.88 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 25.0 111.685 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 139.15 11.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.094 -0.503 . . . . 50.0 109.731 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.64 154.93 72.04 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.348 2.032 . . . . 50.0 112.049 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.747 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 25.6 t80 -55.43 147.3 17.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.034 0.445 . . . . 50.0 109.918 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 21' ' ' LYS . 91.1 m-20 -140.58 109.08 5.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.013 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.3 -14.7 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.1 m -76.65 -29.81 56.56 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -100.9 155.02 18.18 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.234 -1.803 . . . . 50.0 107.997 178.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 32.1 p90 -109.61 152.84 25.02 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.193 -0.603 . . . . 16.66 110.584 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.747 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.9 m-85 -128.24 162.05 27.9 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.46 1.6 . . . . 50.0 114.294 -177.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.032 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.11 117.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 110.883 -2.871 . . . . 16.66 104.188 176.049 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.81 131.17 10.4 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.953 -1.118 . . . . 16.66 115.685 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.411 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -47.36 108.03 0.14 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.481 -1.303 . . . . 16.66 107.481 176.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.715 ' HB3' HG22 ' A' ' 52' ' ' VAL . 51.2 t0 -61.13 -31.8 71.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.313 0.577 . . . . 25.0 109.704 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 7.5 tpt180 -113.1 -16.15 12.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.09 -0.959 . . . . 50.0 112.023 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.192 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -112.15 14.01 20.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.174 -1.01 . . . . 16.66 112.569 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.549 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 21.1 pt20 39.29 44.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.282 1.586 . . . . 16.66 115.282 176.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.595 ' H ' ' CB ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -134.15 165.98 23.81 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.407 -0.917 . . . . 50.0 110.631 177.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -127.52 135.71 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 16.66 111.823 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.704 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -134.97 144.88 47.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.276 -0.42 . . . . 50.0 110.691 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.813 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -53.51 142.11 23.32 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.645 -1.613 . . . . 16.66 106.645 176.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.19 -56.34 4.0 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 119.784 -1.198 . . . . 16.66 111.547 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -18.51 61.96 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.45 -0.5 . . . . 50.0 110.203 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.23 -29.85 10.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 33' ' ' TYR . 4.5 m -119.83 14.61 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.246 -0.888 . . . . 16.66 111.108 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.85 46.18 47.11 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.102 -0.571 . . . . 16.66 111.758 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.488 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -115.58 162.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 16.66 110.85 -179.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.0 tp -64.54 163.79 12.9 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 121.047 0.451 . . . . 50.0 109.992 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.824 ' HG2' ' H ' ' A' ' 43' ' ' SER . 4.2 pt20 -80.05 -53.44 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.009 -0.541 . . . . 25.0 110.075 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.824 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 29.6 t -64.98 -22.38 66.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 1.044 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.8 mt-10 -44.83 -17.45 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.555 ' N ' ' C ' ' A' ' 43' ' ' SER . . . -70.44 -45.11 66.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.479 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.711 ' C ' ' H ' ' A' ' 48' ' ' ILE . 96.4 mt-10 -88.5 -53.29 4.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.256 0.836 . . . . 50.0 113.256 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.868 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.73 11.56 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.144 0.497 . . . . 16.66 110.572 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.044 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -114.42 136.34 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.159 -0.928 . . . . 25.0 112.042 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.07 -73.64 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 50.0 111.818 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.53 71.95 1.24 Allowed 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.191 -0.67 . . . . 50.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.713 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.22 145.3 55.94 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.593 -0.73 . . . . 16.66 109.715 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' A' ' 27' ' ' ASP . 11.2 t -112.57 157.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.659 -0.701 . . . . 50.0 109.234 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.411 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.2 p -86.66 155.82 56.15 Favored Pre-proline 0 N--CA 1.409 -2.485 0 CA-C-N 115.572 -0.74 . . . . 16.66 110.546 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD3' ' OH ' ' A' ' 51' ' ' TYR . 84.2 Cg_endo -67.97 -32.38 28.65 Favored 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 122.099 1.866 . . . . 16.66 111.093 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.38 -32.72 71.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 50.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.238 0 CA-C-N 115.422 -0.808 . . . . 16.66 111.4 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.232 0.154 0 N-CA-C 110.247 -0.279 . . . . 50.0 110.247 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.6 m-85 -100.7 -70.89 0.72 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.0 t -41.22 116.18 0.71 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.195 -0.911 . . . . 16.66 111.034 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.649 HG23 ' CD1' ' A' ' 33' ' ' TYR . 5.1 pt -54.51 -8.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.533 -0.758 . . . . 50.0 109.265 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.971 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -80.67 8.03 8.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.698 -1.137 . . . . 16.66 110.694 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? 65.36 53.5 1.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 25.0 111.773 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 142.77 16.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.53 155.01 67.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.607 2.205 . . . . 50.0 112.643 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.708 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 14.6 t80 -63.09 140.85 58.91 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.243 -0.435 . . . . 50.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 45.2 t0 -140.57 126.32 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 50.0 110.299 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.77 -14.45 32.67 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.669 -0.696 . . . . 50.0 110.328 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -75.35 -30.15 60.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.35 -1.352 . . . . 50.0 107.35 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.568 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 8.2 tptp -99.92 153.95 18.76 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.316 -1.765 . . . . 50.0 108.159 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 45.8 p90 -110.55 152.01 26.92 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.315 -0.554 . . . . 16.66 110.582 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -129.21 165.46 21.31 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.422 1.582 . . . . 50.0 114.645 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.007 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -125.19 123.02 64.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 110.777 -2.92 . . . . 16.66 104.45 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -91.92 123.33 7.18 Favored Glycine 0 C--N 1.317 -0.472 0 C-N-CA 119.52 -1.324 . . . . 16.66 115.913 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.468 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.92 108.59 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.929 -1.508 . . . . 16.66 106.929 175.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 90.3 m-20 -66.67 -23.93 66.2 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -112.58 -22.59 10.7 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.085 -1.416 . . . . 50.0 111.634 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.261 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -106.66 12.85 28.82 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.677 -0.809 . . . . 16.66 111.762 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HG2' ' C ' ' A' ' 29' ' ' CYS . 22.8 pt20 34.97 45.54 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.726 0.639 . . . . 16.66 112.726 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.5 t-20 -132.92 166.59 21.99 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.41 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -135.5 130.47 34.7 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 121.034 -0.267 . . . . 16.66 111.09 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.96 145.45 51.63 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.922 -0.311 . . . . 50.0 111.175 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.845 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -54.78 141.24 33.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.722 -1.585 . . . . 16.66 106.722 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.24 -59.79 2.9 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.433 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -20.27 66.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 50.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.0 t -50.94 -31.11 16.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.888 -0.782 . . . . 16.66 108.888 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 33' ' ' TYR . 2.5 m -120.23 14.04 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.254 -0.885 . . . . 16.66 110.894 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.19 45.7 60.63 Favored Glycine 0 N--CA 1.46 0.287 0 CA-C-N 115.885 -0.598 . . . . 16.66 111.741 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.473 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -107.8 164.63 4.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.949 0.404 . . . . 16.66 110.538 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.792 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 74.2 mt -58.7 163.96 3.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.875 -0.602 . . . . 50.0 109.982 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -78.4 -55.44 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.295 -0.866 . . . . 25.0 110.996 -178.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -70.48 -15.82 62.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.506 -0.77 . . . . 50.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.794 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.3 mt-10 -45.77 -19.83 0.07 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.851 -0.613 . . . . 50.0 111.866 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -64.22 -48.06 77.32 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.931 -0.708 . . . . 25.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.57 -45.88 9.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.182 1.549 . . . . 50.0 115.182 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.794 HD11 ' HA ' ' A' ' 44' ' ' GLU . 1.9 pp -55.26 -32.61 62.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 114.208 1.188 . . . . 16.66 114.208 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.2 pp -86.0 171.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.532 -0.867 . . . . 25.0 109.913 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -162.99 9.62 0.06 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.89 -1.05 . . . . 50.0 109.631 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -145.44 30.63 1.11 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.661 -1.607 . . . . 50.0 106.661 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.697 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 9.6 t80 -66.12 147.56 53.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.225 -1.352 . . . . 16.66 110.873 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.697 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.4 t -132.55 156.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.053 -1.431 . . . . 50.0 108.652 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.468 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -79.53 156.65 75.56 Favored Pre-proline 0 N--CA 1.409 -2.521 0 CA-C-O 121.586 0.708 . . . . 16.66 110.003 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 86.1 Cg_endo -71.27 -28.12 18.84 Favored 'Trans proline' 0 C--N 1.273 -3.412 0 C-N-CA 121.835 1.69 . . . . 16.66 110.601 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -71.85 -35.97 70.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.27 -1.011 . . . . 50.0 108.27 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.243 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.176 0 CA-C-N 115.091 -0.958 . . . . 16.66 110.621 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 110.329 -0.249 . . . . 50.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.35 -68.72 0.79 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.119 0.485 . . . . 25.0 109.952 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.3 t -40.79 115.47 0.58 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 16.66 110.932 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.634 HG22 ' NE2' ' A' ' 55' ' ' GLN . 5.8 pt -52.75 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 50.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.999 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.67 4.22 16.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 16.66 110.333 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm 66.49 55.58 0.81 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.821 -0.627 . . . . 25.0 112.045 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -147.3 142.05 16.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.792 -0.447 . . . . 50.0 109.792 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 15' ' ' THR . 15.8 Cg_exo -65.01 153.43 78.36 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.272 1.982 . . . . 50.0 112.292 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.5 t80 -58.05 146.2 33.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.538 -0.542 . . . . 50.0 109.538 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.515 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 96.0 m-20 -140.93 116.97 10.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.656 -0.702 . . . . 50.0 111.325 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.54 -16.7 26.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.059 -0.519 . . . . 50.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -76.36 -27.99 56.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 5.9 tptm -101.89 154.63 18.76 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.346 -1.752 . . . . 50.0 108.185 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 53.5 p90 -111.17 151.23 28.43 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.376 -0.529 . . . . 16.66 110.548 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.7 m-85 -128.9 168.26 16.22 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 123.314 1.531 . . . . 50.0 114.286 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.011 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.43 126.17 68.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 111.118 -2.764 . . . . 16.66 105.29 176.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.89 122.29 6.87 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.757 -1.211 . . . . 16.66 115.601 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.313 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -48.38 115.29 1.16 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.028 -1.086 . . . . 16.66 108.555 176.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.6 t70 -58.68 -34.02 70.8 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.355 -0.538 . . . . 25.0 109.871 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -113.32 -23.88 9.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.707 -0.678 . . . . 50.0 111.32 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.313 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -91.54 4.88 51.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.983 -0.687 . . . . 16.66 111.324 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.527 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 6.5 pt20 30.75 48.59 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.11 -0.496 . . . . 16.66 111.615 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.63 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -131.55 166.4 21.47 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.847 -0.427 . . . . 50.0 109.847 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.48 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.18 132.57 39.95 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.837 -0.345 . . . . 16.66 111.052 -178.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.02 144.97 51.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.779 -0.369 . . . . 50.0 111.327 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.815 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -56.47 140.06 47.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.392 -1.707 . . . . 16.66 106.392 176.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.12 -58.57 3.23 Favored Glycine 0 C--N 1.31 -0.899 0 C-N-CA 119.622 -1.275 . . . . 16.66 112.098 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -66.75 -21.3 66.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.58 -29.84 18.72 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.656 -0.702 . . . . 16.66 109.304 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.56 2.24 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.706 -0.679 . . . . 16.66 112.002 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.9 46.4 6.72 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.417 -0.673 . . . . 16.66 111.417 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.57 HG22 ' CA ' ' A' ' 35' ' ' GLY . 1.4 tt -118.69 159.92 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.05 0.453 . . . . 16.66 111.828 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.661 ' C ' ' HG3' ' A' ' 44' ' ' GLU . 4.1 mm? -46.91 169.61 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.58 -0.736 . . . . 50.0 110.991 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -56.33 4.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.702 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' ALA . 61.5 m -79.03 -16.07 57.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.637 -0.71 . . . . 50.0 111.446 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.878 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -43.34 -21.35 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.87 0.367 . . . . 50.0 110.166 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.505 ' N ' ' OE1' ' A' ' 44' ' ' GLU . . . -60.14 -51.52 69.24 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.037 -0.528 . . . . 25.0 111.418 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.77 -44.16 10.17 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.808 1.41 . . . . 50.0 114.808 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.965 HD12 ' N ' ' A' ' 48' ' ' ILE . 3.1 pp -55.47 -28.09 52.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.661 0.985 . . . . 16.66 113.661 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.965 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 pp -85.71 172.48 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 119.862 -0.735 . . . . 25.0 110.028 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 48.6 t0 -156.35 0.48 0.14 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.571 -1.195 . . . . 50.0 109.982 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.33 33.67 2.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.413 -1.328 . . . . 50.0 107.413 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.1 t80 -65.94 145.88 55.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.197 -0.91 . . . . 16.66 110.032 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.691 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 20.3 t -133.73 155.73 40.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.058 -1.428 . . . . 50.0 108.991 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.998 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 7.2 p -81.72 154.42 70.78 Favored Pre-proline 0 N--CA 1.413 -2.287 0 CA-C-O 121.501 0.667 . . . . 16.66 109.98 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 50.7 Cg_endo -74.4 -28.22 10.52 Favored 'Trans proline' 0 C--N 1.274 -3.379 0 C-N-CA 122.058 1.839 . . . . 16.66 110.947 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.634 ' NE2' HG22 ' A' ' 12' ' ' ILE . 96.2 mt-30 -70.32 -33.58 71.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.131 -1.063 . . . . 50.0 108.131 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.185 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.7 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 114.767 -1.106 . . . . 16.66 110.277 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 9' ' ' LEU . 2.9 pp . . . . . 0 CA--C 1.527 0.059 0 CA-C-O 120.94 0.4 . . . . 50.0 111.082 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -73.62 -103.21 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.951 -0.568 . . . . 25.0 110.993 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 18.7 t -37.87 120.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.819 0.818 . . . . 16.66 113.206 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 33' ' ' TYR . 7.5 pt -59.29 -8.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.112 -1.404 . . . . 50.0 108.843 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.95 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.94 8.81 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.367 -1.288 . . . . 16.66 110.565 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.634 ' CG ' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 63.43 71.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.571 0.7 . . . . 25.0 110.086 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.03 124.67 1.12 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.939 -0.573 . . . . 50.0 110.757 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.45 154.9 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.287 1.991 . . . . 50.0 112.111 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -56.85 146.1 27.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.044 0.449 . . . . 50.0 110.074 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.2 m-20 -140.75 114.78 9.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.764 -0.653 . . . . 50.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.66 -10.81 2.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.419 ' N ' ' C ' ' A' ' 18' ' ' ASP . 26.4 m -79.97 -24.8 40.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.358 -1.349 . . . . 50.0 107.358 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.7 tptm -107.56 153.56 22.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.59 -1.641 . . . . 50.0 107.94 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 39.2 p90 -110.13 153.47 24.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 120.11 -0.636 . . . . 16.66 111.011 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.742 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -126.59 164.0 22.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 123.504 1.621 . . . . 50.0 114.645 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.104 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.76 117.86 31.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 110.861 -2.881 . . . . 16.66 105.091 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -82.93 133.08 11.57 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 119.944 -1.122 . . . . 16.66 115.06 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -47.94 107.37 0.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.752 -1.224 . . . . 16.66 107.705 176.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.596 ' HB3' HG22 ' A' ' 52' ' ' VAL . 59.1 t0 -51.05 -41.43 59.87 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.85 -0.74 . . . . 25.0 110.23 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.633 ' HG3' ' HB3' ' A' ' 56' ' ' CYS . 14.7 ptp180 -115.67 -4.51 12.19 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.83 0.678 . . . . 50.0 112.83 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.237 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -108.66 13.51 25.1 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 118.825 -1.15 . . . . 16.66 111.326 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER 33.69 52.33 0.42 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.268 -0.423 . . . . 16.66 110.72 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.608 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -132.57 166.44 22.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.189 -0.3 . . . . 50.0 110.189 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.674 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -139.89 132.14 28.24 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.004 0.742 . . . . 16.66 113.004 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.741 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -139.93 152.62 46.51 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.036 -0.529 . . . . 50.0 111.649 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.921 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -59.04 142.55 51.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.694 -1.595 . . . . 16.66 106.694 175.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.84 -60.31 2.98 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.058 -1.068 . . . . 16.66 111.713 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -20.12 65.91 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.324 -0.55 . . . . 50.0 110.183 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.7 t -51.19 -31.32 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.199 -0.667 . . . . 16.66 109.199 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 33' ' ' TYR . 2.7 m -115.67 14.28 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.472 -0.786 . . . . 16.66 110.675 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.14 46.0 23.41 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 115.636 -0.711 . . . . 16.66 112.432 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -112.55 167.24 5.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.928 0.394 . . . . 16.66 110.581 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.584 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 85.6 mt -67.16 164.29 18.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.499 0.666 . . . . 50.0 110.662 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.422 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.6 OUTLIER -80.03 -54.96 5.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.034 -0.985 . . . . 25.0 111.086 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 m -65.81 -17.85 64.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 50.0 110.096 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.792 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.0 mt-10 -45.64 -38.28 6.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.353 -0.539 . . . . 50.0 110.658 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.607 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -51.37 -36.5 43.47 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.077 -0.649 . . . . 25.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -87.74 -44.46 11.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.601 0.963 . . . . 50.0 113.601 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 44' ' ' GLU . 2.2 pp -86.46 17.13 3.98 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.285 -0.87 . . . . 16.66 112.013 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.792 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 4.1 tp -120.81 150.01 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 C-N-CA 119.056 -1.058 . . . . 25.0 112.984 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -170.17 29.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.614 -1.175 . . . . 50.0 110.411 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -161.03 9.02 0.08 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.671 -0.863 . . . . 50.0 108.671 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -67.22 147.63 52.8 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.54 -0.755 . . . . 16.66 109.35 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 27' ' ' ASP . 14.8 t -126.03 157.76 35.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.143 -0.935 . . . . 50.0 109.43 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.9 p -79.84 156.87 74.71 Favored Pre-proline 0 N--CA 1.412 -2.353 0 CA-C-N 115.749 -0.66 . . . . 16.66 110.164 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 28.9 Cg_endo -80.25 -23.78 6.04 Favored 'Trans proline' 0 C--N 1.276 -3.239 0 C-N-CA 121.783 1.655 . . . . 16.66 110.786 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -72.64 -35.63 67.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.485 -0.932 . . . . 50.0 108.485 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.166 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.03 -0.986 . . . . 16.66 110.609 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 N-CA-C 109.93 -0.396 . . . . 50.0 109.93 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.6 m-85 -91.06 -71.34 0.64 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.411 -0.588 . . . . 25.0 109.411 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.1 t -41.38 113.41 0.4 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.653 -0.703 . . . . 16.66 110.772 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.696 HG22 ' NE2' ' A' ' 55' ' ' GLN . 6.5 pt -53.12 -7.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 50.0 109.414 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.972 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -81.25 6.72 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.729 -1.123 . . . . 16.66 110.892 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 66.97 56.12 0.68 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.13 -0.487 . . . . 25.0 111.916 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 135.94 10.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.91 -0.316 . . . . 50.0 110.352 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.48 156.72 39.98 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.321 2.014 . . . . 50.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.724 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.7 t80 -59.35 146.25 40.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.033 0.444 . . . . 50.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.503 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 95.4 m-20 -141.39 113.07 7.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.638 -0.71 . . . . 50.0 111.249 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.36 -20.87 13.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.968 0.413 . . . . 50.0 110.103 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.4 m -71.95 -30.99 65.87 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.602 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -99.05 150.37 22.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.265 -1.789 . . . . 50.0 107.954 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 51.0 p90 -108.78 150.41 27.65 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.06 -0.656 . . . . 16.66 110.601 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.724 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.6 m-85 -127.76 166.0 19.02 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 123.362 1.553 . . . . 50.0 113.925 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.058 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.55 124.3 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 111.114 -2.766 . . . . 16.66 105.57 176.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -87.95 127.1 8.37 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.993 -1.099 . . . . 16.66 115.529 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.474 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -48.62 121.28 4.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.499 -1.297 . . . . 16.66 107.499 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.554 ' HB2' HG22 ' A' ' 52' ' ' VAL . 60.5 t0 -62.55 -34.21 76.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.507 0.67 . . . . 25.0 109.571 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -113.56 -27.85 7.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.841 -1.072 . . . . 50.0 111.477 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.293 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -89.91 8.23 33.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.945 -0.702 . . . . 16.66 111.81 -177.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.566 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 2.8 pt20 30.13 49.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 16.66 112.005 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.673 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -131.6 165.69 23.09 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.92 -0.4 . . . . 50.0 109.92 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -132.54 132.68 42.87 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.939 -0.304 . . . . 16.66 111.389 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.672 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.7 145.76 52.01 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.865 -0.334 . . . . 50.0 111.148 178.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.834 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -54.43 140.2 34.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.285 -1.746 . . . . 16.66 106.285 176.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.745 ' H ' HH21 ' A' ' 36' ' ' ARG . . . -42.29 -56.34 4.06 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 119.433 -1.365 . . . . 16.66 111.516 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.781 ' H ' ' NE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.55 -19.7 62.86 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.516 -0.474 . . . . 50.0 110.241 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.41 -30.94 13.62 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.866 -0.791 . . . . 16.66 108.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.71 13.58 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.117 -0.947 . . . . 16.66 110.631 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 70.34 46.25 50.35 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.345 -0.702 . . . . 16.66 111.345 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.569 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -115.38 167.93 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.124 0.488 . . . . 16.66 111.647 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.3 mp -62.38 163.64 8.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 50.0 110.446 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.587 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.1 pt20 -82.33 -46.56 13.44 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.18 -1.045 . . . . 25.0 108.18 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.948 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -63.8 -29.25 70.47 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.647 -1.615 . . . . 50.0 108.687 179.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.81 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.8 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.005 -0.739 . . . . 50.0 109.005 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 22' ' ' PHE . . . -79.13 -41.93 27.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.298 -0.864 . . . . 25.0 110.538 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' SER . 48.5 mp0 -87.9 -52.13 5.45 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.696 1.369 . . . . 50.0 114.696 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.032 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.56 19.22 0.28 Allowed 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.481 0.658 . . . . 16.66 111.108 -177.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.81 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.3 tp -114.71 144.56 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 114.749 -1.114 . . . . 25.0 113.299 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -168.09 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.155 -1.384 . . . . 50.0 109.313 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -166.39 13.12 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.415 -0.957 . . . . 50.0 108.415 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -67.58 147.26 52.99 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.357 -0.838 . . . . 16.66 109.706 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.1 t -124.71 159.26 31.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.845 -1.071 . . . . 50.0 109.293 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.474 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -83.87 152.93 63.52 Favored Pre-proline 0 N--CA 1.411 -2.383 0 CA-C-O 121.611 0.72 . . . . 16.66 110.359 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.25 -27.61 16.32 Favored 'Trans proline' 0 C--N 1.274 -3.378 0 C-N-CA 121.892 1.728 . . . . 16.66 110.877 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.696 ' NE2' HG22 ' A' ' 12' ' ' ILE . 95.0 mt-30 -70.42 -33.67 71.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.31 -0.859 . . . . 50.0 108.827 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.253 -0.885 . . . . 16.66 110.567 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.37 0.128 . . . . 50.0 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 m-85 -95.53 -68.36 0.8 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.2 t -43.48 116.26 0.91 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.648 -0.705 . . . . 16.66 110.458 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.631 HG23 ' CD1' ' A' ' 33' ' ' TYR . 9.9 pt -51.95 -7.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.071 -0.714 . . . . 50.0 109.071 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -78.31 2.78 17.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.572 -1.195 . . . . 16.66 110.55 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.22 54.41 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.982 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.07 146.77 26.9 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.005 -0.369 . . . . 50.0 110.005 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 152.69 76.08 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.513 2.142 . . . . 50.0 111.941 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.6 t80 -55.97 146.06 23.41 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.759 -0.46 . . . . 50.0 109.759 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.0 m-20 -140.71 113.15 8.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.786 -0.643 . . . . 50.0 111.017 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.64 -17.76 9.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 50.0 109.842 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -71.58 -30.81 66.25 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.112 -1.44 . . . . 50.0 107.112 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 3.1 tptm -100.55 156.88 17.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 112.973 -1.922 . . . . 50.0 108.957 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.8 p90 -113.45 149.07 34.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 115.885 -0.598 . . . . 16.66 110.024 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 m-85 -127.15 166.75 17.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 123.379 1.561 . . . . 50.0 114.236 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.02 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.19 126.22 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 111.013 -2.812 . . . . 16.66 105.007 176.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.58 121.22 6.53 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.587 -1.292 . . . . 16.66 116.157 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.44 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.32 117.69 2.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.911 -1.145 . . . . 16.66 108.002 175.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 51' ' ' TYR . 87.3 m-20 -69.26 -30.18 68.24 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.652 0.739 . . . . 25.0 109.245 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -110.43 -23.15 11.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.597 -1.183 . . . . 50.0 111.452 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.292 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 9.93 40.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.888 -0.725 . . . . 16.66 111.683 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.573 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 8.9 pt20 30.37 48.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 16.66 112.405 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.586 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.14 166.16 22.42 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 120.929 -0.308 . . . . 50.0 110.373 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -133.94 130.75 38.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.184 -0.206 . . . . 16.66 110.906 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -128.45 144.44 51.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.792 -0.363 . . . . 50.0 111.393 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.75 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -54.19 140.59 32.04 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.28 -1.748 . . . . 16.66 106.28 176.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -41.9 -59.94 2.72 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.855 -1.164 . . . . 16.66 111.929 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.47 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -67.87 -19.79 65.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.458 -0.497 . . . . 50.0 109.971 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.1 t -50.4 -30.7 13.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.664 -0.865 . . . . 16.66 108.664 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.6 12.66 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.255 -0.884 . . . . 16.66 110.962 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 70.67 45.84 50.47 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.034 -0.603 . . . . 16.66 111.68 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.504 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -112.5 167.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.421 . . . . 16.66 111.495 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 41' ' ' LEU . 8.0 mp -59.64 164.72 3.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 50.0 110.555 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.06 -55.39 5.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.515 -0.766 . . . . 25.0 110.523 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.4 m -70.86 -15.16 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 50.0 109.368 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.744 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -42.17 -20.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.467 -0.788 . . . . 50.0 110.938 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.34 -47.52 60.67 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.396 -0.522 . . . . 25.0 110.992 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -88.93 -43.46 11.15 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.745 1.387 . . . . 50.0 114.745 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.0 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.5 pp -55.39 -30.84 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.306 0.854 . . . . 16.66 113.306 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.0 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.3 pp -86.67 172.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.744 0.783 . . . . 25.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.35 13.2 0.14 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.403 -1.271 . . . . 50.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -155.54 36.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.753 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 18.5 t80 -65.96 145.88 55.37 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.674 -1.148 . . . . 16.66 111.014 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.753 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 11.7 t -129.71 157.55 42.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.942 -1.481 . . . . 50.0 108.608 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.44 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.2 p -86.35 158.36 54.99 Favored Pre-proline 0 N--CA 1.414 -2.236 0 CA-C-O 121.574 0.702 . . . . 16.66 110.578 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 29.8 Cg_endo -79.8 -22.7 7.44 Favored 'Trans proline' 0 C--N 1.278 -3.133 0 C-N-CA 121.97 1.78 . . . . 16.66 110.403 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -72.52 -35.76 68.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.062 -1.088 . . . . 50.0 108.062 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.17 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 CA-C-N 114.881 -1.054 . . . . 16.66 109.856 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.333 -0.247 . . . . 50.0 110.333 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.726 ' N ' HD22 ' A' ' 9' ' ' LEU . 1.5 m-85 -87.16 -94.99 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.007 0.373 . . . . 25.0 112.007 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -37.45 132.72 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.69 0.757 . . . . 16.66 112.773 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.751 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -61.15 -7.75 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.671 -1.149 . . . . 50.0 108.692 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.59 4.95 14.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.001 -1.454 . . . . 16.66 110.852 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 67.31 47.6 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.269 -0.423 . . . . 25.0 111.038 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.27 124.61 10.84 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.618 -0.264 . . . . 50.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.68 160.47 11.78 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.626 2.217 . . . . 50.0 112.878 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.751 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 10.4 t80 -66.3 138.51 57.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.047 -0.524 . . . . 50.0 111.104 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 54.3 t0 -140.54 127.01 20.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.653 -0.703 . . . . 50.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.92 -12.83 4.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.991 -0.549 . . . . 50.0 109.608 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -75.64 -26.81 58.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.681 ' HG2' ' CG ' ' A' ' 34' ' ' HIS . 15.5 tptt -101.5 152.17 21.09 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.489 -1.687 . . . . 50.0 108.129 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 55.3 p90 -113.08 147.21 37.75 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.182 -0.607 . . . . 16.66 110.154 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.0 m-85 -123.23 164.23 19.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 123.914 1.816 . . . . 50.0 115.538 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.123 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.68 117.96 21.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 109.953 -3.294 . . . . 16.66 104.286 176.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -89.73 129.87 9.92 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.778 -1.201 . . . . 16.66 115.455 -174.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.386 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 106.99 0.11 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.898 -1.519 . . . . 16.66 106.898 175.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -69.54 -20.01 63.69 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -112.86 -25.46 9.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.839 -1.528 . . . . 50.0 111.566 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.21 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -111.31 15.88 21.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.932 -0.707 . . . . 16.66 112.197 -178.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.539 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 30.96 54.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 16.66 111.87 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 5.5 m-20 -132.54 167.06 20.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.411 -0.359 . . . . 50.0 110.223 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.692 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -141.03 129.48 22.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.311 0.856 . . . . 16.66 113.311 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.751 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -141.43 158.34 44.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.873 -0.603 . . . . 50.0 111.771 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.682 ' H ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -63.98 134.85 55.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.9 -1.889 . . . . 16.66 105.9 174.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.6 -44.85 5.44 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 119.502 -1.332 . . . . 16.66 111.545 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 17.9 mtt180 -68.53 -29.88 68.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.57 0.7 . . . . 50.0 109.238 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.933 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 4.2 t -51.6 -26.66 9.25 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.791 -1.095 . . . . 16.66 109.621 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.53 16.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.296 -0.866 . . . . 16.66 110.622 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.21 47.58 57.9 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.733 -0.667 . . . . 16.66 111.828 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -115.63 167.02 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.777 -0.369 . . . . 16.66 110.984 -178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.705 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.8 mm? -62.33 164.59 6.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.287 0.565 . . . . 50.0 110.412 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -56.05 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.13 -0.941 . . . . 25.0 110.911 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -69.35 -16.15 63.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.683 -0.689 . . . . 50.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.81 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.6 tt0 -48.22 -20.24 0.36 Allowed 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.488 -0.778 . . . . 50.0 111.464 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.699 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -57.0 -51.82 67.71 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.944 -0.702 . . . . 25.0 111.671 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 48' ' ' ILE . 78.2 mm-40 -90.1 -46.65 8.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.9 1.445 . . . . 50.0 114.9 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 44' ' ' GLU . 3.1 pp -56.02 16.19 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.347 1.24 . . . . 16.66 114.347 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -134.48 171.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.406 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 46.0 t0 -173.36 36.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.82 -1.082 . . . . 50.0 108.994 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.03 20.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 2.4 t80 -66.82 148.68 51.62 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.547 -1.206 . . . . 16.66 110.522 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.646 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.3 t -129.87 152.26 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.302 -1.317 . . . . 50.0 109.43 178.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.386 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.3 p -78.95 162.45 64.71 Favored Pre-proline 0 N--CA 1.411 -2.391 0 CA-C-N 115.232 -0.894 . . . . 16.66 110.102 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 15.5 Cg_endo -81.23 -27.84 2.68 Favored 'Trans proline' 0 C--N 1.276 -3.279 0 C-N-CA 121.875 1.717 . . . . 16.66 110.848 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -67.93 -35.63 78.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.895 -1.15 . . . . 50.0 107.895 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.189 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 114.892 -1.049 . . . . 16.66 109.552 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD22 ' N ' ' A' ' 15' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.662 ' HB3' ' O ' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -82.28 -89.19 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 1.5 t -39.71 114.43 0.42 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.844 -0.617 . . . . 16.66 111.29 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.833 HD13 ' N ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -59.7 -8.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.16 -0.927 . . . . 50.0 109.588 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 1.137 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -71.21 7.34 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.425 -0.807 . . . . 16.66 109.923 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HB3' ' HZ2' ' A' ' 14' ' ' LYS . 3.5 mtpm? 65.91 48.73 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.576 -0.738 . . . . 25.0 111.484 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.539 ' N ' HD22 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -143.17 124.19 8.2 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.778 -0.369 . . . . 50.0 110.287 179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.1 152.03 3.72 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.748 2.299 . . . . 50.0 112.801 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.7 t80 -67.57 145.02 55.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 91.3 m-20 -140.82 116.68 10.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.831 -0.622 . . . . 50.0 110.355 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 -13.57 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.443 -0.577 . . . . 50.0 109.443 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -75.13 -25.69 58.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.513 -1.291 . . . . 50.0 107.513 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -101.39 155.3 18.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.433 -1.712 . . . . 50.0 108.113 178.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 51.8 p90 -110.25 153.21 25.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.889 -0.724 . . . . 16.66 110.588 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.3 m-85 -125.26 162.71 24.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.47 1.605 . . . . 50.0 114.534 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.035 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -131.58 117.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.803 -2.908 . . . . 16.66 104.601 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.77 131.96 11.03 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 119.782 -1.199 . . . . 16.66 116.025 -174.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.394 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -46.33 105.74 0.07 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.026 -1.472 . . . . 16.66 107.026 175.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.742 ' CG ' HG22 ' A' ' 52' ' ' VAL . 43.4 p-10 -75.4 -11.4 60.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.568 -1.271 . . . . 25.0 107.568 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.483 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 23.4 ttm180 -113.7 -22.98 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.742 -1.572 . . . . 50.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.183 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -120.22 18.5 12.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 119.927 -0.709 . . . . 16.66 112.346 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.519 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 13.9 pt20 32.97 54.11 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.763 0.283 . . . . 16.66 111.763 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.614 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 4.8 m-20 -133.09 167.84 19.58 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 110.165 -0.309 . . . . 50.0 110.165 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.662 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -138.67 133.02 31.79 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.869 0.692 . . . . 16.66 112.869 -177.037 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.646 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -140.83 145.13 35.86 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.97 -0.559 . . . . 50.0 111.283 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.931 ' HD1' ' CB ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -55.89 150.03 13.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 106.368 -1.715 . . . . 16.66 106.368 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.545 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -54.08 -61.56 7.03 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 119.468 -1.348 . . . . 16.66 112.747 -177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HD3' ' HZ1' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.57 -20.69 62.76 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.346 -0.541 . . . . 50.0 110.462 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 13.9 t -54.14 -29.24 44.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.488 -0.885 . . . . 16.66 108.941 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -112.61 11.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 16.66 110.34 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.06 46.96 20.15 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.862 -0.608 . . . . 16.66 111.774 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -116.64 167.58 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 16.66 111.546 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.4 mp -64.68 161.6 17.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.248 -0.887 . . . . 50.0 110.152 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.4 pt20 -82.12 -41.16 20.84 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.779 ' C ' HD21 ' A' ' 47' ' ' LEU . 69.6 m -60.88 -39.04 87.74 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 112.336 -2.211 . . . . 50.0 109.266 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.809 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -41.39 -17.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.935 -0.575 . . . . 50.0 110.037 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -76.4 -46.17 28.42 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.074 -0.512 . . . . 25.0 110.806 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.0 mm-40 -88.95 -51.23 5.73 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.069 1.507 . . . . 50.0 115.069 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.09 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.18 20.32 0.39 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.563 0.697 . . . . 16.66 111.761 -177.07 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.809 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.2 tp -111.43 139.04 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 25.0 111.915 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -116.19 -58.68 2.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.405 -1.27 . . . . 50.0 111.822 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 2.3 pm0 -118.83 59.48 0.82 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.166 -0.679 . . . . 50.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.0 t80 -66.37 142.07 57.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.175 -0.61 . . . . 16.66 109.368 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.742 HG22 ' CG ' ' A' ' 27' ' ' ASP . 6.7 t -117.33 152.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.543 -0.753 . . . . 50.0 109.716 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.394 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.4 p -83.99 157.85 62.54 Favored Pre-proline 0 N--CA 1.41 -2.45 0 CA-C-N 114.936 -1.029 . . . . 16.66 110.35 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -79.19 -25.69 5.69 Favored 'Trans proline' 0 C--N 1.278 -3.183 0 C-N-CA 121.92 1.746 . . . . 16.66 110.477 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -71.96 -33.49 68.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.945 -1.025 . . . . 50.0 108.936 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.168 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.148 0 CA-C-N 115.329 -0.85 . . . . 16.66 110.743 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.025 -0.361 . . . . 50.0 110.025 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.9 m-85 -103.03 -69.96 0.78 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.849 -0.34 . . . . 25.0 110.106 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 35.7 t -41.6 130.61 3.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 16.66 110.719 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.679 HG22 HE21 ' A' ' 55' ' ' GLN . 12.9 pt -57.74 -7.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.269 -1.011 . . . . 50.0 108.269 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.74 -5.85 56.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.899 -1.501 . . . . 16.66 110.897 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 22.1 mtmm 72.18 52.8 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.186 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.68 139.33 23.97 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 109.906 -0.405 . . . . 50.0 109.906 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.66 153.96 74.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.453 2.102 . . . . 50.0 112.331 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -63.05 140.29 58.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.13 0.491 . . . . 50.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 21' ' ' LYS . 82.1 m-20 -141.8 119.86 12.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.487 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.81 -22.34 9.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.95 -0.389 . . . . 50.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 m -68.79 -34.11 74.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.528 -1.286 . . . . 50.0 107.528 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 4.6 ttmt -93.33 139.3 30.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.304 -1.771 . . . . 50.0 107.584 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 45.1 p90 -105.13 143.01 33.9 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.134 -0.627 . . . . 16.66 110.173 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -122.13 173.19 7.73 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 123.941 1.829 . . . . 50.0 114.78 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.029 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.69 179.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 109.685 -3.416 . . . . 16.66 104.018 176.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.06 124.14 2.48 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 117.658 -2.211 . . . . 16.66 114.36 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 1.447 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -48.04 110.65 0.35 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.052 -1.074 . . . . 16.66 108.739 177.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.696 ' HB2' HG22 ' A' ' 52' ' ' VAL . 57.2 t0 -46.57 -41.95 15.22 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.081 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.566 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.39 -13.81 11.0 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 112.407 0.521 . . . . 50.0 112.407 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 1.347 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -88.49 0.17 56.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.937 -1.105 . . . . 16.66 111.272 -178.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.476 HE21 ' C ' ' A' ' 28' ' ' ARG . 8.9 mm-40 40.85 45.98 2.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.551 -0.295 . . . . 16.66 110.347 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.581 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -132.31 166.28 22.27 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.755 -0.378 . . . . 50.0 110.604 -177.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -140.82 127.77 20.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.56 -0.456 . . . . 16.66 111.428 -178.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.74 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -127.67 156.43 42.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.94 -0.573 . . . . 50.0 110.866 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.532 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -61.46 141.0 57.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.154 -1.795 . . . . 16.66 106.154 176.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.593 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -43.4 -48.48 6.96 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 119.42 -1.371 . . . . 16.66 111.261 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -75.06 -19.76 59.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.349 -0.54 . . . . 50.0 110.037 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.92 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -51.6 -30.71 22.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.562 -0.855 . . . . 16.66 109.241 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.43 8.59 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.487 -0.779 . . . . 16.66 111.427 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.57 45.86 7.68 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.124 -0.56 . . . . 16.66 112.204 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.593 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -123.15 167.34 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.222 0.534 . . . . 16.66 111.608 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 40' ' ' ILE . 4.0 mm? -67.02 164.58 17.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.481 -0.781 . . . . 50.0 110.46 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.708 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.8 pt20 -80.55 -54.26 5.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 25.0 110.902 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.708 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 49.5 m -60.35 -28.26 68.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.063 -1.088 . . . . 50.0 108.063 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.958 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -43.67 -17.03 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.305 -1.316 . . . . 50.0 109.928 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.27 -48.16 58.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.98 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.734 ' C ' ' H ' ' A' ' 48' ' ' ILE . 84.8 tt0 -87.66 -52.91 5.06 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.096 0.776 . . . . 50.0 113.096 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.886 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -57.78 5.6 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.385 0.612 . . . . 16.66 110.516 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.958 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -105.15 133.02 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.714 -177.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -87.7 -74.38 0.45 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.995 -1.002 . . . . 50.0 111.522 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 27' ' ' ASP . 80.7 tt0 -122.08 74.0 1.13 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.73 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.09 146.6 54.47 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.774 -0.648 . . . . 16.66 109.324 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 43.7 t -117.09 159.24 17.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.805 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 1.447 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -87.5 161.11 46.38 Favored Pre-proline 0 N--CA 1.415 -2.177 0 CA-C-O 121.425 0.631 . . . . 16.66 110.22 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 34.6 Cg_endo -80.33 -32.55 1.27 Allowed 'Trans proline' 0 C--N 1.28 -3.059 0 C-N-CA 121.862 1.708 . . . . 16.66 111.741 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.679 HE21 HG22 ' A' ' 12' ' ' ILE . 53.5 mt-30 -72.96 -28.81 62.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 1.104 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 61.4 m . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 114.121 -1.4 . . . . 16.66 111.0 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -53.62 147.96 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.756 2.304 . . . . 0.0 112.053 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.1 mt -58.07 -35.0 70.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.402 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.72 174.69 47.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.937 -0.865 . . . . 50.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.4 t -147.87 146.76 29.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 50.0 110.709 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.3 157.39 31.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 50.0 110.227 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -81.09 174.93 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.254 0.55 . . . . 50.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 pttt -128.75 179.89 5.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.338 -0.847 . . . . 50.0 111.119 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.98 176.55 0.69 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 50.0 110.236 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -97.8 -72.77 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.168 -0.613 . . . . 25.0 111.528 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 6.2 t -39.01 112.04 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 16.66 111.597 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.615 HG23 ' CD1' ' A' ' 33' ' ' TYR . 9.1 pt -48.02 -8.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.541 -0.754 . . . . 50.0 109.682 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.969 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -86.02 30.52 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.742 -1.117 . . . . 16.66 110.343 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 14.0 pttp 43.4 58.87 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.77 -0.65 . . . . 25.0 112.144 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.433 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -156.32 124.34 2.85 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 110.022 -0.362 . . . . 50.0 110.022 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 25.0 Cg_exo -57.22 164.17 7.07 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.614 2.209 . . . . 50.0 113.352 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.737 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 16.1 t80 -60.23 145.78 46.04 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.517 -0.765 . . . . 50.0 110.74 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' LYS . 92.6 m-20 -141.46 111.84 6.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.03 -0.986 . . . . 50.0 110.848 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -53.51 -22.45 8.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 50.0 110.448 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -71.11 -30.38 66.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.633 -1.247 . . . . 50.0 107.633 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -100.26 149.36 23.66 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.165 -1.834 . . . . 50.0 108.034 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 39.5 p90 -108.62 151.72 25.75 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.865 -0.734 . . . . 16.66 110.296 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.3 m-85 -126.86 165.44 19.34 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 123.152 1.454 . . . . 50.0 113.943 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.039 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.52 118.71 51.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 111.242 -2.708 . . . . 16.66 105.25 176.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -83.32 127.0 7.78 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.039 -1.077 . . . . 16.66 115.563 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.43 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -48.21 107.27 0.12 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.875 -1.162 . . . . 16.66 107.928 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.666 ' HB2' HG22 ' A' ' 52' ' ' VAL . 76.6 m-20 -51.08 -37.27 44.69 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.993 -0.683 . . . . 25.0 110.53 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.654 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -114.29 -14.56 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.042 0.386 . . . . 50.0 112.042 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.256 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.9 14.2 32.52 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 119.472 -0.891 . . . . 16.66 111.865 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.443 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 14.3 pt20 30.35 48.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.893 0.701 . . . . 16.66 112.893 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.636 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.13 166.11 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.971 -0.381 . . . . 50.0 109.971 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.488 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.61 130.98 37.27 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.868 -0.333 . . . . 16.66 111.279 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.2 144.99 51.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.05 -0.26 . . . . 50.0 111.024 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.828 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -52.03 143.02 14.71 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.714 -1.588 . . . . 16.66 106.714 176.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.577 ' C ' HG22 ' A' ' 40' ' ' ILE . . . -42.18 -60.31 2.72 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.432 -1.366 . . . . 16.66 111.478 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -69.19 -18.24 63.89 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.565 -0.454 . . . . 50.0 110.44 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.09 -30.67 11.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.656 -0.818 . . . . 16.66 108.814 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 33' ' ' TYR . 5.5 m -116.8 4.16 7.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.411 -0.813 . . . . 16.66 111.637 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.72 46.08 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.366 -0.694 . . . . 16.66 111.366 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 41' ' ' LEU . 3.5 tt -119.17 167.73 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 16.66 111.885 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 40' ' ' ILE . 42.0 mt -68.69 164.48 21.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.168 -0.923 . . . . 50.0 110.646 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.582 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 36.8 mt-30 -80.56 -43.97 19.78 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.965 -1.494 . . . . 25.0 106.965 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.773 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -62.76 -41.13 99.08 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 112.378 -2.192 . . . . 50.0 107.714 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.824 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 8.3 mm-40 -43.63 -16.35 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -78.93 -44.47 22.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.427 -0.806 . . . . 25.0 110.468 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 43' ' ' SER . 96.4 mt-10 -87.94 -51.91 5.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.583 1.327 . . . . 50.0 114.583 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.084 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.68 20.38 0.24 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.795 0.807 . . . . 16.66 111.03 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.824 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.5 tp -110.44 143.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.272 -1.331 . . . . 25.0 112.9 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -165.98 29.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.381 -1.281 . . . . 50.0 109.448 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -166.33 11.43 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.593 -0.892 . . . . 50.0 108.593 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -67.09 146.9 53.81 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 16.66 109.761 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 27' ' ' ASP . 21.7 t -125.16 156.95 34.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.912 -1.04 . . . . 50.0 110.016 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.43 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.5 p -78.57 157.23 77.51 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-N 115.592 -0.731 . . . . 16.66 110.078 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 41.5 Cg_endo -77.84 -30.13 3.94 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 121.963 1.776 . . . . 16.66 111.585 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -72.26 -29.59 64.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.99 -1.115 . . . . 50.0 107.99 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.2 m -62.76 -45.42 92.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.324 -1.307 . . . . 16.66 110.735 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -52.61 -36.71 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.677 -0.692 . . . . 50.0 110.566 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -37.04 79.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.514 -0.55 . . . . 50.0 109.514 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 60' ' ' GLU . 72.8 p -83.83 -34.94 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.753 -0.658 . . . . 50.0 111.319 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 59' ' ' THR . 66.6 mm-40 -38.27 -68.29 0.16 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.947 -0.301 . . . . 50.0 111.121 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 52.1 p30 -152.57 170.06 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 50.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.999 -1.001 . . . . 50.0 110.534 -179.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 4' ' ' GLY . 34.8 Cg_endo -65.66 -27.02 53.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.765 2.31 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 3' ' ' LEU . 10.6 mp 39.01 23.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -110.3 128.57 8.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.031 -0.828 . . . . 50.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.1 p -169.74 -149.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.226 -0.287 . . . . 50.0 110.226 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -74.09 105.76 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.882 -0.414 . . . . 50.0 109.882 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -127.36 165.56 19.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.228 0.537 . . . . 50.0 111.262 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -104.57 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.359 -0.837 . . . . 50.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.9 mt -61.26 151.19 32.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.483 -0.562 . . . . 50.0 109.483 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.14 -69.1 0.77 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.385 -0.526 . . . . 25.0 110.463 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -41.59 129.37 3.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 16.66 111.133 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 12' ' ' ILE . 9.1 pt -58.16 -7.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.932 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -82.39 -1.87 51.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.844 -1.525 . . . . 16.66 110.985 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 46.2 mttm 70.95 56.76 0.22 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.463 -0.335 . . . . 25.0 111.299 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.506 ' OG1' ' CE1' ' A' ' 34' ' ' HIS . 23.0 p -141.1 147.74 48.82 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.409 -0.36 . . . . 50.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.32 150.93 47.82 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.411 2.074 . . . . 50.0 111.846 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.723 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 22.2 t80 -62.65 139.98 58.67 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.11 0.481 . . . . 50.0 110.075 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 21' ' ' LYS . 87.4 m-20 -141.32 120.47 12.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.5 -0.773 . . . . 50.0 110.286 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.1 -17.08 6.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -70.21 -32.07 69.8 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.572 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 11.3 tptt -95.8 150.21 20.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 112.782 -2.008 . . . . 50.0 108.165 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 31.6 p90 -111.0 149.15 31.1 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.589 -0.523 . . . . 16.66 109.589 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 11.8 m-85 -128.73 169.78 14.09 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 123.703 1.716 . . . . 50.0 115.374 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.031 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.84 118.39 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 110.167 -3.197 . . . . 16.66 104.464 175.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.64 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -87.12 123.15 6.43 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 119.636 -1.269 . . . . 16.66 115.147 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.421 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -53.41 106.98 0.2 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 113.488 -1.356 . . . . 16.66 108.154 176.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB2' HG22 ' A' ' 52' ' ' VAL . 92.8 m-20 -61.04 -34.96 75.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.474 0.654 . . . . 25.0 109.394 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.53 ' C ' ' NE2' ' A' ' 30' ' ' GLN . 11.6 tpt180 -101.28 -34.51 9.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.891 -1.05 . . . . 50.0 111.632 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.238 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -92.54 5.82 49.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.826 -0.75 . . . . 16.66 112.148 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.869 ' H ' HE21 ' A' ' 30' ' ' GLN . 0.0 OUTLIER 38.95 36.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.751 1.019 . . . . 16.66 113.751 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.556 ' OD1' ' HB2' ' A' ' 26' ' ' CYS . 1.9 p30 -132.83 166.87 21.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.988 0.813 . . . . 50.0 110.449 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.64 ' HE3' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -128.66 138.18 52.03 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.218 0.822 . . . . 16.66 113.218 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' OH ' ' HB2' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -133.63 151.71 51.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.324 -0.398 . . . . 50.0 110.94 177.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.595 ' H ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -58.17 140.19 53.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.589 -1.634 . . . . 16.66 106.589 176.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.583 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.81 -54.3 5.09 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.159 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.646 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.76 -20.3 64.36 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.53 -0.468 . . . . 50.0 110.309 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.2 t -51.32 -31.77 22.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 119.682 -0.807 . . . . 16.66 108.944 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.52 14.92 7.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.183 -0.917 . . . . 16.66 111.358 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.21 46.26 43.83 Favored Glycine 0 N--CA 1.463 0.47 0 C-N-CA 121.254 -0.498 . . . . 16.66 112.039 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.583 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -118.48 167.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.118 0.485 . . . . 16.66 111.381 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.6 mp -61.23 164.69 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.755 -0.657 . . . . 50.0 110.566 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.35 -55.37 5.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.45 -0.796 . . . . 25.0 110.364 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.589 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.3 m -69.5 -15.47 63.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 50.0 109.419 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.852 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.6 -19.8 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.322 -0.854 . . . . 50.0 111.115 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HA ' HG22 ' A' ' 24' ' ' ILE . . . -74.44 -45.13 48.38 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.463 -0.495 . . . . 25.0 111.514 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.05 -45.31 10.29 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.247 1.203 . . . . 50.0 114.247 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.1 pp -55.78 -30.79 61.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.051 0.76 . . . . 16.66 113.051 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.892 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 pp -86.52 172.38 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.931 -0.708 . . . . 25.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.3 28.18 0.17 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.642 -1.163 . . . . 50.0 109.901 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.57 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.166 -1.42 . . . . 50.0 107.166 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.9 t80 -66.7 145.58 55.39 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.799 -1.091 . . . . 16.66 111.121 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.632 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 22.3 t -133.37 154.11 38.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 113.848 -1.524 . . . . 50.0 108.575 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.421 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 5.8 p -79.92 161.99 63.98 Favored Pre-proline 0 N--CA 1.411 -2.405 0 CA-C-O 121.318 0.58 . . . . 16.66 110.005 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 19.3 Cg_endo -82.67 -27.46 2.11 Favored 'Trans proline' 0 C--N 1.28 -3.043 0 C-N-CA 121.997 1.798 . . . . 16.66 111.625 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -74.28 -30.39 62.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.087 -1.079 . . . . 50.0 108.087 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.6 m -61.67 -43.42 98.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.43 -1.259 . . . . 16.66 110.675 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.446 ' OE1' ' OE1' ' A' ' 60' ' ' GLU . 26.5 mm100 -53.07 -36.43 60.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 50.0 110.722 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.1 m -61.83 -38.58 88.71 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.742 -0.383 . . . . 50.0 110.456 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.6 p -98.84 -22.45 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.284 -0.416 . . . . 50.0 111.358 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' CYS . 74.7 tt0 -56.58 -33.98 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.851 -0.339 . . . . 50.0 110.451 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 53.3 p30 -74.25 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 50.0 110.685 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.053 -0.975 . . . . 50.0 110.481 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.74 -21.81 26.81 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.816 2.344 . . . . 0.0 111.978 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 3' ' ' LEU . 2.3 mm? -88.16 142.37 27.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.301 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.0 -175.2 35.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.925 -0.87 . . . . 50.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 7' ' ' THR . 56.5 m -154.31 -116.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.32 . . . . 50.0 110.579 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 5' ' ' SER . 4.6 p-10 43.43 24.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 50.0 110.781 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 5' ' ' SER . 34.1 p -130.43 167.12 19.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 50.0 110.592 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.56 -177.23 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.834 -0.621 . . . . 50.0 110.463 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.888 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -75.35 174.81 9.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 50.0 110.644 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.801 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -97.39 -79.04 0.47 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 34.9 t -41.04 128.43 2.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.27 . . . . 16.66 112.464 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.777 HG23 ' CD2' ' A' ' 33' ' ' TYR . 13.0 pt -62.9 -10.3 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 1.047 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -76.69 -0.76 24.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.59 -1.641 . . . . 16.66 110.375 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 62.84 53.22 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.842 -0.617 . . . . 25.0 111.376 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.82 125.33 11.68 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.4 -0.364 . . . . 50.0 110.097 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.03 146.64 8.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.165 1.91 . . . . 50.0 112.08 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 9.9 t80 -64.76 137.49 57.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.166 0.508 . . . . 50.0 110.689 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 52.6 t0 -140.56 135.42 31.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.838 -0.801 . . . . 50.0 108.838 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.86 -18.12 30.02 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.912 -0.715 . . . . 50.0 109.239 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -60.82 -45.36 94.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.499 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.598 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -86.28 161.7 18.63 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.336 -1.357 . . . . 50.0 107.336 176.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 45.3 p90 -117.82 136.9 53.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.058 -0.719 . . . . 16.66 109.058 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.759 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 5.6 m-85 -112.64 165.84 11.89 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 124.187 1.946 . . . . 50.0 115.591 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.02 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.23 166.58 22.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 109.324 -3.58 . . . . 16.66 103.944 176.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -132.7 123.22 3.45 Favored Glycine 0 C--N 1.319 -0.394 0 C-N-CA 117.928 -2.082 . . . . 16.66 114.709 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.391 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.14 108.8 0.16 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.895 -1.15 . . . . 16.66 107.895 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 22.6 t70 -64.92 -31.04 72.09 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -109.08 -20.09 13.13 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.105 -1.407 . . . . 50.0 111.597 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -109.4 11.81 24.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.334 -0.947 . . . . 16.66 112.2 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.598 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 20.6 pt20 33.84 52.91 0.47 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.789 -0.187 . . . . 16.66 111.481 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.653 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -132.85 166.31 22.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.05 -0.26 . . . . 50.0 110.663 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.653 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -139.44 132.12 28.95 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 121.288 0.566 . . . . 16.66 112.238 -177.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -137.45 153.19 50.14 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.96 -0.564 . . . . 50.0 112.305 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.735 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -58.89 146.62 36.9 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 105.149 -2.167 . . . . 16.66 105.149 175.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -49.3 -48.55 33.2 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 119.247 -1.454 . . . . 16.66 111.008 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -76.91 -18.09 58.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.085 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 4.0 t -50.3 -31.65 14.93 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.645 -0.872 . . . . 16.66 108.645 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.59 14.77 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.972 -1.013 . . . . 16.66 110.798 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 67.74 46.15 70.18 Favored Glycine 0 N--CA 1.462 0.385 0 N-CA-C 111.569 -0.612 . . . . 16.66 111.569 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -113.2 167.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.211 0.529 . . . . 16.66 111.732 -178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 40' ' ' ILE . 21.8 mt -63.07 164.5 8.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.392 -0.822 . . . . 50.0 110.653 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.689 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.3 pt20 -79.86 -53.46 6.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.269 0.557 . . . . 25.0 110.059 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.7 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 74.5 m -63.98 -22.8 67.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.634 -0.876 . . . . 50.0 108.634 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.876 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -42.66 -19.46 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.26 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -69.62 -53.64 17.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.924 -1.034 . . . . 25.0 110.665 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' SER . 11.9 tm-20 -89.52 -43.46 10.8 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.105 1.52 . . . . 50.0 115.105 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.059 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.5 pp -54.72 -30.49 56.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.189 0.811 . . . . 16.66 113.189 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.059 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -85.77 174.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.653 0.74 . . . . 25.0 109.467 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.15 -51.63 0.77 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.475 -1.239 . . . . 50.0 110.206 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -108.65 59.89 0.6 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 50.0 108.067 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.735 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.2 t80 -65.92 144.02 57.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.635 0.731 . . . . 16.66 110.357 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 5.6 t -123.98 156.3 31.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.443 -1.253 . . . . 50.0 109.058 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.391 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.7 p -85.8 160.52 52.72 Favored Pre-proline 0 N--CA 1.414 -2.239 0 CA-C-O 121.675 0.75 . . . . 16.66 110.685 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.1 Cg_endo -78.34 -22.75 9.32 Favored 'Trans proline' 0 C--N 1.278 -3.14 0 C-N-CA 122.061 1.841 . . . . 16.66 111.223 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' HG22 ' A' ' 12' ' ' ILE . 97.0 mt-30 -77.61 -31.09 52.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.382 -0.826 . . . . 50.0 108.963 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.59 -46.4 11.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.344 -0.844 . . . . 16.66 110.952 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' O ' ' A' ' 60' ' ' GLU . 12.1 pt20 -49.96 -22.9 1.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.343 -0.39 . . . . 50.0 110.928 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.2 m -53.08 -36.47 60.71 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.554 -0.458 . . . . 50.0 110.117 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.5 p -80.14 -23.27 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 50.0 110.882 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' GLN . 95.5 mt-10 -104.18 155.37 18.77 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.996 0.427 . . . . 50.0 110.93 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 47.76 44.68 18.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 50.0 110.642 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 118.033 -0.984 . . . . 50.0 110.607 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -53.45 142.22 59.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.728 2.285 . . . . 0.0 112.083 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.7 mp -96.56 142.86 28.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.582 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 7' ' ' THR . . . -79.99 56.21 4.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.87 -0.892 . . . . 50.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 m -54.84 -33.74 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 50.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.0 -35.69 64.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 50.0 110.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 4' ' ' GLY . 30.8 p -119.19 164.37 15.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.439 . . . . 50.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -79.39 154.77 28.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 50.0 110.879 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.847 HD22 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -80.52 168.28 19.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 50.0 110.146 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.659 ' N ' HD22 ' A' ' 9' ' ' LEU . 19.5 m-85 -105.32 -73.4 0.68 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 48.7 t -39.84 128.86 2.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.362 0.601 . . . . 16.66 111.916 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.682 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -59.59 -7.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.128 -1.064 . . . . 50.0 108.128 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -77.42 2.14 16.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.716 -1.584 . . . . 16.66 110.928 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 42.0 mttm 69.34 54.81 0.4 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.189 -0.46 . . . . 25.0 111.773 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.433 HG23 ' HB3' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -158.67 125.18 2.49 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.537 -0.301 . . . . 50.0 110.258 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' N ' ' HB2' ' A' ' 9' ' ' LEU . 24.6 Cg_exo -56.02 176.47 0.18 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.677 2.252 . . . . 50.0 113.586 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -58.18 143.82 42.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.825 0.821 . . . . 50.0 111.402 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.5 m-20 -136.07 98.03 3.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.162 -1.381 . . . . 50.0 108.755 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -50.7 -14.75 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.266 0.555 . . . . 50.0 109.961 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.466 ' N ' ' C ' ' A' ' 18' ' ' ASP . 24.3 m -80.77 -29.53 36.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.802 -1.184 . . . . 50.0 107.802 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 18' ' ' ASP . 25.3 tptt -100.12 130.09 46.23 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.62 -1.627 . . . . 50.0 107.636 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.521 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 43.9 p90 -97.0 142.14 29.31 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.078 -0.51 . . . . 16.66 111.091 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CD2' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -119.96 173.78 6.86 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 124.441 2.067 . . . . 50.0 115.151 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.995 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.13 123.5 60.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 108.994 -3.73 . . . . 16.66 104.623 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.546 ' HA2' ' HE3' ' A' ' 32' ' ' TRP . . . -89.21 126.34 8.18 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 119.478 -1.344 . . . . 16.66 115.656 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.438 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -47.16 121.17 3.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.359 -1.348 . . . . 16.66 107.359 176.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.459 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.4 t70 -68.3 -31.64 71.22 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.578 0.704 . . . . 25.0 109.216 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NE ' ' OG1' ' A' ' 59' ' ' THR . 32.9 ttt-85 -113.56 -26.46 8.27 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.588 -1.187 . . . . 50.0 111.81 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.283 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -95.26 12.58 28.49 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.8 -0.76 . . . . 16.66 112.607 -177.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.5 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 11.4 pt20 29.92 47.69 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.823 0.675 . . . . 16.66 112.823 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.56 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -131.36 164.1 26.41 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.069 -0.252 . . . . 50.0 110.544 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.587 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -134.39 125.6 27.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.907 -0.317 . . . . 16.66 111.832 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.682 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -131.89 157.45 43.95 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 121.033 -0.267 . . . . 50.0 111.605 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.811 ' H ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -55.19 140.48 38.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.392 -1.336 . . . . 16.66 107.392 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -47.56 -42.57 20.03 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.379 -1.391 . . . . 16.66 110.615 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -77.27 -20.47 55.06 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.758 -0.46 . . . . 50.0 109.758 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.3 t -51.33 -32.49 25.57 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.799 -0.815 . . . . 16.66 108.799 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.5 11.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.028 -0.987 . . . . 16.66 110.988 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.96 45.57 50.37 Favored Glycine 0 N--CA 1.461 0.318 0 CA-C-N 115.934 -0.576 . . . . 16.66 111.837 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.526 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -106.55 163.81 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.89 0.376 . . . . 16.66 110.462 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.748 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.2 mm? -64.73 163.2 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 50.0 110.262 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -56.6 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.413 -0.812 . . . . 25.0 110.63 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.9 m -66.81 -14.64 62.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.151 -0.931 . . . . 50.0 109.164 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.006 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 3.0 tt0 -44.93 -44.47 9.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.523 -0.762 . . . . 50.0 111.056 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.12 -35.04 6.64 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.538 -0.465 . . . . 25.0 111.624 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -87.03 -52.64 5.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.796 0.665 . . . . 50.0 112.796 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.2 pp -71.95 4.98 2.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.372 -0.831 . . . . 16.66 111.452 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.006 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -107.34 130.62 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 119.695 -0.802 . . . . 25.0 111.21 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.88 -72.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.815 -1.084 . . . . 50.0 112.345 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.21 68.68 0.81 Allowed 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.302 -0.629 . . . . 50.0 109.302 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.677 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.3 147.43 53.32 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.612 -0.722 . . . . 16.66 109.53 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.677 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.6 t -119.99 155.11 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 115.469 -0.787 . . . . 50.0 109.023 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.438 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 11.2 p -84.83 160.79 54.95 Favored Pre-proline 0 N--CA 1.412 -2.334 0 CA-C-N 115.596 -0.729 . . . . 16.66 110.944 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 39.0 Cg_endo -77.81 -26.34 6.91 Favored 'Trans proline' 0 C--N 1.279 -3.127 0 C-N-CA 122.251 1.967 . . . . 16.66 111.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.79 -34.05 71.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.193 -1.04 . . . . 50.0 108.193 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -86.12 -32.92 21.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.784 -1.098 . . . . 16.66 110.309 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -54.1 -35.7 62.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 50.0 111.579 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -53.94 -36.23 62.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.5 -0.318 . . . . 50.0 111.114 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.519 ' OG1' ' NE ' ' A' ' 28' ' ' ARG . 55.3 p -90.72 -8.69 49.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.4 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -112.6 155.73 23.9 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.924 0.393 . . . . 50.0 110.971 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -83.8 120.09 25.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 50.0 110.694 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.991 -1.004 . . . . 50.0 110.486 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.91 -22.75 25.12 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.694 2.262 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.9 mt -97.06 143.4 27.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.653 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.23 -29.17 55.95 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.016 -0.834 . . . . 50.0 111.016 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p 54.79 -150.4 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.754 0.312 . . . . 50.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.776 ' OD1' HG23 ' A' ' 7' ' ' THR . 52.6 p30 -91.92 8.18 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 50.0 111.166 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.776 HG23 ' OD1' ' A' ' 6' ' ' ASP . 68.8 p -121.62 160.93 23.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.447 -0.342 . . . . 50.0 110.459 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -89.4 -177.84 5.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 50.0 110.892 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 7.1 mt -113.68 142.92 45.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 50.0 111.419 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.0 m-85 -101.85 -67.34 0.87 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.498 -0.927 . . . . 25.0 108.498 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 4.6 t -41.43 114.71 0.54 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.957 -1.019 . . . . 16.66 110.638 177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.626 HG23 ' CD1' ' A' ' 33' ' ' TYR . 4.3 pt -50.92 -8.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.575 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.946 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.68 6.72 10.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.832 -1.076 . . . . 16.66 110.7 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm 64.09 52.63 1.97 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.145 -0.48 . . . . 25.0 111.405 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.43 144.31 22.62 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 50.0 109.669 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.71 155.85 68.35 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.585 2.19 . . . . 50.0 112.408 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.705 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 30.6 t80 -58.24 148.48 27.06 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 50.0 109.833 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.491 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 91.3 m-20 -140.57 111.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.763 -0.653 . . . . 50.0 111.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.84 -17.37 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 50.0 110.043 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.5 m -76.35 -29.27 57.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.585 -1.265 . . . . 50.0 107.585 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 6.7 tptm -99.49 156.47 17.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.456 -1.702 . . . . 50.0 108.492 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 35.4 p90 -111.06 152.25 27.12 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.45 -0.5 . . . . 16.66 110.364 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.705 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 9.5 m-85 -130.46 168.83 16.38 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 123.42 1.581 . . . . 50.0 114.256 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.03 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.36 123.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 110.932 -2.849 . . . . 16.66 105.53 176.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.52 120.08 6.16 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 119.876 -1.154 . . . . 16.66 115.773 -174.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.439 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.21 107.6 0.13 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.273 -1.38 . . . . 16.66 107.273 175.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 89.7 m-20 -65.52 -34.08 77.43 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HE ' HG23 ' A' ' 59' ' ' THR . 37.4 ttt85 -92.71 -39.55 11.2 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.519 -1.673 . . . . 50.0 110.935 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.276 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.09 -28.4 27.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.918 -0.713 . . . . 16.66 111.49 -178.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.779 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER 76.13 28.68 0.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.486 0.921 . . . . 16.66 113.486 178.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.523 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.96 166.18 22.97 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 119.776 -0.77 . . . . 50.0 111.079 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 140.66 50.72 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.922 0.712 . . . . 16.66 112.922 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.69 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -133.62 144.38 49.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.454 -0.339 . . . . 50.0 111.061 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.814 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.7 OUTLIER -56.34 139.31 48.88 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.395 -1.706 . . . . 16.66 106.395 176.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.499 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.8 -54.34 5.07 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 119.843 -1.17 . . . . 16.66 111.53 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.61 -20.28 62.76 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.486 -0.486 . . . . 50.0 109.784 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.039 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.5 -31.88 25.43 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.281 -0.637 . . . . 16.66 109.281 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.57 13.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.344 -0.844 . . . . 16.66 111.185 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.51 45.98 57.42 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.793 -0.523 . . . . 16.66 111.793 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.499 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -113.86 167.51 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.137 0.494 . . . . 16.66 111.363 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 40' ' ' ILE . 42.4 mt -61.47 164.85 5.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.555 -0.748 . . . . 50.0 110.582 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.514 ' HB3' HE21 ' A' ' 42' ' ' GLN . 1.1 tt0 -77.92 -55.1 5.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.128 -0.942 . . . . 25.0 110.314 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.62 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 72.7 m -70.78 -15.24 62.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.507 -0.769 . . . . 50.0 109.441 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.872 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -41.97 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.564 -0.744 . . . . 50.0 110.755 -178.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.64 -45.5 58.65 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.939 -0.573 . . . . 25.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 43' ' ' SER . 97.1 mt-10 -88.93 -45.69 9.48 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.593 1.331 . . . . 50.0 114.593 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 48' ' ' ILE . 1.8 pp -55.29 -29.28 57.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.948 0.721 . . . . 16.66 112.948 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.053 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -86.06 174.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.803 0.811 . . . . 25.0 109.641 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -124.51 -69.74 0.79 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.261 -1.336 . . . . 50.0 110.91 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -101.31 70.57 1.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.916 -1.142 . . . . 50.0 107.916 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.72 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.3 t80 -65.74 140.12 58.42 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.433 -0.803 . . . . 16.66 110.728 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.72 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.5 t -120.29 155.16 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 114.458 -1.246 . . . . 50.0 108.556 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.439 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.7 p -87.28 160.21 49.03 Favored Pre-proline 0 N--CA 1.414 -2.275 0 CA-C-O 121.39 0.614 . . . . 16.66 110.491 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 24.8 Cg_endo -81.52 -25.24 3.86 Favored 'Trans proline' 0 C--N 1.279 -3.095 0 C-N-CA 122.085 1.857 . . . . 16.66 110.764 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -71.34 -35.67 71.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.095 -0.957 . . . . 50.0 108.565 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -70.39 -31.82 69.2 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.225 -0.898 . . . . 16.66 110.413 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 53' ' ' CYS . 94.3 mt-30 -55.96 -29.86 60.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.924 0.392 . . . . 50.0 110.456 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.4 p -59.1 -24.62 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.031 -0.531 . . . . 50.0 110.867 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.521 HG23 ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -122.72 -16.71 7.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.925 -0.31 . . . . 50.0 111.794 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' C ' ' CD ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -57.0 139.59 51.69 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.256 -0.577 . . . . 50.0 110.429 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 87.7 m-20 -107.74 151.58 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 50.0 110.672 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 61' ' ' ASP . . . . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.957 -1.021 . . . . 50.0 110.406 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' GLY . 53.5 Cg_exo -48.88 -175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.803 2.335 . . . . 0.0 112.048 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.9 tp -52.21 -38.76 58.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.265 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.38 163.67 29.21 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.07 -0.812 . . . . 50.0 111.07 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -29.37 70.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.815 0.34 . . . . 50.0 110.825 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -74.38 122.04 22.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 50.0 110.87 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -123.62 176.52 6.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.909 -0.587 . . . . 50.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -70.1 -176.26 1.11 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.785 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.837 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -61.28 -178.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.851 -0.613 . . . . 50.0 110.303 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.643 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 4.9 m-85 -69.46 -99.13 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.173 -0.676 . . . . 25.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 15.6 t -40.34 121.86 1.46 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.497 -0.774 . . . . 16.66 112.456 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.729 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.2 pt -59.09 -7.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.521 -1.218 . . . . 50.0 108.807 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.981 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.11 10.45 2.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.414 -1.266 . . . . 16.66 110.848 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.0 mttm 65.63 51.5 1.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.045 -0.525 . . . . 25.0 111.989 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.01 148.1 31.37 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.736 -0.385 . . . . 50.0 110.552 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.3 158.56 48.38 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.728 2.285 . . . . 50.0 111.8 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.2 t80 -58.31 144.84 39.97 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 120.662 -0.415 . . . . 50.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 92.5 m-20 -140.79 116.64 10.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.85 -0.614 . . . . 50.0 110.48 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -58.87 -12.86 4.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.389 -0.597 . . . . 50.0 109.389 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 m -79.33 -21.12 46.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.541 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.1 tptm -112.98 153.08 28.61 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.524 -1.671 . . . . 50.0 107.824 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.2 p90 -111.13 154.11 24.77 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.228 -0.589 . . . . 16.66 110.607 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.765 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.5 m-85 -127.8 169.8 13.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 123.779 1.752 . . . . 50.0 114.475 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.049 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -126.79 178.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.128 -3.214 . . . . 16.66 103.796 176.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.89 125.45 2.71 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 117.521 -2.275 . . . . 16.66 114.158 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.38 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 105.66 0.08 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.366 -1.346 . . . . 16.66 107.366 176.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' TYR . 84.5 m-20 -71.19 -19.95 62.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.227 -1.027 . . . . 25.0 108.227 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.622 HH21 ' CB ' ' A' ' 61' ' ' ASP . 6.9 tpt180 -111.61 -18.22 12.85 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.002 -1.454 . . . . 50.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.207 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -122.8 18.06 10.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.323 -0.951 . . . . 16.66 112.708 -178.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.594 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 19.3 pt20 32.93 54.42 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.202 0.445 . . . . 16.66 112.202 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.622 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.5 OUTLIER -133.94 167.51 20.46 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 121.096 -0.242 . . . . 50.0 110.485 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.642 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -138.76 133.26 31.95 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.432 0.53 . . . . 16.66 112.432 -177.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.729 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -139.49 155.02 47.82 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.006 -0.543 . . . . 50.0 112.06 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.891 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.51 141.79 57.48 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 106.243 -1.762 . . . . 16.66 106.243 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.537 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -43.52 -58.53 4.0 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.633 -1.27 . . . . 16.66 111.518 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.426 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -66.79 -20.95 66.05 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.985 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.5 t -51.72 -31.77 27.62 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.126 -0.63 . . . . 16.66 109.482 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.34 12.52 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.442 -0.799 . . . . 16.66 111.128 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.85 25.09 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 111.608 -0.597 . . . . 16.66 111.608 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -122.01 167.46 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.178 0.513 . . . . 16.66 112.038 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.4 mm? -62.49 164.15 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 50.0 110.432 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.661 ' HG2' ' H ' ' A' ' 43' ' ' SER . 7.9 pt20 -82.12 -49.38 10.24 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.905 ' C ' HD21 ' A' ' 47' ' ' LEU . 5.7 m -59.53 -39.0 82.5 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.422 -1.717 . . . . 50.0 107.459 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.757 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -40.15 -16.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.394 -0.821 . . . . 50.0 110.288 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.663 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -63.1 -61.65 2.23 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.249 -0.581 . . . . 25.0 111.649 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.4 mp0 -91.87 -47.35 7.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.857 1.799 . . . . 50.0 115.857 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.155 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -65.71 14.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.495 1.295 . . . . 16.66 114.495 -174.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 44' ' ' GLU . 2.5 pp -117.15 169.45 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 120.133 -0.627 . . . . 25.0 109.962 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 53.3 t0 -165.42 27.59 0.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.748 0.785 . . . . 50.0 109.935 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.46 16.09 0.52 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.248 -1.39 . . . . 50.0 107.248 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.634 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.3 t80 -67.37 147.61 52.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.802 -1.09 . . . . 16.66 110.511 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 25.2 t -137.26 157.57 34.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.888 -1.505 . . . . 50.0 108.917 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.38 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.0 p -80.03 158.21 72.71 Favored Pre-proline 0 N--CA 1.414 -2.254 0 N-CA-C 108.887 -0.783 . . . . 16.66 108.887 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 11.0 Cg_endo -81.35 -27.94 2.57 Favored 'Trans proline' 0 C--N 1.273 -3.406 0 C-N-CA 121.842 1.694 . . . . 16.66 110.932 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -71.97 -33.83 68.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.461 -0.79 . . . . 50.0 108.877 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.151 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -65.43 -34.68 78.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.59 -0.732 . . . . 16.66 110.559 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -51.29 -36.99 45.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 50.0 110.34 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.2 p -78.62 -31.88 47.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.354 -0.384 . . . . 50.0 110.159 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' C ' ' A' ' 60' ' ' GLU . 33.3 m -71.87 -50.66 27.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.158 -0.473 . . . . 50.0 111.289 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.582 ' C ' ' O ' ' A' ' 59' ' ' THR . 98.6 mt-10 12.01 59.99 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.325 0.391 . . . . 50.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.622 ' CB ' HH21 ' A' ' 28' ' ' ARG . 91.2 m-20 36.88 -88.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 50.0 111.049 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.029 -0.986 . . . . 50.0 110.52 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.482 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 50.0 Cg_endo -69.21 158.02 59.24 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.784 2.322 . . . . 0.0 111.987 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.7 mt -56.96 -32.75 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.72 -69.46 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.899 -0.88 . . . . 50.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.6 m -64.86 165.38 10.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 50.0 110.81 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -48.88 160.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 50.0 110.312 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.454 HG22 ' HB3' ' A' ' 2' ' ' PRO . 50.5 p -81.29 161.85 23.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.486 0.66 . . . . 50.0 111.556 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.674 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -151.45 -176.95 5.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.753 -1.112 . . . . 50.0 109.158 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.575 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 17.3 mt -83.75 137.44 33.74 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.924 -0.31 . . . . 50.0 110.714 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 2.7 m-85 -106.12 -6.26 18.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.364 0.602 . . . . 25.0 111.014 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -104.15 123.08 46.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.923 -1.035 . . . . 16.66 110.844 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.692 HG23 ' CD2' ' A' ' 33' ' ' TYR . 14.0 pt -59.96 -8.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.203 -1.406 . . . . 50.0 107.203 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.961 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -84.79 2.19 43.37 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 113.47 -1.696 . . . . 16.66 109.472 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mttp 67.78 64.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.553 -0.749 . . . . 25.0 112.246 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.3 141.64 13.13 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 120.409 -0.516 . . . . 50.0 110.709 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.98 158.73 52.66 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.657 2.238 . . . . 50.0 112.104 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.753 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 20.0 t80 -69.37 139.07 54.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.078 0.466 . . . . 50.0 110.936 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 11.5 t70 -140.58 128.62 22.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.593 -0.731 . . . . 50.0 109.47 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.6 -21.9 41.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.074 -0.512 . . . . 50.0 110.907 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -67.17 -33.79 76.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.744 -1.206 . . . . 50.0 107.744 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -85.41 152.49 23.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.259 -1.791 . . . . 50.0 109.114 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 22.0 p90 -114.17 140.6 48.4 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.32 -0.993 . . . . 16.66 108.32 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.753 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 28.5 m-85 -122.61 171.35 9.19 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 124.089 1.9 . . . . 50.0 115.621 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.041 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.28 118.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 109.513 -3.494 . . . . 16.66 103.977 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -90.42 125.64 8.01 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.58 -1.295 . . . . 16.66 116.279 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.415 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -46.64 108.45 0.14 Allowed 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.31 -1.367 . . . . 16.66 107.31 175.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.673 ' HB3' HG22 ' A' ' 52' ' ' VAL . 57.3 t0 -61.52 -29.3 69.9 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.018 -0.734 . . . . 25.0 109.018 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.42 ' O ' ' CG ' ' A' ' 28' ' ' ARG . 13.6 ttt85 -113.72 -20.36 11.19 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.705 -1.134 . . . . 50.0 112.344 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.245 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -107.96 20.29 18.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.317 -0.953 . . . . 16.66 112.981 -177.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 29' ' ' CYS . 16.4 pt20 31.06 47.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.521 0.563 . . . . 16.66 112.521 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.529 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 0.6 OUTLIER -131.54 159.79 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.748 -0.381 . . . . 50.0 110.703 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -135.74 122.87 21.56 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.727 0.299 . . . . 16.66 111.049 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.692 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -124.09 153.66 41.1 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.456 -0.307 . . . . 50.0 111.406 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.839 ' CE1' ' HG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -54.8 146.42 17.24 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.728 -1.953 . . . . 16.66 105.728 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.543 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -46.2 -53.18 9.52 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 119.461 -1.352 . . . . 16.66 111.505 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -73.7 -19.4 60.83 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.715 -0.476 . . . . 50.0 109.715 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.6 t -49.96 -31.29 12.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 33' ' ' TYR . 4.0 m -115.77 9.45 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.203 -0.908 . . . . 16.66 110.3 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.79 45.83 20.16 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.395 -0.682 . . . . 16.66 111.395 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.543 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -117.3 167.53 10.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.91 0.386 . . . . 16.66 110.876 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 40' ' ' ILE . 90.1 mt -65.64 163.24 16.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.338 0.589 . . . . 50.0 109.666 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.07 -54.88 5.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.937 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.0 t -70.32 -14.77 62.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.431 -0.804 . . . . 50.0 110.677 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.68 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.7 mt-10 -44.4 -30.1 0.79 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.648 -0.421 . . . . 50.0 111.159 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -37.66 88.11 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.07 -0.652 . . . . 25.0 110.53 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.3 mm-40 -87.89 -33.17 18.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.227 1.195 . . . . 50.0 114.227 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.666 HD11 ' HA ' ' A' ' 44' ' ' GLU . 3.7 pp -94.31 16.24 15.51 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 112.716 0.636 . . . . 16.66 112.716 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -120.17 146.87 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 C-N-CA 118.704 -1.198 . . . . 25.0 112.888 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -94.38 -81.22 0.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.074 -0.966 . . . . 50.0 111.792 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -103.27 69.89 1.03 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.585 -0.279 . . . . 50.0 110.449 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.637 ' CG ' ' HB ' ' A' ' 24' ' ' ILE . 5.1 t80 -67.28 138.85 57.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.476 -0.89 . . . . 16.66 108.802 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 27' ' ' ASP . 23.9 t -119.38 150.81 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 115.722 -0.672 . . . . 50.0 109.315 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.415 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.8 p -80.99 160.91 64.94 Favored Pre-proline 0 N--CA 1.411 -2.395 0 CA-C-N 115.316 -0.857 . . . . 16.66 110.052 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 27.9 Cg_endo -80.43 -29.16 2.52 Favored 'Trans proline' 0 C--N 1.278 -3.177 0 C-N-CA 122.001 1.8 . . . . 16.66 111.405 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -70.83 -32.88 70.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 3.0 m -62.61 -39.69 94.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.789 -1.096 . . . . 16.66 110.34 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -55.01 -17.23 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 50.0 110.352 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 m -54.51 -33.92 60.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 50.0 110.42 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.2 p -123.9 -17.03 6.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.903 0.335 . . . . 50.0 111.903 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 41.68 -114.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.738 -0.385 . . . . 50.0 110.679 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 54.5 p30 -67.81 175.15 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 50.0 110.406 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.983 -1.008 . . . . 50.0 110.55 -179.878 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 4' ' ' GLY . 35.8 Cg_exo -54.38 -29.07 56.67 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.022 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' C ' HD13 ' A' ' 3' ' ' LEU . 0.2 OUTLIER 62.78 -77.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.392 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -84.81 -179.54 51.21 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.898 -0.881 . . . . 50.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.1 p -75.16 158.32 33.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.854 0.359 . . . . 50.0 110.593 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.76 120.64 27.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 50.0 110.41 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -81.39 165.04 21.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 50.0 110.481 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' NZ ' HG22 ' A' ' 12' ' ' ILE . 3.2 ptmt -130.33 158.07 40.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 50.0 110.655 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.83 ' CD1' ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.1 -174.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.587 . . . . 50.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -59.55 -104.16 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.389 0.614 . . . . 25.0 110.491 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 43.4 t -37.67 122.51 0.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.034 -0.985 . . . . 16.66 113.298 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.753 HG23 ' CD2' ' A' ' 33' ' ' TYR . 8.8 pt -59.95 -13.98 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 114.862 -1.063 . . . . 50.0 108.138 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.965 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -72.25 4.5 3.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 113.811 -1.54 . . . . 16.66 110.137 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt 65.85 50.29 1.54 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.488 -0.778 . . . . 25.0 112.065 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.23 123.51 9.41 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 110.242 -0.281 . . . . 50.0 110.242 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.01 156.66 12.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.346 2.031 . . . . 50.0 111.948 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 4.5 t80 -61.28 134.25 56.77 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.293 0.568 . . . . 50.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 20' ' ' SER . 88.1 m-20 -141.46 116.02 9.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.085 -0.961 . . . . 50.0 108.83 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -43.92 -13.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.627 -0.429 . . . . 50.0 110.481 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -62.84 -38.41 90.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.748 -0.834 . . . . 50.0 108.748 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -99.85 167.52 10.47 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.566 -0.901 . . . . 50.0 108.566 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.1 p90 -120.77 142.32 49.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.694 -0.684 . . . . 16.66 109.168 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 2.9 m-85 -114.03 155.49 25.82 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 123.791 1.758 . . . . 50.0 115.414 -175.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.01 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -121.92 126.43 74.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 110.2 -3.182 . . . . 16.66 105.123 176.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.66 123.68 7.41 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.556 -1.307 . . . . 16.66 115.054 -175.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER -49.86 107.0 0.13 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 113.65 -1.275 . . . . 16.66 108.89 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.635 ' HB2' HG22 ' A' ' 52' ' ' VAL . 80.8 m-20 -56.88 -35.13 68.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.265 -0.574 . . . . 25.0 110.317 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.497 ' HE ' ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -112.71 -12.71 13.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 50.0 111.873 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.27 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -110.21 12.58 23.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.323 -0.951 . . . . 16.66 111.57 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.52 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 10.0 pt20 29.92 53.43 0.12 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.941 0.4 . . . . 16.66 111.101 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.645 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 2.8 m-20 -132.45 166.64 21.54 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.31 -0.404 . . . . 50.0 110.189 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.645 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -141.36 132.8 26.81 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.333 -0.547 . . . . 16.66 111.676 -177.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.753 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -138.56 155.47 48.34 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 50.0 112.494 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.824 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -60.62 146.58 44.87 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 105.064 -2.198 . . . . 16.66 105.064 175.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.0 -51.27 25.37 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 119.136 -1.507 . . . . 16.66 110.831 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -73.84 -18.48 60.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.712 -0.395 . . . . 50.0 109.953 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.015 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.0 t -50.39 -32.48 17.65 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.066 -0.716 . . . . 16.66 109.066 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.18 18.68 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.016 -0.993 . . . . 16.66 111.219 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.98 46.19 82.92 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 111.513 -0.635 . . . . 16.66 111.513 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.88 164.01 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.864 0.364 . . . . 16.66 110.934 -178.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.755 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 10.4 mp -58.0 164.76 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.245 0.545 . . . . 50.0 110.162 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -56.26 4.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.34 -0.845 . . . . 25.0 110.985 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.494 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 67.4 m -71.23 -15.55 62.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.59 -0.732 . . . . 50.0 109.236 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.779 ' HA ' HD11 ' A' ' 47' ' ' LEU . 2.1 tt0 -43.36 -19.13 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.481 -0.781 . . . . 50.0 111.172 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -68.56 -47.01 67.92 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.432 -0.507 . . . . 25.0 111.19 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.25 -45.69 9.86 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.261 1.208 . . . . 50.0 114.261 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.089 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.3 pp -55.15 -28.16 50.76 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.842 0.682 . . . . 16.66 112.842 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.089 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.6 pp -85.76 174.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.607 0.718 . . . . 25.0 109.349 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -137.46 -53.88 0.68 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.642 -1.163 . . . . 50.0 110.455 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -103.69 56.35 0.74 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.823 -1.177 . . . . 50.0 107.823 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.66 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 6.3 t80 -65.27 141.46 58.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.537 0.684 . . . . 16.66 109.876 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.1 t -126.06 154.83 35.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.375 -1.284 . . . . 50.0 109.288 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -82.21 159.51 64.84 Favored Pre-proline 0 N--CA 1.413 -2.289 0 CA-C-N 115.69 -0.686 . . . . 16.66 109.824 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 22.6 Cg_endo -81.28 -25.65 3.79 Favored 'Trans proline' 0 C--N 1.275 -3.297 0 C-N-CA 121.962 1.775 . . . . 16.66 111.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -74.79 -32.59 62.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.719 . . . . 50.0 109.101 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.145 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -65.92 -38.5 88.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.363 -0.835 . . . . 16.66 110.907 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -50.72 -40.19 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.802 -0.444 . . . . 50.0 109.802 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -72.76 -29.18 63.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 50.0 109.323 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -72.88 -54.84 7.7 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.633 -0.712 . . . . 50.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.497 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 95.5 mt-10 -128.37 155.22 45.03 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.861 0.362 . . . . 50.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -131.44 162.67 29.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.099 -0.501 . . . . 50.0 110.408 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' OXT' ' NH2' ' A' ' 28' ' ' ARG . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.094 -0.955 . . . . 50.0 110.638 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.0 142.34 44.17 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.455 2.104 . . . . 0.0 112.159 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 3' ' ' LEU . 5.9 mp -95.46 149.28 21.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.365 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.63 51.93 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.86 -0.896 . . . . 50.0 110.86 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' ASP . 28.7 p -79.54 5.4 13.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 50.0 110.601 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 52.8 p30 -56.25 -155.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.258 -0.428 . . . . 50.0 110.569 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 14.8 m -80.96 116.22 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.885 -0.326 . . . . 50.0 110.754 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 7' ' ' THR . 8.3 mtpt -145.69 -177.18 5.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.214 0.53 . . . . 50.0 110.771 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.685 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.2 158.91 24.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.799 . . . . 50.0 109.426 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.9 m-85 -94.04 -71.92 0.64 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.562 -0.533 . . . . 25.0 109.562 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 37.4 t -40.52 111.0 0.17 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.5 -0.773 . . . . 16.66 110.334 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.696 HG23 ' CD2' ' A' ' 33' ' ' TYR . 18.8 pt -51.84 -7.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.918 -0.771 . . . . 50.0 108.918 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -83.49 30.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.484 -1.234 . . . . 16.66 109.392 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 12' ' ' ILE . 48.8 pttt 42.66 55.81 4.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.489 -0.778 . . . . 25.0 111.619 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 p -145.54 141.55 17.06 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.51 -0.314 . . . . 50.0 110.28 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.2 154.01 56.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.451 2.101 . . . . 50.0 111.482 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 17.5 t80 -57.81 138.71 55.37 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.05 -0.66 . . . . 50.0 109.84 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.5 m-20 -141.56 118.58 11.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.1 -0.955 . . . . 50.0 110.435 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -51.23 -22.9 2.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.055 -0.72 . . . . 50.0 109.055 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.5 p -63.45 -35.4 80.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.972 -1.121 . . . . 50.0 107.972 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -90.9 155.14 18.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 113.868 -1.514 . . . . 50.0 108.926 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 46.0 p90 -118.39 123.34 45.02 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.03 0.919 . . . . 16.66 110.168 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 m-85 -103.03 162.55 12.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 123.769 1.747 . . . . 50.0 114.879 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.057 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -130.8 117.46 38.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 110.183 -3.189 . . . . 16.66 103.63 176.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.28 135.46 13.34 Favored Glycine 0 C--N 1.316 -0.543 0 N-CA-C 116.866 1.507 . . . . 16.66 116.866 -173.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.45 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.7 OUTLIER -46.86 117.78 1.8 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.946 -1.627 . . . . 16.66 108.503 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.704 ' HB2' HG22 ' A' ' 52' ' ' VAL . 23.9 t70 -51.71 -46.49 63.93 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.662 -0.815 . . . . 25.0 109.818 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.526 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -117.34 -5.94 11.27 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.212 0.819 . . . . 50.0 113.212 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.265 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -98.08 14.66 26.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 118.669 -1.212 . . . . 16.66 111.37 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.569 ' CD ' ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER 30.53 50.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.716 . . . . 16.66 111.963 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.567 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 10.2 m-20 -131.87 163.92 27.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.414 -0.357 . . . . 50.0 110.193 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.549 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -136.57 126.22 25.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.74 0.305 . . . . 16.66 110.832 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.696 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -124.8 141.82 51.85 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.796 ' ND1' ' SG ' ' A' ' 37' ' ' CYS . 6.6 p-80 -56.02 146.99 20.94 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.649 -1.612 . . . . 16.66 106.649 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.51 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -40.36 -60.7 1.95 Allowed Glycine 0 C--N 1.306 -1.111 0 C-N-CA 119.913 -1.137 . . . . 16.66 113.382 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.524 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -68.82 -20.36 64.31 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.221 0.534 . . . . 50.0 109.783 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -49.3 -25.9 2.69 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.343 -0.984 . . . . 16.66 108.343 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 33' ' ' TYR . 17.7 m -124.32 7.8 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.184 -0.916 . . . . 16.66 111.345 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 79.35 46.38 8.14 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.824 -0.91 . . . . 16.66 110.824 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 41' ' ' LEU . 1.1 tp -106.0 155.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.019 0.437 . . . . 16.66 110.692 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.7 mt -61.92 166.19 4.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.942 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -70.61 -53.55 15.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.76 -0.654 . . . . 25.0 109.362 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 45' ' ' ALA . 75.6 m -75.58 -14.65 60.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.218 -0.901 . . . . 50.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.995 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -43.11 -18.17 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.932 -0.576 . . . . 50.0 110.203 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -72.06 -43.55 64.72 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.519 -0.472 . . . . 25.0 110.969 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.67 ' C ' ' H ' ' A' ' 48' ' ' ILE . 97.4 mt-10 -87.6 -52.98 5.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.138 0.792 . . . . 50.0 113.138 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.817 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.67 9.08 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.049 -0.523 . . . . 16.66 110.63 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.995 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -112.62 135.66 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.282 -0.872 . . . . 25.0 112.146 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 59.5 t0 -91.59 -71.89 0.61 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.996 -1.002 . . . . 50.0 110.992 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' OE1' ' OD1' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -130.29 78.42 1.84 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.889 -0.782 . . . . 50.0 108.889 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.762 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.31 147.32 53.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.026 -0.731 . . . . 16.66 109.026 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.762 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 21.5 t -110.71 158.87 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.243 -0.583 . . . . 50.0 109.9 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.45 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -89.38 159.61 44.06 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 115.704 -0.68 . . . . 16.66 110.12 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 43.4 Cg_endo -79.28 -30.45 2.6 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 C-N-CA 121.746 1.631 . . . . 16.66 110.834 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.91 -32.99 73.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.588 -1.264 . . . . 50.0 107.588 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.115 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.1 m -60.73 -42.69 97.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.177 -1.374 . . . . 16.66 109.914 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' O ' ' A' ' 60' ' ' GLU . 93.1 mt-30 -57.73 -37.64 73.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.425 -0.807 . . . . 50.0 110.245 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.5 m -60.84 -38.93 87.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.312 -0.625 . . . . 50.0 109.312 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.427 HG22 ' OE2' ' A' ' 60' ' ' GLU . 28.4 m -77.83 -48.33 16.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.629 -0.714 . . . . 50.0 110.629 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 57' ' ' GLN . 51.9 mp0 -114.78 147.35 39.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.669 -0.412 . . . . 50.0 110.804 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 55.78 45.67 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 50.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.019 -0.991 . . . . 50.0 110.481 179.912 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.79 120.38 7.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.545 2.164 . . . . 0.0 111.93 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.701 ' O ' HD23 ' A' ' 3' ' ' LEU . 7.6 tt -63.86 -37.86 88.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.33 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.43 49.56 5.43 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.326 -0.71 . . . . 50.0 111.326 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.427 ' HB2' HD22 ' A' ' 3' ' ' LEU . 34.6 t -97.61 128.85 44.64 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.838 0.351 . . . . 50.0 110.315 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 7' ' ' THR . 33.7 p-10 -67.33 -39.62 85.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 50.0 111.476 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.534 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 19.5 p -149.39 -170.28 3.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.259 0.552 . . . . 50.0 111.559 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 17.7 mmmt -104.14 -177.6 3.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.373 -0.83 . . . . 50.0 111.082 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.58 144.45 30.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.733 -0.667 . . . . 50.0 110.894 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.8 m-85 -106.17 -67.35 0.94 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.7 t -41.63 116.53 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.27 -0.877 . . . . 16.66 110.742 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' CD1' ' A' ' 33' ' ' TYR . 11.3 pt -52.3 -7.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.18 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.947 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -79.85 3.08 20.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.662 -1.153 . . . . 16.66 110.671 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.1 mttp 67.94 55.17 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.187 -0.46 . . . . 25.0 111.786 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.412 ' CG2' ' NE2' ' A' ' 34' ' ' HIS . 0.6 OUTLIER -147.62 145.2 20.7 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 110.063 -0.347 . . . . 50.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.58 150.37 79.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.447 2.098 . . . . 50.0 111.874 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.741 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.0 t80 -54.26 146.24 15.82 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.49 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 91.2 m-20 -140.56 112.75 7.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.999 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.21 -17.6 7.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 50.0 109.934 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 t -72.11 -31.93 66.49 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.313 -1.366 . . . . 50.0 107.313 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 0.9 OUTLIER -97.93 157.28 16.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.07 -1.877 . . . . 50.0 109.006 179.079 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 45.5 p90 -114.17 146.58 40.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.303 -0.559 . . . . 16.66 109.978 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.741 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 5.7 m-85 -122.83 165.22 16.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 123.355 1.55 . . . . 50.0 114.269 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.008 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -123.96 119.66 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 111.099 -2.773 . . . . 16.66 105.18 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -84.96 124.33 6.69 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.545 -1.312 . . . . 16.66 114.534 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.435 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -46.8 107.78 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.656 -1.609 . . . . 16.66 106.656 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 54.9 t0 -59.89 -29.82 68.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' NH2' ' OE2' ' A' ' 60' ' ' GLU . 13.6 tpp180 -113.89 -13.34 12.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.548 -1.205 . . . . 50.0 111.695 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.326 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -112.3 10.54 20.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 119.861 -0.735 . . . . 16.66 111.798 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.593 ' NE2' ' O ' ' A' ' 29' ' ' CYS . 3.8 pp0? 34.02 49.65 0.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.188 0.44 . . . . 16.66 112.188 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.705 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.1 m120 -132.25 166.19 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.946 -0.39 . . . . 50.0 109.946 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -134.53 133.04 39.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 120.801 -0.36 . . . . 16.66 111.936 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.77 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -132.94 143.58 49.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.496 -0.32 . . . . 50.0 111.012 178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.883 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -51.27 143.33 11.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.923 -1.51 . . . . 16.66 106.923 176.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.11 -59.59 2.91 Favored Glycine 0 C--N 1.318 -0.437 0 C-N-CA 119.885 -1.15 . . . . 16.66 111.396 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.18 -19.06 63.99 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.762 -0.375 . . . . 50.0 110.394 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.08 -30.2 10.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.539 -0.911 . . . . 16.66 108.539 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 33' ' ' TYR . 6.7 m -117.52 8.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.251 -0.886 . . . . 16.66 111.146 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 77.66 45.52 10.76 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.167 -0.54 . . . . 16.66 112.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.491 ' CG2' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -112.98 167.07 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.131 0.491 . . . . 16.66 110.923 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 41' ' ' LEU . 6.5 mp -64.24 161.87 15.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.654 -0.703 . . . . 50.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -54.33 6.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.859 -0.793 . . . . 25.0 108.859 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' GLU . 32.9 t -60.01 -12.52 8.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.707 -1.133 . . . . 50.0 109.07 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.821 ' CD ' ' N ' ' A' ' 45' ' ' ALA . 1.9 pp20? -40.49 -55.75 2.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.211 -0.904 . . . . 50.0 111.068 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.821 ' N ' ' CD ' ' A' ' 44' ' ' GLU . . . -56.55 -26.22 54.36 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.342 -0.844 . . . . 25.0 110.473 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' SER . 84.6 tt0 -86.77 -25.45 24.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.181 0.515 . . . . 50.0 111.965 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 47' ' ' LEU . 4.2 pp -117.92 11.51 13.48 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 115.599 -0.728 . . . . 16.66 112.35 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.809 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -119.15 145.39 25.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.097 -1.041 . . . . 25.0 111.864 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.617 ' H ' HD13 ' A' ' 48' ' ' ILE . 22.5 t70 -146.65 -42.62 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.163 -0.926 . . . . 50.0 111.628 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -94.21 24.88 4.09 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.67 -0.863 . . . . 50.0 108.67 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 2.7 t80 -65.28 141.74 58.51 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.47 -0.786 . . . . 16.66 109.061 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' H ' ' A' ' 27' ' ' ASP . 4.9 t -129.32 157.77 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.822 -1.081 . . . . 50.0 108.423 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.435 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 7.3 p -79.62 158.92 72.84 Favored Pre-proline 0 N--CA 1.414 -2.265 0 CA-C-O 121.66 0.743 . . . . 16.66 110.693 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 23.8 Cg_endo -81.05 -15.75 10.24 Favored 'Trans proline' 0 C--N 1.278 -3.146 0 C-N-CA 122.15 1.9 . . . . 16.66 111.573 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.533 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 11.4 pt20 -87.53 -30.38 20.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 50.0 109.52 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.156 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -86.22 -39.16 16.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.924 -0.58 . . . . 16.66 111.023 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -49.61 -32.87 13.8 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.736 -0.386 . . . . 50.0 110.612 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.1 p -56.99 -31.84 65.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.006 -0.368 . . . . 50.0 110.006 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.2 p -71.21 -37.97 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 50.0 110.33 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.561 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 23.8 pt-20 -174.71 -174.81 0.85 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.115 -0.493 . . . . 50.0 110.632 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 55.69 45.44 24.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 50.0 110.712 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.028 -0.987 . . . . 50.0 110.533 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 4' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.44 -64.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.659 2.239 . . . . 0.0 112.067 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.45 -36.52 82.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -103.66 134.86 12.08 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.05 -0.82 . . . . 50.0 111.05 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.8 t -128.45 142.51 51.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 50.0 110.583 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 6' ' ' ASP . 46.5 p30 -148.62 104.14 3.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 50.0 110.652 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -121.82 161.0 23.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.158 -0.473 . . . . 50.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -136.95 173.73 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.99 -0.55 . . . . 50.0 110.246 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.759 ' CD1' ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.51 -176.1 0.1 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.694 -0.402 . . . . 50.0 110.461 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.616 ' CD2' ' CD1' ' A' ' 32' ' ' TRP . 2.6 m-85 -95.38 -75.49 0.52 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 120.107 -0.637 . . . . 25.0 112.04 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 11.4 t -38.39 118.54 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.428 0.632 . . . . 16.66 112.146 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.508 HG23 ' CD1' ' A' ' 33' ' ' TYR . 6.6 pt -53.31 -7.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.148 -0.933 . . . . 50.0 108.97 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.27 5.51 19.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.396 -1.274 . . . . 16.66 110.911 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 68.14 51.68 0.71 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.168 -0.469 . . . . 25.0 111.891 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 124.96 4.67 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.932 -0.307 . . . . 50.0 110.792 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 38.1 Cg_exo -55.19 162.68 5.34 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.644 2.229 . . . . 50.0 112.654 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.87 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 11.4 t80 -63.3 138.39 58.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.538 0.685 . . . . 50.0 111.128 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.546 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 70.8 m-20 -142.91 131.6 22.59 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.652 -1.158 . . . . 50.0 109.951 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.07 -20.74 62.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 50.0 110.395 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -63.11 -30.03 71.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.699 0.761 . . . . 50.0 109.1 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.735 ' HG3' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -106.09 158.35 16.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 114.378 -1.283 . . . . 50.0 107.685 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE2' ' HA3' ' A' ' 35' ' ' GLY . 45.8 p90 -119.38 137.91 53.43 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.082 -0.647 . . . . 16.66 109.288 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.87 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 2.2 m-85 -111.02 170.3 8.19 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 124.066 1.889 . . . . 50.0 115.331 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.03 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.32 118.72 24.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 109.747 -3.388 . . . . 16.66 105.07 177.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.63 124.8 6.99 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.037 1.175 . . . . 16.66 116.037 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.472 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -49.17 107.41 0.14 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.6 -1.259 . . . . 16.66 107.6 175.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.687 ' HB2' HG22 ' A' ' 52' ' ' VAL . 83.7 m-20 -61.4 -35.61 77.99 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.352 0.596 . . . . 25.0 109.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -19.56 14.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.103 -0.953 . . . . 50.0 111.327 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.315 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -94.39 -29.07 15.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.611 -0.835 . . . . 16.66 110.53 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.607 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 75.89 26.16 1.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.336 0.865 . . . . 16.66 113.336 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.708 ' OD1' ' OH ' ' A' ' 33' ' ' TYR . 14.7 p30 -132.63 167.41 20.11 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.859 -0.525 . . . . 50.0 110.091 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.616 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -121.31 145.04 48.28 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.429 0.899 . . . . 16.66 113.429 -176.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.708 ' OH ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -132.39 146.65 52.11 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.108 -0.496 . . . . 50.0 110.457 176.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.891 ' CE1' ' HG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -55.03 143.23 27.33 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.578 -1.638 . . . . 16.66 106.578 176.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 22' ' ' PHE . . . -42.6 -58.3 3.57 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.0 -1.095 . . . . 16.66 111.697 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -71.61 -18.36 62.22 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.822 -0.351 . . . . 50.0 110.178 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.9 t -49.54 -31.47 10.4 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.799 -0.76 . . . . 16.66 109.003 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 33' ' ' TYR . 4.5 m -117.96 12.27 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.229 -0.896 . . . . 16.66 111.066 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 69.79 45.44 58.11 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.811 -0.631 . . . . 16.66 111.709 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -109.04 167.66 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.161 0.505 . . . . 16.66 111.219 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 40' ' ' ILE . 43.8 mt -62.76 164.5 7.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.584 -0.734 . . . . 50.0 110.911 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' CA ' HE21 ' A' ' 42' ' ' GLN . 0.4 OUTLIER -80.1 -55.13 5.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.166 -0.925 . . . . 25.0 110.426 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.61 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 61.8 m -66.11 -15.78 63.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.863 -1.062 . . . . 50.0 109.625 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.709 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -42.65 -32.88 0.63 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.267 0.556 . . . . 50.0 109.753 -179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.05 -38.8 72.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.56 -0.745 . . . . 25.0 110.399 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' SER . 36.5 tp10 -88.31 -10.67 48.75 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.808 1.04 . . . . 50.0 113.808 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.709 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -115.76 16.51 16.33 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 112.34 0.496 . . . . 16.66 112.34 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -124.7 160.08 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 118.45 -1.3 . . . . 25.0 113.763 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' H ' HG13 ' A' ' 48' ' ' ILE . 54.3 t0 -130.43 -44.8 1.11 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.163 -1.38 . . . . 50.0 111.027 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' C ' ' OD2' ' A' ' 27' ' ' ASP . 95.5 mt-10 -120.97 52.22 1.21 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.593 -0.276 . . . . 50.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.612 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 1.5 t80 -66.78 137.56 56.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.267 -0.973 . . . . 16.66 108.375 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 27' ' ' ASP . 12.3 t -116.92 153.46 18.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.472 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.3 p -82.13 161.83 58.88 Favored Pre-proline 0 N--CA 1.409 -2.513 0 CA-C-N 115.217 -0.901 . . . . 16.66 110.859 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 33.4 Cg_endo -79.48 -26.47 4.86 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.113 1.876 . . . . 16.66 111.388 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -74.37 -30.96 62.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.194 -1.039 . . . . 50.0 108.194 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 2.5 m -68.34 -40.77 81.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.608 -1.178 . . . . 16.66 110.988 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 60' ' ' GLU . 96.5 mt-30 -50.56 -32.0 17.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 50.0 110.746 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -55.78 -39.78 71.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.36 -0.607 . . . . 50.0 109.36 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 m -70.75 -42.94 69.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.835 -0.621 . . . . 50.0 110.563 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.0 mt-10 -82.36 149.21 27.83 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.309 -0.405 . . . . 50.0 110.878 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 52.7 p30 -88.21 7.61 31.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 50.0 110.64 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.037 -0.982 . . . . 50.0 110.527 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.3 -13.69 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.973 2.449 . . . . 0.0 112.09 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 mt -82.32 135.86 35.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.53 -30.6 72.27 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 50.0 111.191 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 m 64.7 56.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 50.0 110.407 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.74 120.0 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 50.0 110.708 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.429 ' OG1' ' OH ' ' A' ' 10' ' ' TYR . 67.6 p -96.58 -175.82 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 50.0 110.848 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -70.83 -177.97 1.75 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 50.0 111.184 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.82 146.78 46.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.599 -0.728 . . . . 50.0 110.235 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.8 m-85 -99.71 -64.44 1.04 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.9 t -46.47 118.55 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.084 -0.962 . . . . 16.66 110.28 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.704 HG23 ' CD2' ' A' ' 33' ' ' TYR . 12.0 pt -53.62 -7.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.927 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -87.78 28.76 0.97 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.319 -1.309 . . . . 16.66 110.665 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 13' ' ' CYS . 19.9 pttm 41.56 65.88 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 25.0 111.685 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 139.15 11.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.094 -0.503 . . . . 50.0 109.731 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.64 154.93 72.04 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.348 2.032 . . . . 50.0 112.049 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.747 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 25.6 t80 -55.43 147.3 17.7 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.034 0.445 . . . . 50.0 109.918 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 21' ' ' LYS . 91.1 m-20 -140.58 109.08 5.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.013 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.3 -14.7 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.1 m -76.65 -29.81 56.56 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.245 -1.391 . . . . 50.0 107.245 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -100.9 155.02 18.18 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.234 -1.803 . . . . 50.0 107.997 178.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 32.1 p90 -109.61 152.84 25.02 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.193 -0.603 . . . . 16.66 110.584 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.747 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.9 m-85 -128.24 162.05 27.9 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.46 1.6 . . . . 50.0 114.294 -177.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.032 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -128.11 117.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 110.883 -2.871 . . . . 16.66 104.188 176.049 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -86.81 131.17 10.4 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.953 -1.118 . . . . 16.66 115.685 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.411 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -47.36 108.03 0.14 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.481 -1.303 . . . . 16.66 107.481 176.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.715 ' HB3' HG22 ' A' ' 52' ' ' VAL . 51.2 t0 -61.13 -31.8 71.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.313 0.577 . . . . 25.0 109.704 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.587 HH21 ' N ' ' A' ' 61' ' ' ASP . 7.5 tpt180 -113.1 -16.15 12.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.09 -0.959 . . . . 50.0 112.023 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.192 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.8 OUTLIER -112.15 14.01 20.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.174 -1.01 . . . . 16.66 112.569 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.549 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 21.1 pt20 39.29 44.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.282 1.586 . . . . 16.66 115.282 176.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.595 ' H ' ' CB ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -134.15 165.98 23.81 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.407 -0.917 . . . . 50.0 110.631 177.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.496 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -127.52 135.71 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.932 0.396 . . . . 16.66 111.823 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.704 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -134.97 144.88 47.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.276 -0.42 . . . . 50.0 110.691 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.813 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -53.51 142.11 23.32 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.645 -1.613 . . . . 16.66 106.645 176.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.19 -56.34 4.0 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 119.784 -1.198 . . . . 16.66 111.547 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -18.51 61.96 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.45 -0.5 . . . . 50.0 110.203 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.019 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.23 -29.85 10.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.609 -0.886 . . . . 16.66 108.609 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 33' ' ' TYR . 4.5 m -119.83 14.61 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.246 -0.888 . . . . 16.66 111.108 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.85 46.18 47.11 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.102 -0.571 . . . . 16.66 111.758 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.488 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -115.58 162.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 16.66 110.85 -179.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' ILE . 2.0 tp -64.54 163.79 12.9 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 121.047 0.451 . . . . 50.0 109.992 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.824 ' HG2' ' H ' ' A' ' 43' ' ' SER . 4.2 pt20 -80.05 -53.44 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.009 -0.541 . . . . 25.0 110.075 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.824 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 29.6 t -64.98 -22.38 66.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 1.044 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.8 mt-10 -44.83 -17.45 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.555 ' N ' ' C ' ' A' ' 43' ' ' SER . . . -70.44 -45.11 66.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.479 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.711 ' C ' ' H ' ' A' ' 48' ' ' ILE . 96.4 mt-10 -88.5 -53.29 4.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.256 0.836 . . . . 50.0 113.256 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.868 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.3 pp -61.73 11.56 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.144 0.497 . . . . 16.66 110.572 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.044 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -114.42 136.34 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.159 -0.928 . . . . 25.0 112.042 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.07 -73.64 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 50.0 111.818 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.53 71.95 1.24 Allowed 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.191 -0.67 . . . . 50.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.713 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.22 145.3 55.94 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.593 -0.73 . . . . 16.66 109.715 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' A' ' 27' ' ' ASP . 11.2 t -112.57 157.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.659 -0.701 . . . . 50.0 109.234 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.411 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.2 p -86.66 155.82 56.15 Favored Pre-proline 0 N--CA 1.409 -2.485 0 CA-C-N 115.572 -0.74 . . . . 16.66 110.546 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HD3' ' OH ' ' A' ' 51' ' ' TYR . 84.2 Cg_endo -67.97 -32.38 28.65 Favored 'Trans proline' 0 C--N 1.276 -3.289 0 C-N-CA 122.099 1.866 . . . . 16.66 111.093 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.38 -32.72 71.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 50.0 109.053 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -79.31 -21.98 45.21 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.422 -0.808 . . . . 16.66 111.4 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -52.38 -32.86 40.74 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.176 -0.61 . . . . 50.0 109.804 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.4 m -80.39 8.47 7.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.901 -0.777 . . . . 50.0 108.901 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 56' ' ' CYS . 20.9 p 57.61 94.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.145 -0.934 . . . . 50.0 110.795 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.502 ' C ' HH21 ' A' ' 28' ' ' ARG . 63.9 mm-40 -58.59 -28.05 65.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.483 -0.487 . . . . 50.0 110.674 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.684 ' OD1' ' N ' ' A' ' 62' ' ' ALA . 55.9 p30 -58.2 -31.52 67.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.339 . . . . 50.0 110.808 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.684 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.051 -0.976 . . . . 50.0 110.569 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 34.2 Cg_exo -54.16 -27.93 49.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.666 2.244 . . . . 0.0 111.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.08 -35.66 77.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.19 48.78 0.93 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.682 -0.967 . . . . 50.0 110.682 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -56.86 -36.85 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.627 0.251 . . . . 50.0 110.87 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.21 110.06 10.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.92 0.39 . . . . 50.0 111.105 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.75 ' OG1' HD11 ' A' ' 9' ' ' LEU . 45.1 p -131.02 174.36 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.89 -0.595 . . . . 50.0 110.148 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.629 ' NZ ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -71.33 102.98 2.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 50.0 110.661 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.75 HD11 ' OG1' ' A' ' 7' ' ' THR . 1.4 mt -142.12 152.71 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.356 -0.384 . . . . 50.0 110.247 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.6 m-85 -100.7 -70.89 0.72 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 9.0 t -41.22 116.18 0.71 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.195 -0.911 . . . . 16.66 111.034 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.649 HG23 ' CD1' ' A' ' 33' ' ' TYR . 5.1 pt -54.51 -8.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.533 -0.758 . . . . 50.0 109.265 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.971 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -80.67 8.03 8.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.698 -1.137 . . . . 16.66 110.694 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? 65.36 53.5 1.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 25.0 111.773 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.53 142.77 16.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.53 155.01 67.87 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.607 2.205 . . . . 50.0 112.643 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.708 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 14.6 t80 -63.09 140.85 58.91 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.243 -0.435 . . . . 50.0 110.274 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 45.2 t0 -140.57 126.32 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 50.0 110.299 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.77 -14.45 32.67 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.669 -0.696 . . . . 50.0 110.328 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -75.35 -30.15 60.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.35 -1.352 . . . . 50.0 107.35 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.568 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 8.2 tptp -99.92 153.95 18.76 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.316 -1.765 . . . . 50.0 108.159 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 45.8 p90 -110.55 152.01 26.92 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.315 -0.554 . . . . 16.66 110.582 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -129.21 165.46 21.31 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.422 1.582 . . . . 50.0 114.645 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.007 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -125.19 123.02 64.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 110.777 -2.92 . . . . 16.66 104.45 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -91.92 123.33 7.18 Favored Glycine 0 C--N 1.317 -0.472 0 C-N-CA 119.52 -1.324 . . . . 16.66 115.913 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.468 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.92 108.59 0.19 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.929 -1.508 . . . . 16.66 106.929 175.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 90.3 m-20 -66.67 -23.93 66.2 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 60' ' ' GLU . 44.6 ttm-85 -112.58 -22.59 10.7 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.085 -1.416 . . . . 50.0 111.634 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.261 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -106.66 12.85 28.82 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.677 -0.809 . . . . 16.66 111.762 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HG2' ' C ' ' A' ' 29' ' ' CYS . 22.8 pt20 34.97 45.54 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.726 0.639 . . . . 16.66 112.726 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.5 t-20 -132.92 166.59 21.99 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.41 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -135.5 130.47 34.7 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 121.034 -0.267 . . . . 16.66 111.09 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -129.96 145.45 51.63 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.922 -0.311 . . . . 50.0 111.175 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.841 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -54.78 141.24 33.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.722 -1.585 . . . . 16.66 106.722 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.24 -59.79 2.9 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 119.712 -1.232 . . . . 16.66 111.433 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -20.27 66.03 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 50.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.0 t -50.94 -31.11 16.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.888 -0.782 . . . . 16.66 108.888 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 33' ' ' TYR . 2.5 m -120.23 14.04 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.254 -0.885 . . . . 16.66 110.894 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.19 45.7 60.63 Favored Glycine 0 N--CA 1.46 0.287 0 CA-C-N 115.885 -0.598 . . . . 16.66 111.741 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.473 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -107.8 164.63 4.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.949 0.404 . . . . 16.66 110.538 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.792 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 74.2 mt -58.7 163.96 3.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.875 -0.602 . . . . 50.0 109.982 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -78.4 -55.44 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.295 -0.866 . . . . 25.0 110.996 -178.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -70.48 -15.82 62.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.506 -0.77 . . . . 50.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.794 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.3 mt-10 -45.77 -19.83 0.07 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.851 -0.613 . . . . 50.0 111.866 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -64.22 -48.06 77.32 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.931 -0.708 . . . . 25.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.57 -45.88 9.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.182 1.549 . . . . 50.0 115.182 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.794 HD11 ' HA ' ' A' ' 44' ' ' GLU . 1.9 pp -55.26 -32.61 62.49 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 114.208 1.188 . . . . 16.66 114.208 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 44' ' ' GLU . 2.2 pp -86.0 171.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.532 -0.867 . . . . 25.0 109.913 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -162.99 9.62 0.06 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.89 -1.05 . . . . 50.0 109.631 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -145.44 30.63 1.11 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.661 -1.607 . . . . 50.0 106.661 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.697 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 9.6 t80 -66.12 147.56 53.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.225 -1.352 . . . . 16.66 110.873 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.697 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 9.4 t -132.55 156.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.053 -1.431 . . . . 50.0 108.652 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.468 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -79.53 156.65 75.56 Favored Pre-proline 0 N--CA 1.409 -2.521 0 CA-C-O 121.586 0.708 . . . . 16.66 110.003 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 86.1 Cg_endo -71.27 -28.12 18.84 Favored 'Trans proline' 0 C--N 1.273 -3.412 0 C-N-CA 121.835 1.69 . . . . 16.66 110.601 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -71.85 -35.97 70.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.27 -1.011 . . . . 50.0 108.27 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.243 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -85.44 -16.53 39.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.091 -0.958 . . . . 16.66 110.621 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.451 ' C ' ' H ' ' A' ' 59' ' ' THR . 49.8 tt0 -48.14 -34.13 9.39 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.616 -0.434 . . . . 50.0 110.239 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.482 ' O ' ' OG1' ' A' ' 59' ' ' THR . 79.8 p -59.66 -9.01 2.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 56' ' ' CYS . 16.9 p 53.86 78.11 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.99 -1.005 . . . . 50.0 110.823 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' ASP . 78.8 mm-40 -66.87 142.14 57.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 50.0 110.296 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' GLU . 93.1 m-20 39.89 -164.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 50.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.968 -1.015 . . . . 50.0 110.585 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.33 -23.27 29.84 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.812 2.342 . . . . 0.0 112.063 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.7 mt -92.18 140.94 29.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.49 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.43 -173.42 49.64 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.909 -0.877 . . . . 50.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.3 m -77.31 -2.38 34.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 50.0 110.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.11 -35.78 71.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 50.0 110.481 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -81.71 169.06 17.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.019 -0.537 . . . . 50.0 110.721 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -74.45 -177.75 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.89 -0.595 . . . . 50.0 110.971 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.691 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -65.38 157.15 30.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 50.0 110.329 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.5 m-85 -97.35 -68.72 0.79 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.119 0.485 . . . . 25.0 109.952 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.3 t -40.79 115.47 0.58 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 16.66 110.932 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.634 HG22 ' NE2' ' A' ' 55' ' ' GLN . 5.8 pt -52.75 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 50.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.999 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -79.67 4.22 16.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 16.66 110.333 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm 66.49 55.58 0.81 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.821 -0.627 . . . . 25.0 112.045 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -147.3 142.05 16.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.792 -0.447 . . . . 50.0 109.792 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 15' ' ' THR . 15.8 Cg_exo -65.01 153.43 78.36 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.272 1.982 . . . . 50.0 112.292 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.727 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.5 t80 -58.05 146.2 33.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.538 -0.542 . . . . 50.0 109.538 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.515 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 96.0 m-20 -140.93 116.97 10.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.656 -0.702 . . . . 50.0 111.325 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.54 -16.7 26.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.059 -0.519 . . . . 50.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.4 m -76.36 -27.99 56.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 5.9 tptm -101.89 154.63 18.76 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.346 -1.752 . . . . 50.0 108.185 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 53.5 p90 -111.17 151.23 28.43 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.376 -0.529 . . . . 16.66 110.548 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.727 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.7 m-85 -128.9 168.26 16.22 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 123.314 1.531 . . . . 50.0 114.286 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.011 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -126.43 126.17 68.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 111.118 -2.764 . . . . 16.66 105.29 176.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.89 122.29 6.87 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 119.757 -1.211 . . . . 16.66 115.601 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.313 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -48.38 115.29 1.16 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.028 -1.086 . . . . 16.66 108.555 176.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HA ' ' A' ' 52' ' ' VAL . 23.6 t70 -58.68 -34.02 70.8 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.355 -0.538 . . . . 25.0 109.871 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' NH1' ' OE2' ' A' ' 60' ' ' GLU . 1.4 ttm105 -113.32 -23.88 9.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.707 -0.678 . . . . 50.0 111.32 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.313 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -91.54 4.88 51.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.983 -0.687 . . . . 16.66 111.324 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.527 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 6.5 pt20 30.75 48.59 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.11 -0.496 . . . . 16.66 111.615 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.63 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -131.55 166.4 21.47 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.847 -0.427 . . . . 50.0 109.847 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.48 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -134.18 132.57 39.95 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.837 -0.345 . . . . 16.66 111.052 -178.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.02 144.97 51.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.779 -0.369 . . . . 50.0 111.327 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.815 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -56.47 140.06 47.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.392 -1.707 . . . . 16.66 106.392 176.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.12 -58.57 3.23 Favored Glycine 0 C--N 1.31 -0.899 0 C-N-CA 119.622 -1.275 . . . . 16.66 112.098 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -66.75 -21.3 66.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.032 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 t -51.58 -29.84 18.72 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.656 -0.702 . . . . 16.66 109.304 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.56 2.24 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.706 -0.679 . . . . 16.66 112.002 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.9 46.4 6.72 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.417 -0.673 . . . . 16.66 111.417 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.57 HG22 ' CA ' ' A' ' 35' ' ' GLY . 1.4 tt -118.69 159.92 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.05 0.453 . . . . 16.66 111.828 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.661 ' C ' ' HG3' ' A' ' 44' ' ' GLU . 4.1 mm? -46.91 169.61 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.58 -0.736 . . . . 50.0 110.991 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -56.33 4.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.702 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' ALA . 61.5 m -79.03 -16.07 57.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.637 -0.71 . . . . 50.0 111.446 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.878 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -43.34 -21.35 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.87 0.367 . . . . 50.0 110.166 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.505 ' N ' ' OE1' ' A' ' 44' ' ' GLU . . . -60.14 -51.52 69.24 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.037 -0.528 . . . . 25.0 111.418 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.77 -44.16 10.17 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.808 1.41 . . . . 50.0 114.808 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.965 HD12 ' N ' ' A' ' 48' ' ' ILE . 3.1 pp -55.47 -28.09 52.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.661 0.985 . . . . 16.66 113.661 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.965 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 pp -85.71 172.48 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 119.862 -0.735 . . . . 25.0 110.028 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 48.6 t0 -156.35 0.48 0.14 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.571 -1.195 . . . . 50.0 109.982 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.33 33.67 2.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.413 -1.328 . . . . 50.0 107.413 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.691 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 22.1 t80 -65.94 145.88 55.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.197 -0.91 . . . . 16.66 110.032 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.691 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 20.3 t -133.73 155.73 40.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.058 -1.428 . . . . 50.0 108.991 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.998 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 7.2 p -81.72 154.42 70.78 Favored Pre-proline 0 N--CA 1.413 -2.287 0 CA-C-O 121.501 0.667 . . . . 16.66 109.98 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 50.7 Cg_endo -74.4 -28.22 10.52 Favored 'Trans proline' 0 C--N 1.274 -3.379 0 C-N-CA 122.058 1.839 . . . . 16.66 110.947 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.634 ' NE2' HG22 ' A' ' 12' ' ' ILE . 96.2 mt-30 -70.32 -33.58 71.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.131 -1.063 . . . . 50.0 108.131 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.185 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.7 m -70.02 -33.87 72.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.767 -1.106 . . . . 16.66 110.277 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -55.75 -34.3 65.08 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.183 -0.462 . . . . 50.0 110.795 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -54.14 -39.44 66.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.3 m -71.24 -47.06 59.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 50.0 110.331 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.531 ' OE2' ' NH1' ' A' ' 28' ' ' ARG . 78.1 mm-40 -64.09 -33.08 74.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.25 -0.432 . . . . 50.0 110.618 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -82.73 119.44 24.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 50.0 110.717 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.058 -0.973 . . . . 50.0 110.586 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -53.91 -27.91 46.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.794 2.33 . . . . 0.0 112.046 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.83 141.84 32.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.41 34.41 40.52 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.638 -0.985 . . . . 50.0 110.638 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.508 ' O ' ' C ' ' A' ' 6' ' ' ASP . 22.7 t -56.14 -34.16 65.86 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.193 -0.203 . . . . 50.0 110.695 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' C ' ' O ' ' A' ' 5' ' ' SER . 47.2 p30 22.59 -138.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 50.0 111.488 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 20.6 p -124.11 163.71 20.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.978 0.418 . . . . 50.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -136.0 -174.5 3.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.983 -0.553 . . . . 50.0 110.015 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 9' ' ' LEU . 2.9 pp -58.13 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 50.0 111.082 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -73.62 -103.21 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.951 -0.568 . . . . 25.0 110.993 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 18.7 t -37.87 120.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.819 0.818 . . . . 16.66 113.206 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 33' ' ' TYR . 7.5 pt -59.29 -8.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.112 -1.404 . . . . 50.0 108.843 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.95 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -77.94 8.81 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.367 -1.288 . . . . 16.66 110.565 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.634 ' CG ' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 63.43 71.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.571 0.7 . . . . 25.0 110.086 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.03 124.67 1.12 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.939 -0.573 . . . . 50.0 110.757 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.45 154.9 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.287 1.991 . . . . 50.0 112.111 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -56.85 146.1 27.49 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.044 0.449 . . . . 50.0 110.074 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 21' ' ' LYS . 94.2 m-20 -140.75 114.78 9.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.764 -0.653 . . . . 50.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.66 -10.81 2.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.419 ' N ' ' C ' ' A' ' 18' ' ' ASP . 26.4 m -79.97 -24.8 40.68 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 107.358 -1.349 . . . . 50.0 107.358 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 4.7 tptm -107.56 153.56 22.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.59 -1.641 . . . . 50.0 107.94 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 39.2 p90 -110.13 153.47 24.66 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 120.11 -0.636 . . . . 16.66 111.011 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.742 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 15.8 m-85 -126.59 164.0 22.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 123.504 1.621 . . . . 50.0 114.645 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.104 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -132.76 117.86 31.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 110.861 -2.881 . . . . 16.66 105.091 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -82.93 133.08 11.57 Favored Glycine 0 C--N 1.315 -0.617 0 C-N-CA 119.944 -1.122 . . . . 16.66 115.06 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.392 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -47.94 107.37 0.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.752 -1.224 . . . . 16.66 107.705 176.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.596 ' HB3' HG22 ' A' ' 52' ' ' VAL . 59.1 t0 -51.05 -41.43 59.87 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.85 -0.74 . . . . 25.0 110.23 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.633 ' HG3' ' HB3' ' A' ' 56' ' ' CYS . 14.7 ptp180 -115.67 -4.51 12.19 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.83 0.678 . . . . 50.0 112.83 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.237 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -108.66 13.51 25.1 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 118.825 -1.15 . . . . 16.66 111.326 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER 33.69 52.33 0.42 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.268 -0.423 . . . . 16.66 110.72 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.608 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -132.57 166.44 22.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.189 -0.3 . . . . 50.0 110.189 -178.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.674 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -139.89 132.14 28.24 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.004 0.742 . . . . 16.66 113.004 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.741 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -139.93 152.62 46.51 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.036 -0.529 . . . . 50.0 111.649 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.921 ' HD1' ' HG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -59.04 142.55 51.0 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 106.694 -1.595 . . . . 16.66 106.694 175.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.84 -60.31 2.98 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.058 -1.068 . . . . 16.66 111.713 -178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -20.12 65.91 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.324 -0.55 . . . . 50.0 110.183 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.7 t -51.19 -31.32 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.199 -0.667 . . . . 16.66 109.199 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 33' ' ' TYR . 2.7 m -115.67 14.28 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.472 -0.786 . . . . 16.66 110.675 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.14 46.0 23.41 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 115.636 -0.711 . . . . 16.66 112.432 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -112.55 167.24 5.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.928 0.394 . . . . 16.66 110.581 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.584 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 85.6 mt -67.16 164.29 18.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.499 0.666 . . . . 50.0 110.662 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.422 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.6 OUTLIER -80.03 -54.96 5.29 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.034 -0.985 . . . . 25.0 111.086 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 m -65.81 -17.85 64.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 50.0 110.096 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.792 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 2.0 mt-10 -45.64 -38.28 6.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 120.353 -0.539 . . . . 50.0 110.658 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.607 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -51.37 -36.5 43.47 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.077 -0.649 . . . . 25.0 110.897 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -87.74 -44.46 11.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.601 0.963 . . . . 50.0 113.601 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 44' ' ' GLU . 2.2 pp -86.46 17.13 3.98 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.285 -0.87 . . . . 16.66 112.013 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.792 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 4.1 tp -120.81 150.01 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 C-N-CA 119.056 -1.058 . . . . 25.0 112.984 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -170.17 29.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.614 -1.175 . . . . 50.0 110.411 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -161.03 9.02 0.08 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.671 -0.863 . . . . 50.0 108.671 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -67.22 147.63 52.8 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.54 -0.755 . . . . 16.66 109.35 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 27' ' ' ASP . 14.8 t -126.03 157.76 35.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.143 -0.935 . . . . 50.0 109.43 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.392 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.9 p -79.84 156.87 74.71 Favored Pre-proline 0 N--CA 1.412 -2.353 0 CA-C-N 115.749 -0.66 . . . . 16.66 110.164 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 28.9 Cg_endo -80.25 -23.78 6.04 Favored 'Trans proline' 0 C--N 1.276 -3.239 0 C-N-CA 121.783 1.655 . . . . 16.66 110.786 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -72.64 -35.63 67.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.485 -0.932 . . . . 50.0 108.485 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.166 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -73.24 -33.69 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.03 -0.986 . . . . 16.66 110.609 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -49.83 -41.03 43.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.581 . . . . 50.0 110.653 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.616 ' O ' ' OG1' ' A' ' 59' ' ' THR . 90.6 p -65.37 -32.2 73.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.7 -0.4 . . . . 50.0 110.103 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 58' ' ' SER . 3.3 m 145.77 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.563 -0.744 . . . . 50.0 109.849 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 40.7 -109.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 50.0 110.624 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.19 117.46 21.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.36 -0.382 . . . . 50.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.93 -1.033 . . . . 50.0 110.593 -179.87 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 4' ' ' GLY . 69.5 Cg_endo -76.92 8.73 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.917 2.411 . . . . 0.0 112.12 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 3' ' ' LEU . 10.0 mp 45.09 -87.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.434 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -173.45 177.96 45.6 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.017 -0.833 . . . . 50.0 111.017 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.6 p -76.3 160.27 29.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 50.0 110.575 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.512 ' OD1' HG23 ' A' ' 7' ' ' THR . 33.4 p-10 -90.48 8.15 35.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 50.0 110.692 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.512 HG23 ' OD1' ' A' ' 6' ' ' ASP . 37.3 p -124.16 169.48 11.68 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.07 0.462 . . . . 50.0 110.914 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.442 ' H ' ' HG3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -109.4 -175.76 2.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.531 -0.759 . . . . 50.0 109.923 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -60.77 166.31 3.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 50.0 109.93 -179.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.6 m-85 -91.06 -71.34 0.64 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.411 -0.588 . . . . 25.0 109.411 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 10.1 t -41.38 113.41 0.4 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.653 -0.703 . . . . 16.66 110.772 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.696 HG22 ' NE2' ' A' ' 55' ' ' GLN . 6.5 pt -53.12 -7.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 50.0 109.414 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.972 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -81.25 6.72 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.729 -1.123 . . . . 16.66 110.892 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 84.0 mttt 66.97 56.12 0.68 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.13 -0.487 . . . . 25.0 111.916 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 135.94 10.2 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.91 -0.316 . . . . 50.0 110.352 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.48 156.72 39.98 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.321 2.014 . . . . 50.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.724 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 23.7 t80 -59.35 146.25 40.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.033 0.444 . . . . 50.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.503 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 95.4 m-20 -141.39 113.07 7.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.638 -0.71 . . . . 50.0 111.249 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.36 -20.87 13.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.968 0.413 . . . . 50.0 110.103 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.4 m -71.95 -30.99 65.87 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.602 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -99.05 150.37 22.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.265 -1.789 . . . . 50.0 107.954 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 51.0 p90 -108.78 150.41 27.65 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.06 -0.656 . . . . 16.66 110.601 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.724 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 8.6 m-85 -127.76 166.0 19.02 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 123.362 1.553 . . . . 50.0 113.925 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.058 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.55 124.3 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 111.114 -2.766 . . . . 16.66 105.57 176.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -87.95 127.1 8.37 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.993 -1.099 . . . . 16.66 115.529 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.474 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.6 OUTLIER -48.62 121.28 4.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.499 -1.297 . . . . 16.66 107.499 175.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.554 ' HB2' HG22 ' A' ' 52' ' ' VAL . 60.5 t0 -62.55 -34.21 76.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.507 0.67 . . . . 25.0 109.571 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -113.56 -27.85 7.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.841 -1.072 . . . . 50.0 111.477 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.293 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -89.91 8.23 33.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.945 -0.702 . . . . 16.66 111.81 -177.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.566 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 2.8 pt20 30.13 49.23 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 16.66 112.005 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.673 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -131.6 165.69 23.09 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.92 -0.4 . . . . 50.0 109.92 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD1' ' CD2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -132.54 132.68 42.87 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.939 -0.304 . . . . 16.66 111.389 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.672 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -130.7 145.76 52.01 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.865 -0.334 . . . . 50.0 111.148 178.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.834 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.8 OUTLIER -54.43 140.2 34.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.285 -1.746 . . . . 16.66 106.285 176.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.745 ' H ' HH21 ' A' ' 36' ' ' ARG . . . -42.29 -56.34 4.06 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 119.433 -1.365 . . . . 16.66 111.516 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.781 ' H ' ' NE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -70.55 -19.7 62.86 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.516 -0.474 . . . . 50.0 110.241 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.9 t -50.41 -30.94 13.62 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.866 -0.791 . . . . 16.66 108.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.71 13.58 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.117 -0.947 . . . . 16.66 110.631 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 70.34 46.25 50.35 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.345 -0.702 . . . . 16.66 111.345 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.569 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -115.38 167.93 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.124 0.488 . . . . 16.66 111.647 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.3 mp -62.38 163.64 8.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 50.0 110.446 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.587 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.1 pt20 -82.33 -46.56 13.44 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.18 -1.045 . . . . 25.0 108.18 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.948 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -63.8 -29.25 70.47 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.647 -1.615 . . . . 50.0 108.687 179.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.81 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.8 -17.56 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.005 -0.739 . . . . 50.0 109.005 178.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 22' ' ' PHE . . . -79.13 -41.93 27.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.298 -0.864 . . . . 25.0 110.538 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 43' ' ' SER . 48.5 mp0 -87.9 -52.13 5.45 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.696 1.369 . . . . 50.0 114.696 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.032 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.56 19.22 0.28 Allowed 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.481 0.658 . . . . 16.66 111.108 -177.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.81 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.3 tp -114.71 144.56 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 114.749 -1.114 . . . . 25.0 113.299 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -168.09 28.07 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.155 -1.384 . . . . 50.0 109.313 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -166.39 13.12 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.415 -0.957 . . . . 50.0 108.415 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.678 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -67.58 147.26 52.99 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.357 -0.838 . . . . 16.66 109.706 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 16.1 t -124.71 159.26 31.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.845 -1.071 . . . . 50.0 109.293 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.474 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 8.8 p -83.87 152.93 63.52 Favored Pre-proline 0 N--CA 1.411 -2.383 0 CA-C-O 121.611 0.72 . . . . 16.66 110.359 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.25 -27.61 16.32 Favored 'Trans proline' 0 C--N 1.274 -3.378 0 C-N-CA 121.892 1.728 . . . . 16.66 110.877 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.696 ' NE2' HG22 ' A' ' 12' ' ' ILE . 95.0 mt-30 -70.42 -33.67 71.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.31 -0.859 . . . . 50.0 108.827 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -76.38 -43.21 41.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.253 -0.885 . . . . 16.66 110.567 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -57.15 -26.83 61.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 50.0 111.035 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 m -48.58 -32.7 8.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.382 -0.372 . . . . 50.0 110.397 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -11.28 7.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.419 -0.355 . . . . 50.0 110.963 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -107.48 140.25 40.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.857 0.361 . . . . 50.0 110.912 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.6 140.75 46.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 50.0 110.316 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.044 -0.979 . . . . 50.0 110.588 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.08 144.85 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.693 2.262 . . . . 0.0 111.983 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.849 HD22 ' N ' ' A' ' 3' ' ' LEU . 1.4 mm? -92.34 141.35 28.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.479 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.23 -126.52 5.83 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.659 -0.977 . . . . 50.0 110.659 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 46.8 m -62.77 155.16 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.793 0.33 . . . . 50.0 110.513 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 5' ' ' SER . 87.1 m-20 -136.29 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 50.0 110.507 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -81.5 162.38 23.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 50.0 110.182 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -134.84 -177.4 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.28 0.562 . . . . 50.0 111.611 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.36 152.63 20.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.344 -0.843 . . . . 50.0 110.712 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 m-85 -95.53 -68.36 0.8 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 7.2 t -43.48 116.26 0.91 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.648 -0.705 . . . . 16.66 110.458 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.631 HG23 ' CD1' ' A' ' 33' ' ' TYR . 9.9 pt -51.95 -7.72 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.071 -0.714 . . . . 50.0 109.071 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 1.035 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -78.31 2.78 17.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.572 -1.195 . . . . 16.66 110.55 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 67.22 54.41 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.982 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.07 146.77 26.9 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.005 -0.369 . . . . 50.0 110.005 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 152.69 76.08 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.513 2.142 . . . . 50.0 111.941 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.6 t80 -55.97 146.06 23.41 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.759 -0.46 . . . . 50.0 109.759 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 21' ' ' LYS . 89.0 m-20 -140.71 113.15 8.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.786 -0.643 . . . . 50.0 111.017 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.64 -17.76 9.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 50.0 109.842 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -71.58 -30.81 66.25 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.112 -1.44 . . . . 50.0 107.112 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 34' ' ' HIS . 3.1 tptm -100.55 156.88 17.05 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 112.973 -1.922 . . . . 50.0 108.957 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 52.8 p90 -113.45 149.07 34.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 115.885 -0.598 . . . . 16.66 110.024 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.6 m-85 -127.15 166.75 17.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 123.379 1.561 . . . . 50.0 114.236 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.02 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.19 126.22 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 111.013 -2.812 . . . . 16.66 105.007 176.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -93.58 121.22 6.53 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 119.587 -1.292 . . . . 16.66 116.157 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.44 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.32 117.69 2.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.911 -1.145 . . . . 16.66 108.002 175.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 51' ' ' TYR . 87.3 m-20 -69.26 -30.18 68.24 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.652 0.739 . . . . 25.0 109.245 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 60' ' ' GLU . 45.3 ttm-85 -110.43 -23.15 11.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.597 -1.183 . . . . 50.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.292 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 9.93 40.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.888 -0.725 . . . . 16.66 111.683 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.573 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 8.9 pt20 30.37 48.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 16.66 112.405 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.586 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -132.14 166.16 22.42 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 120.929 -0.308 . . . . 50.0 110.373 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -133.94 130.75 38.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.184 -0.206 . . . . 16.66 110.906 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -128.45 144.44 51.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.792 -0.363 . . . . 50.0 111.393 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.75 ' CE1' ' HG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -54.19 140.59 32.04 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.28 -1.748 . . . . 16.66 106.28 176.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -41.9 -59.94 2.72 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.855 -1.164 . . . . 16.66 111.929 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.47 ' HD3' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -67.87 -19.79 65.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.458 -0.497 . . . . 50.0 109.971 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.086 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 3.1 t -50.4 -30.7 13.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.664 -0.865 . . . . 16.66 108.664 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.6 12.66 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.255 -0.884 . . . . 16.66 110.962 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 70.67 45.84 50.47 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.034 -0.603 . . . . 16.66 111.68 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.504 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -112.5 167.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.983 0.421 . . . . 16.66 111.495 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 41' ' ' LEU . 8.0 mp -59.64 164.72 3.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.746 -0.661 . . . . 50.0 110.555 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.06 -55.39 5.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.515 -0.766 . . . . 25.0 110.523 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.532 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.4 m -70.86 -15.16 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 50.0 109.368 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.744 ' HA ' HD11 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -42.17 -20.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.467 -0.788 . . . . 50.0 110.938 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.34 -47.52 60.67 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.396 -0.522 . . . . 25.0 110.992 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -88.93 -43.46 11.15 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.745 1.387 . . . . 50.0 114.745 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.0 HD12 ' N ' ' A' ' 48' ' ' ILE . 2.5 pp -55.39 -30.84 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.306 0.854 . . . . 16.66 113.306 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.0 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.3 pp -86.67 172.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.744 0.783 . . . . 25.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.35 13.2 0.14 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.403 -1.271 . . . . 50.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -155.54 36.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.753 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 18.5 t80 -65.96 145.88 55.37 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.674 -1.148 . . . . 16.66 111.014 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.753 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 11.7 t -129.71 157.55 42.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.942 -1.481 . . . . 50.0 108.608 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.44 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.2 p -86.35 158.36 54.99 Favored Pre-proline 0 N--CA 1.414 -2.236 0 CA-C-O 121.574 0.702 . . . . 16.66 110.578 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 29.8 Cg_endo -79.8 -22.7 7.44 Favored 'Trans proline' 0 C--N 1.278 -3.133 0 C-N-CA 121.97 1.78 . . . . 16.66 110.403 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -72.52 -35.76 68.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.062 -1.088 . . . . 50.0 108.062 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.17 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -84.34 -31.72 24.66 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.881 -1.054 . . . . 16.66 109.856 179.09 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -49.78 -31.59 11.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.83 -0.623 . . . . 50.0 110.753 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -50.19 -31.52 13.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.2 -0.455 . . . . 50.0 110.179 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.31 69.75 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 50.0 111.09 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 95.3 mt-10 -56.8 -30.43 63.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 50.0 110.055 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 61' ' ' ASP . 53.1 p30 -138.8 174.72 10.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.897 -0.592 . . . . 50.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.017 -0.992 . . . . 50.0 110.533 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.3 153.49 59.26 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.922 2.414 . . . . 0.0 111.917 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.8 mt -74.4 153.2 39.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.301 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.32 -174.81 35.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.966 -0.854 . . . . 50.0 110.966 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.4 m 56.65 51.23 11.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 50.0 110.44 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.27 150.76 39.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.525 . . . . 50.0 110.327 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -121.47 161.8 21.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 50.0 110.792 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.45 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -94.66 161.08 14.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.061 -0.518 . . . . 50.0 110.729 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -73.84 -179.69 3.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.619 -0.718 . . . . 50.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.726 ' N ' HD22 ' A' ' 9' ' ' LEU . 1.5 m-85 -87.16 -94.99 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.007 0.373 . . . . 25.0 112.007 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 42.1 t -37.45 132.72 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.69 0.757 . . . . 16.66 112.773 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.751 HG23 ' CD2' ' A' ' 33' ' ' TYR . 7.5 pt -61.15 -7.75 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.671 -1.149 . . . . 50.0 108.692 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.59 4.95 14.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.001 -1.454 . . . . 16.66 110.852 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt 67.31 47.6 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.269 -0.423 . . . . 25.0 111.038 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.27 124.61 10.84 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.618 -0.264 . . . . 50.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.68 160.47 11.78 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.626 2.217 . . . . 50.0 112.878 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.751 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 10.4 t80 -66.3 138.51 57.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.047 -0.524 . . . . 50.0 111.104 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 54.3 t0 -140.54 127.01 20.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.653 -0.703 . . . . 50.0 109.142 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.92 -12.83 4.97 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.991 -0.549 . . . . 50.0 109.608 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -75.64 -26.81 58.06 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.681 ' HG2' ' CG ' ' A' ' 34' ' ' HIS . 15.5 tptt -101.5 152.17 21.09 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.489 -1.687 . . . . 50.0 108.129 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 55.3 p90 -113.08 147.21 37.75 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.182 -0.607 . . . . 16.66 110.154 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 7.0 m-85 -123.23 164.23 19.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 123.914 1.816 . . . . 50.0 115.538 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.123 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -135.68 117.96 21.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 109.953 -3.294 . . . . 16.66 104.286 176.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -89.73 129.87 9.92 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 119.778 -1.201 . . . . 16.66 115.455 -174.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.386 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -48.1 106.99 0.11 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.898 -1.519 . . . . 16.66 106.898 175.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -69.54 -20.01 63.69 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -112.86 -25.46 9.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.839 -1.528 . . . . 50.0 111.566 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.21 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -111.31 15.88 21.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.932 -0.707 . . . . 16.66 112.197 -178.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.539 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 0.0 OUTLIER 30.96 54.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 16.66 111.87 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.642 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 5.5 m-20 -132.54 167.06 20.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.411 -0.359 . . . . 50.0 110.223 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.692 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -141.03 129.48 22.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.311 0.856 . . . . 16.66 113.311 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.751 ' CD2' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -141.43 158.34 44.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.873 -0.603 . . . . 50.0 111.771 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.682 ' H ' ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -63.98 134.85 55.81 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.9 -1.889 . . . . 16.66 105.9 174.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -42.6 -44.85 5.44 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 119.502 -1.332 . . . . 16.66 111.545 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 36' ' ' ARG . 17.9 mtt180 -68.53 -29.88 68.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.57 0.7 . . . . 50.0 109.238 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.933 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 4.2 t -51.6 -26.66 9.25 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.791 -1.095 . . . . 16.66 109.621 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.53 16.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.296 -0.866 . . . . 16.66 110.622 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.21 47.58 57.9 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.733 -0.667 . . . . 16.66 111.828 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG12 ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -115.63 167.02 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.777 -0.369 . . . . 16.66 110.984 -178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.705 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 2.8 mm? -62.33 164.59 6.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.287 0.565 . . . . 50.0 110.412 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.31 -56.05 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.13 -0.941 . . . . 25.0 110.911 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -69.35 -16.15 63.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.683 -0.689 . . . . 50.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.81 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.6 tt0 -48.22 -20.24 0.36 Allowed 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.488 -0.778 . . . . 50.0 111.464 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.699 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -57.0 -51.82 67.71 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.944 -0.702 . . . . 25.0 111.671 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 48' ' ' ILE . 78.2 mm-40 -90.1 -46.65 8.33 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.9 1.445 . . . . 50.0 114.9 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 44' ' ' GLU . 3.1 pp -56.02 16.19 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.347 1.24 . . . . 16.66 114.347 -176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -134.48 171.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.406 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 46.0 t0 -173.36 36.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.82 -1.082 . . . . 50.0 108.994 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.03 20.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.646 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 2.4 t80 -66.82 148.68 51.62 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.547 -1.206 . . . . 16.66 110.522 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.646 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 17.3 t -129.87 152.26 37.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.302 -1.317 . . . . 50.0 109.43 178.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.386 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 9.3 p -78.95 162.45 64.71 Favored Pre-proline 0 N--CA 1.411 -2.391 0 CA-C-N 115.232 -0.894 . . . . 16.66 110.102 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 15.5 Cg_endo -81.23 -27.84 2.68 Favored 'Trans proline' 0 C--N 1.276 -3.279 0 C-N-CA 121.875 1.717 . . . . 16.66 110.848 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -67.93 -35.63 78.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.895 -1.15 . . . . 50.0 107.895 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.189 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -78.19 -44.26 26.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.892 -1.049 . . . . 16.66 109.552 179.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.492 ' NE2' ' OE1' ' A' ' 60' ' ' GLU . 60.6 tp60 -51.66 -38.25 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.683 -0.69 . . . . 50.0 109.747 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 18.4 m -60.3 -37.26 80.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 50.0 109.671 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 m -65.47 -40.03 92.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 50.0 110.43 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' OE1' ' NE2' ' A' ' 57' ' ' GLN . 96.8 mt-10 -59.56 -36.49 76.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.431 -0.349 . . . . 50.0 110.841 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 58' ' ' SER . 50.0 p30 -107.14 168.22 9.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.383 -0.371 . . . . 50.0 110.671 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.078 -0.963 . . . . 50.0 110.601 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.06 -22.8 32.7 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.174 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 mt -90.72 141.46 28.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.0 -168.91 42.03 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.076 -0.81 . . . . 50.0 111.076 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -62.86 170.91 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.188 -0.301 . . . . 50.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 60.24 60.85 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.952 0.406 . . . . 50.0 110.197 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -80.31 165.23 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 50.0 110.852 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -175.82 1.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.737 -0.665 . . . . 50.0 111.282 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD22 ' N ' ' A' ' 15' ' ' THR . 0.2 OUTLIER -60.73 -174.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.311 -0.859 . . . . 50.0 110.242 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.662 ' HB3' ' O ' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -82.28 -89.19 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 1.5 t -39.71 114.43 0.42 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.844 -0.617 . . . . 16.66 111.29 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.833 HD13 ' N ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -59.7 -8.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.16 -0.927 . . . . 50.0 109.588 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 1.137 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -71.21 7.34 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.425 -0.807 . . . . 16.66 109.923 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HB3' ' HZ2' ' A' ' 14' ' ' LYS . 3.5 mtpm? 65.91 48.73 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.576 -0.738 . . . . 25.0 111.484 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.539 ' N ' HD22 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -143.17 124.19 8.2 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.778 -0.369 . . . . 50.0 110.287 179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.1 152.03 3.72 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.748 2.299 . . . . 50.0 112.801 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.77 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 24.7 t80 -67.57 145.02 55.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 17' ' ' TYR . 91.3 m-20 -140.82 116.68 10.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.831 -0.622 . . . . 50.0 110.355 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 -13.57 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.443 -0.577 . . . . 50.0 109.443 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -75.13 -25.69 58.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.513 -1.291 . . . . 50.0 107.513 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -101.39 155.3 18.14 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.433 -1.712 . . . . 50.0 108.113 178.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 51.8 p90 -110.25 153.21 25.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.889 -0.724 . . . . 16.66 110.588 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.77 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.3 m-85 -125.26 162.71 24.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 123.47 1.605 . . . . 50.0 114.534 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.035 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -131.58 117.9 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.803 -2.908 . . . . 16.66 104.601 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -92.77 131.96 11.03 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 119.782 -1.199 . . . . 16.66 116.025 -174.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.394 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.4 OUTLIER -46.33 105.74 0.07 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.026 -1.472 . . . . 16.66 107.026 175.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.742 ' CG ' HG22 ' A' ' 52' ' ' VAL . 43.4 p-10 -75.4 -11.4 60.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.568 -1.271 . . . . 25.0 107.568 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.483 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 23.4 ttm180 -113.7 -22.98 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.742 -1.572 . . . . 50.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.183 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -120.22 18.5 12.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 119.927 -0.709 . . . . 16.66 112.346 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.519 ' N ' ' HB3' ' A' ' 26' ' ' CYS . 13.9 pt20 32.97 54.11 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.763 0.283 . . . . 16.66 111.763 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.614 ' C ' ' CD2' ' A' ' 32' ' ' TRP . 4.8 m-20 -133.09 167.84 19.58 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 110.165 -0.309 . . . . 50.0 110.165 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.662 ' O ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -138.67 133.02 31.79 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.869 0.692 . . . . 16.66 112.869 -177.037 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.646 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -140.83 145.13 35.86 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.97 -0.559 . . . . 50.0 111.283 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.931 ' HD1' ' CB ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -55.89 150.03 13.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 106.368 -1.715 . . . . 16.66 106.368 176.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.545 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -54.08 -61.56 7.03 Favored Glycine 0 C--N 1.311 -0.815 0 C-N-CA 119.468 -1.348 . . . . 16.66 112.747 -177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HD3' ' HZ1' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.57 -20.69 62.76 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.346 -0.541 . . . . 50.0 110.462 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 1.177 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 13.9 t -54.14 -29.24 44.45 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.488 -0.885 . . . . 16.66 108.941 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -112.61 11.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 16.66 110.34 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 36' ' ' ARG . . . 74.06 46.96 20.15 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.862 -0.608 . . . . 16.66 111.774 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -116.64 167.58 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 16.66 111.546 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 41' ' ' LEU . 7.4 mp -64.68 161.6 17.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.248 -0.887 . . . . 50.0 110.152 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' CG ' ' N ' ' A' ' 43' ' ' SER . 8.4 pt20 -82.12 -41.16 20.84 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.779 ' C ' HD21 ' A' ' 47' ' ' LEU . 69.6 m -60.88 -39.04 87.74 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 112.336 -2.211 . . . . 50.0 109.266 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.809 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -41.39 -17.32 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.935 -0.575 . . . . 50.0 110.037 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -76.4 -46.17 28.42 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.074 -0.512 . . . . 25.0 110.806 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' SER . 78.0 mm-40 -88.95 -51.23 5.73 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.069 1.507 . . . . 50.0 115.069 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.09 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.18 20.32 0.39 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.563 0.697 . . . . 16.66 111.761 -177.07 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.809 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 1.2 tp -111.43 139.04 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 25.0 111.915 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -116.19 -58.68 2.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.405 -1.27 . . . . 50.0 111.822 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 2.3 pm0 -118.83 59.48 0.82 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.166 -0.679 . . . . 50.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.0 t80 -66.37 142.07 57.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.175 -0.61 . . . . 16.66 109.368 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.742 HG22 ' CG ' ' A' ' 27' ' ' ASP . 6.7 t -117.33 152.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.543 -0.753 . . . . 50.0 109.716 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.394 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 6.4 p -83.99 157.85 62.54 Favored Pre-proline 0 N--CA 1.41 -2.45 0 CA-C-N 114.936 -1.029 . . . . 16.66 110.35 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -79.19 -25.69 5.69 Favored 'Trans proline' 0 C--N 1.278 -3.183 0 C-N-CA 121.92 1.746 . . . . 16.66 110.477 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -71.96 -33.49 68.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.945 -1.025 . . . . 50.0 108.936 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.168 ' SG ' ' CB ' ' A' ' 29' ' ' CYS . 0.4 OUTLIER -69.08 -38.76 79.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.329 -0.85 . . . . 16.66 110.743 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -52.06 -36.51 50.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.633 -0.506 . . . . 50.0 109.633 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.2 p -75.24 -34.38 61.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 61' ' ' ASP . 26.0 m -72.88 -49.04 32.26 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HA ' HH11 ' A' ' 28' ' ' ARG . 85.6 mt-10 60.52 -5.47 0.1 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.407 -0.36 . . . . 50.0 111.039 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 59' ' ' THR . 85.6 m-20 56.08 46.62 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 50.0 110.672 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.027 -0.987 . . . . 50.0 110.569 179.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.77 -25.34 78.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.913 2.408 . . . . 0.0 112.305 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.8 mt 44.37 85.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.403 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.55 103.02 0.75 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.007 -0.837 . . . . 50.0 111.007 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.3 m -130.66 153.59 48.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 50.0 110.525 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.1 146.16 39.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.361 . . . . 50.0 110.097 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 4.6 m -81.68 109.7 16.34 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.799 -0.361 . . . . 50.0 110.932 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.601 ' O ' ' CE1' ' A' ' 10' ' ' TYR . 8.7 mtpt -149.98 -177.07 5.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 50.0 109.894 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.72 139.38 51.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.726 -0.39 . . . . 50.0 110.025 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 8' ' ' LYS . 4.9 m-85 -103.03 -69.96 0.78 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.849 -0.34 . . . . 25.0 110.106 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 35.7 t -41.6 130.61 3.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 16.66 110.719 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.679 HG22 HE21 ' A' ' 55' ' ' GLN . 12.9 pt -57.74 -7.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.269 -1.011 . . . . 50.0 108.269 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.943 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -79.74 -5.85 56.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.899 -1.501 . . . . 16.66 110.897 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 22.1 mtmm 72.18 52.8 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.186 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.68 139.33 23.97 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 109.906 -0.405 . . . . 50.0 109.906 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.66 153.96 74.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.453 2.102 . . . . 50.0 112.331 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 23' ' ' TYR . 21.6 t80 -63.05 140.29 58.86 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.13 0.491 . . . . 50.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 21' ' ' LYS . 82.1 m-20 -141.8 119.86 12.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.487 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.81 -22.34 9.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.95 -0.389 . . . . 50.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 m -68.79 -34.11 74.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.528 -1.286 . . . . 50.0 107.528 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' CD ' ' CD2' ' A' ' 34' ' ' HIS . 4.6 ttmt -93.33 139.3 30.82 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.304 -1.771 . . . . 50.0 107.584 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 45.1 p90 -105.13 143.01 33.9 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.134 -0.627 . . . . 16.66 110.173 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 8.3 m-85 -122.13 173.19 7.73 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 123.941 1.829 . . . . 50.0 114.78 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.029 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -127.69 179.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 109.685 -3.416 . . . . 16.66 104.018 176.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 31' ' ' ASN . . . -141.06 124.14 2.48 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 117.658 -2.211 . . . . 16.66 114.36 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 1.447 ' SG ' ' CB ' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -48.04 110.65 0.35 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.052 -1.074 . . . . 16.66 108.739 177.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.696 ' HB2' HG22 ' A' ' 52' ' ' VAL . 57.2 t0 -46.57 -41.95 15.22 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.081 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.566 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.39 -13.81 11.0 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 112.407 0.521 . . . . 50.0 112.407 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 1.347 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -88.49 0.17 56.58 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 118.937 -1.105 . . . . 16.66 111.272 -178.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.476 HE21 ' C ' ' A' ' 28' ' ' ARG . 8.9 mm-40 40.85 45.98 2.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.551 -0.295 . . . . 16.66 110.347 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.581 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -132.31 166.28 22.27 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.755 -0.378 . . . . 50.0 110.604 -177.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -140.82 127.77 20.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.56 -0.456 . . . . 16.66 111.428 -178.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.74 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -127.67 156.43 42.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.94 -0.573 . . . . 50.0 110.866 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.532 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -61.46 141.0 57.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.154 -1.795 . . . . 16.66 106.154 176.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.593 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -43.4 -48.48 6.96 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 119.42 -1.371 . . . . 16.66 111.261 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' CD ' ' H ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -75.06 -19.76 59.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.349 -0.54 . . . . 50.0 110.037 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.92 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -51.6 -30.71 22.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.562 -0.855 . . . . 16.66 109.241 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.43 8.59 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.487 -0.779 . . . . 16.66 111.427 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.57 45.86 7.68 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.124 -0.56 . . . . 16.66 112.204 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.593 HG22 ' CA ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -123.15 167.34 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.222 0.534 . . . . 16.66 111.608 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 40' ' ' ILE . 4.0 mm? -67.02 164.58 17.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.481 -0.781 . . . . 50.0 110.46 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.708 ' HG2' ' H ' ' A' ' 43' ' ' SER . 5.8 pt20 -80.55 -54.26 5.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 25.0 110.902 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.708 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 49.5 m -60.35 -28.26 68.03 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.063 -1.088 . . . . 50.0 108.063 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.958 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -43.67 -17.03 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.305 -1.316 . . . . 50.0 109.928 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 43' ' ' SER . . . -70.27 -48.16 58.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.98 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.734 ' C ' ' H ' ' A' ' 48' ' ' ILE . 84.8 tt0 -87.66 -52.91 5.06 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.096 0.776 . . . . 50.0 113.096 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.886 HD11 ' HA ' ' A' ' 44' ' ' GLU . 4.1 pp -57.78 5.6 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.385 0.612 . . . . 16.66 110.516 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.958 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -105.15 133.02 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.714 -177.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -87.7 -74.38 0.45 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.995 -1.002 . . . . 50.0 111.522 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' OE2' ' OD2' ' A' ' 27' ' ' ASP . 80.7 tt0 -122.08 74.0 1.13 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.73 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -66.09 146.6 54.47 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.774 -0.648 . . . . 16.66 109.324 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' CZ ' ' A' ' 51' ' ' TYR . 43.7 t -117.09 159.24 17.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.805 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 1.447 ' CB ' ' SG ' ' A' ' 26' ' ' CYS . 4.5 p -87.5 161.11 46.38 Favored Pre-proline 0 N--CA 1.415 -2.177 0 CA-C-O 121.425 0.631 . . . . 16.66 110.22 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 53' ' ' CYS . 34.6 Cg_endo -80.33 -32.55 1.27 Allowed 'Trans proline' 0 C--N 1.28 -3.059 0 C-N-CA 121.862 1.708 . . . . 16.66 111.741 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.679 HE21 HG22 ' A' ' 12' ' ' ILE . 53.5 mt-30 -72.96 -28.81 62.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 1.104 ' CB ' ' SG ' ' A' ' 53' ' ' CYS . 61.4 m -57.59 -42.83 83.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.121 -1.4 . . . . 16.66 111.0 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -56.16 -34.33 66.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.813 -0.63 . . . . 50.0 110.196 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.569 ' O ' ' CB ' ' A' ' 59' ' ' THR . 52.4 p -79.66 -1.21 37.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.303 -0.628 . . . . 50.0 109.303 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.569 ' CB ' ' O ' ' A' ' 58' ' ' SER . 2.7 m 97.46 80.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.205 -0.907 . . . . 50.0 110.356 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 44.81 -87.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.286 -0.416 . . . . 50.0 110.664 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 59' ' ' THR . 60.1 t0 -132.89 131.13 40.57 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.277 -0.42 . . . . 50.0 110.432 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.984 -1.008 . . . . 50.0 110.596 -179.995 . . . . . . . . 0 0 . 1 stop_ save_